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Abstract 
Fish meals (FM) and fish oils (FO) are used extensively as the main protein and lipid sources 
respectively in industrially compounded salmon feeds, mainly due to their excellent 
nutritional properties. Nevertheless, several reasons dictate the utilisation of sustainable 
alternative protein and lipid sources and the subsequent reduction in the reliance on fishery-
products in aquafeeds. Soy protein concentrate (SPC) is a very promising alternative to FM 
Hence, the main objective of the present thesis was to investigate the effects of the increased 
substitution of FM withSPC, lysine and methionine on the growth performance and immune 
responses of early and late stage Atlantic salmon parr prior to and after vaccination with 
commercial vaccines (Experiments II and V presented in Chapters 4 and 6). Furthermore the 
effects of increasing dietary levels of SPC with consistent and/or increasing dietary 
supplementation of phosphorus on the Atlantic salmon parr’ body proximate and mineral 
composition or the skeletal mineral composition respectively, prior and post-vaccination 
with commercial vaccines; under continuous light or under 12 hours light: 12 hours dark 
photoperiod (Experiments I and V presented in Chapters 3 and 5 respectively). Lastly the 
impact of FM-, FO- and fishery-free diets on the growth, carcass proximate composition and 
immune status of Atlantic salmon post-smolts was investigated (Experiment III presented in 
Chapter 7). In the latter experiment six diets were tested including: two  commercially 
applied marine based  diets, one with partial inclusion of vegetable proteins (VPs) and oils 
(VOs) according to the EU standards (2011-12) (MBE) and one with partial inclusion of 
VPs, VOs and land animal-by product (ABP) proteins according to the non-EU standards 
(MBABP); a fully vegetable protein (VP) diet; a fully algal and vegetable oil (VO) diet; a 
marine-free VP and VO and algal oil diet (VP/VO) diet; and a marine-free diet with a mix 
of VPs and land ABP proteins and lipid from VOs and algal oils (MFABP).  
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The results of the Experiments I and II (Chapters 3 and 4) show that late Atlantic 
salmon parr can grow efficiently on SPC80 diets, however, they require longer periods to 
adapt to these diets compared to fish fed diets containing lower levels of SPC as a protein 
source. Decreased mineralisation of body cross-section was observed for salmon fed 
increasing dietary SPC. Vaccination improved mineralisation for the high dietary SPC 
salmon groups.  However, continuous light exposure promoting fast growth appeared to be 
detrimental for Atlantic salmon body cross ash, Ca, Mg, Mn, P and Zn. Moreover, it was 
demonstrated that substitution of up to 50% of high quality FM protein with SPC and 
constantly added P has the minimum possible impact on late salmon parr growth, whereas it 
stimulates several immune parameters prior to immunisation. Immunostimulatory effects 
were also shown for the diets with higher dietary SPC levels. It is not clear if these results 
were an effect of increased FM replacement with SPC or not properly balanced levels of 
dietary P. The Experiments III and IV (Chapters 5 and 6) illustrated that early stage Atlantic 
salmon parr can accept diets with up to 58% protein from SPC without serious effects on 
body growth. However, higher levels can severely affect salmon growth performance. 
Moreover, it was shown that long-term feeding of salmon with increasing dietary SPC 
combined with increasing phosphate supplementation, alone or in combination with 
vaccination can actually be beneficial for Atlantic salmon parr bone mineralisation. 
However, mineralisation in vaccinated fish was higher than in PBS-injected fish. This could 
be linked to the slower growth of vaccinated salmon allowing their developing bones to 
mineralise properly. Changes in the modulation of the different components of the 
complement activity was revealed in Atlantic salmon fed increasing dietary levels of SPC. 
The modulation of complement activity was demonstrated at both studies utilising increasing 
dietary SPC concentrations, indicating that complement componenets are among the most 
prominent immunological markers upon dietary FM replacement with SPC. However, 
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overall no differences in total complement activity and therefore the immune capacity and 
resistance against Aeromonas salmonicida were observed among the salmon groups 
receiving increasing levels of SPC.  
Lastly in Experiment V (Chapter 7) higher growth performance indices (weight gain, 
SGR and TGC) were evident in the MBE salmon compared to the MBABP group, salmon 
fed diets with complete eleimintion of FM or FO (VP and VO respectively) and fish fed two 
diets with total substitution of both marine derived feed ingredients, three months after the 
start of the feeding trial. Higher feed intake was demonstrated for both MBE and VP salmon 
compared to the other groups for the duration of the first period. The above results could 
have been influenced by discrepancies in the size of the fish at the start ofthe trial, revealing 
flaws in the experimental design. Both MBE and VP salmon groups also presented the 
highest feed conversion ratios, revealing the lowest efficiency in dietary nutrient utilisation 
in comparison to the rest of salmon which exhibited no differences in feed efficiency, 
revealing an overall better performance of the MBABP and diets with low levels of marine 
feedstuffs. Improved FI compared to the values of the first period and higher SGR and TGC 
values were demonstrated for salmon from the latter treatments compared to MBE and VP 
salmon, during the second part of the study, revealing compensatory growth for these groups. 
VP salmon demonstrated the highest and VO salmon the lowest condition factor values. The 
former finding might possibly be related with higher fat accumulation in the viscero-hepatic 
tissues. No differences were observed in carcass moisture, protein, fat and ash concentrations 
among the dietary groups of fish. Furthermore, no differences were demonstrated in terms 
of total and differential leucocyte counts, plasma haemolytic activity, plasma protein and 
total IgM levels, stimulated and non-stimulated HKM burst activity among the different 
dietary groups. However, lower haematocrit values were observed in the MB and VO-fed 
groups  compared  to the  MFABP  and  VP/VO  groups.  Furthermore, decreased  lysozyme  
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activity was observed for all diets in contrast to the control groups, whereas FM-free diets 
promoted plasma anti-protease activity. The former result could have been an effect of either 
immune or stress induction, whereas the second is regarded as an immunostimulatory effect. 
The results suggest that marine-oil,  marine-protein and marine-free diets could be 
satisfactorily used for Atlantic salmon post-smolts without severe reductions in their innate 
immune responses, although longer adaptation periods might be required for the fish to fully 
accept these diets. 
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Abbreviations and acronyms 
AA amino acid(s) 
ABP animal by-products 
AC (P) alternative complement (pathway) 
ANF antinutritional factors 
BAPNA N-a-benzoyl-DL-arginine-p-nitroanilide 
BSA bovine serum albumin 
Ca calcium 
CC (P) classical complement (pathway) 
cfu colony forming units 
CO canola oil 
CP crude protein 
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DHA docosahexaenoic acid (22:6n-3) 
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DMSO dimethyl sulfoxide 
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dpPBSinj days post PBS injection 
dpi days post injection or days post PBS injection 
dpv days post vaccination 
EDTA ethylene diamino tetra-acetic acid 
EGTA ethylene glycol tetra-acetic acid 
ELISA enzyme linked immunosorbent assay 
EPA eicosapentaenoic acid (20:5n-3) 
FA fatty acid(s) 
FCR feed conversion ratio 
Fe Iron 
FF fishery free  
FI feed intake 
FM fish meal 
FO fish oil 
FTU phytase units 
G-CFB gelatine-complement fixation buffer 
hct haematocrit 
HKM head kidney macrophages 
HPFM hydrolysed poultry feather meal  
HSWB high salt wash buffer 
HUFA Highly Unsaturated Fatty Acid(s) 
IAA indispensable amino acids 
ICP/MS Inductively Coupled Plasma/Mass-Spectrometry 
i.m. intramuscular 
i.p. intraperitoneal 
IPNV infectious pancreatic necrosis virus 
IU International Units 
K condition factor 
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LC-PUFA long chain polyunsaturated fatty acids 
LRT likelihood ratio test 
LSWB low salt wash buffer 
MAb monoclonal antibodies 
MBE marine based diet according to European standards 2011-12 (inclusion of vegetable proteins 
and vegetable oils) 
MBABP marined based diet with inclusion of animal by-products according to non-EU standards 
2011-12 (combined inclusion of vegetable and animal by-product proteins and vegetable oils) 
Mg magnesium 
Mn manganese 
n-3 omega-3 polyunsaturated fatty acids 
n-6 omega-6 polyunsaturated fatty acids 
NBT nitroblue tetrazolium 
NSP non-starch polysaccharides 
NQC Norwegian quality cuts 
O.D. optical density 
P phosphorus 
PBS phosphate buffered saline 
PMA phorbol myristate acetate 
PUFA poly-unsaturated fatty acid(s) 
RO rapeseed oil 
rpm revolution per minute 
SBM soy bean meal 
SCO single cell oils 
SGR specific growth rate 
SPB sodium phosphate buffer 
SPC soy protein concentrate 
SPC35 diet with 35% of total dietary protein derived from SPC  
SPC50 diet with 50% of total dietary protein derived from SPC 
SPC58 diet with 58% of total dietary protein derived from SPC  
SPC65 diet with 65% of total dietary protein derived from SPC 
SPC80 diet with 80% of total dietary protein derived from SPC 
SRBC sheep red blood cells 
TC total complement 
TGC thermal growth coefficient 
TSA tryptic soy agar 
TSB tryptic soy broth 
TSE transmissible spongiform encephalopathies 
V vanadium 
VO vegetable oil(s) 
VP vegetable protein(s) 
VP/VO diet fully vegetal diet 
WG weight gain 
Zn zinc 
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1.1 OVERVIEW OF WORLDWIDE AQUACULTURE WITH A FOCUS ON FARMED 
ATLANTIC SALMON PRODUCTION 
1.1.1 Atlantic salmon culture 
Salmonids, along with cyprinids, are the two most important groups of fish farmed in 
aquaculture (FAO, 2012), with Atlantic salmon, (Salmo salar, Linnaeus, 1758) representing 
the most important farmed salmonid (FAO, 2012). Farmed Atlantic salmon are hatched from 
eggs and raised in inland freshwater facilities to the smolt stage before being transferred for 
on-growing to floating sea cages or net pens, anchored in sheltered bays or fjords (FAO, 
2004). The on-growing phase can be up to 16-18 months until salmon reach the desired 
marketable size, which usually varies between 2 to 6 kg (FAO, 2004). The production of 
farmed Atlantic salmon has presented an approximate 53-fold increase (from 39.000 tonnes 
to 2.067.000 tonnes) during the past 3 decades (Fig. 1 from FAO, 2014). The main points 
contributing to the large success of the Atlantic salmon aquaculture industry are: the 
carnivorous characteristics of the specie, the fact that it grows well under culture conditions, 
it has a relatively high commercial value, it adapts well to farming conditions outside its 
native environment and most importantly the early onset of selective breeding programs 
which led to the production of genetically improved salmon growing faster than wild salmon 
strains while requiring less feed (Thodesen et al., 1999; FAO, 2004). 
 
Figure 1 Total aquaculture production for Atlantic salmon from 1984 to 2012 (FAO, 2014).
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1.1.2 Current and future status of salmonid aquaculture 
Global farmed finfish production levels are still modest compared to worldwide poultry and 
swine production (Brugère and Ridler, 2004; FAO, 2012). However the aquaculture industry 
is the most rapidly growing sector of animal production globally, expanding at an average 
annual rate of more than 8 percent, from 5.2 million tonnes in 1981 to 62.7 million tonnes 
in 2011 over the past three decades (FAO, 2012). In contrast capture fisheries production 
has remained fairly stable for the past decade (FAO, 2012) (Fig.2). Moreover, as the global 
demand for aquatic products increases, it is believed that the production of farmed aquatic 
species will continue to rise over future decades (FAO, 2012). In 2012 world food fish 
(finfish, crustaceans, molluscs and other aquatic animals) aquaculture production was 
estimated at 66.6 million tonnes and almost 42.2 % of total food fish production (aquaculture 
and fisheries), while in 2013 FAO estimated that worldwide farmed food fish production 
rose by 5.8 % to 70.5 million tonnes (FAO, 2012). World farmed food fish production 
presented an average annual rate of expansion of 6.2% between 2000-2012, which was 
slower than in the periods 1980-1990 (10.8%) and 1990-2000 (9.5%) (FAO, 2012). 
Nonetheless, between 1980 and 2012, worldwide cultured food fish production volume 
increased at an average rate of 8.6% per annum. World aquaculture production more than 
doubled from 32.4 million tonnes in 2000 to 66.6 million tonnes in 2012 (FAO, 2012). By 
2030 global aquaculture is expected to grow to approximately 93.6  million tonnes (World 
Bank, 2013) (representing a 24% increase compared to 2013 and an annual growth of 1.4%), 
supplying a bit more than half of global demand for aquatic products. While aquaculture 
expansion for the majority of countries within the European Union is predicted to be similar 
to that of worldwide aquaculture growth between 2000 and 2030, Norwegian aquaculture 
production (based mainly on marine cage aquaculture of Atlantic salmon) is estimated to 
increase by as much as 4% per annum until 2030 (World Bank, 2013). An overview of the 
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evolution of global fish production from 1984 until 2009 and followed the projections until 
2030, underlining the increasingly significant role of farmed fish production in total fish 
production are presented in Fig. 2. Farmed Atlantic salmon’s production, like other farmed 
salmonids, is expected to rise significantly over forthcoming decades (Brugère and Ridler, 
2004; FAO, 2012).  
 
Figure 2 Evolution of global fish production from 1984-2009 (FAO, 2012). 
1.2 NUTRITIONAL REQUIREMENTS OF ATLANTIC SALMON AND THE USE OF 
FISH PRODUCTS IN SALMON DIETS 
1.2.1 Atlantic salmon nutritional requirements 
Atlantic salmon, like most living organisms, have a requirement for a well-balanced mixture 
of indispensable (IAA) and dispensable amino acids (DAAs) (Wilson, 2002), lipids, 
essential and non-essential fatty acids (FAs), vitamins and essential elements for normal 
development and survival. Indispensable AAs (IAAs) required by Atlantic salmon include 
arginine (arg), histidine (his), isoleucine (ile), leucine (leu), lysine (lys), methionine (met), 
phenylalanine (phe), threonine (thr), tryptophan (trp) and valine (val) (reviewed by Brown 
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et al., 1997). AAs are essential for body growth as well as precursors for the synthesis of 
many bioactive proteins including enzymes, hormones, neurotransmitters and immune 
factors (D’Mello, 2003). Dietary lipids help to fulfil energy requirements in the form of 
essential (EFA) (i.e. linoleic acid and α-linolenic acid) and non-essential fatty acids (NEFA), 
while assisting the absorption of fat-soluble vitamins in the digestive tract (NRC, 1993). 
Moreover, FAs are involved in maintaining membrane integrity and serve as precursors for 
hormone-like compounds, the eicosanoids, which help to regulate inflammatory and immune 
processes (Bell et al., 1986; de Pablo et al., 2000). Lastly, chemical elements are required 
for the formation of the skeletal structure, the maintenance of homeostasis and regulation of 
the acid - base equilibrium, while they can act as salient components for the normal function 
of various hormones, enzymes and enzyme activators (Lall, 2003).  
1.2.2 FM and FO production and nutritional value 
Fishmeal (FM) is a nutrient-rich powder obtained after cooking, pressing, drying and 
grinding whole fish and fish by-products, while fish oil (FO) is normally the liquid extracted 
from squeezed cooked fish. FM and FO are primarily used as dietary ingredients for 
domestic animals (poultry, pigs, cattle, etc) and farmed aquatic species (Hertrampf and 
Piedad-Pascual, 2000; IFFO, 2010). They are generally manufactured from wild, short-lived, 
fast-growing, pelagic marine fish (forage fish) for which there is little or no demand for 
human consumption. The main fish species used for the production of FM and FO include 
anchovies, blue whiting, herrings, mackerels, capelin, pilchard, menhaden, sardines and sand 
eel (Hertrampf and Piedad-Pascual, 2000; Tacon et al., 2004; IFFO, 2010; FIN, 2010; 2012). 
The International Fishmeal and Fish Oil Organisation has estimated that in 2008, almost 75 
% of all FM production was derived from forage fish, while the remaining 25% (1.23 million 
tonnes) came from by-products like fish trimmings from the seafood processing industry, 
with an estimated 6 million tonnes of food fish waste used for FM and FO production during 
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2009 (FAO, 2012). This amount is expected to grow as the processing of waste from farmed 
piscine species steadily increases (FAO, 2012). 
FM is grouped into four product categories: “High quality” which is largely used by 
small scale aquaculture units for carnivorous marine or freshwater (FW) fish, “low 
temperature” (LT), which is characterised by its high digestibility, and is usually utilised as 
a feedstuff in industrially compounded salmon feeds and piglet production and “Prime” and 
“Fair Average Quality (FAQ)” which have much lower protein content, used as food 
additives pig and poultry feeds (IFFO, 2010; FIN, 2010; 2012). FM is recognized by 
nutritionists as a high-quality, very digestible feed ingredient used as an excellent source of 
protein and essential amino acids (EAA), EFA, minerals and vitamins (FAO, 1986; NRC, 
1993). However, FM derived from different fish species can vary significantly in terms of 
chemical composition (Hertrampf and Piedad-Pascual, 2000). For instance, the protein 
content ranges from less than 60% to more than 70% in different types of FM, while the fat 
varies from 5% to 10%  (NRC, 1993). On the other hand, FOs are an almost unique source 
of EFA and especially docosahexaenoic (DHA) and eicosapentaenoic acid (EPA), which 
constitute about 10% to 25% of total FAs. Moreover, FOs are very good energy sources due 
to their high content of hexadecanoic acid and monoenes such as octadecenoic acid, and in 
the case of Northern hemisphere FO, eicosenoic and docosenoic acid (NRC, 1993). FM and 
FO have always been a major protein and energy sources in aqua-feeds used for the feeding 
of carnivorous species (Sargent and Tacon, 1999). 
1.2.3 Current and future production, consumption and demand 
The quantities of landed pelagic fish and shellfish from capture fisheries destined for use as 
FM and FO for animal-feeds and other non-food purposes increased from 20.6 million 
tonnes in 1976 to 34.2 million tonnes in 1994 (a proportionate increase from 31.5 to 37.1 
percent of total catch  (FAO, 2012). Since 1995, these quantities have been decreasing both 
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in absolute terms and as a proportion of total catch (FAO, 2012). In 1995, 31.3 million tonnes 
of global capture fisheries landings were destined for non-food uses (33.9 percent of the total 
catch), however only 27.2 million tonnes (29.5 percent of total catch) were reduced into FM 
and FO. In 2009 total capture fisheries landings destined for FM and FO production were 
22.8 million tonnes, which was equivalent to 25.7 percent of the total caught. Out of this 
17.9 million tonnes (20.2 percent of total catch) were reduced into FM and FO (FAO, 2012).  
Tacon, (2004), summarizing the global exploitation status of about 80% of total wild 
capture fisheries landings, stated that most of wild caught fish are either totally exploited, 
over-exploited or in a recovery state, after being over-exploited. Moreover, fully exploited 
fishes cannot be expanded further as they are already at, or very close to, their maximum 
sustainable harvest limits (Tacon, 2004), and hence, there is no space for further expansion 
of capture fisheries production. For several decades the proportion of the industrial fisheries 
catch (whole fish) fluctuated between 20 and 30 million tonnes. This means that the 
resources of wild feed grade fisheries have remained static or demonstrated a slight decline 
for the past two decades affecting FM and FO production, which reached approximately 5.5 
and 1.2 million tonnes respectively in 2008 (Tacon and Metian, 2008). In 2009, 
aquaculture’s share for FM and FO was estimated at 68 and 88% respectively with salmonid 
aqua-feeds consuming 13.7 and 16.9% of globally produced FM and FO respectively (FAO, 
2012) (Fig. 3 and 4 respectively).  
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Figure 3 Global consumption of FM (percentage of total usage in compounded aqua feeds) by major 
aquaculture species groups in 2008 (FAO, 2012). 
 
Figure 4 Global consumption of FO (percentage of total usage in compounded aqua feeds) by major  
aquaculture species groups in 2008 (FAO, 2012). 
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1.3 ATLANTIC SALMON FEEDS 
1.3.1 Increasing substitution of FM and FO in salmon diets 
On-growing Atlantic salmon are fed with pelleted, extruded diets of varying sizes depending 
on fish size (Helland et al., 1991; NRC, 1993; Lovell, 2002). Atlantic salmon feeds contain 
high amounts of protein, lipid and energy (Helland et al., 1991; Lovell, 2002). However, the 
trend over the last 20 years has been to increase the dietary lipid level at the expense mainly 
of protein but also of carbohydrates (Einen and Roem, 1997; Hillestad et al., 1998; Lovell, 
2002; FAO, 2004; Solberg, 2004). Given the estimated significant growth of aquaculture 
during the following years and the steady production of forage fisheries, reliance of 
aquaculture on marine resources could severely impair the viability, growth and profitability 
of the sector (FAO, 2012). Therefore, in the last decade, cheaper, alternative ingredients to 
FM and FO available from other sources have been included in salmon feeds (Tacon and 
Metian, 2008; Crampton et al., 2010; Hatlen et al., 2013; Hatlen et al., 2014; Hartviken et 
al., 2014; Liland et al., 2014). The most commonly applied feedstuffs are mainly derived 
from grains and oilseeds and material recovered from livestock and poultry processing 
(rendered or slaughter by-products). Moreover, single cell (microbial) proteins and oils, and 
marine products from lower trophic levels (plankton and algae) have been successfully 
applied in salmon feeds, however their high production costs still limit their wider use in the 
aquafeed sector (Olsen et al., 2004). Today, FM inclusion levels in Atlantic salmon aqua-
feeds span from 15% to 55% while FO levels range from 3% to 40%. These variations 
largely depend on the country they are manufactured and they partly reflect differences in 
the production systems employed as well as differences among farmed salmon breeds 
(DeSilva et al., 2012). 
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1.3.2 Alternatives to FM and FO 
The utilisation of plant based feedstuffs as sustainable alternatives to marine meals in aqua-
feeds has a great potential. The main advantages of plant proteins and oils are that they have 
high global availability at competitive prices compared to FM and FO, and their nutritional 
properties can satisfy the nutritional requirements of the fish (NRC, 1993). However, the use 
of plant based proteins in aqua-feeds requires that these feedstuffs possess certain nutritional 
properties, including low levels of non-starch polysaccharides (NSPs) and anti-nutritional 
factors (ANFs), relatively high protein content, a favourable AA profile, high nutrient 
digestibility and reasonable acceptability by fish (Naylor et al., 2009; Hardy, 2010). Quite 
often methionine and lysine, two indispensable amino acids (IAAs) found at low levels in 
several plant proteins, have to be supplemented in the form of crystalline AAs (Mambrini et 
al., 1999; Espe et al., 2007). Some plant-derived feedstuffs including oilseed meals and oils, 
plant protein concentrates and cereal by-product meals and oils have most of these desirable 
traits (FAO, 2012). Nowadays, the sharp increases in the prices of FM and FO, driven by the 
competition between livestock farming, aquaculture and various other food and medical 
sectors, have made the use of these refined ingredients more economical. 
Animal by-products (ABPs) already play an important role as an ingredient in 
aquaculture feed pellets. Most of them have a reasonably balanced AA profiles. However, 
IAAs including methionine and lysine, which are usually limited in several animal by-
products, should be supplemented as described previously (Kureshy et al., 2000). Regarding 
by-products from fish processing plants, there are some issues related to potential pathogens 
and contaminants that could be harmful to both fish and consumers, which need to be 
addressed through improved treatment of these ingredients prior to their incorporation into 
aquafeeds (Kureshy et al., 2000). An example of the importance of animal by-products as a 
feedstuff in fish feeds is given by fish producer Marine Harvest, who used pellets containing 
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12% poultry by-products and only 19% FM at their Chilean salmon farms in 2008 (Marine 
Harvest, 2010). The use of ABPs, in the European Union (EU), was until recently limited by 
legal restrictions with some exceptions as a means to prevent the inclusion of transmissible 
spongiform encephalopathies (TSE) (EU, 2003, 2001), however these restrictions have 
changed for aqua-feeds in Europe (EU, 2012). To date, many studies have evaluated the 
potential use of some of these terrestrial animal meals in the diets of several salmonids 
(Higgs et al., 1979; Steffens, 1994; Twibell et al., 2012; Hatlen et al., 2013; Hatlen et al., 
2014; Hartviksen et al., 2014).  
The potential use of zooplanktonic crustaceans as substitutes for FM and/or FO has 
been the focus of several studies ( Storebakken, 1988; Olsen et al., 2006; Suontama et al., 
2006), with the aims of mapping the sustainable harvesting potential (Aksnes and Blindheim, 
1996; Melle et al., 2004; Skjoldal et al., 2004), the development of efficient harvesting 
techniques (Nicol and Foster, 2003) and industrial processes, and evaluating the nutritional 
properties of raw materials with respect to fish feed (Storebakken, 1988; Moran et al., 2006; 
Olsen et al., 2006;  Suontama et al., 2006). The crustaceans of interest include copepods, 
euphausiids, krill and amphipods, grazing on phytoplankton (Suontama et al., 2006). 
However, this research is still at an early stage, but if it should prove commercially viable it 
could be a major catalyst for further aquaculture growth. 
Another research area that recently has received a great deal of attention is the 
prospects of substituting FM with unicellular organisms such as yeast, moulds, bacteria, 
microalgae and fungi as additives to aquaculture feeds. Research in this field has 
demonstrated that partial replacement of marine-based feedstuffs with yeast and bacterial 
products does not have any negative impacts on fish survival, growth, or disease resistance 
(Murray and Marchant, 1986; Storebakken et al., 1998a; Romarheim et al., 2011). Similarly, 
FO could be replaced by single cell oils (SCO), extracted from microbial organisms grown 
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under heterotrophic conditions or even whole cell organisms (Carter et al., 2003; Miller et 
al., 2007). Nowadays the major advantage in the use of unicellular organisms is that there 
are several processes designed to produce industrial quantities under controlled and 
environmentally safe conditions. Moreover, the chemical composition of many 
microorganisms can be manipulated for the achievement of higher protein and lipid levels, 
through their enrichment with specific IAAs or FAs ( Kangas et al., 1982; Sanchez et al., 
1995; Day and Tsavalos, 1996). Although various studies have reported the incorporation of 
microalgae oils and meals in aquafeeds (Day et al., 1990; Zhou et al., 1991; Laing and 
Millican, 1992; Day and Tsavalos, 1996; Langden and Onal, 1999; Carter et al., 2003; Miller 
et al., 2007), this approach cannot be applied commercially for the replacement of marine-
based feedstuffs, mostly due to their high production costs and culture inefficiency 
(Borowitzka, 1991; Chaumont, 1993; Wilkinson, 1998). As the technology continues to 
develop, higher oil yields and greater densities of cells in the fermentation broth will 
continue to drive the costs down to the point where perhaps these oils can compete with the 
less expensive marine oils. And if the price of FO continues to rise, it would stimulate further 
research to develop these alternative sources at a competitive price (Bimbo, 2007). 
1.3.3 Challenges and limitations in the use of vegetal proteins and oils in aqua-feeds 
Relative to FM, plant protein ingredients generally contain more indigestible organic matter, 
in the form of insoluble carbohydrates and fibre, leading to higher levels of fish excretion 
and waste. Moreover, certain elements in plant products, such as phosphorus (Lall, 2003), 
have limited uptake in fish. However, recent advances in fish nutrition, feeding, and dietary 
manipulation have significantly reduced the production of fish waste and increased 
substantially nutrient uptake and growth efficiency of cultured aquatic species (Hardy and 
Gatlin, 2002). Further advances in this area continue to be made through classic breeding, 
transgenic manipulation, exogenous enzyme treatment (e.g. phytase in salmonid feed)  
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(Forster et al., 1999), and post-harvest processing technologies that enhance the quality of 
plant protein concentrates (Barrows et al., 2008). Even without improved genetic lines and 
post-harvest processing of plant protein ingredients, numerous dietary manipulations have 
proven beneficial in increasing the utilisation of these feedstuffs in aquaculture diets. Some 
of these techniques include the blending of complementary ingredients for the achievement 
of amino acid profiles that better meet the metabolic requirements of the targeted species, or 
in some cases, supplementing commercially available forms of the most limiting AAs and 
elements such as synthetic methionine analogues (Forster and Dominy, 2006), various 
sulphur AA compounds (for methionine), or lysine (Gatlin et al., 2007) inorganic phosphates 
and other minerals (Lall, 2003).  
FO substitution with vegetal oils (VOs) should be able to provide sufficient energy in 
the form of the preferred FAs. Saturated and monounsaturated FAs are preferred over 
PUFAs for energy generation in fish as suggested by previous studies investigating 
mitochondrial β oxidation (Henderson, 1996). Moreover, another negative impact of FO 
substitution with VOs is the lack of long-chain n-3 fatty acids, including EPA, 
docosapentaenoic acid and DHA, which represent up to 30% of total lipids and they are 
considered to be essential for optimal growth, development and for an efficient immune 
response in Atlantic salmon (Sargent et al., 2002). On the other hand VOs contain high levels 
of C18 PUFAs, which are found in moderate levels within FO (NRC, 1993; Hertrampf and 
Piedad-Pascual, 2000; Gatlin et al., 2007). 
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1.3.4 Vegetal oils and vegetal proteins in Atlantic salmon diets 
Previous studies reported that total (Mambrini et al., 1999; de Francesco et al., 2004; Espe 
et al., 2006) or partial substitution of FM (Gomes, 1995; Kaushik et al., 2004) with vegetal 
proteins in salmonid diets can adversely affect feed intake and weight gain. Further, Adelizi 
et al. (1998) reported that rainbow trout (Oncorhynchus mykiss) fed on FM-free diets, 
presented lower weight gain, higher feed intake and increased FCR. Growth retardation for 
the diets with complete or partial substitution of FM could be attributed to changes in 
physical texture of the diets, reduced feed intake, the increment in ANFs including phytate 
and non-starch polysaccharides (NSPs) present in vegetal proteins (Francis et al., 2001), not 
properly balanced AA levels and the lack of some specific bioactive compounds in which 
FM-based diets are rich in (Espe et al., 2006). Moreover, significantly lower feed intake was 
observed in Atlantic salmon fed diets in which FO was totally replaced by rapeseed oil (RO) 
(Moya-Falcón et al., 2005). Furthermore, self-selecting feeding trials illustrated that rainbow 
trout prefer FO diets over those with VO (Geurden et al., 2005, 2007), which suggests that 
some fish do actively select diets according to the dietary source of lipids. However, despite 
any reductions in feed intake many studies on salmonids have demonstrated that VOs are 
good substitutes for FO in terms of growth (Bell et al., 2001; Rosenlund et al., 2001; Bell et 
al., 2002; Caballero et al., 2002; Tocher et al., 2003; Ng et al., 2004; Torstensen et al., 2004; 
Fonseca-Madrigal et al., 2005; Torstensen et al., 2005; Bell et al., 2006; Richard et al., 2006; 
Crampton et al., 2010; Hartviksen et al., 2014). Torstensen et al. (2008) reported reduced 
feed intake and growth performance in Atlantic salmon post-smolts fed on a diet with 80% 
VPs and 70% VOs for an initial period followed by a period of increased growth, which was 
concomitant with no reductions in feed intake. This is an indication that Atlantic salmon 
requires a longer adaptation time before fully accepting any feed treatment containing very 
low levels of FM and FO or even total substitution of FM and/or FO with alternative protein 
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or lipid sources of animal or plant origin (Torstensen et al., 2008). Moreover, it was proposed 
that Atlantic salmon have the ability to compensate growth after periods of restricted feed 
intake since these fish have a greater potential for growth (Johansen et al., 2001). 
Espe et al. (2006) reported that condition factor was not significantly affected in 
Atlantic salmon post smolts fed on diets devoid of FM. On the contrary Torstensen et 
al.(2008) reported lower condition factor in Atlantic salmon maintained on diets with 80% 
of dietary protein from VP and moderate or high substitution of FO with VO (35 and 70% 
respectively) compared to fish fed the fishery based diet and the diet with moderate VP 
inclusion (40% of dietary protein from VP and 70% of dietary lipid from VO). 
It was also reported that Atlantic salmon is able to digest and utilise VOs efficiently 
for energy production at low water temperatures (Torstensen et al., 2008), suggesting that 
VO can support good growth despite restricting feed intake, providing a protein sparing 
effect (Karalazos et al., 2007; Torstensen et al., 2008). Espe et al.(2006) demonstrated that 
condition factor was not significantly affected in Atlantic salmon fed on diets with complete 
replacement of FM with plant proteins. 
Studies have demonstrated no effects of dietary VO on the carcass lipid composition 
of salmonids  (Karalazos et al., 2007; Turchini and Francis, 2009), whereas others reported 
an increase in whole body lipid levels of VO fed salmonids (Turchini et al., 2003; Karalazos 
et al., 2011). In addition, Espe et al. (2006) reported lower levels of fat deposition in salmon 
fed on a VP diet compared to a marine based (MB) control group. Furthermore, mineral 
availability varies considerably among different sources and ingredients (Hilton, 1989). 
Mineral deficiencies in Atlantic salmon could be revealed as reduction in salmon tissue ash 
levels (Shearer et al., 1994). To avoid potential deficiencies, feed formulations including 
high levels of FM substitution are supplemented with inorganic minerals known to be 
available to fish. However, various compounds within applied feedstuffs lower the 
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availability of supplemented inorganic and non-supplemented organic dietary minerals 
through direct or indirect interactions (Sugiura et al., 1998). Mineral availability in 
commonly used feedstuffs; and potential interactions of different fractions of added 
feedstuffs on dietary organic mineral availability or their interactions with supplemented 
inorganic mineral sources have not been well researched (Sugiura et al., 1998).  
1.3.5 Soy Protein Concentrate (SPC) in diets for salmonids 
The most common method of manufacturing SPC for aqua-feed production is through 
aqueous ethanol or methanol extraction, which reduces the carbohydrate fraction (Peisker, 
2001). A schematic representation of SBM and SPC production from soybeans by Peisker 
(2001) is illustrated in Fig.5. Alcohol extracted SPC (referred to as SPC from this point 
forward) contains approximately 65% crude protein, 1% fat and 6% ash (Peisker, 2001). 
Compared to SBM (~48% protein in solvent extracted, dehulled SBM), the protein content 
of SPC is more similar to that of FM, which typically ranges between 60-70% depending on 
the source species and efficiency of lipid extraction (NRC, 1993). With the exception of 
methionine, and potentially lysine, the EAA content of SPC compares favourably with FM 
(Masumoto et al., 1996). SPC also contains low levels of ANF; specifically trypsin 
inhibitors, lectins, saponins, soy antigens and oligosaccharides (Peisker, 2001; Russett, 
2002). Lectin, saponins and trypsin inhibitors, which are the main anti-nutrients related with 
soybean induced intestinal enteritis (Krogdahl et al., 1995; van den Ingh et al., 1996; 
Krogdahl et al., 2000, 2003), are typically found in much lower concentrations than  the 
concentrations reported to induce inflammation in salmonid fish (Hart et al., 2007; Russett, 
2002). Moreover, many studies have shown no signs of enteritis in salmonids fed on diets 
with up to 100% substitution of FM with SPC (Bureau et al., 1998; Krogdahl et al., 2000; 
Escaffre et al., 2007). Because of its favourable traits, SPC has gained interest as a FM 
substitute in aqua-feeds. Several studies have shown that SPC produced mostly through 
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aqueous alcohol extraction of defatted soy flakes, are more acceptable or supported better 
growth than soybean meal for salmonids and other fish species (Murai, 1989; Shimeno et 
al., 1992; Olli et al., 1994; Kaushik et al., 1995). Regarding Atlantic salmon, literature 
studies showed that up to 75% of dietary protein (with methionine supplementation) could 
be replaced by SPC without negatively influencing growth performance (Olli et al., 1994; 
Refstie et al., 1998; Storebakken et al., 1998b; 2000). Most of the above nutritional studies 
regarding the effects of dietary SPC on Atlantic salmon to date have been performed in 
salmon post-smolts. Nonetheless, Brown et al.(1997) reported that early stage Atlantic 
salmon parr can efficiently utilise diets with up to 30% of protein from SPC without negative 
effects on their growth performance. Moreover, commercial trials by EWOS (personal 
communication) have shown that diets with up to 35% of protein from SPC can be utilised 
by Atlantic salmon fingerlings without any problems. However, it seems that the tolerance 
of salmon for plant feedstuffs depends on salmon size and stage. Burr et al. (2012) 
demonstrated that early stage Atlantic salmon parr are much more sensitive to dietary vegetal 
protein inclusion than late stage parr. To date, studies regarding the general performance of 
freshwater Atlantic salmon parr fed on increasing levels of dietary SPC are scarce. 
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Figure 5 Production of soybean meal and soy protein concentrate (Peisker, 2001). The asterisks points at the 
product used for the formulations of the diets in the studies presented in Chapters 3, 4, 5, 6 and 7. 
1.4 SKELETAL TISSUE MINERALISATION 
1.4.1 Description of fish skeletal system and skeletal metabolism 
Fish skeleton, like most vertebrates, represents a reservoir of Ca, P, and many other ions, 
which are in a state of continuous exchange with electrolytes present in body fluids (Lall, 
2003). These functions require continuous remodelling of the skeletal tissue throughout the 
whole lifecycle of the fish. Skeletal remodelling involves three types of cells: osteoblasts 
(bone forming cells), osteocytes (cells entrapped inside the bone matrix) and osteoclasts 
(multinucleated bone resorbing cells). Most importantly, fish skeleton supports the structure 
of the body for normal posture, development and locomotion (Lall and Lewis-McCrea, 
2007). Furthermore, other important functions of the skeletal system include the provision 
of sites for muscular attachment and the protection of fish’ vital organs.  
Fish skeletal tissues consist of calcium hydroxyapatite salts embedded in a matrix of 
type I collagen fibres. Therefore, bones are comprised of an organic bone matrix and 
inorganic minerals. Scales do not contain osteocytes, but instead they are covered by 
scleroblasts, which are involved in matrix production and mineralisation (Lall, 2003). Bones 
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containing osteocytes (cellular bones) and bones without the presence of them (acellular 
bones) have been identified in fish. Acellular bones are formed from osteoblasts moving 
away from the site of mineralisation, while bone deposition occurs (Moss, 1963). Salmonids 
and more specifically Atlantic salmon have cellular bones. 
Fish skeletal elemental composition varies with the age of the bone. The inorganic 
phase of fish skeleton is poorly crystallized apatite (Neuman and Mulryan, 1968). Calcium, 
phosphate, and carbonate and small amounts of magnesium, manganese, zinc, strontium, 
citrate, fluoride, hydroxide, and sulphate are the main bone constituents (Lall, 2003). 
Although fish have the ability to derive most of these constituents from their aquatic 
environment, diet represents the main source for certain elements, including P and Mg, for 
the coverage of their nutritional requirements and ensure normal growth, bone development 
and health.  
1.4.2 Essential elements for normal development with an emphasis on skeletal 
development 
Macro and micro-elements in vertebrates are involved in a plethora of structural, catalytic 
and signal transductions, in which the functions of these two elemental classes overlap 
considerably. Similar to other vertebrates, Ca and P are the most abundant macro-elements 
present, displaying an important role in maintaining the fish skeletal structure and 
development. Moreover, many essential micro-elements, including magnesium, zinc and 
manganese, are required for normal bone formation and mineralisation (Lall, 2003).  
1.4.2.1 Phosphorus and calcium 
Despite the importance of Ca in bone formation and maintenance of skeletal structure, it is 
widely distributed in all soft tissues, having an integral role in muscle contraction, blood clot 
formation, transmission of nerve impulses across synapses, maintenance of cell membrane 
integrity and activation of several important enzymes. Furthermore, Ca in the cell membrane 
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is closely bound to phospholipids, regulating membrane permeability and nutrient uptake by 
the cells (Lall, 2003). Moreover, Ca and P are both involved in the maintenance of acid-base 
equilibrium (Lall, 2003). 
Phosphate serves as a structural cell component, a factor in intermediate metabolism 
and a component of genetic material (Lall, 2003). Phospholipids constitute the major 
component of the cell membranes and intracellular organelles, while phosphate is also an 
integral constituent of nucleic acids (DNA and RNA) (Lall, 2003). Moreover, phosphorus is 
part of high energy phosphate esters such as adenosine phosphate (ATP), the hydrolysis of 
which can release high energy for metabolic processes and muscle contraction. In addition, 
phosphate is essential for carbohydrate, lipid and amino acid metabolism and in muscle and 
nervous tissue metabolism. 
As mentioned previously, Ca and P are closely connected to the normal bone formation 
and mineralisation, while the stability of the vertebral bone is maintained by a solid form of 
calcium phosphate (Lall, 2003; Lall and Lewis-McCrea, 2007). Fish can derive Ca and P 
from the surrounding aquatic environment, while Ca requirements can be met by their ability 
to sequester this mineral from the water. On the contrary, the concentration of P in the water 
is very low making the dietary supply of this element the main source of P. In fish, gills are 
the major site of Ca regulation (Lall, 2003). Other sites of significant Ca regulation include 
the fins and oral epithelia and tissues (Lall, 2003). The absorbed Ca is then deposited in the 
bones, scales and skin. While scale chemical composition is similar to that of other bony 
tissues, Ca metabolism in scales is physiologically different compared to the other skeletal 
structures. Generally, the regulation of P is considered to be more crucial than that of Ca, 
since fish have to absorb, store, mobilise and conserve P in both fresh and saline aquatic 
environments (Lall, 2003; Lall and Lewis-McCrea, 2007). Absorbed P is mainly 
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accumulated in soft tissues (heart, liver, muscle, blood etc) and to a lesser degree in skeletal 
tissues.  
In general, chemical analysis of the diets cannot be used to define the biological 
effectiveness of a nutrient. It has been shown that the actual bioavailability of an element 
can vary considerably when it is provided from different feed ingredients or even within the 
same feed component in different diets (Lall, 2003). Moreover, it has been reported that 
elemental bioavailability can be influenced by a wide range of factors. These include levels 
of mineral, the particle size, interactions with other dietary components (chelators or 
inhibitors) or nutrients, the physiological and pathological status of the animal and the type 
of feed processing (Lall, 2003). Dietary mineral bioavailability can differ depending on the 
molecular form of the element, its valence state and the number of ligands in the ingested 
dietary element (Lall, 2003). Furthermore, several mechanisms that are associated with the 
formation of insoluble and non-absorbable substances in the intestinal tract may inhibit or 
promote the mucosal absorption, transport and metabolism of an element in the body (Lall, 
2003). Feedstuffs of animal origin, such as FM and meat meals, demonstrate the highest 
levels of Ca and P with P ranging between 1.5-3.2 % and 3.5-5.5 % in these ingredients 
respectively. In these feedstuffs, the bony tissues contribute significantly to the P content, 
where the major proportion is present as inorganic phosphates, whereas the remainder is 
found as organic phosphate complexes, which increase the availability of P to fish compared 
to the P forms found in plant feedstuffs.  
Phosphorus in cereal grains and plant protein concentrates varies from 0.3-0.4 % and 
0.5-1.4 % respectively. However, oilseeds including soybean store P as phytates, i.e., salts 
of phytic acid (inositol hexaphosphoric acid). The average amount of phytic acid in cereal 
and oilseed feedstuffs is 1-2% by weight, however certain varieties may contain higher levels 
of this compound (3-7%) (Lall, 2003). In soy products phytic acid, phosphatides and 
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inorganic P constitute approximately 75, 12 and 4% of the total P, respectively. Phytate is 
not digestible by fish, due to the lack of an endogenous enzyme (phytase) in the gut, which 
is able to break down the phytic acid to its moieties. Due to the high volume of negatively 
charged phosphate groups, phytate can reduce the availability of several positively charged 
ions, including Ca, Mg and Zn at high pH, by binding them and forming insoluble salts 
within the intestine (Francis et al., 2001). As mentioned before many dietary minerals are 
found as organic salt complexes, which have to be broken down by intestinal enzymes to be 
released. Phytate has also been shown to inhibit the function of intestinal enzymes, especially 
the ones involved in proteolysis (Francis et al., 2001; Denstadli et al., 2006), while inhibition 
of lipid digestibility has also been reported in rainbow trout (Mambrini et al., 1999). 
Furthermore, phytate has been proven to form insoluble complexes with proteins reducing 
their digestibility and availability (Francis et al., 2001). Lastly, non-starch polysaccharides 
(NSPs) and oligosaccharides in plant derived protein ingredients have been linked with 
reduced nutrient availability (including minerals) due to the formation of gelatinized 
solutions within the gut, entrapping nutrients and decreasing their availability, reducing the 
distribution of digestive enzymes and the flow on the mucosal layer (Storebakken et al., 
2000, 1998b).  
Dietary available P requirements for Atlantic salmon range between 6 to 10 g × kg-1 
(Åsgard and Shearer, 1997).  Many studies with mono-gastric animals have reported that an 
optimum dietary Ca:P ratio is important and that by increasing it, the absorption of P could 
be adversely affected, whereas a high P: Ca ratio may cause reductions in Ca absorption. 
Commercial feed trials have shown that diets with an adverse Ca: P ratio (≤ 1) are preferred 
for salmonid nutrition due to their higher digestibility and increased availability of P 
(Aliphos, 2012). 
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Calcium deficiency is not very common in fish since this mineral can be obtained 
straight from the aquatic environment. However, P deficiencies can lead to reduced growth, 
decreased feed efficiency, reduced bone mineralisation, skeletal deformities and increased 
mortalities (Lall, 2003). Atlantic salmon fed on low dietary P possessed abnormally soft 
bones; wrinkly ribs and scoliotic spines (Baeverfjord et al., 1998). In general, P and other 
elemental deficiencies have been proposed as the main cause of vertebral deformities in 
farmed Atlantic salmon (Witten et al., 2005; Fjelldal et al., 2007; 2009a, 2009b). The reason 
for this, is the production of fish with under-mineralised bones which are soft, brittle and 
more prone to the effects of muscular contructions (Lall and Lewis-McCrea, 2007). 
Vertebral fusions and compressions are the most commonly occurring types of skeletal 
deformities (Witten et al., 2005, 2006, 2009), however, curvatures have been observed in 
farmed Atlantic salmon (Waagbø et al., 2000; Silverstone and Hammell, 2002; Fjelldal et 
al., 2004; Waagbø,  2006, 2008; Gil Martens et al., 2012).  Moreover, a condition  termed  
as hyper-dense vertebrae, caused by the replacement of the adipose tissue with ectopic 
cartilage within the trabecular network, giving vertebrae a denser appearance in radiographic 
images, has been reported in Atlantic salmon parr (Helland et al., 2006). The number of fish 
with this condition was found to increase when salmon parr were fed with increasing 
amounts of dietary phytate (Helland et al., 2006).  
In P deficient fish exhibiting bone deformities, a decrease in bone mineralisation  has 
been described, due to an increment in the amount of osteoid tissue and osteoclast numbers 
combined with a subsequent reduction in the number of osteoblasts (Takagi and Yamada, 
1991;  Roy, 2002). Hence, normal development and growth of bones are dependent on the 
amounts of dietary P, and even most importantly the levels of dietary available P. A 
deficiency or excessive intake of P can result in the formation of skeletal anomalies (Lall 
and Lewis-McCrea, 2007). 
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1.4.2.2 Magnesium, zinc and manganese 
Magnesium (Mg) is an essential cofactor in a wide range of catabolic and anabolic enzymatic 
processes of the intermediary metabolism including the transfer of phosphate groups, the 
hydrolysis of phosphate and pyrophosphate groups, the oxidation of fatty acids and the 
synthesis of amino acids (Lall, 2003). However, Mg is also required in skeletal metabolism, 
osmoregulation and neuromuscular transmission (Lall, 2003). Most of the Mg in fish is 
located in the bone with the remainder being found within the cells of soft tissues. Fish in 
general can obtain Mg ions either from the aquatic environment or from dietary sources 
(Lall, 2003). Magnesium deficiency in Atlantic salmon include anorexia, reduced growth, 
sluggishness, high mortality and decreased body and bone Mg concentrations (El-Mowafi 
and Maage, 1998). Moreover, in rainbow trout Mg deficiency has been linked with 
nephrocalcinosis, vertebral deformities and degeneration of muscle fibres and epithelial cells 
of the pyloric cecum and gill filaments (Cowey et al., 1977; Ogino and Yang, 1978). Mg 
requirements for Atlantic salmon have been estimated to be around 0.04% (NRC, 1993). In 
general, Mg levels in freshwater are quite low (200 μM) to satisfy the metabolic 
requirements of fish, and Mg must be supplied in the diet (Lall, 2003). In rainbow trout it 
was shown that the Mg requirement is not influenced by an increase in the dietary Ca and P 
levels (Knox et al., 1981). Among food sources cereal grains contain less Mg (0.15-2%) than 
other commonly applied aqua-feed ingredients. In cereals, most of the Mg is found in the 
bran fraction. Vegetal proteins may contain 0.4-0.6% of Mg. Moreover skeletal tissues found 
in meat and fish meals contribute significantly to the Mg levels detected in these Mg rich 
feedstuffs.  
Zinc is a cofactor in several metalloenzymes or has been shown to act as a catalyst for 
the regulation of specific Zn-dependent enzymes (Lall, 2003). Zn is in general involved in 
the regulation of a wide range of metabolic processes including carbohydrate, lipid and 
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protein metabolism, while it may also have a structural role in nucleoproteins and it is 
involved in the metabolism of prostaglandins (Lall, 2003). Zn is abundant in the bone tissue 
of the fish and like in other vertebrates it seems to have a role in the maintenance of bone 
mineral density and bone metabolism (Helland et al., 2006). In humans Zn is utilised in every 
step of bone metabolism and its deficiency result in osteoporosis (Molokwu and Li, 2006). 
Adequate amounts of Zn are required for the proper function of proteins within mammalian 
bones’ organic matrix, while also Zn acts as a cofactor for the maintenance of osteoblast’s 
proper function and is required for peak bone density (Molokwu and Li, 2006). Fish can 
derive Zn from both aquatic environment and dietary sources, however dietary Zn is more 
efficiently utilised (Lall, 2003). Zn deficiency signs in rainbow trout include growth 
depression, high mortality rates, lens cataracts, fin and skin erosions and short body 
dwarfism (Satoh et al., 1983). The dietary requirement of Atlantic salmon for Zn ranges 
between 37-67 mg × kg-1 (Maage and Julshamn, 1993). Moreover, among the dietary factors 
affecting dietary Zn uptake in the gut, Ca and P levels and Ca: P ratios, the presence of phytic 
acid, protein source, the form of Zn and Ca content are the most important (Lall, 2003). Most 
uncontaminated animal and fish feedstuffs contain 30-100 mg Zn × kg-1 of dry matter, while 
among plant feedstuffs cereal, grains contain 15 to 30 mg Zn × kg-1 and plant protein 
concentrates contain 40-80 mg Zn × kg-1. Zinc sulphate (ZnSO4) and nitric zinc (ZnNO3) are 
effectively utilised by rainbow trout, as dietary Zn supplements in low Zn diets, containing 
white FM (referring to FM varieties containing no more than 6 % oil and not more than 4 % 
salt, mainly obtained from white fish or white fish waste such as filleting offal) eliminating 
the adverse effects of dietary Zn deficiency including dwarfism and cataracts (Satoh et al., 
1983). Furthermore the presence of phytate in dietary oilseed protein ingredients has been 
shown to reduce Zn availability in Atlantic salmon diets (Storebakken et al., 1998b, 2000; 
Denstadli et al., 2006). It has been suggested that the higher supplementation of practical 
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feeds with Zn can increase Zn bioavailability, especially in diets with increased dietary levels 
of phytate, Ca and P (Lall, 2003). 
Manganese (Mn) is an essential mineral widely distributed in all animal and fish 
tissues including the liver, muscle, kidney, gonads and skin, however the highest amounts 
of this mineral are found in the bones (Lall, 2003). Mn is mainly found in mitochondria 
rather than cytoplasm or other cell organelles. It is an integral cofactor for the activation of 
a large number of metalloenzymes or an essential constituent of certain metalloenzymes 
involved in carbohydrate, lipid and protein metabolism (Lall, 2003). Due to similar 
chemistry of Mn with Mg, many enzymes can be activated by both ions. In mammalian 
bones Mn seems to be involved in the proper function of bone cells and the synthesis of the 
organic matrix (Strause and Saltman, 1987). Fish can derive Mn either from the water or 
from their diet. It has been demonstrated that dietary Mn uptake can be adversely affected 
by the increased dietary levels of Ca or P. Mn deficiencies in rainbow trout have been linked 
with reduced growth, cataracts, and reduced skeletal mineralisation and vertebral 
malformations (Knox et al., 1981; Satoh et al., 1983; Yamamoto et al., 1983). Dietary Mn 
requirements for Atlantic salmon range between 7.5 and 10.5 mg × kg-1 (Maage et al., 2000). 
The Mn requirement for juvenile Atlantic salmon ranges between 2 to 15 mg×kg-1(Lall, 
2003). High amounts of dietary P may lower the absorption of Mn, and thus increase the 
necessity for dietary Mn supplementation (Lall, 2003). Animal protein feedstuffs are 
generally low in Mn. For example, Mn concentrations in the most commonly used applied 
FMs vary from 3-70 mg Mn × kg-1 with the majority of them (capelin, herring and anchovy 
meal) demonstrating low levels of Mn (3-10 mg Mn × kg-1) and menhaden meal being the 
richest source of Mn (~70 mg Mn × kg-1) (Sugiura et al., 1998). Among plant feedstuffs, 
cereal proteins contain 8-50 mg Mn × kg-1 (Lall, 2003), while oilseed proteins contain 40-70 
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mg Mn × kg-1. The availability of Mn differs in various dietary inorganic salt supplements 
(Lall, 2003).  
1.4.3 Other biotic and abiotic factors affecting salmon elemental composition and 
normal vertebral development 
Whole body and skeletal elemental amounts could be used as an index for the bone 
mineralisation and general health status of the fish (Shearer et al., 1994; Helland et al., 2005, 
2006). Low bone mineralisation in on-growing and healthy salmon could be an index of 
subclinical deficiency in a range of elements, which in the long term could increase the 
prevalence of bone deformities (Fjelldal et al., 2007, 2009a, 2009b, 2012) or even worst, 
cause increased mortalities due to a negative elemental balance (Lall, 2003). Baeverfjord et 
al., (1998) demonstrated that Atlantic salmon have the homeostatic mechanism to manage 
the reduced dietary supply of P and possibly other elements, the dietary uptake of which is 
influenced by dietary P. This is done by sacrificing skeletal deposition of these elements to 
aid other more essential metabolic roles of these elements. Moreover, Fjelldal et al., (2009b) 
demonstrated that proper bone mineralisation during the early seawater phase, induced by 
supplementation with extra dietary minerals, prevents the development of vertebral 
deformities in on-growing under-yearling smolt transferred to seawater at high temperature 
and long day-length in August.  
The intensive rearing conditions applied nowadays for the achievement of optimal 
growth rates, are associated with increased occurrence of production related conditions 
including reduced bone mineralisation, which could promote problems such as the ones 
described above. In addition the growing need of replacing FM in commercial aqua-feeds 
could initiate several nutritional imbalances, which could reduce bone mineralisation. A 
previous study by Fjelldal et al., (2010) revealed no negative effects of increasing dietary 
vegetal ingredients on bone deformities, which could be an indication of unaffected skeletal 
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mineralisation by vegetal feedstuffs. However, since bone development and mineralisation 
seems to be influenced by the developmental stage of salmon (Fjelldal et al., 2010)  the use 
of such products in diets for Atlantic salmon parr could be detrimental for body and skeletal 
mineral levels. Nevertheless, several environmental and physiological factors related with 
intensive rearing conditions, have been associated with the problem. For example, the use of 
elevated temperatures and continuous light in order to supress early maturation and prevent 
smoltification, during the freshwater phase of Atlantic salmon are two widely applied 
techniques in salmon industry aiming to optimise salmon growth performance at this stage 
(Bromage et al., 2001; Berrill et al., 2003; Stefansson et al., 2007; Stefansson et al., 2008; 
Ytteborg et al., 2010; Grini et al., 2011). However, enhancement of salmon growth rate 
followed by the application of any of the two techniques has been associated with deprived 
bone mineralisation and increased prevalence of bone deformities (Fjelldal et al., 2004, 
2005; Ytteborg et al., 2010; Grini et al., 2011). Moreover, vaccination used as a prophylactic 
method against certain diseases has also been linked with changes in bone mineralisation 
status and in some cases with increased prevalence of skeletal deformities (Berg et al., 2005; 
Grini et al., 2011; Berg et al., 2012).  
The removal of the light sensitive pineal gland Fjelldal et al., (2004) and photoperiod 
manipulation (continuous light or increased exposure to light) (Fjelldal et al., 2005, 2006; 
Wargelius et al., 2009), inducing increased growth performance, have been shown to 
adversely affect vertebral bone mineralisation in Atlantic salmon, thus compromising the 
normal development of the vertebral body by increasing the prevalence of bone deformities. 
One of the most commonly used prophylactic methods against several diseases in 
Atlantic salmon culture is the intra-peritoneal administration of oil adjuvanted vaccines to 
fish prior to seawater transfer. Some studies have shown that vaccination induces vertebral 
deformities in Atlantic salmon, visible at the time of harvest (Berg et al., 2006, 2012). 
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Moreover, Berg et al., (2012) demonstrated a correlation in the increased occurrence of bone 
deformities with reduced bone mineralisation. On the contrary, other studies have 
demonstrated increased bone mineralisation after vaccination in salmon under certain post-
vaccination temperature regimes (Grini et al., 2011), while Berg et al., (2005) also reported 
increased bone mineralisation in vaccinated salmon. Further studies have also reported no 
signs of vertebral deformities in Atlantic salmon at the post vaccination period (Gil Martens 
et al., 2010; Grini et al., 2011). It is apparent that the effect of vaccination on bone health 
depends on the vaccination strategy used (Berg et al., 2006), especially the size of the fish 
during vaccination (Berg et al., 2006; Grini et al., 2011), the type of the vaccine applied 
(Aunsmo et al., 2008) and on-growing conditions (Fjelldal et al., 2005; 2006; 2009a, 2009b; 
Grini et al., 2011).  
1.4.4 Dietary SPC effects on salmon elemental composition 
Early studies by Storebakken et al., (1998b, 2000) have demonstrated that substitution of 
FM (61% of the diet) with SPC (50% SPC and 16% FM in the diet) in Atlantic salmon post-
smolt diets can reduce whole body Ca, Mg and Zn levels, apparent digestibility coefficients 
of the same elements and retentions of P and Zn. This was an indication that increased 
amounts of phytate present within SPC based diets for Atlantic salmon could influence 
salmon’s mineral composition and adversely affect bone mineralisation. 
As mentioned before, P is the most critical chemical element when formulating fish 
feeds that contain a high level of oilseed proteins, such as SPC (Lall, 2003). The main 
concern regarding the use of SPC in salmon diets is the low P availability, the high 
prevalence of phytate, which is a heat-stable and non-soluble in alcohol chemical component 
and the presence of NSPs, which can cause problems in nutrient digestibility (Francis et al., 
2001; Kraugerud et al., 2007). However, despite the reduced nutrient digestibility, Atlantic 
salmon fed on high SPC diets (75% of total protein) can maintain rapid somatic growth 
Chapter 1. General Introduction 
 
 
30 | P a g e  
 
developing subclinical Ca, P, Mg, Mn and Zn deficiencies (Baeverfjord et al., 1998; 
Storebakken et al., 2000), which can impair growth and increase mortalities at the clinical 
stage (Baeverfjord et al., 1998). 
While research and commercial application of exogenous enzymes for the degradation 
of NSPs, have shown promise, a few studies have explored the potential of these enzymes 
in aqua-feeds. On the other hand, phytate levels can be decreased to some extent by taking 
advantage of the endogenous enzyme phytase during processing, such as soaking or 
fermentation at a suitable temperature and pH (Liener, 1994). The effects of supplemental 
phytase on nutrient utilisation or the growth of salmonids have been reported since the late 
1990s (Vielma et al., 1998; Storebakken et al., 1998b; Vielma et al., 2000; Carter and Sajjadi, 
2004; Cheng et al., 2004; Carter and Sajjadi , 2011). Several phytases have been applied 
both prior to pelletizing (pre-treatment of feedstuffs; dephytinization) ( (Storebakken et al., 
1998b; Vielma et al., 2002; Denstadli et al., 2007) and onto pellets (direct phytase 
supplementation) (Denstadli et al., 2007; Nwanna et al., 2008; Wang et al., 2008). 
Nevertheless, despite the great potential of the use of exogenous phytase in plant based 
aquafeeds, there is still a lack of information on the site of phytase activity on phytate within 
the gastrointestinal tract, while it has been reported that phytase has an optimum activity in 
two pH ranges i.e., alkaline and acidic pH (Debnath et al., 2005). Moreover, optimum 
phytase inclusion varied markedly between studies and depended on several important 
variables such as the plant ingredient and its dietary inclusion level, total available dietary 
phosphorus and Ca: P ratio and environmental conditions such as water temperature (Carter 
and Sajjadi, 2011). The aforementioned reasons combined with the high costs, inactivation 
of the enzyme at high temperatures required for pelleting (>80°C), inactivation under certain 
storage temperatures and the narrow optimum pH range (Debnath et al., 2005) are the main 
factors limiting the use of phytase in aqua-feeds. 
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To date the most common practice in commercial aquafeed industries regarding the 
enhancement of P and mineral availability in fish, is the supplementation of fish diets with 
phosphates and other minerals (Baeverfjord et al., 1998). 
1.5 FISH IMMUNE SYSTEM 
1.5.1 An overview of fish immune system 
Fish use layered defences of increasing specificity in order to avoid infections. A general 
overview of the fish’s immune system is presented in Fig.6. Fish infection pressure in the 
wild is much lower than in farmed populations, mainly due to the commonly followed 
intensive aquaculture practices. These practices often compromise the primary defence 
barriers (skin, gills and gut) composing local immune defences, through the formation of 
abrasions which increase the accessibility of pathogens to the tissues and the circulation 
(Kiron, 2012). Systemic defences take over at this stage, providing an immediate, but non-
specific innate immune response. Nonetheless, pathogens are able to overcome the complex 
innate immune responses of fish that are generally weak, and finally the third layer of 
protection, the adaptive immunity, is activated. In this phase, the immune system adapts its 
response during an infection to improve its recognition of the pathogen. This improved 
response is then retained after the pathogen has been eliminated, in the form of 
immunological memory, which gives the adaptive immune system an opportunity to mount 
a faster and stronger attack against the pathogen each time the pathogen is encountered. 
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Figure 6 An overview of the fish immune system. 
 
1.5.2 Mucosal associated lymphoid tissues 
The mucosal associated tissues of the fish include the gut, the skin and the gills. These tissues 
are directly exposed to environmental pathogens and comprise the primary defence barriers. 
Mucus secreted by specialized cells of these tissues contains a wide range of antimicrobial 
factors inhibiting the infection by pathogenic organisms (Alexander and Ingram, 1992; 
Ruangsri et al., 2010). Gills are primarily a respiratory organ, but they are also involved in 
the immune defence of fish through the presence of tissues characterised by a wide range of 
leucocytes including macrophages, lymphocytes, neutrophils, mast cells and eosinophilic 
granulocytes (Reite and Evensen, 2006). Similarly to mammalian mucosa, lymphoid cell 
aggregations (T cells) are found at the base of fish gill filaments, which suggests gill 
involvement in the immune defence of fish (Haugarvøll et al., 2008). The gastrointestinal 
tract (GIT), primarily involved in nutrition, has also a role in local immunity. The gut 
lymphoid tissue in fish is a diffusely organized system, which is morphologically and 
functionally different to that of mammalian; containing a wide variety of leucocyte types 
necessary for local immune response (Georgopoulou and Vernier, 1986). Furthermore, the 
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GIT mucosal interface provides habitat for a diverse ecosystem of microorganisms, which 
is involved primarily in the nutrition, but also in the health of the host fish (Montalto et al., 
2009). Lastly, the skin mucosal barrier serves basic roles of which protection from pathogens 
is one of the most important. Teleost fish are able to exhibit skin associated adaptive 
immunity, through their residual antibody secreting cells (ASCs), such as lipopolysaccharide 
(LPS) inducible B cells and non-replicating plasma cells producing immunoglobulins (Ig). 
Lastly, skin lymphoid tissues have been reported to contain several leucocyte types involved 
in innate and specific immune processes (Xu et al., 2013). 
1.5.3 The immune organs in fish 
The main immunological organs in fish are the anterior kidney (pronephros), the spleen, the 
thymus (Uribe et al., 2011). The anterior kidney is the largest site of haematopoiesis (Zapata 
et al., 2006) displaying a critical role in phagocytosis; antigen degradation/processing; and 
the production of immunoglobulin M (IgM) (Dannevig et al., 1994; Brattgjerd and Evensen, 
1996). Furthermore, the concentration of melanomacrophage centres, which are aggregates 
of reticular cells, macrophages, lymphocytes, plasma cells and a variety of pigments in this 
organ, suggests its participation in antigen trapping and immunologic memory (Herraez and 
Zapata, 1986). The spleen has a secondary role compared to the anterior kidney in both the 
specific and non-specific defence mechanisms (Kiron, 2012). It is believed to be a major 
haemopoietic organ, whilst it also participates in the clearance of macromolecules, antigen 
degradation/processing and antibody production (Kiron, 2012). It is believed that the 
melanomacrophage centres, in which most of the spleen macrophages are found, are 
associated with antigenic stimulation, suggesting a possible engagement in immunologic 
memory (van Muiswinkel et al., 1991).  Lastly the thymus, situated at the dorsolateral region 
of the gill chamber, has an important role in the generation of T lymphocytes and antibody 
producing B cells (Zapata and Amemiya, 2000). 
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1.5.4 Innate immune responses 
1.5.4.1 Non-specific Immune Cells 
Immune cells associated with innate immunity in fish consist of monocytes/macrophages, 
neutrophils and non-specific cytotoxic cells or natural killer cells. Monocytes/macrophages 
are probably the most important cell types in the fish immune response,  not only by 
displaying a critical role of producing cytokines (Clem et al., 1985), but also as the primary 
cells involved in phagocytosis  and pathogen killing (Shoemaker et al., 1997). Neutrophils 
are the primary cells involved in the initial stages of inflammation in fish, displaying similar 
roles as monocytes or macrophages (Manning, 1994). Non-specific cytotoxic cells are also 
present in teleosts and they respond to virus-infected host cells and protozoan parasites 
(Secombes, 1996). 
1.5.4.2 Phagocytosis 
Phagocytosis is one of the most primitive defence mechanisms that occur in fish. The first 
step in phagocytosis is the movement of the immune cell (monocyte or macrophage) in 
response to a foreign agent. This movement occurs through chemokinesis (non-directional 
movement of the phagocyte) or chemotaxis (directional movement of the phagocyte)  
(Weeks-Perkins and Ellis, 1995; Klesius and Sealey, 1996) in response to a bacterial or a 
viral antigen. After movement in response to a non-self agent, attachment occurs via lectins 
and is enhanced by opsonisation (Ainsworth, 1993). The next step of this process is the 
engulfment of the foreign agent by the cell membrane of the phagocyte to form an internal 
phagosome. The final steps of phagocytosis in fish include oxygen dependent or oxygen-
independent killing mechanisms and lastly the digestion of the agent. Oxygen independent 
mechanisms involve low pH, lysozyme, and lactoferrin plus proteo- and hydro-lytic 
enzymes. The oxygen dependent mechanism, the so-called respiratory burst is characterised 
by an increased oxygen uptake, which is used for the generation of free oxygen and nitrogen 
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radicals known to be toxic for bacteria and protozoan parasites (Secombes, 1990). Analysis 
of this phagocytic activity (percentage of phagocytosis, and production of microbicidal 
oxygen free radicals or reactive oxygen species) in a range of leucocyte types (e.g. 
macrophages, monocytes and neutrophils), isolated from lymphoid organs, is considered a 
very reliable technique for the determination of the fish’ ability to combat bacterial infections 
(Secombes, 1990).  
1.5.4.3 Lysozyme 
Lysozyme is considered a mucolytic enzyme of leucocytic origin (Saurabh and Sahoo, 
2008),  however, it was shown to be synthesized in the liver and several other extrahepatic 
tissues (Bayne and Gerwick, 2001). It is found on all body surfaces in contact with the 
environment including the skin, the gills and the GIT, whilst is also present in blood 
circulation (Ellis, 1999). This enzyme damages bacterial cell walls by catalyzing hydrolysis 
of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues 
in a peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrins and it is 
very effective in killing Gram-positive bacteria (Imoto et al., 1972; Saurabh and Sahoo, 
2008).  
1.5.4.4 Protease inhibitors 
Protease inhibitors are present in fish serum and other body fluids. They have an essential 
role in the maintenance of body fluid homeostasis (Bowden et al., 1997), in acute phase 
reactions and defence against various pathogens producing proteolytic enzymes 
(Magnadottir, 2010). Protease inhibitors are divided in active-site inhibitors, which 
inactivate the active site of proteases by binding to it and the most widely studied is a2- 
macroglobulins (a2-Ms),which have high specificity, inhibition involving the encapsulation 
of bacterial and parasitic proteolytic enzymes (Armstrong, 2006).  
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1.5.5 Humoral Components involved in Innate and Adaptive Immunity 
1.5.5.1 Complement 
Complement is composed from several glycoproteins, synthesized mainly as inactive pro-
enzymes, which function either as enzymes or as binding proteins after their activation by 
the presence of invading microorganisms and their secreted substances in the bloodstream 
(Boshra et al., 2006). Complement signals to the host fish the presence of potential 
pathogens, and engages in the annihilation and elimination of these pathogens through 
phagocytosis, cytolysis of the pathogens and inflammatory responses, mediates and 
enhances humoral immunity and lastly coordinates the development of adaptive immunity 
(Boshra et al., 2006). Complement is triggered by one or a combination of three pathways, 
the alternative, lectin and classical (Boshra et al., 2006). The alternative complement 
pathway, which is a major humoral component of the innate immune response facilitating 
chemotaxis, opsonisation and pathogen destruction (Boshra et al., 2006). Unlike the 
mammalian alternative complement system, quite high titres and increased capacity for the 
recognition of a wider range of non-self components is demonstrated in fish (Boshra et al., 
2006). The classical complement pathway is an integral part of the specific humoral 
immunity of the fish, initiated by a complex between an antigen and an antibody, which 
activates the enzymatic cascade associated with this pathway (Gasque, 2004). Lastly, the 
lectin pathway is triggered by the formation of complexes between lectins including 
mannose binding lectin and ficolins, with sugar moieties located on the surface of invading 
microorganisms (Fujita, 2002; Turner, 2003). The interaction of lectins with microbial sugar 
moieties activates the enzymes related with these compounds. The initiation of this pathway 
is also independent of antibody and seems to operate in the crossroads of innate and adaptive 
immune response (Nikoskelainen et al., 2002).  
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1.5.5.2 Natural antibodies (Immunoglobulins) 
Albeit antibodies are generally considered as components of acquired immunity, natural 
antibodies can also be classified as elements of the innate immune system and they are 
present in the serum of healthy vertebrates (Uribe et al., 2011). The former are produced in 
the presence of a specific antigen, which activates B cells for their formation, while the latter 
are constantly produced in the absence of general arrangement and without any particular 
antigenic stimulation (Magnadóttir, 2006). Natural antibodies are integral components of 
innate immunity providing immediate and broad protection against a wide range of bacterial 
and viral pathogens, while they are also linked to adaptive immunity (Uribe et al., 2011). In 
the case of salmonid fish, immunoglobulins are represented by the tetrameric IgM like 
immunoglobulin generally referred to in the literature as IgM and as of 2005, also IgT, 
another isotype which has been characterised in rainbow trout (Hansen et al., 2005) as 
explained in more detail below. 
1.5.6 Adaptive Immunity 
1.5.6.1 Cell-mediated adaptive immunity 
The cells of the adaptive immune system in fish, like in mammals, are special types of 
leucocytes, called lymphocytes. B and T cells are the major types of lymphocytes. B cells 
are mainly derived from hematopoietic stem cells of the anterior kidney, while T cells are 
produced in the thymus (Clem et al., 1991). B cells and plasma cells are involved in the 
humoral immune response comparably to the mammalian analogous cells, being able to 
produce antibodies which they can bear on their cell membrane or secrete into body fluids 
(Zelikoff, 1998). However there are some noticeable discrepancies, which suggest a broader 
functional activity than that of mammals (Kiron, 2012). Teleost fish species contain three 
different immunoglobulin isotypes, IgM, IgD and the recently described IgT (Danilova et 
al., 2005; Hansen et al., 2005; Solem and Stenvik, 2006). In all species analysed so far IgM 
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is the most abundant Ig present in serum and until recently it was thought to be the only 
teleost fish Ig responding to antigenic stimulation (Warr, 1995; Solem and Stenvik, 2006).  
Zhang et al., (2010), however, have shown that IgT can also respond to antigenic stimulation. 
With regards to IgD, this Ig has only been characterised in catfish as having a monomeric 
form (Edholm et al., 2011), but has been cloned in several other fishes (wilson et al., 1997; 
Solem and Stenvik, 2006); whilst it was shown to lack the variable immune related region 
(Edholm et al., 2011), thus having an unclear role in immunity. Lastly IgT was first described 
in 2005 (Hansen et al., 2005) in rainbow trout and seems to be related with mucosal 
immunity (Zhang et al., 2010).  Like B cells, teleostean T lymphocyte populations are 
analogous to the mammalian T cells. Nakanishi, (2002), first reported the presence of 
specific cytotoxic T lymphocytes in teleosts through the use of graft rejection and cell-
mediated cytotoxicity studies.  However, the recent advances in molecular biology and the 
application of genomic tools have led to the identification of several key T cell markers 
(CD4, CD8, CD3, CD28, CTLA-4) and cytokines, indicating the existence of discrete 
regulatory T subtypes including helper, memory, regulatory and natural killer T cells ( 
Manning and Nakanishi, 1996; Castro et al., 2011). In general cell mediated adaptive 
immunity appears to be similar to that of higher vertebrates considering the wide range of 
cell types present as well as the activity of effector cells (Kiron, 2012).  
1.5.6.2 Humoral components of adaptive Immunity 
When B cells and T cells are activated and begin to replicate, some of their offspring will 
become long-lived memory cells. These memory cells remember each specific pathogen 
encountered and can mount a strong response if the pathogen is detected again. Memory IgM 
responses have been demonstrated in teleost fish, although they are substantially less 
enduring than those exhibited in mammals (Arkoosh and Kaattari, 1991; van Muiswinkel 
and Wiegertjes, 1997; Bromage et al., 2004; Zwollo et al., 2005), while they also require 
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much longer for the generation of significant antigen-specific response (Bromage et al., 
2004; Zwollo et al., 2005). These are secreted by plasmablasts or plasma like cells (Bromage 
et al., 2004; Zwollo et al., 2005), which are mainly localized in the anterior kidney and they 
present poor affinity maturation of their IgM responses (Warr, 1997; Kaattari et al., 2002; 
Solem and Stenvik, 2006). 
1.6 ASSESSMENT OF IMMUNE RESPONSES 
1.6.1 Assessing the effects of nutrition on the immune response and disease resistance 
of fish 
The fish immune system involves a wide variety of cell types with distinct characteristics 
and functions, and several humoral components, which govern several complex defence 
mechanisms both locally and systemically. Immunity is highly reliant on dietary provision 
of nutrients for the synthesis of all components orchestrating fish immunity (Kiron, 2012; 
Sanchez, 2005). To evaluate the status and functionality of the immune system, the 
measurement of an extended range of immunological parameters that are indicative of the 
fish innate or specific immunity is required. 
The recent development of monoclonal antibodies (MAbs) against fish 
immunoglobulins have helped to implement the use of serological immunoassays for the 
measurements of total and specific immunoglobulins (Coll and Dominguez-Juncal, 1995). 
The measurement of total antibodies and specific antibody production in vitro is used to 
evaluate both innate and specific immune response respectively, in fish after immune 
stimulation (e.g. via vaccination), after subjecting the fish to different dietary treatments for 
example (Kiron, 2012). Despite the fact that vaccination and measurement of total and 
specific antibody generation could be a very informative technique for the evaluation of 
immune function and vaccine efficacy in nutritional studies, it is not frequently applied. 
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Another point to note is that there can be significant variation in antibody production 
between fish with both high and low responders being found in vaccinated populations  
(Wiegertjes et al., 1996; Schrøder et al., 2009). In general, antibody responses in fish are 
determined using techniques such as agglutination, precipitation or enzyme linked immune-
sorbent assays (ELISA). 
The use of ex vivo studies through the application of in vitro assays using cells isolated 
from specific tissues of fish subjected to a prescribed treatment, is another approach for the 
evaluation of immune defences (Kiron, 2012). However, the main disadvantage of in vitro 
assays is the removal of key components during the isolation procedure, which could 
potentially misrepresent the results in vivo (Kiron, 2012). However, the ex vivo studies have 
revealed differences, reflecting feed effects. Furthermore, the results of such studies help to 
confirm observations obtained from in vivo experiments (Kiron, 2012). The use of cells 
isolated from blood, lymphoid organs (head kidney, spleen or intestine) or the peritoneal 
cavity of fish (Rowley, 1990), which have been subjected to different dietary treatments, is 
the main way in which ex vivo studies are performed (Kiron, 2012). The analysis of the 
phagocytic activity of isolated leucocyte populations is considered a very reliable technique 
for the determination of the fish ability to combat bacterial infections (Secombes, 1990).  
The examination of fish blood is also a very useful diagnostic tool in establishing the 
health status of fish stocks, and the diagnosis of early disease or stress (Hemre et al., 1995; 
Waagbø et al., 1988). A variety of techniques are used to investigate the various properties 
of fish blood such as the measurement of haematocrit (hct), total leucocytes and differential 
immune-related cell counts. Serum-based assays constitute another useful array of 
measurements for the evaluation of immune defences, primarily ones involved in innate 
immunity. The most commonly examined humoral (circulating) constituents are 
complement activity, lysozyme activity, total Ig, acute phase proteins etc (Kiron, 2012). 
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These immune parameters are the most indicative of dynamic in vivo immune defences in 
fish. Lysozyme is a salient constituent of fish innate immunity with antiviral, antibacterial 
and anti-inflammatory properties (Saurabh and Sahoo, 2008) influenced by a wide variety 
of factors including nutrition (Kiron, 2012). Anti-proteases are also important humoral 
components of the innate immunity influenced by several factors, including nutrition, and 
have been used to evaluate the fish’s health status (Kaleeswaran et al., 2011). Complement 
is another important humoral component modulated by a wide range of extrinsic factors 
including nutrition in fish (Thompson et al., 1996; Panigrahi et al., 2005; Kiron, 2012). More 
specifically, the alternative complement activity can function at varying temperatures and 
can mediate the lysis of target erythrocytes from several animals (Yano et al., 1988, 1987), 
suggesting increased capacity for the recognition of a wider range of non-self compounds 
compared to the mammalian (Boshra et al., 2006).  
Lastly, the most informative way for the evaluation of the effects that diets have on 
the general health status of fish is the application of pathogen challenges where either 
mortality or morbidity of fish is recorded, or a stress challenge with post-exposure stress 
mapped (Kiron, 2012). Challenge studies can be very useful since they are indicative of the 
integrated fish-defences (Kiron, 2012). To date many studies have used this technique to 
assess the effects of experimental aqua-feeds containing different dietary components on 
fish resistance to various diseases (Thompson et al., 1996; Bransden et al., 2001; Krogdahl 
et al., 2000; Kiron, 2012). The reliability of challenge experiments is very much dependent 
on their repeatability. However, contrary to the stressful and unfavourable environmental 
conditions fish encounter in sea cages or other exposed locations, laboratory challenge 
experiments are often described, based on controlled experimental conditions. This major 
difference could certainly influence an increased requirement for nutrients in order for the 
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fish to develop efficient defence mechanisms and cope under the unfavourable conditions of 
cage culture (Blazer, 1992; Lall and Olivier, 1993). 
1.6.2 Effect of plant ingredients on fish immunity 
1.6.2.1 The effect of plant proteins 
Kumar et al. (2010) found unaffected leucocyte counts and haematocrit levels in rainbow 
trout (Oncorhynchus mykiss) when fish were fed on diets in which detoxified jatropha kernell 
meal replaced 50 and 62.5% of FM protein. Similarly, Jalili et al. (2013) reported no changes 
in blood parameters (haematocrit, leucocytes and differential leucocyte levels) in rainbow 
trout fed on 0, 40, 70 and 100% of protein from vegetable proteins (VPs). Rumsey (1993) 
demonstrated that rainbow trout fed on toasted SBM, containing high or low levels of 
antigenic proteins glycinin and β-conglycinin or SPC, presented an increased number of 
circulating leucocytes. This could be translated as an immunostimulatory effect of soy 
inclusion in trout diets or could be attributed to inflammatory and hypersensitivity processes, 
since the ANFs in the aforementioned soy products (including SPC) have been linked with 
intestinal enteritis (Krogdahl et al., 2000). However, Hemre et al. (2005) observed a 
significant reduction of cell size, measured as MCV, as the content of plant proteins 
increased in some of the dietary groups of Atlantic salmon fed soybean products Enlarged 
spleens were also noted in the soybean-fed salmon. Hemre et al. (2005) proposed that 
increased dietary inclusion of soybeans could be associated with the early release of 
immature erythrocytes. 
Bransden et al.(2001) demonstrated that Atlantic salmon could be supplied diets with 
40 % of total protein provided by dehulled lupin meal or a combination of dehulled lupin 
and hydrolysed poultry feather meal without any adverse effects to their innate immune 
responses (neutrophil oxygen radical production, lysozyme levels, total IgM), blood 
chemistry or resistance to Vibrio anguillarum. Similarly Jalili et al. (2013) found total serum 
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immunoglobulin levels, alternative complement activity, serum lysozyme concentration and 
resistance to Yersinia ruckerii to be unaffected in rainbow trout fed on diets with up 50 % 
protein from vegetable proteins (VPs). However, adverse effects were noted on serum total 
immunoglobulins and alternative complement activity when the trout were fed diets with 
higher than 70% of dietary protein from plant derived products. This was in agreement with 
the findings of Sitjà-Bobadilla et al. (2005) who found that the alternative complement 
activity was decreased in juvenile gilthead sea bream (Sparus aurata) fed on diets with over 
75% of FM substitution with plant proteins. However, contrary to the results reported by 
Jalili et al. (2013), diets with up to 50% FM substitution with VP appeared to stimulate 
alternative complement activity in sea bream (Sitjà-Bobadilla et al., 2005). Discrepancies 
between the studies could be due to the use of different species, differences regarding the 
macro- and micro- nutrient balance of the diets or even the feedstuffs that were used in the 
diets. 
Krogdahl et al.(2000) demonstrated increased resistance to Aeromonas salmonicida in 
Atlantic salmon fed on diets with 30% of total protein, provided by SPC, compared to the 
FM-fed control salmon and salmon fed on feeds where 30% of protein was provided by 
SBM. The increased resistance to furunculosis and the lower mortalities observed in SPC 
fed salmon challenged with A. salmonicida was believed to be influenced by the increased 
levels of polyspecific antibodies (IgMs) and lysozyme in the intestine of SPC fed salmon. 
These could serve as opsonins; promoting phagocytosis of the pathogen by activated 
macrophages (Krogdahl et al. 2000). It was thus proposed that SPC could have an 
immunostimulatory effect in Atlantic salmon. 
Increased respiratory burst of head kidney leucocytes was noted in rainbow trout and 
juvenile sea bream fed on diets with 75 and 100% substitution of FM by a mixture of PP 
sources balanced with IAAs. Moreover, rainbow trout fed on low or high antigen-toasted 
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SBM or SPC demonstrated increased neutrophil, monocyte and macrophage activity, when 
they were assessed by oxidative radical production assays (Rumsey et al., 1994). As 
mentioned earlier, this could be attributed to either an immunostimulatory effect of soy or 
an anti-inflammatory effect due to the promotion of intestinal enteritis in rainbow trout fed 
on such products or could even be a combination of both. Contrary to this, Burrells et al. 
(1999) found that dehulled solvent extracted soybean meal (DSSM), at inclusion rates of 10-
50 % of total protein, had no significant effects on macrophage oxidative radical formation, 
whereas inclusion levels of up to 80% reduced macrophage respiratory burst activity. 
Restoration of macrophage respiratory burst activity was observed when fish were fed on 
diets with 89 % of protein from DSSM. 
1.6.2.2 The effect of plant oils 
Examination of the literature shows that substitution of the n-3 PUFA rich FOs with the n-6 
PUFA rich VO can have both beneficial and in some instances, detrimental effects on 
Atlantic salmon immune response and disease resistance. For example, when Atlantic 
salmon was challenged with A. salmonicida or Vibrio anguillarum,VO fed Atlantic salmon 
was less resistant to infection when compared to the FO fed salmon (Thompson et al., 1996). 
In the same study no effects were seen on the non-specific immune parameters (i.e. 
haematocrit, leucocytes and differential leucocyte counts, head kidney macrophage 
phagocytic activity, head kidney macrophage intracellular and extracellular oxidative radical 
production, serum haemolysis, anti-protease activity, lysozyme concentration) of naive 
Atlantic salmon. It was then proposed by Thompson et al. (1996) that measuring defence 
mechanisms prior to immune stimulation (challenge or vaccination) only represents resting 
levels. In another study by Bransden et al. (2003) resistance to V. anguillarum was severely 
impaired in Atlantic salmon fed on diets where FO was substituted by sunflower oil at 
different levels. Similarly Balfry et al. (2006) have demonstrated unaffected innate immune 
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responses and decreased antibody titres against V. anguillarum and peripheral blood 
respiratory burst activity in Atlantic salmon fed on diets supplemented with up to 60% of 
the lipid as a mixture of canola oil and poultry fat compared to the FO control group. In line 
with the previous results, Thompson et al. (1996) showed that fish fed high levels of FOs 
had better survival when infected with A. salmonicida despite the fact that head kidney 
macrophage phagocytosis and bacterial killing activity was reduced in these salmon. On the 
other hand, Gjøen et al. (2004) demonstrated that Atlantic salmon fed on diets in which FO 
was completely replaced by soybean oil, presented no differences in phagocytic activity and 
resistance to A. salmonicida when compared to fully FO fed salmon. In a similar study using 
algal products, Carter et al. (2003) showed that the replacement of FO with algal oil, in 
canola-oil-based diets for Atlantic salmon, decreased their resistance to disease, whereas 
innate immune responses in salmon from different dietary groups remained unaffected. The 
reason why some diets presented improved disease resistance in salmon while others did not 
may be an indication of an optimal n-3/n-6 ratio promoting disease resistance, which have 
not yet been identified. 
1.7 FURUNCULOSIS 
Furunculosis is a highly infectious disease caused by the Gram negative bacterium A. 
salmonicida (Austin, 1997). Characteristic symptoms of the disease is the reddening or the 
presence of haemorrhages at the base of the fins, the presence of boils and haemorrhages on 
the body, the distention of the abdomen due to intestinal inflammation, exopthalmia and the 
increased mortality of the infected fish. Some of the most commonly occurring symptoms 
of the disease are illustrated in Fig. 7. The seriousness of furunculosis in Atlantic salmon 
farming was illustrated by the epidemic in 1991-1992, which led to the loss of ~10000 tonnes 
(about 25% of the total cultured salmon production) of Atlantic salmon in Scotland. 
Aeromonas salmonicida can affect Atlantic salmon in both the freshwater and saltwater 
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phases of their lifecycle (Austin, 1997). The major route of infection is poor water quality; 
however, it can also be linked with stress factors such as overcrowding, high temperatures 
and trauma (Austin, 1997). The site(s) of uptake of the pathogen into fish, although 
remaining the subject of conjecture, seems likely to include gills, mouth, anus and/or surface 
injury (Klontz, 1968; McCarthy, 1980; Hodgkinson et al., 1987). 
 
 
 
 
 
 
 
 
In a previous study Krogdahl et al. (2000) demonstrated increased resistance of SPC 
fed Atlantic salmon compared to SBM-fed and FM-fed control Atlantic salmon, challenged 
through cohabitation with A. salmonicida. During the challenge trial in which 
intraperitoneally infected cohabitants were used for the disease transmission, the bacteria 
were thought to enter the fishes’ gastrointestinal tract via pellets dropped on the water surface 
of the tanks where they became coated with bacteria (Enger et al., 1992).  Previously Michel 
Figure 7 Atlantic salmon parr with external signs of furunculosis. a) exopthalmia, b) furunculs and 
hemorrages at the base of the pelvic fins; c) furuncles and haemorrhage at the base of the pelvic fin (showing 
erosion) and distended abdomen; d) parr parr with an extended abdominal furuncle. 
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et al. (1990) reported enhanced resistance of rainbow trout against furunculosis despite the 
absence of A. salmonicida-specific antibodies, mainly due to the increased levels of poly-
specific antibodies induced by the feed, serving as opsonins; enhancing macrophages to 
increase phagocytosis of the pathogen. Furthermore many studies have demonstrated that 
non-specific immune responses are crucial in resistance against furunculosis (Oliviet et al., 
1985; Grinde, 1989; Møyner et al., 1993; Lamas and Ellis, 1994; Secombes and Olivier, 
1997). The aforementioned studies were used as a reference to explain the increased survival 
in SPC-fed salmon in the study by Krogdahl et al.  (2000), since relatively high total IgM 
levels were found in the mid-intestine of salmon fed the SPC diet. Since the exact route of 
infection has not yet been identified, an intraperitoneal injection of A. salmonicida was used 
for the infection of experimental Atlantic salmon parr in this study to describe the effects of 
increasing dietary SPC levels on the resistance of Atlantic salmon parr against furunculosis. 
1.8 SALMON VACCINATION 
1.8.1 An overview of salmon vaccination 
Vaccination is the administration of antigenic material from a specific pathogen in order to 
stimulate an individual’s immune system for the development of adaptiveimmunityagainst 
the pathogens. Fish vaccination is considered a very effective method of  control against 
certain pathogens, aimed at the prevention or reduction of morbidity from infection and is 
now a common prophylactic practice in large scale salmon culture (Poppe and Koppang, 
2014). These vaccines have been effective in reducing losses against furunculosis and other 
bacterial diseases (Sommerset et al., 2005). Vaccines are administered to fish in one of three 
ways, orally or by immersion or injection (Sommerset et al., 2005).  
More specifically injection vaccination allows direct delivery of a small volume of 
antigen into the muscle (intramuscular or i.m. injection) or into the body cavity 
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(intraperitoneal or i.p. injection), allowing for more direct stimulation of a systemic immune 
response (Vinitnantharat et al., 1999). Injection vaccines normally include an oil-based or a 
water-based compound, known as adjuvant that serves to further stimulate the immune 
system  (Tafalla et al., 2013). Over the past few decades a wide range of adjuvants have been 
tested in fish vaccines, including aluminium salts (Lillehaug et al., 1992), potassium 
aluminium salts (Horne et al., 1984; Mulvey et al., 1995) and hydrocarbon oils (Haugarvøll 
et al., 2010). The protection offered through this injection vaccination is much longer than 
by any other method  (Poppe and Koppang, 2014). Another advantage is that multiple 
antigens from different pathogens (multivalent vaccines) can be delivered at the same time. 
Multivalent oil-adjuvanted injected vaccines are the most commonly used vaccines in 
salmon aquaculture nowadays (Poppe and Koppang, 2014). 
1.8.2 Side-effects of fish vaccination 
Vaccination in general causes pain (Poppe and Koppang, 2014) and induces stress, causing 
the reduction of circulating hormones related with the promotion of fish growth, while it also 
increases energy expenditure for immune induction (Pickering, 1993; van Muiswinkel and 
Wiegertjes, 1997; Wendelaar Bonga, 1997).  Most administration forms may cause acute or 
prolonged side effects, but those caused by injection of oil-adjuvanted vaccines in salmon 
are by far the most severe. The acute side-effects can be divided into those resulting from 
poorly calibrated equipment, poor handling, anaesthesia, contamination of the vaccine or 
unhygienic vaccination processes and genuine side-effects caused by the vaccine itself 
(Lillehaug, 1989). For example, high levels of post-vaccination mortalities have been 
reported in Atlantic salmon due to the use of poorly calibrated equipment and/or techniques 
delivering the vaccine within internal organs (liver, spleen, intestine, swim bladder) or 
vessels and causing embolic lesions or necrosis in parts of these organs (Skrudland et al., 
2002). The acute reduction in fish appetite and growth due to injection-vaccination is most 
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of the times correlated with the severity of the lesions at the site of injection (Poppe and 
Koppang, 2014). Furthermore, the post-vaccination effect on the fish feeding activity seems 
to depend on the size of the fish, water temperature, water quality and several other factors, 
while acute mortalities are related to poor equipment and handling techniques (Poppe and 
Koppang, 2014).  
Chronic side effects of fish vaccination include long term loss of appetite, growth 
retardation, which may be recovered later in production (Berg et al., 2006), injection-site 
localized fibrinous peritonitis (Midtlyng, 1996; Mutoloki et al., 2006), extensive lesions on 
the abdomen, abdominal organs and muscle (Poppe and Breck, 1997) autoimmunity  
(Koppang et al., 2008; Haugarvøll et al., 2010) and lastly skeletal lesions and deformities 
(Berg et al., 2006; Aunsmo et al., 2008; Haugarvøll et al., 2010; Fjelldal et al., 2012) 
1.9 AIMS OF THE STUDY 
Several studies have investigated the effects of different levels of FM substitution with SPC 
on the growth performance of Atlantic salmon post-smolts (Olli et al., 1994; Refstie et al., 
1998; Storebakken et al., 1998b, 2000). Furthermore, one published study has investigated 
the effects of diets with 30% of dietary protein from SPC on the disease resistance and 
intestinal immunity of seawater adapted Atlantic salmon (Krogdahl et al. 2000). A gap in 
information regarding the effects of increasing dietary levels of SPC on the growth 
performance, composition and general immune status of Atlantic salmon parr still exists. To 
date most of the reported nutritional studies focusing on immune responses relate to 
measuring innate immune responses of fish, which have not been stimulated 
immunologically though infection or vaccination. It has been proposed that measuring 
defence mechanisms prior to immune stimulation only represents resting levels (Thompson 
et al., 1996). However, measuring immune parameters shortly after immune stimulation may 
highlight the effects of dietary modifications that were not evident before. Vaccination is an 
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integral prophylactic practice in large scale salmon farming, which usually takes place 
during the sensitive parr stage, increasing salmon’s resilience against commonly occurring 
lethal diseases such as furunculosis (Poppe and Koppang, 2014). Nonetheless, vaccination 
as mentioned previously has been linked with reduced feed intake, growth reduction, 
changes in bone composition and morphology and many other side effects (Poppe and 
Koppang, 2014). While most of the reported studies have focused solely on the effects of 
SPC diets on the performance, composition and immunity of naïve salmon, the present study 
aims to investigate the effect of the provision of diets with increasing dietary SPC prior and 
post -immunization with commercial vaccines, representing a more possible scenario. 
The overall aim of the present study was to investigate the effects of FM replacement 
with SPC as well as FM-, FO- and fish-free aqua feeds on the growth, feed efficiency, 
composition and immune responses of cultured Atlantic salmon. The specific objectives 
were: 
1) To investigate the effects of increasing dietary SPC levels combined with increased 
dietary supplementation of lysine and methionine and consistent dietary supply of P on the 
growth performance (weight gain) and proximate composition of juvenile Atlantic salmon 
exposed to continuous light and subjected to vaccination.  
2) To assess the effects diets with increasing levels of SPC, methionine and lysine and 
constant dietary supplementation of phosphorus on the immune responses of juvenile 
Atlantic salmon prior and post-vaccination with a commercial A. salmonicida vaccine. 
3) To explore the effects of increasing levels of SPC, lysine and methionine, combined with 
increasing dietary supplementation of phosphorus on growth and bone mineral composition 
of Atlantic salmon (Salmo salar L.) parr held under a 12h light: 12h dark photoperiod prior 
to and at post-vaccination or injection with Phosphate Buffered Saline (PBS) (control fish). 
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4) To evaluate the resistance and general immune response of vaccinated against A, 
salmonicida and PBS-injected Atlantic salmon parr fed on increasing levels of SPC and 
challenged against furunculosis in a controlled disease challenge laboratory. 
5) To investigate the effects of FM-, FO- and fish-free diets on growth, feed efficiency, 
whole body proximate composition as well as the innate immune responses of farmed 
Atlantic salmon post smolts (seawater phase) compared to salmon fed commercially applied 
feed FM- and FO- based formulations. 
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2.1 EXPERIMENTAL DIETS 
The experimental diets for Experiments I, II, III, IV, V (described in Chapters 3, 4, 5, 6 and 
7 respectively) were produced at the EWOS Innovation Technological Centre (Dirdal, 
Norway) as practical-type extruded pellets. The diets were formulated to meet all the known 
nutritional requirements of Atlantic salmon (NRC, 1993). The formulations, proximate and 
fatty acid compositions of the experimental diets used in each experiment, along with details 
regarding the feeding practices used, are described in the methodology of the relevant 
chapter. Prior to each feeding trial or during an initial acclimatisation period the fish were 
fed commercial extruded feeds produced by EWOS. 
2.2 EXPERIMENTAL ANIMALS AND HUSBANDRY 
The experiments were conducted in accordance with the guidelines relating to research on 
experimental animals from either the Norwegian Government (Chapters 3, 4 and 5) or the 
British Home Office (Chapters 4, 5). The experimental animals used in this study were 
Atlantic salmon parr for Chapters 3, 4, 6, 7, and Atlantic salmon post-smolts for Chapter 5. 
The fish for Chapters 3, 4 and 5 were held in enclosed tanks at the aquarium facilities of 
EWOS Innovation experimental facilities at Dirdal, Norway, whilst salmon parr used in 
Chapters 6and 7 at the aquarium facilities of the Institute of Aquaculture of the University 
of Stirling (Stirling, Scotland). The specific experimental conditions for each individual 
dietary trial are described in the specific methodology section of the relevant chapter. 
2.3 SAMPLING PROCEDURES 
2.3.1 Feed sampling 
At the beginning of each feeding trial samples of diets were collected for analyses as 
described below. The diets were kept at 4ºC until analysed and used in the trials. 
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2.3.2 Fish sampling 
Prior to any experimental procedure (e.g. weighing, measuring, vaccinating and challenging) 
all fish were anaesthetized using MS222 (Tricaine Mesylate, Sigma-Aldrich) (50 mg× l-1 for 
Atlantic salmon parr or smolts). After the experimental procedure the fish were placed in 
clean aerated water and allowed to recover (usually within 5 min) before being returned to 
their tank. Measurements of fish weight and length were made throughout the experiments. 
The fish were weighed to the nearest 0.1g. Where fish required to be sacrificed for blood 
and tissue sampling, they were anaesthetized with MS222 (100 mg × ml-1 for salmon parr in 
the first trial and 7 g × l-1 for Atlantic salmon growers in the second trial) or benzocaine 
(E1501, Sigma-Aldrich) (100 mg × ml-1 for salmon parr in the third trial). 
2.3.3 Body cross-sections, carcass and vertebral samples for chemical analyses 
Pools of body cross-sections between the end of the dorsal and the start of the anal fin were 
used for chemical analysis in the study presented in Chapter 3. Each pool was made using 6 
individuals per tank. In the study shown in Chapter 5 Norwegian quality cut (NQC) fillet 
samples were used for proximate analyses. Four NQC samples from each tank were skinned, 
deboned and pooled together and then frozen until analysed. In the study presented in 
Chapter 6 the sampled fish were divided into 3 groups of 96 fish each, consisting of 96 naïve 
fish prior to vaccination or injection with 0.02 M phosphate buffered saline pH 7.3 (PBS), 
96 salmon from 62 days post vaccination/PBS injection (dpv/dPBSinj) and 96 fish from 62 
days post-vaccination (dpv/dPBSinj). After undergoing an initial external gross 
examination, fish were placed within trays and stored at -70°C. Salmon were defrosted prior 
to the analysis. The thawed samples were placed on trays, weighed individually, and 
transferred into an oven at 160°C for 30 min in order to soften the flesh. The flesh was then 
removed carefully with the help of a scalpel blade; the spine was excised and visually 
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examined for any obvious bone anomalies. The spine of each individual was then defatted 
in isohexane for 20 h, placed on small trays and weighed prior to any chemical analyses. 
2.3.4 Tissue sampling for the evaluation of the immune responses 
Blood was collected from the caudal vein into heparinised syringes. Two capillary tubes 
were filled with blood and haematocrit values measured after centrifugation of the capillary 
tubes at 5400×g for 20 min. Blood cell counts were determined as described below by 
placing 10 µl of blood into an 1.5 ml plastic eppendorf tube containing 990 µl of L-15 
medium (Sigma-Aldrich) and immediately 100 µl of this cell suspension was pipetted into a 
second tube containing 900 µl of L-15 medium to achieve a blood dilution in L-15 of 1/1000. 
Finally after preparing two blood smears per sampled fish as described in Section 2.4.2, the 
remaining blood was centrifuged at 600 × g for 5 min at 4°C. A hundred and fifty microliters 
of plasma from 3 fish derived from the same tank were pooled together producing a 450 µl 
pooled plasma aliquot, which was further aliquoted into 7 aliquots of about 65 µl and stored 
at -80°C (2 plasma pools from 3 fish/tank). Anterior kidney samples were then sampled 
aseptically from each fish after partial decapitation to expose the head kidney area, which 
were placed in plastic bjoux vials containing ice-cold L-15 medium (Sigma-Aldrich) (2 
pools of 3 head kidney samples per tank).  
2.4 IMMUNOASSAYS 
2.4.1 Head kidney macrophages respiratory burst and phagocytic activity 
determination 
For the isolation of head kidney macrophages, the head kidney samples were teased through 
a 100 µm nylon mesh (BD Falcon; BD Biosciences, Franklin Lakes, NJ, USA) into 2.5 ml 
L-15 containing 40 µl of heparin (10 IU×ml-1). The mesh was rinsed with 2.5 ml of the 
medium and the cell suspension placed on ice. Levels of O-2 production by head kidney 
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macrophage suspensions were measured by the conversion of nitroblue tetrazolium (NBT; 
Sigma-Aldrich) to formazan, following the method of Secombes (1990) with some 
modifications described by Korkea-aho et al. (2011). One hundred µl of macrophage 
suspension was added to the 96-well plate (Iwaki, Tokyo, Japan), incubating at 15°C for 2 h 
to allow cell attachment. The supernatant was removed and wells washed three times with 
L-15. After washing, 100 µl of L-15 containing 1 mg × ml-1 NBT was added to three replicate 
wells, and this together with phorbol myristic acetate (1 µl × ml-1 PMA) was added to another 
three replicate wells, while 100 µl of lysis buffer (citric acid, 0.1 mol× l-1; Tween 20, 1.0 % 
(v⁄v); crystal violet, 0.05 % (w⁄v); Sigma-Aldrich) was added to two additional replicate 
wells. The plate was incubated for 60 min at 15°C, the medium removed and cells fixed with 
100 % (v⁄v) methanol for 2–3 min before washing three times with 70 % (v/v) methanol. 
The plates were air-dried before adding 120 μl of 2 M potassium hydroxide (Sigma-Aldrich) 
and 140 μl of 2 M dimethyl sulfoxide (Sigma-Aldrich) to each well to dissolve the resulting 
formazan. The absorbance was determined at 610 nm using an automated multi-mode 
microplate reader (Synergy HT; BioTek Instruments, Winooski, VT, USA). The number of 
macrophages attached to the plate was determined by counting the average number of nuclei 
released by the addition of lysis buffer for two replicate wells. The number of released 
macrophage nuclei was achieved using a Neubauer chamber, by counting the number of 
nuclei in the 4 sets of the 16 corner squares from one grid. The total number of nuclei within 
the 4 sets of squares was then divided by 4 and then multiplied by the dilution factor giving 
the number of nuclei × 104 × ml-1. The level of respiratory burst was expressed as an 
absorbance at 610 nm for 105 cells × sample-1.The head kidney cell suspension was also used 
for the determination of phagocytic activity by head kidney macrophages. Duplicate 100-μl 
cell samples were placed on glass slides and incubated for 1 h at 15°C to allow macrophages 
to attach. After this time, non-adherent cells were removed by washing the slides three times 
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with L-15 medium. Baker’s yeast resuspended in L-15 medium at 5 mg ml−1 (100 μl) was 
added to one of the samples on the microscope slide. An equal volume of L-15 medium was 
added to the other sample on the same slide as a negative control. Samples were incubated 
for 1 h at 15°C to allow phagocytosis to proceed. The slides were then washed three times 
with L-15 medium before 100-μl volumes of 100% methanol were added for 5 min. Slides 
were washed three times with 70% methanol and stained with rapid Romanowsky stain 
(Raymond A Lamb, Eastbourne, UK). The slides were viewed at × 1000 magnification, and 
100 macrophages were counted per sample. The phagocytic activity was determined as the 
percentage of macrophages performing phagocytosis (% phagocytosis) and as the number 
of yeast cells engulfed by each macrophage (phagocytic index). Examples of HKMs fixed 
on glass slides under normal conditions and performing phagocytosis of yeast cells is 
depicted in Fig. 8. 
 
 
 
Figure 8 Head kidney macrophages from phagocytosis assays. A) Head kidney macrophage (HKM); B) 
HKM; C) HKM with 2 engulfed yeast cells; D) HKM with 4 engulfed yeast cells; E) HKM with 4 engulfed 
yeast cells; F) HKM with 7 engulfed yeast cells (× 1000 magnification). 
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2.4.2 Leucocyte counts and blood smears 
A 1/1000 dilution of blood was used to estimate the total number of leucocytes × ml-1of 
blood. The number of leucocytes within each blood dilution was achieved using a Neubauer 
chamber, by counting the number of leucocytes in the 4 sets of the 16 corner squares of one 
Neubauer grid. The total number of leucocytes within the 4 sets of squares was then divided 
by 4 and multiplied by the dilution factor giving the number of leucocytes × 104 × ml-
1.Differential leucocyte counts were estimated using blood smears (Rowley, 1990). Briefly, 
a drop of heparinized blood was placed at one end of a clean dry microscope slide and spread 
uniformly across the slide using another microscope slide and then allowed before staining 
them with a rapid Romanowsky staining kit (Raymond A Lamb, Eastbourne, East Sussex). 
Each slide was immersed for 30 sec in each of the three stock solutions provided in the kit, 
and then washed with tap water. Two hundred leucocytes were counted and identified under 
a light microscope (× 100magnification) as lymphocytes, granulocytes, monocytes, or 
thrombocytes. Each leucocyte type was expressed initially as a percentage of total leucocytes 
and then each percentage was transformed into an actual number of cells based on the total 
leucocyte count. An example of the different types of leucocytes found in Atlantic salmon 
is presented in Fig. 9. 
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Figure 9 Head kidney macrophages from phagocytosis assays. A) Head kidney macrophage (HKM); B) HKM; 
C) HKM with 2 engulfed yeast cells; D) HKM with 4 engulfed yeast cells; E) HKM with 4 engulfed yeast cells; 
F) HKM with 7 engulfed yeast cells (× 1000 magnification). 
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2.4.3 Determination of lysozyme activity from serum 
Serum lysozyme activity was based on the lysis of lysozyme sensitive Micrococcus 
lysodeikticus as described by Korkea-aho et al. (2011) with some modifications. Briefly, 
serum (10 μl × well-1) was placed in quadriplicate wells of a 96-well plate (Sterilin, Newport, 
UK), and 190 μl of M. lysodeikticus (Sigma-Aldrich) solution (0.2 mg × ml-1) in sodium 0.04 
mol × 1-1 phosphate buffer (SPB, pH 5.8) then added. The absorbance was measured at 540 
nm after 1 and 5 min. Two columns of the plate contained 200 μl of SPB and were used as 
negative control while another set of two columns contained 10 μl of SPB and 190 μl of M. 
lysodeikticus and represented the amount of bacteria at time 0 in the bacterial suspension prior 
to the addition of serum. A unit of lysozyme activity was defined as the amount of serum 
causing a decrease in absorbance of 0.001 × min-1. Readings at 5 min were subtracted by the 
average O.D.540 reading taken for M. lysodeikticus (Sigma-Aldrich) suspension, which 
represents the O.D.540 at time zero. 
2.4.4 Determination of total protein from serum 
Protein content of serum was determined by the Pierce BCA (bicinchoninic acid) Protein 
Assay kit (Thermo Scientific, IL, USA) based on the conversion of Cu2+ to Cu1+ under 
alkaline conditions (Biuret reaction). Serum samples were diluted at a level of 1:100 in 
phosphate buffered saline (PBS) and were measured in duplicates in 96-well plates using 25 
μl of each serum dilution with 200 μl of the kit’s working reagent. For the determination of 
total protein in serum samples, a standard curve was plotted, using fixed solutions of bovine 
serum albumin (BSA) (Sigma-Aldrich) in PBS as shown below (Table 1) and their estimated 
O.Ds.562. Total protein concentration of plasma samples (in mg × ml
-1) was extrapolated 
from this graph after obtaining the O.D.562 for each sampled plasma dilution. 
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Table 1 Detailed description of the protocol followed to obtain the standard curve for the 
protein assay. 
Vial Volume of PBS  
(µl) 
Volume of BSA/stock 
solution (µl) 
Volume of BSA/stock 
solution (µl) 
A 
B 
C 
D 
E 
F 
G 
H 
I 
0 
125 
325 
175 
325 
325 
325 
400 
400 
300 stock sol. 
375 stock sol. 
325 stock sol. 
175 stock B 
325 stock C 
325 stock E 
325 stock F 
100 stock G 
0 
2000 
1500 
1000 
750 
500 
250 
125 
25 
0 
 
2.4.5 Estimation of complement activity (alternative complement and classical 
complement activity) and natural haemolytic activity 
2.4.5.1 Preparation of sheep red blood cell suspension (SRBCs) 
Defibrinated SRBCs in Alsever’s solution (no more than 2 weeks old from the day of their 
collection) were washed three times with saline buffer (NaCl 0.85%) by centrifugation at 
750 × g for 6 min and then suspended to 0.1% gelatin-complement fixation buffer (G-CFB) 
(0.1% gelatine, barbitone 0.575 μg × ml-1, sodium chloride 8.5 μg × ml-1, magnesium 
chloride 0.168 μg × ml-1, calcium chloride 0.028 μg × ml-1, barbitone soluble 0.185 μg × ml-
1, pH 7.2±2) to an approximately 5% suspension. Then the SRBC suspension is diluted 1:15 
in 0.1% anhydrous Na2CO3 (v/v). The absorbance of the haemolysate was determined using 
distilled water as a blank reference at 540nm, determined using a spectrophotometer (CECIL 
CE 2021 2000 Series, Cambridge, UK). Since 5% suspension of SRBC has an absorbance 
of approximately 0.700 and about 109 SRBC × ml-1, the volume was adjusted according to 
the following formula:  
𝑉 𝑓𝑖𝑛𝑎𝑙 = 𝑉 𝑖𝑛𝑖𝑡𝑖𝑎𝑙 ×  
𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 540 𝑜𝑓 5% 𝑆𝑅𝐵𝐶 𝑠𝑢𝑠𝑝𝑒𝑛𝑠𝑖𝑜𝑛 𝑖𝑛 0.1% Na2CO3 (100% lysis)
0.700
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Then 1 volume of blood was diluted in three volumes of 0.1% G-CFB to give a final 
concentration of 2.5 × 108 cells × ml-1 of blood. 
2.4.5.2 Preparation of 0.1% Gelatine Complement Fixation Buffer (G-CFB) 
A complement fixation test diluent tablet (Oxoid, UK) and 0.1 g of gelatine (Sigma-Aldrich) 
were added in 100 ml of warm distilled water and stirred until the tablet was dissolved and 
gelatin created froth on the top of the mixture. The buffer was then poured into a 100 ml 
glass container, vigorously shaken and stored at 4°C. 
2.4.5.3 Preparation of 20mM EDTA; 0.1% Gelatine Complement Fixation Buffer (G-
CFB) 
The buffer prepared in Section 2.4.5.2 was subsequently used to prepare this buffer. Prior to 
using the buffer, 20 ml of 0.1 M EDTA (Sigma-Aldrich) was added to obtain 0.1% G-CF 
Buffer 20 mM EDTA. 
To prepare the 0.1M EDTA solution, 2.9224 g of EDTA (Sigma-Aldrich) was added 
to 100 ml of distilled water. The EDTA was solubilised in water by adding some drops of 
10 M NaOH and the pH of the solution then adjusted to 8.5. The solution was shaken 
vigorously and stored at 4°C.  
2.4.5.4 Preparation of 20mM EDTA 0.1% G-CFB 
Twenty millilitres of 0.1 M EDTA was added to 80 ml of G-CFB to prepare a 20 mM EDTA 
0.1% G-CFB solution. 
2.4.5.5 Preparation of 0.1M EGTA-Mg 
For the preparation of 0.1M EGTA-Mg, 38 g of EGTA was added together with 20.3 g of 
MgCl2.6H2O to 700 ml of distilled water. EGTA was solubilised by adding 10 M NaOH 
drop-wise to the solution to adjust the pH to 7.2. 
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2.4.5.6 Preparation of 20mM EGTA-Mg /G-CFB 
Twenty millilitres of 0.1 M EGTA-Mg was added to 80 ml of 0.1% G-CFB for the 
preparation of a 20mM EGTA-Mg 0.1% G-CFB solution. 
2.4.5.7 Collection of salmon anti-SRBC serum 
Salmon antiserum against sheep RBC was produced in ten 300g Atlantic salmon post-smolts 
held in saltwater tanks by injecting them intra-peritoneally with 109 SRBC in PBS (0.15 M, 
pH 7.2). Four weeks after priming, a booster injection of 109 SRBC was given to the fish. 
Two weeks later, fish were bled and the anti-SRBC serum collected. Control fish were 
injected with PBS. Endogenous complement activity of anti-SRBC salmon serum was 
inactivated by heating the serum for 30 min at 50°C before using it. 
2.4.5.8 Dilution of Antiserum Required for Optimal Sensitization 
Two-fold serial dilutions of heat inactivated antiserum as described in Section 2.4.5.7, anti-
SRBC serum ranging from 1:400 to 1: 6400 in duplicate was prepared in 0.1% G-CFB in U-
well plate (two 5-well replicate rows). Ten microliters of SRBCs (2.5 × 108 cells × ml-1 in 
0.1% G-CFB) were added in two 5-well replicate rows of another U-well plate before 
transferring ten micro-litres of each anti-SRBC serum from the first plate. To each well 130 
μl of 1: 4 dilution of pooled serum samples of the experimental fish described in Chapter 7, 
were added. The plates were incubated at 22ºC for 60 min with constant shaking. Two 
replicate wells of 100 % haemolysis (containing 10 of SRBCs and 140 μl of 0.1% anhydrous 
Na2CO3 -v/v-) and another two of 0 % haemolysis (containing 10 of SRBCs and 140 μl of 
G-CFB -v/v-) were used as controls. The plates were then centrifuged at 1500 × g for 5 min 
and 100 µl of the supernatant from each well was transferred to a new flat-bottomed 96-well 
non-absorbent micro-titre plate (Sterilin) before measuring the absorbance of the wells at 
450 nm using a micro-plate reader (Synergy HT; BioTek Instruments, Winooski, VT, USA) 
and the percentage lysis of SRBCs was then calculated. The absorbance values of samples 
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were corrected by subtracting the absorbance of the sample blank control (0% haemolysis). 
Then the percentage haemolysis (based on the O.D. values) obtained was plotted against the 
reciprocal of the anti-serum dilution to identify the point at which the rate of haemolysis 
reached a plateau. The dilution of the antiserum providing roughly twice the amount of 
antibody present at this point was used for optimal sensitization of SRBCs. 
2.4.5.9 Preparation of sensitized SRBCs 
Heat-inactivated anti-SRBC fish serum diluted with the addition of 0.1% G-CFB with 20mM 
EDTA, was added to an equal volume of SRBC suspension (2.5 × 108 cells × ml-1 20mM 
EDTA 0.1% G-CFB) with constant mixing, and the cell suspension was incubated at 25ºC 
for 30 min. The sensitized cells were then washed by centrifugation at 500 × g with 0.1% G-
CFB and adjusted to 2.5 × 108 cells × ml-1. 
2.4.5.10 Measurement of natural haemolytic activity 
Measurement of natural plasma haemolytic activity was based on a method described by 
Langston et al. (2001) with modifications. Plasma was diluted in double serial dilutions in 
0.1% gelatine-complement fixation buffer (0.1% G-CFB) (1 complement fixation tablet 
(Oxoid, UK) and 0.1g of gelatine (Sigma-Aldrich) in 100 ml of warm distilled water) and 
25 μl added to each well of a non-absorbent U-well micro-plate (Sterilin) in duplicate. Ten 
microliters of 2.5 × 108 cells × ml-1 SRBC suspension was added to each serum dilution. 
Controls on each plate comprised of 0.1% anhydrous Na2CO3 (v/v) (100% lysis) replacing 
serum and G-CFB replacing serum (0% lysis). The micro-titre plates were incubated at 22°C 
for 90 min with constant shaking and the reaction terminated by the addition of 140 μl G-
CFB with 20mM EDTA, followed by centrifugation at 1500 × g to spin down the remaining 
SRBC. After centrifugation, 100 μl of supernatant was transferred to the wells of a new flat-
bottomed 96-well non-absorbent micro-titre plate. The absorbance of the wells was read at 
450 nm using the micro-plate reader and the percentage lysis of SRBCs calculated. The 
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absorbance values of the complement samples and the 100% haemolysis controls were 
corrected by subtracting the absorbance of the sample blank control (0 % haemolysis). The 
estimation of the complement sample haemolysis percentage was done according to the 
following equation: 
Complement sample haemolysis % =(
𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑜𝑓 𝑐𝑜𝑚𝑝𝑙𝑒𝑚𝑒𝑛𝑡 𝑠𝑎𝑚𝑝𝑙𝑒
𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑜𝑓 100% 𝑙𝑦𝑠𝑖𝑠 𝑐𝑜𝑛𝑡𝑟𝑜𝑙
) × 100 
A graph of log x (x = concentration of plasma) (ordinate axis) vs log y/ (1-y) (y = % SRBC 
haemolysis) (abscissa axis) was drawn and after estimating the volume of plasma giving 50 
% haemolysis (H50%), and the haemolytic activity of plasma was calculated in Units H50 × 
ml-1 by dividing the dilution factor of plasma with the estimated plasma volume causing lysis 
to the 50% of the RBCs in the wells expressed in ml. 
2.4.5.11 Performance of complement assays 
Unsensitised SRBCs were used to determine lysis caused by the alternative complement 
pathway (ACP), while sensitized SRBCs (see Section 2.4.5.10), were used to determine total 
complement (TC) and classical complement pathway (CCP) activity. Buffer for the AC was 
0.01 M EGTA-Mg-G-CFB and for determination of total and classical haemolytic activity 
G-CFB. Tests were performed in round-bottomed 96-well microtiter plates (Sterilin). 
Briefly, complement activity determination was based on methods described by (Yano et al., 
1987, 1988) with modifications. Briefly, serum was diluted four times in double serial 
dilutions accordingly (starting from 1: 4 for the estimation of AC activity and 1:16 for the 
estimation of TC and CC activity) and 25 μl of each dilution was added to wells of a non-
absorbent U-well micro-plate in duplicate. Ten microliters of 2.5 × 108 cells ml-1SRBC 
suspension was added to each serum dilution. Controls on each plate comprised 0.1 % 
anhydrous Na2CO3 (v/v) (100% lysis) replacing serum. G-CFB replacing serum (0% lysis) 
and serum blanks (duplicate wells of serum dilutions with G-CFB replacing SRBC 
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suspension). The plates destined for the estimation of TC and CCP activity also included, a 
CC control sensitization of sheep RBC with non-immune pooled carp serum and a standard 
complement sample (serum pool) for correction of plate differences were 
included.Microtitre plates were incubated at 22°C for 90 min with constant shaking and the 
reaction terminated by the addition of 140μl G-CFB with 20mM EDTA, followed by 
centrifugation at 1500 × g to pellet the remaining SRBCs. After centrifugation, 100 μl of the 
supernatant from each well was transferred to a new flat-bottomed 96-well non-absorbent 
micro-titre plate. The absorbance of the wells was read at 450 nm using a micro-plate reader 
(Synergy HT; BioTek Instruments, Winooski, VT, USA) and the percentage lysis of the 
SRBCs calculated. The absorbance values of samples were corrected by subtracting the 
absorbance of the sample blank control (0 % haemolysis). A graph of log x (x = 
concentration of plasma) (ordinate axis) vs log y/ (1-y) (y = % SRBC haemolysis) (abscissa 
axis) was drawn and after estimating the volume of plasma giving 50% haemolysis (H50%), 
and the units of serum haemolytic activity (AC from the plates using 0.01 M EGTA-Mg-G-
CFB and TC from the plates using G-CFB as dilution buffer)(Units H50×ml
-1) were 
calculated by dividing the dilution factor of plasma with the estimated plasma volume 
causing lysis to the 50% of the SRBCs in the wells expressed in ml. CC was calculated by 
subtracting AC activity from TC activity. 
2.4.6 Antiprotease Activity 
The method to detect anti-protease activity in trout plasmawas based on the method 
described by Ellis (1990), modified for use in microtitre plates. A 100 µg × ml-1 trypsin 
solution was prepared by adding 1 ml of 25 mg × ml-1 of trypsin stock solution (Invitrogen, 
UK) in 249 ml 0.1 M Tris.HCl (pH 8.2). Plasma samples were diluted two-fold in the 
Tris.HCl buffer in round-bottomed 96 well plates (Sterilin); giving final plasma volumes of 
2.5, 1.25, 0.625 and 0.313 µl. In a flat-bottomed 96 well plate, 5 µl of diluted samples were 
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added to 15µl trypsin and incubated for 5 min; duplicates were used where enough plasma 
was available. Finally, 200 µl of freshly made chromogen solution in distilled water (0.1% 
Na-Benzoyl- L -arginine 4-nitroanilide hydrochloride (Sigma-Aldrich) -BAPNA- 0.1 g of 
BAPNA were dissolved in distilled water at > 65°C and then cooled to 22°C prior to using 
it) was added to each well. Wells containing only BAPNA solution and Tris.HCl buffer 
without the addition of plasma samples served as a zero reference. The plates were then 
incubated for 30 min at 22ºC before centrifuging them for 6 min at 750 × g. One hundred µl 
from each well was transferred to wells of a flat bottom 96-well plate and the absorbance 
measured with a micro-plate reader (Biotek Synergy HT) set on a 5 min kinetic run, reading 
every 1 min at 410 nm. Tryptic activity was a measure of the difference in values at 5 min 
from the ones at time zero divided by 5 (units expressed as change of 0.001 units of 
absorbance at 410 nm × min-1). The 75% inhibition value was calculated from the blank 
samples, which represent the 100% inhibition of tryptic activity and reference samples which 
represent the 0% inhibition of trypsin. The volume of plasma required to achieve 75% 
inhibition of trypsin activity was calculated from a graph of % trypsin inhibition against the 
volume of plasma used. The units of trypsin inhibited at a percentage of 75% per ml of 
plasma were obtained by multiplying the estimated value of tryptic activity by 1000; as a 
unit of trypsin activity was the amount of trypsin causing a decrease in absorbance of 0.001 
and dividing this number by the volume of plasma required to inhibit the activity of trypsin 
at a percentage equal to 75%. The values obtained were then multiplied by 1000 to transform 
μl to ml so as to express 75% trypsin inhibition in Units × min-1 × ml-1. 
2.4.7 Total plasma Immunoglobulin M (IgM) assay 
The level of plasma/serum IgM in experimental fish was determined using an indirect 
enzyme linked immunosorbent assay (ELISA) (Magnadottir and Gudmundsdottir, 1992), 
with modifications. Briefly, two replicate rows of a 96-well an Immulon™ 4HBX plate 
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(Thermo Scientific, Maine, USA) were coated with 100 µl × well-1 serial dilution of purified 
IgM (Aquatic Diagnostics Ltd, Stirling, Scotland) in 0.05 M sodium carbonate/bicarbonate 
buffer, pH 9.6 (starting from 0.32 mg × ml-1 – 0.00016 mg × ml-1) to form a standard curve 
of IgM concentration vs. absorbance at 450 nm. To the remainder of the wells, 100 µl of a 
1/500 and 1/1000 dilution of serum was added from experimental fish, diluted in 0.05 M 
sodium carbonate/bicarbonate buffer, pH 9.6, using two replicates wells for each dilution. 
The plates were then incubated overnight at 4°C and washed 5 times with low salt wash 
buffer (LSWB; 0.02 M Trizma base, 0.38 M NaCl, 0.05% (v/v) Tween 20, pH 7.2). Non-
specific binding site on the ELISA plates were blocked with 250 µl of 3% w/v dried skimmed 
milk (Marvel, Dublin, Ireland) in water and the plates were incubated for 120 min at 21°C. 
The casein solution was removed before adding 100 µl of mouse anti-trout/salmon IgM 
(F11-monoclonal anti trout/salmon IgM - Aquatic Diagnostics Ltd, Stirling, Scotland) (1:66) 
solution in antibody buffer (1% BSA in LSWB) for 1 h at 21°C. Plates were then washed  
with 5 washes of high salt wash buffer (HSWB; 0.02 M Trizma base, 0.5 M NaCl, 0.01% 
(v/v) Tween 20, pH 7.4) and incubated for 5 min on last wash before adding 100 µl × well-1 
goat anti-mouse immunoglobulin-G labelled with horseradish peroxidase (HRP) (Sigma-
Aldrich) diluted 1/4000 in conjugate buffer-1% BSA in LSWB) incubating for 60 min at 
21°C. Plates were washed with 5 washes of HSWB, incubating for 5 min on last wash and 
the reaction was developed by adding 100µl × well-1 of substrate/chromogen (i.e. 15 ml 
substrate buffer containing 5 µl hydrogen peroxide and 150µl trimethyl-benzidine (TMB) 
dihydrochloride) and incubating for 10 min at 22°C. The reaction was stopped with 50µl × 
well-1 of 2M H2SO4 and plate read at 450 nm after 5 seconds in a micro-plate reader (Biotek 
Synergy HT). 
From the 2 first rows of each plate; a standard curve was obtained (known amounts of 
purified salmon IgM against O.D.450). A graph correlating log10 of O.D.450 and log10 of IgM 
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concentration was formed, which gave a better fit. The intercept and slope of the equation 
of the standard curve of each plate was used for the estimation of the total amount of IgM in 
mg × ml-1 for each dilution. Then obtained values were multiplied by the plasma dilution 
factor to obtain the amount of IgM mg × ml-1 of plasma sample.  
2.4.8 Enzyme linked immunosorbent assay antibody titres against A.salmonicida 
An ELISA was used to measure the specific antibody response of Atlantic salmon to the A. 
salmonicida vaccine using a modification of the method outlined by Adams et al.(1995). 
Briefly, 96-well Immulon™ 4HBX plates (ThermoScientific, Maine, USA) were coated 
with 50µl of 0.05% w/v poly-L-lysine (Sigma-Aldrich) in 0.05M sodium 
carbonate/bicarbonate buffer, pH 9.6 and incubated for 60 min at 21°C. Plates were then 
washed twice with a LSWB. Bacteria were added to the wells at 100 μl well-1 and plates 
incubated overnight at 4°C. The bacteria had been cultured at 22°C in tryptic soy broth (TSB) 
overnight, washed twice with PBS (10 min at 3000 × g) and the bacterial concentration 
adjusted to an absorbance of 1.0 at 610 nm. Fifty µl × well-1 of 0.05% v/v glutaraldehyde in 
0.02M PBS was added to the bacteria and the plate were incubated at 21°C for 30 min before 
washing three times with low salt wash buffer (LSWB; 0.02 M Trizma base, 0.38 M NaCl, 
0.05% (v/v) Tween 20, pH 7.2). Non-specific binding sites were blocked by incubating 
plates with 3% w/v skimmed milk powder in water at 21°C for 120 min. After washing the 
plates three times with LSWB, 100 µl of serially diluted fish serum diluted in 1 % casein 
(from 1:32 to 1:1024) was transferred to the ELISA plate, which was then incubated 
overnight at 4°C. Both positive (monoclonal antibodies against A. salmonicida) and negative 
controls (serum blanks/ sham- injected controls and naïve fish sampled at the first time-
point) were also added to each plate. Plates were washed five times with high salt wash 
buffer (HSWB; 0.02 M Trizma base, 0.5 M NaCl, 0.01% (v/v) Tween 20, pH 7.4) with a 5 
min soak on the last wash. Anti-rainbow trout/Atlantic salmon MAb (F11-monoclonal anti 
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trout/salmon IgM - Aquatic Diagnostics Ltd, Stirling, Scotland) diluted (1:33) in 1% BSA 
in 0.02M PBS was then added and plates are incubated at 21°C for 60 min. The plates were 
washed with HSWB as previously described, before adding goat anti-mouse IgG labelled 
HRP (Sigma-Aldrich), diluted 1/4000 in conjugate buffer (1% w/v BSA in LSWB) at 100 
μl × well−1 for 60 min at 21°C. Plates were once again washed with HSWB as above. The 
assays were developed with 100 μl × well−1 of substrate/chromogen (i.e. 15ml substrate 
buffer containing 5µl hydrogen peroxide and 150µl trimethyl-benzidine -TMB- 
dihydrochloride). After incubating for 10 min at 21°C, the reaction was stopped by the 
addition of 50 μl × well−1 2 M H2SO4 and the absorbance measured at 450 nm on a micro-
plate reader (Biotek Synergy HT). The antibody titre was defined as the reciprocal of the 
highest dilution (1/x dilution) showing an absorbance at least two times greater than the 
negative control. 
2.5 DISEASE CHALLENGES 
2.5.1 Pre Challenges 
The challenge bacterium, A. salmonicida (Hooke) was passaged one time through Atlantic 
salmon prior to increase the virulence of the pathogen. Recovered bacteria from the head 
kidney of the dead fish on TSA plates were then cultured in TSB for 27 h at 22°C, and 
washed twice with sterile PBS solution. The OD of the bacterial suspension was adjusted to 
1.0, which represented approximately 6 × 108 cfu×ml-1, according to the standard curve for 
this particular strain of bacteria. Bacteria were then stored at -20°C in 15% sterile glycerol 
in PBS. Bacteria were used for pre-challenges after culturing the bacteria on TSA plates for 
48 h, and then picking 6 discrete bacterial colonies and culturing them in TSB for 27 h as 
described above. The lethal dose 50% (LD50) of A. salmonicida (low dose) was determined 
using non-vaccinated Atlantic salmon parr of an average weight of 25g. Forty-two fish were 
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anaesthetized with 0,005% benzocaine, divided into 7 groups using random sampling 
method and stocked into four 25 l fiberglass tanks supplied with a flow through water at a 
rate of 0.3 l × min-1. Water temperature was maintained at 13.5°C. Each group contained six 
animals (2 per diet), which were injected intraperitoneally (i.p.) with 0.1 ml volumes of 
freshly prepared A.salmonicida (Hooke) bacterial suspensions in PBS. Fish groups were 
injected with different bacterial suspensions corresponding to 0.1 × 101, 0.3× 101, 1 × 101, 2 
× 101, 3 × 101, 6 × 102, 6 × 103, 6 × 104 and 6 × 105 colony forming units-cfu × ml-1). Tanks 
were examined 4 times per day for mortalities. The dose giving mortalities of about 70% 
was chosen as the high lethal dose (LD70) with which vaccinated fish and PBS-injected 
salmon were. injected with i.p. Dead fish were subjected to standard microbiological and 
pathological examinations and specific mortality was determined from kidney swabs 
cultured on TSA plates and TSA plates containing 0.01% (w/v) Coomassie brilliant blue 
(see Fig. 10).  
 
 
 
 
 
 
 
 
 
 
B A 
Figure 10 Aeromonas salmonicida (Hooke strain) culture recovered from head kidney of moribund fish 
during pre- challenge. A) TSA agar and (note the brown colouration diffused in the TSA agar and around the 
bacterial colonies is characteristic of Aeromonas salmonicida); B) TSA containing 0.01% (w/v) Coomassie 
brilliant blue (blue colourization of the bacterial colonies due to the presence of A-layer protein). 
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2.5.2 Infection trial 
Twenty five Atlantic salmon from each one of the twelve tanks holding the vaccinated 
dietary salmon and the twelve tanks carrying the PBS-injected dietary groups were removed 
and stocked in another two sets of 12 replicate tanks in the Aquatic Research Facility (ARF) 
challenge aquarium at the Institute of Aquaculture, University of Stirling (see Section 6.4.2). 
The tanks used were circular fiberglass tanks supplied with flow-through fresh water. The 
fish were housed under a controlled photoperiod (12 h of light: 12 h of darkness) at a 
controlled temperature of 13-15ºC. Seventy five hours before administering A. 
Salmonicidato the fish, a fresh culture of the bacterium was grown on blood agar. Twenty 
seven hours before starting the infection trial, seven bacterial colonies were cultured in 
tryptone soy broth (TSB) and prior to infecting the fish, bacteria were washed twice with 
sterile PBS by centrifuging at 3500×g, 10 min. The OD of the bacterial suspension was 
adjusted to 1.0 at 610 nm (equivalent to 8 × 108 cfu × ml-1). The bacterial suspension was 
then serially diluted to 0.25 × 10-7 (corresponding to ~2 ×102 cfu × ml-1), which was the 
dilution found to give almost 70 % mortalities. Cell densities were confirmed by distributing 
eight 25μl drops of each dilution (1.0 × 10-7,0.25 × 10-7,0.5 × 10-7, 1.0 × 10-6) onto plates 
TSA and counting colonies after 48 h. One-hundred microlitres of the 0.25×10-7 dilution 
(corresponding to 1.5×101 cfu×fish-1) was injected i.p. into each fish after being 
anaesthetized with benzocaine (30 mg×l-1). Tanks were examined four times per day, and 
the cause of death confirmed by culturing kidney swabs (after sterile dissection) onto TSA 
and checking colonial morphology. The challenge was terminated after 30 days at which 
time mortalities had ceased.  
2.6 CHEMICAL ANALYSES OF DIETS AND TISSUES 
Chemical composition of the diets, pooled body cross-sections and pooled defatted vertebral 
bones were analysed according to the following methods described by (AOAC, 1990).  
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2.6.1 Moisture 
Moisture content in samples was determined by examining the weight lost after oven drying 
the samples. Samples were first weighed into pre-weighed aluminium dishes, then placed 
into the drying oven (Gallenkamp Oven 300) overnight at 110oC and were subsequently 
allowed to cool in a desiccator before weighing the dishes with the dried samples.  
𝑀𝑜𝑖𝑠𝑡𝑢𝑟𝑒 (%) = 100 − [( 
𝑑𝑟𝑦 𝑤𝑒𝑖𝑔ℎ𝑡(𝑔)
𝑤𝑒𝑡 𝑤𝑒𝑖𝑔ℎ𝑡(𝑔)
 ) × 100] 
2.6.2 Crude Protein 
The crude protein content of the samples was estimated by using the tecator Kjeltec system. 
Approximately 250 mg of each sample were weighed into a Kjeldahl digestion tube and 2 
mercury Kjeltabs and 5ml conc. sulphuric acid were added. The tube was then placed into 
the digestion block at 420oC for 1 h. The tubes were then removed from the block and 
allowed to cool inside the fume cupboard for at least 20 min. Then, 20ml de-ionised water 
were added to the digestion tube and mixed thoroughly. The tubes were subsequently 
distilled using the Kjeltec 2300 analyser. All samples were analysed in duplicates. Similarly, 
for each batch of samples, 2 glycine standard tubes and 3 blank tubes were prepared and 
analysed. The calculation for the percentage of protein was made by using the following 
equation: 
𝑃𝑟𝑜𝑡𝑒𝑖𝑛(%) =
(𝑆𝑎𝑚𝑝𝑙𝑒 𝑡𝑖𝑡𝑟𝑒 − 𝐵𝑙𝑎𝑛𝑘 𝑡𝑖𝑡𝑟𝑒) × 1750.875
𝑆𝑎𝑚𝑝𝑙𝑒 𝑤𝑒𝑖𝑔ℎ𝑡 (𝑚𝑔)
 
where 1750.875 is a multiplication factor to convert titre vol. to % protein based on a 
standardised protein factor. 
2.6.3 Crude Fat 
The fat content of the samples were analysed using a Soxhlet apparatus (NAS, Institute of 
Aquaculture, Stirling, U.K.). Approximately 1g of homogenised dried sample (feed/flesh 
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weight taken to 4 decimal places) was mixed thoroughly with an almost equal portion of 
Celite into an extraction thimble. Extraction cups (containing 5-10 glass balls) for each 
thimble were weighed and recorded to 4 decimal places. Cups were then placed into the cup 
holders of the Soxhlet apparatus and filled with 80 ml of chloroform methanol. The thimbles 
were placed into the pre-set and heated unit, and after adjusting the cup holder to the unit, 
being sure that the matching of the thimbles with the cups, samples were run. After the 
completion of this, the cups were removed and placed in the drying oven at 100 – 105oC for 
an hour. The cups were then removed and allowed to cool within a chemical desiccator over 
fresh silica gel. The cups were re-weighed after 1 h. The fat content of finely ground diets 
was analysed in the Soxhlet apparatus after the diets were hydrolysed with 37% HCl. Briefly, 
approximately 1 g of diet sample was mixed with almost an equal portion of Celite into a 
250 ml hydrolysis Foss tube. Subsequently, 100 ml of 37% HCl was added within the tubes 
and the contents thoroughly mixed, before being placed on the hot plate of a hydrolysing 
unit (Tecator, Soxtec system 1047) set at 75-80ºC for an hour. The solutions within the tubes 
were then filtered through the Foss glass thimbles, placed in the thimble supports of the 
hydrolysing unit, by opening the support taps. Each tube was washed with 5 × 50 ml hot 
deionised water (from the hot plate approximately 50ºC) using a spray gun and the solutions 
were then filtered through the thimbles as described above. The thimbles were removed from 
the hydrolysing unit and placed in an oven set at 80ºC overnight before being analysed for 
fat using the Soxhlet apparatus. 
2.6.4 Ash content 
Total ash content of the fish was determined by ashing 1 g of sample into pre-weighed 
porcelain crucibles at 600°C for 22 h in a muffle furnace (Carbolite, Parson Lane Hope, 
Hope Valley, S33 6RB, England). The samples were then removed and cooled to room 
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temperature in a desiccator and reweighed to determine the ash content using the following 
equation 
𝑀𝑒𝑎𝑛 𝑎𝑠ℎ (%) =
𝐴𝑠ℎ 𝑤𝑒𝑖𝑔ℎ𝑡 (𝑔)
𝐷𝑟𝑖𝑒𝑑 𝑠𝑎𝑚𝑝𝑙𝑒 𝑤𝑒𝑖𝑔ℎ𝑡 (𝑔)
× 100 
2.6.5 Phosphorus and mineral analysis 
One hundred micrograms of the feed, pooled body cross-section samples or 20-25 mg of 
pooled defatted vertebral bones were placed into Teflon digestion tubes with 5ml of nitric 
acid 69 % (v/v), which were then sealed and incubated within a microwave digester for 1 h. 
The relevant digestion method was selected from a menu on the microwave digester (Step 
1: 21-190°C for 10 min at 800 W; Step 2: 190°C for 20 min at 800 W; Step 3: Cooling period 
from 190-21°C for 30 min). The samples were then poured carefully from the digestion tubes 
into 10 mL volumetric flasks, with the digestion tubes being rinsed with a small amount of 
distilled water and poured into a volumetric flask. The flask was filled up to 10 ml using 
distilled water and digested samples were then stored at 4°C until ICP-MS analysis). The 
volume of 10ml was used to calculate the final concentration of phosphorus or minerals. For 
ICP-MS analysis: 400 µL of digested sample was taken and added to a 10 ml sample tube 
and then the final volume was made to up to 10 ml with distilled water (adding 9.6ml distilled 
water). A dilution factor of 1:25 resulting in a final concentration of 2 % nitric acid was 
required before placing the samples into the ICP-MS. The calculation for the final elemental 
concentration in µg/mg was made by using the following equation: 
𝐸𝑙𝑒𝑚𝑒𝑛𝑡𝑎𝑙 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (
µg
mg
) =
𝑆𝑎𝑚𝑝𝑙𝑒 𝑣𝑜𝑙𝑢𝑚𝑒
1000
×
𝑅𝑒𝑠𝑢𝑙𝑡 𝑓𝑟𝑜𝑚 𝐼𝐶𝑃
𝑆𝑎𝑚𝑝𝑙𝑒 𝑤𝑒𝑖𝑔ℎ𝑡 (𝑔)
 
2.6.6 Energy content by bomb calorimetry 
One gram of feed sample was pelleted with a briquette press and weighed in a crucible. The 
pelleted sample was connected to the firing wire, which was fitted between the electrodes, 
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by a cotton thread. The electrode assembly was placed into the bomb and the bomb was 
tightened. The circuit was tested and the bomb was filled with oxygen to a pressure of 3000 
Pa (30 bar). The calorimeter vessel was filled with water (total weight 2812.8 kg) at 20-21°C 
and the prepared bomb was placed inside the calorimeter vessel and then the calorimeter 
vessel was placed into the water jacket. The machine was switched on and left for a while 
(10-15 min) to warm up. Prior to firing, the initial temperature of the water was checked and 
recorded and 10-15 min after firing the final temperature was recorded. Benzoic acid was 
used as a standard. The energy value determined from such a standard of known energy was 
used to calibrate the system. Finally, the sample energy content was calculated according to 
the formula: 
𝐺𝑟𝑜𝑠𝑠 𝐸𝑛𝑒𝑟𝑔𝑦 (
𝑘𝐽
𝑔
) =
(𝐹𝑖𝑛𝑎𝑙 𝑇𝑒𝑚𝑝. − 𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝑇𝑒𝑚𝑝) × 10.82.
𝑆𝑎𝑚𝑝𝑙𝑒 𝑤𝑒𝑖𝑔ℎ𝑡 (𝑔)
 
2.6.7 Crude fibre analysis 
One gram of the defatted feed samples within a pre-weighed organic capsule was digested 
with 350ml of boiling sulphuric acid solution (1.25% v/v) for 35 min in a glass crucible 
attached to the extraction unit (Fibertec system 1020 hot Extractor). The process was then 
stopped and the acid was drained out and the samples were washed thrice with 350 ml of 
boiling distilled water. After this, samples were placed in 350 ml of boiling 1.25% sodium 
hydroxide solution and digested for 35 min. The alkali was then drained out and the sample 
was washed three times with 350 ml of boiling distilled water. Finally, the samples were 
defatted once more, the crucible was removed from the extraction unit and oven dried at 
65°C overnight. The samples were cooled in a desiccator and weighed (W1). The samples 
were then ashed at 600°C in a muffle furnace (Gallenkamp Muffle Furnace) for 4 h, cooled 
in a desiccator and reweighed (W2). Extracted fibre was expressed as percentage of the 
original undefatted sample and calculated according to the formula:  
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𝐹𝑖𝑏𝑟𝑒(%) =
(𝑊1 × 1.0011) − 𝐶𝑎𝑝𝑠𝑢𝑙𝑒 𝑤𝑒𝑖𝑔ℎ𝑡 − (𝑊2 − 0.0025)
𝑆𝑎𝑚𝑝𝑙𝑒 𝑤𝑒𝑖𝑔ℎ𝑡 (𝑔)
  × 100 
Where: 
W1= digested sample weight  
W2=ashed sample weight 
2.6.8 Total carbohydrate content analysis 
Four portions of 3.0-5.0 mg sample (2 decimal places) were weighed and placed into pyrex 
test tubes. Subsequently, 2.5ml of deionised water were placed within each tube. The 
following tubes were analysed in duplicate to prepare a calibration curve: (1) 2.5 ml of 
deionised water only (blank); (2) 0.5 ml glucose standard and 2.0 ml deionised water (0.5 
mg glucose); (3) 1.0 ml glucose standard and 1.5 ml deionised water (1.0 mg glucose); (4) 
1.5 ml glucose standard and 1.0 ml deionised water (1.5 mg glucose); (5) 2.0 ml glucose 
standard and 0.5 ml deionised water (1.0 mg glucose); (6) 2.5 ml glucose standard only (2.5 
mg glucose). The content of the tubes was then mixed vigorously and 1 ml of phenol solution 
was added to each tube. The content of the tubes was mixed thoroughly and the tubes were 
then placed into an ice bath for approximately 5 min, before adding 8 ml of concentrated 
H2SO4 to each tube. The solutions were then allowed to stabilise before reading the 
absorbance of each tube at 520 nm. Absorbance and glucose concentration were plotted to 
form a calibration curve, from which the amount of glucose within the samples was 
determined. 
2.6.9 Phytate Analysis 
For the determination of phytate content in the diets a Megazyme Phytate / Total Phosphorus 
Assay kit (Megazyme, Ireland) was used. The assay is based on the hydrolysis of phytate 
into myo-inositol (phosphate)n and inorganic phosphate (Pi) and a further hydrolysis of myo-
inositol (phosphate)n by alkaline phosphatase into myo-inositol and Pi and the reaction 
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between Pi and ammonium molybdate to form 12-molybdophosphoric acid, which is reduced 
under acidic conditions to molybdenum blue. Approximately 1 g of finely ground (40 mesh) 
feed samples were weighed and dispensed into 250 ml glass tubes (Foss). Phytate was 
extracted in 100 ml of 0.66 M HCl overnight with mechanical shaking at room temperature. 
One millilitre of the extract was transferred in a 1.5 ml eppendorf tube and was centrifuged 
at 13000 × g for 10 minutes. Immediately after, 0.5 ml of the supernatant was transferred to 
a fresh 1.5ml eppendorf tube and was neutralised by the addition of 0.5 ml of 0.75M NaOH 
solution. Fifty microliters of the neutralised sample extract was transferred in two fresh 
eppendorf tubes for an enzymatic dephosphorylation reaction process described in Table2: 
Table 2 Standard protocol for the enzymatic dephosphorylation reaction process of dietary 
samples  
Solutions pipetted in 1.5ml eppendorf tube Free 
Phosphorus 
Total 
Phosphorus 
Distilled water 0.62 ml 0.60 ml 
Megazyme phytate/total phosphorus kit Buffer I (pH 5.5) 0.20 ml 0.20 ml 
Sample extract 0.05 ml 0.05 ml 
Megazyme phytate/total phosphorus kit Phytase 
suspension 
 0.02 ml 
Content within microfuge tubes was vigorously mixed and incubated in a water bath set at 40ᵒC 
for 10 min. After 10 min, the next reaction was initiated by the addition of: 
Distilled water 
Megazyme phytate/total phosphorus kit Buffer II (pH 
10.4), plus MgCl2, ZnSO4 
0.02 ml 
0.20 ml 
- 
0.20 ml 
Megazyme phytate/total phosphorus kit alkaline 
phosphatase suspension 
- 0.02 ml 
Content within microfuge tubes was vigorously mixed and incubated in a water bath set at 40ᵒC 
for 15 min. After 15 min, the next reaction was initiated by the addition of: 
Trichloroacetic acid (50% v/v) 
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Content within microfuge tubes was centrifuged at 13000 rpm for 10 minutes. The supenatant 
was subsequently used for colorimetric determination of phosphorus. 
Standard phosphorus solutions were prepared as described in Table 3 below and were then 
treated as samples for the colorimetric determination of phosphorus. 
Table 3 Protocol for the preparation of standard phosphorus solutions 
Solutions pipetted into a 
1.5ml microfuge tube 
STD0 STD1 STD2 STD3 STD4 
Distilled water 5.00 ml 4.95 ml 4.75 ml 4.50 ml 4.25 ml 
Phosphorus standard 
solution 5 
- 0.05 ml 0.25 ml 0.50 ml 0.75 ml 
Total volume 
5.00 ml 5.00 ml 5.00 ml 5.00 ml 5.00 ml 
The colorimetric determination of phosphorus for both samples and standard phosphorus 
solutions was achieved following the process described in Table 4: 
Table 4 Preparation protocol for samples and standards prior to colorimetric determination 
Solutions pipetted into a 1.5ml microfuge tube Sample 
Sample or phosphorus standard 1.00 ml 
Colour reagent 0.50 ml 
Contents were then mixed by vortex and incubated in a water bath set at 40ºC for an hour.  
After an hour, the contents were mixed again by vortex and then 1 ml was transferred to a semi-
micro cuvette and absorbance was read at 655nm (A655) immediately. 
  
After the determination of the absorbance (A655) for both free phosphorus sample and the 
total phosphorus sample the difference between the absorbance values of the two samples 
was estimated obtaining ΔAPHOSPHORUS. 
The concentration of phosphorus (CPHOSPHORUS) was calculated as shown below: 
𝐶𝑝ℎ𝑜𝑠𝑝ℎ𝑜𝑟𝑢𝑠 =
𝑚𝑒𝑎𝑛 𝑀 × 100 × 𝐹
10000 × 1.0 × 𝑣
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Where: 
Mean M = mean value of phosphorus standards (μg/ ΔAPHOSPHORUS) 
100 = original sample extract volume (ml) 
F = dilution factor 
ΔA = absorbance change for the sample 
10000 = conversion from μg/g to g/100g 
1.0 = weight of original sample material (g) 
v = sample volume (used in the colorimetric determination step) 
2.8 CALCULATIONS 
The following formulae were applied to the data: 
Feed Conversion Ratio: 
𝐹𝐶𝑅 =
 𝐹𝑒𝑒𝑑 𝐼𝑛𝑡𝑎𝑘𝑒 (𝑔)
𝑊𝑒𝑡 𝑤𝑒𝑖𝑔ℎ𝑡 𝑔𝑎𝑖𝑛 (𝑔)
 
Specific Growth Rate: 
𝑆𝐺𝑅 = (
𝑙𝑛𝑊1 − 𝑙𝑛𝑊0
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑑𝑎𝑦𝑠
) × 100 
Thermal Growth Rate: 
𝑇𝐺𝐶 = (
√𝑊1
3
− √𝑊0
3
(𝑡 × 𝑇)
) × 100 
Weight gain: 
𝑊𝐺 (
𝑔
𝑓𝑖𝑠ℎ
) =
𝐹𝑖𝑛𝑎𝑙  𝑏𝑖𝑜𝑚𝑎𝑠𝑠(𝑔) − 𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝐵𝑖𝑜𝑚𝑎𝑠𝑠 (𝑔)
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑓𝑖𝑠ℎ
 
In the above formulae W is the weight of the sampled fish in grams; W0 and W1 are the 
initial and the final biomasses (per tank or per group) in grams. 
 
Chapter 2. General Materials and Methods 
 
 
81 | P a g e  
 
2.9 STATISTICS 
Initially for each one of the studies the sample size of the fish was estimated through the 
application of power testing. Prior to the commencement of the studies, fish from the same 
population of salmon that were used in the trials were sampled for the evaluation of several 
immune responses such as (lysozyme activity, leucocyte and differential leucocyte counts, 
total IgM and HKM respiratory burst activity as described previously). Moreover, data from 
the literature were collected, regarding the normal range of these values. For the power 
testing, R language was used without the application of any specific R package. Briefly the 
procedure applied followed the steps presented below: 
1) Firstly the normal distributions for each one of the immune responses of interest 
according to literature data, was assumed for the performance of power test analysis. 
2) The location and spread of the parameters (depending on the distribution above, for 
the normal distribution these are mean and standard deviation) for the control 
treatment was subsequently assumed. 
3) Then the expected location (e.g. expressed as % effect in relation to the control) for 
the treatment (i.e. the responses of interest were assumed to be the same as for the 
control). 
4) The number of replicate tanks and the number of fish sampled from each tank was 
then assumed. 
5) Then the number of trials in which the power estimates were based on, was assumed 
(for the present study we used 1000 trials). 
6) Subsequently expected outcomes were used (i.e. generated pseudo data) 
corresponding to the structure of the data (e.g. multiple fish sampled from each 
replicate tank), from the correct distribution, with the location and spread of the  
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parameters for both the control and treatment for the number of trials decided above 
by using random number generators specific for the distribution in question 
7) Then the simulated results were estimated, using a hierarchical (multilevel) model 
which was the case in the reported studies of the present thesis (further details are 
given below). 
8) The effect size estimates and standard errors were then saved for the assessment of 
all the experimental trials. 
9) An operational curve with the data from the simulated trials was subsequently built, 
by using, e.g. p < 0.05 criteria (for the studies presented herein, a mean of +/- 2 
standard errors was used to approximate the p = 0.05 threshold). 
Power testing of all the studies focused on the immunological responses of salmon, in the 
present thesis indicated that the sampling of 6 individuals from each tank would give an 80 
% chance of detecting a specific effect in any immune response whilst accepting a type 1 
error of 0.05. 
In all studies presented herein multiple observations from a single tank are available 
(several individuals, several pools or repeated measurements). For this reason a hierarchical 
(multilevel) statistical model was applied. Such models are also called mixed-effects models 
and statistical analyses using this method allow for a random tank effect when applicable 
(Crampton et al., 2010; Nanton et al., 2012; Hartviksen et al., 2014). 
Any response that was a proportion and bound to 0-100% (or 0-1) could not be 
analysed according to a normal distribution assumption since at the extremities of the 
distribution range, values are compressed towards the brims (0-100). Because some of such 
responses in this study include zero values, a so-called arcsin transformation was applied to 
make the distributions normal. The arcsin transformation is defined as follows: 
ŷ = sin-1√𝑃 
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where ŷ is the transformed value and p is the original proportion (in the case of percentages 
they need to be divided by 100 to get p). Absorbance response that has a lower bound at zero 
(or 0-1) is considered to follow the log-normal distribution and all such response values are 
transformed to logarithms before statistical modelling. The logarithmic transformation is 
defined as follows: 
ŷ= log10(y) for y > 0 
where ŷ is the transformed value and y is the original observation. 
All other responses were assumed to follow a normal distribution (either without or 
with transformation) except counts that follow the Poisson distribution. However, microbe 
counts that are in millions can be safely assumed to be normally distributed since with large 
counts the Poisson and normal distributions become similar. 
The statistical approach applied was model-based. This means that for finding if any 
specific effect is statistically significant two models were fitted to the data: (1) a model with 
the term of interest and (2) a model without the terms of interest. These two models were 
then nested together and compared with a likelihood ratio test (LRT) assessing if the 
improvement in the likelihood by using a more complex model was warranted or whether a 
simpler model could be considered as equally efficient. Subsequently the simplest possible 
model was adopted according to Occam's razor principle that Einstein formulated as 
“Everything should be made as simple as possible, but no simpler”.  
Fish weight could be used as a covariate since many responses may be size-dependent. 
However, for the immunological responses in this study no such prior information, 
supporting the use of fish weight as a covariate is still present. Doing it blindly could be 
harmful, in particular when fish weight correlates with the treatments, as is the case in this 
study because SPC inclusion affected growth. Hence, fish weight was not included in the 
statistical models of immunological responses.  
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The adopted model is demonstrated by plotting and/or tabulating the expected mean 
response with 95% confidence intervals (C.I.). For a categorical effect these were 
represented as points with error bars (denoting 95% C.I.) and for a continuous effect as a 
curve with shaded confidence region. The expected mean and 95% C.I. were solved by a 
posterior simulation from the adopted statistical model (n=1500 random draws were used 
throughout this study). Sampling time in this study was considered as a categorical variable, 
i.e. discrete time points and no attempt to model any time-dependent effects were made. 
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3.1 INTRODUCTION 
Aquaculture is the most rapidly expanding sector of worldwide animal production, with 
Atlantic salmon (Salmo salar, Linnaeus, 1758) representing the most important cultured fish 
species in European and worldwide aquaculture. Atlantic salmon is typically raised in 
intensive aquaculture production systems and fed nutritionally complete formulated diets, 
which have traditionally been made with a high inclusion of FM as the main source of protein 
and indispensable amino acids (IAAs). As the demand for, and production of, farmed fish 
increases however, it is necessary to reduce FM inclusion since its supply is limited. Given 
that plant feedstuffs are readily available, they have received most attention over the past 
years as alternative protein sources to FM (Kaushik et al., 1990; Carter et al., 1994; Tacon 
et al., 1994; Carter and Hauler, 2000). 
Alcohol extracted SPC is increasingly important as a protein alternative to FM. SPC 
in aquafeeds is produced by immobilising the soy globulin proteins while allowing the 
soluble carbohydrates, soy whey proteins, and salts to be leached from the defatted flakes 
or flour (Peisker, 2001). This process results to a final product with increased concentration 
of protein compared to other soybean products which are characterised by decreased 
amounts of non-digestible carbohydrates. A growing body of research indicates that SPC is 
a high quality protein product for use in aqua-feeds for Atlantic salmon post smolts (Olli et 
al., 1994; Refstie et al., 1998; Storebakken et al., 1998b, 2000). The main advantages of 
using SPC over other plant products include its high protein level, its favourable comparison 
to the EAA profile of FM with the exception of methionine and lysine, low levels of harmful 
indigestible components (such as trypsin inhibitors, lectins and soy antigens) and other anti-
nutrients reported to cause soybean-induced enteritis, the fact that they are resistant to 
oxidation and spoilage, and that they are naturally free of organisms such as fungi, viruses 
and bacteria (NRC, 1993; Peisker, 2001). However, while SPC has been shown to be an 
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excellent ingredient for practical feeds for many commercially important salmonid species 
at the adult stage (Dersjant-Li, 2002), and is widely used in such feeds, further information 
is required regarding the effects of this product on the growth, proximate composition and 
especially phosphorus (P) and mineral compositions of Atlantic salmon parr. The main 
reason for that is the presence of a certain anti-nutritional factor (ANF) which is not removed 
through the aqueous ethanol process namely phytic acid and its corresponding salts. Phytic 
acid is largely bound on the protein fraction of soybeans resulting in the increased 
concentration of this substance in SPCs. 
Much of the P in soybeans is found in the form of phytate, which is not digestible by 
the peptic enzymes of Atlantic salmon, thus decreasing the availability of P (Francis et al., 
2001). Furthermore, phytate reduces the availability of many positively charged cations, thus 
rendering them unavailable for the fish (Francis et al., 2001) while it was also found to form 
complexes with proteins and amino acids and inhibit protein hydrolysis, thus reducing their 
availability (Riche and Garling, 2004). Clearly phytic acid and phytate levels also depend 
on the genetic background of the soy used for the production of SPCs. Therefore the presence 
phytate found in SPC, could potentially, affect salmon carcass proximate and bone elemental 
compositions, since the two aforementioned tissues consist the main protein and mineral 
reservoirs respectively. For this reason, and due to the fact that many of the internal organs 
were sampled for immunological evaluation, as the current study was designed to mainly 
focus on the immune performance of the fish (the results of the immune performance are not 
provided in the present manuscript), body cross-sections were preferred over whole body 
samples for the assessment of proximate and elemental composition (therefore reducing 
pressure at sample collection). In the present study the use of body cross-sections over whole 
body proximate and elemental composition analysis is explored, by comparison of the data 
obtained in the experimental trial herein, to previously reported whole body values 
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(Baeverfjord et al., 1998; Storebakken et al., 1998; Helland et al., 2007). Furthermore, the 
growth performance and body cross-section proximate and elemental composition of 
Atlantic salmon fed on four different diets with increasing levels of dietary protein from SPC 
is investigated. 
The main objective of the present study was to monitor how growth and proximate 
composition of Atlantic salmon was affected after feeding them on four different diets with 
increasing levels of dietary protein from SPC, under intensive commercial rearing conditions 
prior to (Day 63) and post-vaccination with a commercial vaccine (Day 97/34 days post 
vaccination (dpv)). Vaccination is a common prophylactic measure in salmon culture, which 
can provide protective immunity against a wide range of diseases, but can also result 
influence negatively or positively vertebral bone mineral levels (Berg et al., 2005, 2006;  
Grini et al., 2011; Berg et al., 2012). On the other hand application of continuous light to 
prevent salmon smoltification and maturation (Stefansson et al., 1991; Handeland and 
Stefansson, 2001; Berrill et al., 2003; Stefansson et al., 2007) has been found to speed up 
salmon growth rate (Krakenes, 1990; Stefansson et al., 2008) demoting the mineralisation 
process in salmon skeletal tissues (Fjelldal et al., 2004, 2005).Atlantic salmon can  still 
maintain fast growth while developing subclinical deficiencies of Ca, Mg, P and Zn, 
increasing their susceptibility to diseases (Åsgard and Shearer, 1997; Baeverfjord et al., 
1998; Helland et al., 2006). Therefore P and mineral compositions were monitored using 
pooled body cross-sections of Atlantic salmon parr from the four different dietary groups of 
salmon prior to (Day 63 of the feeding trial) and 34 dpv (Day 97 of the feeding trial).  
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3.2 MATERIALS AND METHODS 
3.2.1 Diets and growth trial 
Four experimental diets were prepared. These were formulated so that SPC supplied 35, 50, 
65 and 80 % of total dietary protein (termed SPC35, SPC50, SPC65 and SPC80, 
respectively) with high quality FM providing the rest of the dietary protein in all cases. Diet 
formulations are provided in Table 5. The diets were manufactured by EWOS Innovation, 
Dirdal, Norway and were formulated so that protein: fat ratios were constant whereas lysine, 
methionine and threonine were supplemented to give the same AA: protein ratios across 
dietary treatments. The amount of supplemented dicalcium phosphate was constant among 
the diets, representing 3% of all experimental dietary formulations, exceeding Atlantic 
salmon’s phosphorus (P) requirement (Lall, 2003). 
The feeding trial was conducted at EWOS Innovation facilities in Dirdal, Norway. For 
the trial, fresh water was supplied to 16 square tanks with rounded corners each containing 
approximately 60 l of water. Water temperature was maintained at 13 ± 1ºC, whilst 
photoperiod was constant (24 h of light). The diffused oxygen level of inlet water to the 
tanks was constantly 90-100 % saturation. . A total of one thousand nine hundred and twenty 
(1920 fish) unvaccinated S0 Atlantic salmon parr (from a commercial SalmoBreed strain 
selected for improved growth performance) of an average weight of 29 g (i.e. 120 fish/tank) 
were randomly allocated to the 16 tanks. Fish were acclimatised to experimental tanks for 
28 days prior to commencing the trial, during which time they were fed a commercial EWOS 
freshwater diet for salmonids (EWOS micro). During the study period quadruplicate tanks 
of fish were fed one of the 4 experimental diets. Fish were fed with automatic belt feeders, 
continuously every 435 seconds for 20 seconds.  
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Table 5 Formulation and calculated chemical composition of experimental diets with varying soy protein concentrate levels. 
Feed composition (× kg-1) SPC35 SPC50 SPC65 SPC80 SPC35 SPC50 SPC65 SPC80 
 2mm 3mm 
Fishmeal a (g) 462.86 344.15 230.64      121.98 462.86 344.15 230.64 121.98 
SPCb (g) 274.64 384.25 489.16 590.97 274.64 384.25 489.16 590.97 
Tapiocac (g) 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 
Di-calcium phosphated (g) 30.0 30.0 30.0 30.0 30.0 30.0 30.0 30.0 
Vitamin and mineral premixese (g) 3.55 3.55 3.55 3.55 3.55 3.55 3.55 3.55 
Vitamin C 35% e (g) 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 
MgSO4 d (g) 0.45 0.45 0.45 0.45 0.45 0.45 0.45 0.45 
Methionine f (g) 2.10 3.50 4.50 5.50 2.10 3.50 4.50 5.50 
Lysine 78% f (g) 1.80 2.40 2.80 3.30 1.80 2.40 2.80 3.30 
L-Threonine f (g) 0.60 0.70 0.90 0.98 0.60 0.70 0.90 0.98 
Ultralec g (g) 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 
Fish Oil h (g) 1130 120.0 127.0 132.26 113.0 12.0.0 127.0 132.26 
Chemical composition (× kg-1)         
Dry matter (g) 937.4 938.7 932.5 911.9 920.6 907.7 921.3 931.2 
In dry matter basis 
Crude protein (g) 504.2 502.1 491.7 471.0 501.2 488.9 491.2 485.4 
Crude fat (g) 175.6 166.2 157.6 144.4 174.3 158.5 151.4 146.1 
Crude prt: Crude fat ratio 2.9 3.0 3.1 3.3 2.9 3.1 3.2 3.4 
Phytate levels (g) 11.87 13.24 14.12 15.33 11.54 13.14 14.00 15.16 
Ash (g) 108.4 106.3 103.0 97.1 106.2 102.8 100.9 100.1 
Phosphorus (P) (g) 16.56 16.03 15.33 14.58 16.4 15.98 15.45 14.65 
Calcium (Ca) (g) 33.44 26.78 22.46 18.96 31.82 27.75 23.07 18.54 
Ca: P ratio 2.0 1.7 1.5 1.3 1.9 1.7 1.5 1.3 
Zn (mg) 295.41 285.3 273.43 265.87 286.99 285.49 275.39 268.43 
Mg (mg) 2.18 2.32 2.39 2.44 2.21 2.34 2.39 2.43 
Mn (mg) 83.54 87.32 86.99 86.78 83.87 87.45 86.32 85.89 
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Abbreviations: SPC 35 - diet with 35 % of dietary protein soy protein concentrate (SPC); SPC 50 - diet with 50 % of dietary protein from SPC; SPC 65 - diet with 65 % of 
dietary protein from SPC; SPC 80 - diet with 80% of dietary protein from SPC.  
a Fishmeal (Egersund  Sildoljefabrikk, Norway) with an apparent protein digestibility coefficient (ADC protein) of 90.2 %; b SPC (Imcopa, - Importação, Exportação e Indústria 
de Óleos Ltda., Araucária - Paraná, Brazil) with an apparent protein digestibility coefficient (ADC protein) of 90.8 %; a Fishmeal (Egersund  Sildoljefabrikk, Norway) with an 
apparent protein digestibility coefficient (ADC protein) of 90.2 % ; b SPC (Imcopa, Brazil) with an apparent protein digestibility coefficient (ADC protein) of 90.8%; c Tapioca 
(Hoff Norske Potetindustrier, Gjøvik, Norway); d Dicalcium Phosphate (Normin AS, Hønefoss, Norway); e Vitamin premix and Mineral premix (EWOS AS, Bergen, Norway); 
f Amino acids (Evonik Degussa International AG, Hanau, Germany); g Ultralec: De-oiled lecithin powder (ADM, Decatur, USA); h Fish Oil (Egersund  Sildoljefabrikk, Norway).  
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Feeding time and period within feed intervals were the same for the acclimation and 
trial period. The daily ration depended on the trial period and fish appetite.A daily ration of 
3.5 % of tank biomass was recorded during the acclimation period, while this proportion was 
decreased to 2.75, 2.5 and 1.5% of tank biomass during the first, second and third month of 
the trial period, respectively. A high daily feed ration was used to avoid differences in feed 
intake often associated with satiation feeding of plant substituted diets (Refstie et al., 1998). 
It should be mentioned that as the level of SPC was increased in the diets of Atlantic salmon 
parr, the food ration was decreased, however direct feed intake through waste feed collection 
was not determined due to the difficulty in dividing uneaten feed of such a small size from 
faecal material.  
Fish were weighed after being anaesthetized (metacaine, 30 mg × l-1). The growth trial 
was conducted for a total of 97 days, at which time all fish were removed and weighed. On 
Day 37 all fish in the tanks were bulk weighed. Fish were also weighed on Day 63 (pre-
vaccination) before being intraperitoneally (i.p.) vaccinated with 100μl of a commercial 
vaccine (AquaVac™ Furovac, Intervet UK Ltd., Milton Keynes) against A. salmonicida, and 
on Day 97 (34 days post vaccination (dpv)). On Days 63 and 97, pools of body cross-sections 
between the end of the dorsal fin and the start of the anal fin were obtained from six fish per 
tank for proximate composition analyses. 
3.2.2 Calculations 
Estimated FCR values in the current trial were based on the feed amount given to the fish 
and do not represent the actual FCR; therefore they were not included in the current report 
or statistical analyses. For simplicity, growth performance was evaluated by monitoring the 
mean salmon weight from each tank and estimating the weight gain of the experimental 
salmon groups: 
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Weight gain: 
Weight gain (𝑊𝐺)  =
𝐵𝑖𝑜𝑚𝑎𝑠𝑠 𝑓𝑖𝑛𝑎𝑙 (𝑔)−𝐵𝑖𝑜𝑚𝑎𝑠𝑠 𝑖𝑛𝑖𝑡𝑖𝑎𝑙 (𝑔)
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑓𝑖𝑠ℎ
 
Specific Growth Rate: 
𝑆𝐺𝑅 = (
𝑙𝑛𝑊1 − 𝑙𝑛𝑊0
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑑𝑎𝑦𝑠
) × 100 
Thermal Growth Rate: 
𝑇𝐺𝐶 = (
√𝑊1
3
− √𝑊0
3
(𝑡 × 𝑇)
) × 100 
3.2.3 Proximate composition analysis 
Cross-section samples obtained as described at the end of the Section 3.2.1. were stored 
frozen and then thawed prior to analysis. Feeds were homogenised prior to the analysis. Dry 
matter and moisture were determined according to standard methods (AOAC, 1990) by oven 
drying of both homogenised feeds and pooled body cross-sections, for 16 h at constant 
weight. After drying the pooled cross-sections were homogenised and used for ash, crude 
protein, crude lipid and elemental determination. Pulverised body cross-section and feed 
samples were ashed in a muffle furnace at 550oC according to (AOAC, 1990). Crude protein 
was estimated by the Kjeldahl method using the TecatorKjeltec System (AOAC, 1990) and 
crude fat was determined using Soxhlet extraction with chloroform: methanol  (2:1 v/v) 
(Christie, 2003). The methodologies applied are described in more detail in Section 2.6. 
Minerals and phosphorus from homogenised feed and dried body cross-section pools were 
determined using inductively coupled plasma mass spectroscopy, ICP-MS with collision cell 
technology (CCT) (Thermo X Series 2). One hundred milligrams of pooled body cross-
section homogenates were added to Teflon digestion tubes with 5 ml of 69 % nitric acid. The 
tubes were then put into a microwave digester (Mars Fish digester) for the initiation of the 
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digestion process (Step 1: 21-190°C for 10 min at 800 W; Step 2: 190°C for 20 min at 800 
W; Step 3: 190-21°C for 30 min cooling period). Samples from digestion tubes were then 
poured into 10 ml volumetric flasks and made up to 10 ml with the addition of distilled water. 
Four hundred µl of the digest were poured into another plastic 10 ml sample tube and made 
up to a final volume of 10 ml with distilled water prior to measuring the elemental 
concentration within pooled dried carcass and bone homogenates using ICP-MS. Mineral 
concentration was calculated as µg g-1 using Equation 1. 
𝐸𝑙𝑒𝑚𝑒𝑛𝑡𝑎𝑙 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (
µ𝑔
𝑔
) =
𝑆𝑎𝑚𝑝𝑙𝑒 𝑣𝑜𝑙𝑢𝑚𝑒
1000
×
𝑅𝑒𝑠𝑢𝑙𝑡 𝑓𝑟𝑜𝑚 𝐼𝐶𝑃
𝑆𝑎𝑚𝑝𝑙𝑒 𝑤𝑒𝑖𝑔ℎ𝑡 (𝑔)
 
Phytate levelsin the diets were estimated using a Megazyme Phytate/Total Phosphorus Assay 
kit (Megazyme, Ireland). 
3.2.4 Statistics 
Growth trajectories based on the mean weight estimates at Day 36/prior vaccination, Day 
63/prior vaccination and Day 97/ 34 days post vaccination were modelled as repeated 
measures (Crampton et al., 2010; Espe et al., 2012). Growth performance indices (mean 
daily weight gain, SGR and TGC) were also assessed in a similar manner. Moreover, a 
hierarchical (multilevel) statistical model was used for the proximate and mineral analysis 
of pooled body cross-sections from each tank, since multiple observations from a single tank 
were available (several pools) (Espe et al., 2012; Nanton et al., 2012; Hartviksen et al., 2014). 
The statistical analysis was carried out with the help of the R language (R Core Development 
Team, 2014) and its lme4 package (Bates et al., 2014). The statistical approach applied was 
model-based. This means that to find if any specific effect was statistically significant data 
were fitted in three different models with increasing complexity where tank was included as 
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a random effect, sampling time as a categorical variable and the percentage of protein from 
SPC as a continuous factor possibly having non-linear effects: 
1. a model with only sampling time (Tank considered as a random effect). 
2. a model with sampling time and % protein from SPC with their interaction (Tank 
considered as a random effect). 
3. a model as above but with an additional quadratic effect of % protein from SPC with 
interactions to reveal any non-linearity in the response (Tank considered as a random 
effect). 
The three models were nested and compared with a likelihood ratio test (LRT) that evaluated 
if the improvement in the likelihood required a more complex model or whether the simpler 
model could be applied. Models demonstrating possibilities (P values) < 0.05 were selected 
for the description of data. The simplest possible model was adopted according to Occam's 
razor principle. The adopted model was demonstrated by plotting the expected mean 
response with 95% confidence intervals. For a categorical effect these were represented as 
points with error bars and for a continuous effect as a curve with shaded confidence region. 
The expected mean and 95% confidence intervals were solved by a posterior simulation from 
the adopted statistical model (n=1500 random draws were used throughout this study) 
(Gelman and Hill, 2007).  
3.3 RESULTS 
3.3.1 Growth performance 
The mortalities among the four experimental groups of Atlantic salmon were negligible 
(<1%). Figure 11 demonstrates the weight development of the four dietary groups of Atlantic 
salmon. The models with the linear effect of the dietary percentage of protein from SPC were 
favoured using the LRTs (likelihood ratio tests) for both expected mean weight of salmon 
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and expected mean daily weight gain (WG) (Statistical models are presented in Fig. 12 and 
13). The mean expected values of the aforementioned growth parameters with their 
estimated 95% confidence intervals (C.I.) are demonstrated with different colour for each 
timepoint or period respectively. More specifically the black line (expected mean values) 
and its corresponding shaded region (estimated 95 % C.I.) represents the expected mean 
weight values for Day 36 and the credible mean weight gain for the pre vaccination period 
from Day 0 to Day 36. The values in red represent the mean weight estimates for Day 63 
and the expected mean daily WGs for the pre-vaccination period from Day 36 to Day 63, 
while values in blue demonstrate the corresponding values for Day 97 and the post 
vaccination period, from Day 63 (day of vaccination) to Day 97 (34dpv). Overall, increasing 
levels of SPC resulted in lower mean weight and daily weight gain in Atlantic salmon 
juveniles at all timepoints of the study. Approximate reductions of 12 and 10% in expected 
mean weight were observed in SPC80 compared to SPC35 salmon at Day 36 and 63 of the 
feeding trial respectively, while an 8% reduction in weight was demonstrated at Day 97 
(34dpv) between the two dietary groups (Fig. 12). Moreover, SPC65 and SPC80 salmon 
exhibited significantly lower mean weights compared to the SPC35 group at all timepoints. 
In a similar manner, the reduction in daily WG observed in the high SPC inclusion dietary 
groups was improved at post-vaccination compared to the SPC35 group. This could be 
observed by the slope of the WG curve for the post-vaccination period when 8% reduction 
in WG for SPC80 compared to SPC35 salmon was recorded. This slope was much shallower 
compared to the slopes obtained for the pre-vaccination periods, when 17 and 10% reduction 
in WG in SPC80 compared to SPC35 salmon  was observed (Fig. 13). Overall, SPC65 and 
SPC80 salmon demonstrated significantly lower mean daily WG compared to the SPC35 
group, for the first (Day 0 –Day 63) and second (Day 63 – Day 97) period of the feeding 
trial while no differences were noted for the last bit of the study, further supporting the 
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improved performance of fish receiving higher SPC levels compared to the SPC35 group. 
SGR and TGC values for the experimental groups did not present significant differences 
among the four dietary groups and were only affected by the study period and the 
developmental stage of the fish. Overall, Atlantic salmon experienced the highest SGR and 
TGC values during the first part of the study, while the lowest values were demonstrated at 
the last part of the study and after the vaccination of the fish, while intermediate SGRs and 
TGCs were exhibited for the second period of the study.  
 
Figure 9 Observed weight development of the four dietary groups of Atlantic salmon juveniles. Dashed 
bold vertical lines separate different study periods: pre vaccination period, Day0-Day36; pre-vaccination 
period, Day36-Day63; post-vaccination period Day 63-Day 97. Broken lines with different colours within each 
treatment subplot connect the mean weight values of each replicate tank.  
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Figure 10 Modelled values of mean salmon weight for the four dietary groups at each timepoint. 
Statistical model showing a significant linear effect of the percentage of protein from SPC on salmon 
performance data with P values < 0.05; Expected mean weight (g) (with 95% C.I.) in relation to % SPC 
inclusion over the course of the study. Black, Red, and blue lines connect the expected mean weight gain for 
each one of the groups at different study periods: Black line refers to Day 36 of the feeding trial and prior to 
the vaccination; Red line represents the expected mean values from Day 63 of the feeding trial and prior to the 
vaccination and Blue line represents the expected mean weights from Day 97 of the feeding trial and at 34 days 
post vaccination. Shaded regions of the same colours indicate the 95% confidence interval regions for these 
measurements. Dashed horizontal lines denote the mean values for the salmon fed diets with 35% of dietary 
protein from SPC. Mean values which lie outside the 95% C.I. of the the group receiving 35% of dietary protein 
from SPC are considered significant. Asterisks denote significant differences between salmon fed 35% of 
protein from SPC and salmon fed diets with higher percentage of dietary protein from SPC at different 
timepoints. 
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Figure 11 Modelled daily weight gain per study period. Statistical model showing a significant linear effect 
of the percentage of protein from SPC on salmon performance data with P values < 0.05; Expected mean daily 
weight gain per fish (g × day-1) (with 95% C.I.) in relation to % SPC inclusion over the course of the study. 
Black, Red, and blue lines connect the expected mean weight gain for each one of the groups at different study 
periods: Black line refers to Day 0 - Day 36 of the feeding trial prior to the vaccination; Red linerepresents the 
expected mean weigth gains from Day36 - Day 63 of the feeding trial and prior to the vaccination and Blue 
line represents the expected mean weight gains from Day 63 - Day 97 of the feeding trial and the 34-day post 
vaccination. Shaded regions of the same colours indicate the 95% confidence interval regions for the values of 
these measurements. Dashed horizontal lines of the aforementioned colours denote the mean values for salmon 
fed diets with 35% of dietary protein from SPC. Mean values which lie outside the 95% C.I. of the group 
receiving 35% of dietary protein from SPC are considered significant. Asterisks of the same colours denote 
significant differences between salmon fed 35% of protein from SPC and salmon fed diets with higher 
percentage of dietary protein from SPC at different timepoints. 
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3.3.2 Proximate and mineral composition of pooled body cross-sections 
No differences due to the inclusion of SPC in the feeds were demonstrated among dietary 
groups of salmon in terms of lipid, protein and moisture concentrations; whereas a linear 
reduction in body cross-section ash levels both prior to vaccination (Day 63) and at 34 dpv 
(Day 97) was demonstrated in salmon fed on high dietary levels of SPC (Model is plotted in 
Fig.14A). Overall, moisture, lipid and protein concentrations were only affected by time. A 
reduction of about 36% was observed in the vaccinated salmon body cross-section credible 
moisture levels at 34 dpv compared to pre vaccination levels. Furthermore, an increase of 
18% and 4% was demonstrated in Atlantic salmon body cross-section credible lipid and 
protein levels respectively at 34 dpv in comparison to levels prior to vaccination. Expected 
ash values in salmon juveniles were affected linearly by the increased inclusion of SPC in 
the diets with the SPC80 group demonstrating a 13% decrease in credible ash content 
compared to SPC35 salmon. Lower levels of ash were demonstrated at 34 dpv for all dietary 
groups. However, the groups receiving lower levels of dietary protein from SPC were the 
ones demonstrating the highest reduction in body cross-section ash levels while at this 
timepoint the SPC80 group exhibited a decrease of only 5% in expected ash concentration 
compared to the SPC35 group of fish.   
The “raw data” for the pooled body cross-section elemental compositions are 
presented numerically in Table 6. Credible calcium to phosphorus (Ca:P) ratio, calcium (Ca), 
phosphorus (P), manganese (Mn) and zinc (Zn) levels in pooled body cross-section samples 
were affected  in a linear fashion by increasing levels of dietary SPC, since the model with 
linear description of the data was found to describe the data in a better manner compared to 
the other two models (Models selected are presented in Fig. 14B, 14C, 14D, 15B and15C). 
Therefore the dietary groups receiving feeds with higher levels of SPC inclusion exhibited 
lower amounts of the abovementioned elements. On the other hand, the model showing a 
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quadratic effect of the percentage of dietary SPC, improved the fit over the linear model for 
body cross-section expected Mg levels (Model selected is plotted in Fig. 15A). Overall, at 
Day 63, SPC35 salmon demonstrated significantly higher Ca: P ratio, Ca, P and Mg 
concentrations than the SPC50, SPC65 and SPC80 groups and higher amounts of Zn and 
Mn in comparison to the SPC65 and SPC80 groups.  
In general, lower body cross-section elemental amounts were demonstrated for all 
dietary groups at Day 97 (34 dpv) compared to Day 63 (prior to vaccination). At this 
timepoint significantly lower Ca: P ratio, Ca, P and Zn concentrations were recorded for 
SPC65 and SPC80 salmon compared to the SPC35 group. Despite the observed reduction in 
body cross-section elemental concentrations at Day 97 compared to Day 63, an overall 
improvement in expected Ca:P ratio, Ca, P, Mg and Mn was demonstrated from the modelled 
based statistical analysis in vaccinated salmon receiving increased dietary SPC. This was 
apparent from the slope  connecting the expected mean values for the dietary groups at this 
timepoint (blue lines in Fig. 14B, 14C, 14D, 15A and 15C) which was much shallower 
compared to Day 63 and the fact that SPC35 salmon was the group demonstrating the 
greatest reduction for all elements except Zn compared to the other groups. Expected Zn was 
the only mineral with no marked improvement in the body cross-sections of Atlantic salmon 
fed increasing dietary SPC-inclusions, at Day 97 (34dpv). 
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Table 6 Ash and elemental composition of Atlantic salmon parr pooled body cross-sections. 
Mineral Composition (× kg-1) 
Day 63(prior to vaccination) 
SPC35 SPC50 SPC65 SPC80 
Ash (g) 2.12±0.06           2.00±0.03 1.90±0.06        1.83±0.08 
Phosphorus (P) (mg) 4887±208 4875±472   4220±102 4336±314 
Calcium (Ca) (mg) 4265±286 4269±511   3602±95 3069±704 
Ca: P ratio 0.87±0.03           0.87±0.03 0.85±0.01        0.70±0.01 
Magnesium (Mg) (mg) 369±11 351±12 320±4 345±22 
Manganese (Mn) (mg) 0.96±0.05           1.09±0.21 0.85±0.11        0.82±0.05 
Zinc (Zn) (mg) 22.02±0.67          22.29±2.78     19.41±0.88       20.88±1.64 
Day 97(34 days  post 
vaccination) 
    
Ash (g) 1.77±0.02           1.85±0.05 1.74±0.05        1.71±0.09 
Phosphorus (P) (mg) 3480±25 3602±53   3439±114 3261±62 
Calcium (Ca) (mg) 2127±171 2328±190   2002±101 1816±89 
Ca: P ratio 0.61±0.04           0.65±0.05 0.58±0.02        0.56±0.04 
Magnesium  (Mg) (mg) 305±5 315±5   308±12 298±4 
Manganese (Mn) (mg) 0.56±0.05           0.70±0.08 0.58±0.06        0.54±0.02 
Zinc (Zn) (mg) 13.29±1.28          14.60±1.11 13.19±0.67       12.06±0.58 
Data for ash and elemental composition are referred as means ± SD of 4 pooled samples (1 pool of 6 body cross-section homogenates per tank).  
Abbreviations: SPC 35 - diet with 35 % of dietary protein from soy protein concentrate (SPC); SPC 50 - diet with 50 % of dietary protein from SPC; SPC 65 - diet with 65 % 
of dietary protein from SPC; SPC 80 - diet with 80% of dietary protein from SPC. 
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Figure 12 Modelled ash, Ca: P ratio, P and Ca pooled body cross-section levels. Statistical models showing 
a significant linear effect of the percentage of protein from SPC on pooled body cross-section ash and elemental 
levels with P values < 0.05; Expected (A) Ash (g × kg-1); (B) Ca: P ratio; (C) Phosphorus (P) (mg × kg-1); (D) 
Calcium (Ca) (mg × kg-1) (with 95% C.I.) (y axis) in relation to % SPC inclusion (x axis) over the course of 
the study. Red, and blue lines connect the expected mean values for each measurement at Day 63 post feeding 
prior to vaccination and Day 97 post feeding (34 days post vaccination) respectively, while shaded regions of 
the same colours indicate the 95% confidence regions for the values of these measurements. Dashed horizontal 
lines of the aforementioned colours denote the mean values for salmon fed diets with 35% of dietary protein 
from SPC. Mean values which lie outside the 95% C.I. of the group receiving 35% of dietary protein from SPC 
are considered significant. Asterisks of the same colours denote significant differences between salmon fed 
35% of protein from SPC and salmon fed diets with higher percentage of dietary protein from SPC at different 
timepoints. 
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Figure 13 Modelled Mg, Zn and Mn pooled body cross-section levels. Statistical models showing a 
significant linear effect of the percentage of protein from SPC on pooled body cross-section elemental levels 
with P values < 0.05; Expected (A) Magnesium (Mg) (mg × kg-1); (B) Zinc (Zn) (mg × kg-1); (C) Manganese 
(Mn) (mg × kg-1) (with 95% C.I.) (y axis) in relation to % SPC inclusion (x axis) over the course of the study. 
Red, and blue lines connect the expected mean values for each measurement at Day 63 post feeding prior to 
vaccination and Day 97 post feeding (34 days post vaccination) respectively, while shaded regions of the same 
colours indicate the 95% confidence regions for the values of these measurements. Dashed horizontal lines of 
the aforementioned colours denote the mean values for salmon fed diets with 35% of dietary protein from SPC. 
Mean values which lie outside the 95% C.I. of the group receiving 35% of dietary protein from SPC are 
considered significant. Asterisks of the same colours denote significant differences between salmon fed 35% 
of protein from SPC and salmon fed diets with higher percentage of dietary protein from SPC at different 
timepoints. 
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3.4 DISCUSSION 
The results obtained in the current study indicate that an increase in dietary SPC inclusion 
can influence an overall reduction in the growth performance (mean weight and mean daily 
weight gain) of Atlantic salmon pre-smolts. The reduction in WG was much more obvious 
during the first (Day 0 - Day 36) and second (Day 36 – Day 63) period of the study prior to 
the vaccination of the fish. The lowered daily WG observed during this period, could be 
attributed to reduced feed intake; however the exact amount of feed intake (FI) by the 
experimental groups of fish was not determined in the present study. Decreased FI resulting 
in reduced growth, has been previously reported in several feeding trials testing increasing 
levels of dietary SPC in several farmed piscine species (Kissil et al., 2000; Arãgao et al., 
2003; Deng et al., 2006), while Mambrini et al. (1999) demonstrated decreased feed intake 
and growth in rainbow trout receiving diets with more 80% of dietary protein from SPC. 
However, at the last period of the study and post vaccination, despite the observed reduction 
in salmon WG upon increased dietary SPC inclusion, no significant differences were 
obtained among the four dietary groups. The former finding indicates an improvement in the 
growth performance of fish receiving higher levels of SPC (SPC65 and SPC80) compared 
to the best performing SPC35 and SPC50 groups of the first trial period.  
Reduced WGs were observed for the last part of the study, at post vaccination 
compared to the previous study period from Day 36 to Day 63 despite the larger size of the 
fish and the longer duration of the last part of the trial. This could be attributed to increased 
post-vaccination stress (Van Muiswinkel and Wiegertjes, 1997), reduced fish appetite 
(Melingen and Wergeland, 2000), stress-induced reduction of growth modulating hormones 
(Pickering, 1993) or reduced energy expenditure for growth due to immune induction 
(Wendelaar Bonga, 1997). The fact that no differences in WG were obtained among the four 
dietary groups of salmon at the last timepoint could have also been influenced by the 
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vaccination of the dietary groups. Nevertheless, an overall improvement in daily WG was 
observed at the previous period of the study for the SPC65 and SPC80 groups of fish, 
pointing at a gradual enhancement salmon mean daily WG. Traditionally used growth 
performance indicators including SGRs and TGCs demonstrated no differences among the 
four dietary groups of salmon at all timepoints, revealing minor changes in the overall 
growth performance of Atlantic salmon pre-smolts and that the use of WG for the 
aforementioned type of statistical analysis was much more useful. 
Juvenile Atlantic salmon are much more sensitive to the inclusion of vegetal protein 
in their diets than smolts. Burr et al. (2012) demonstrated that the growth performance of 
Atlantic salmon parr fed diets in which protein was supplied from alternative protein blends 
improved with the age of the fish, with late stage parr presenting improved growth. In the 
present study, despite the obvious reduction in growth performance during the full period of 
the trial, an improvement in WG was witnessed for high SPC inclusion dietary salmon during 
the post-vaccination period. This was an indication that late stage Atlantic salmon of ~125 
g can utilise the nutrients of these diets more efficiently either due to having a more 
developed digestive tract or due to the fact that they require a longer adaptation time to 
accept these diets. This is partly in accordance with the findings of Burr et al. (2012). The 
results of the present study are also in line with several other studies in which early stage 
Atlantic salmon post-smolts exhibited reduced growth when fed diets containing less than 
30% FM and high levels of plant proteins, supplied as blends or as a single protein source 
(Refstie et al., 2001; Refstie and Tiekstra, 2003; Espe et al., 2006; Torstensen et al., 2008; 
Øverland et al., 2009). Previously it was proven that Atlantic salmon needs a longer 
adaptation period before fully accepting any diet with low levels of FM with alternative 
protein sources (Torstensen et al., 2008). Moreover,several studies have suggested that 
salmon are able to compensate growth after periods of restricted feed intake (Johansen et al., 
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2001; Torstensen et al., 2008). This could explain the enhanced growth performance 
observed during the last period of the trial (from Day 63 prior to vaccination at Day 97 at 34 
dpv) in fish fed increasing amounts of SPC.  
Overall, despite the observed significant reduction in salmon growth upon increased 
dietary inclusion of SPC, numerically this decrease was not very large. Thus, a reduction in 
WG of 11 g (SPC80 vs SPC35 group of salmon) was only 8% of the WG in SPC35-fed fish 
during the study. It is also worth noting that the differences detected in the present study are 
much less than between feeds of different FM qualities (Anderson et al., 1997). 
Phytate represents almost two thirds of the soybean phosphorus content and is not 
bioavailable to fish since it cannot be digested by the fish’s gastrointestinal enzymes (Francis 
et al., 2001). Moreover analyses of the experimental dietary treatments demonstrated an 
increment in the amounts of phytate upon increased inclusion of SPC. Phosphorus was 
therefore supplemented in the diets of experimental fish by adding 30 g × kg-1 dicalcium 
phosphate (Storebakken et al., 1998b) to their diets, while the minimum reported dietary 
requirement for Atlantic salmon is around 10 g × kg-1 (Åsgard and Shearer, 1997). Proximate 
composition and mineral analysis of pooled body cross-section homogenates revealed a 
linear reduction of ash level, Ca:P ratio, Ca, P, Mn, and Zn content and an overall reduction 
in Mg in salmon parr fed on increasing dietary proportions of SPC prior to (Day 63) and 34 
dpv (Day 97), which could be attributed to the increasing amounts of ANFs present in high 
SPC inclusion diets. The reason for this seems to be the reduced availability of P in high 
SPC inclusion diets, since most of the P in SPC is found in the form of phytic acid and 
phytate which are largely indigestible by salmon digestive enzymes, negatively influencing 
the concentrations of body minerals (Lall, 2003). Similarly to our findings Storebakken et 
al.(1998b) reported decreased levels of whole body ash, P, Ca Mg, Zn and Ca:P ratio in 
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salmon fed 75% of dietary protein from undephytinized SPC (i.e. non-treated with phytase) 
for 84 days compared to a FM fed salmon.  
Expected phosphorus levels in the current study for the experimental groups, lay 
between the values for full body P levels reported by Shearer et al. (1994) and Baeverfjord 
et al. (1998) (~5000  mg × kg-1); and those reported by Helland et al. (2006) (4000 - 4200 
mg × kg-1) for Atlantic salmon parr of a similar size to the fish in the present trial at Day 63 
(Denstadli et al., 2006). However on Day 97 (34 dpv) of the feeding trial, credible P levels 
were estimated to be 3500 mg × kg-1 for salmon parr fed SPC35 and 3250 mg × kg-1 for 
salmon parr fed SPC80. These values are lower than the whole body P concentrations 
reported by Helland et al.  (2006), possibly pointing at P deficiency in the experimental fish 
by the end of the trial. However, fish at this time point were at least 1.6 times larger (~165 
g) than fish from the study of  Helland et al. (2006) revealing far higher growth rates in the 
present trial, which could be attributed to the application of continuous light and intense 
feeding regime (Kråkenes et al., 1991; Fjelldal et al., 2005). Helland et al. (2006) reported 
that phytate did not promote any negative effects on either whole body or vertebral P levels; 
however P levels in the experimental diets were properly balanced, upon increased phytate 
inclusion which was not the case in the present study.  
Expected calcium  concentrations  at Day 63 were lower compared to the whole body 
Ca levels stated by Shearer et al. (1994) for Atlantic salmon parr, who reported 
concentrations of up to 5000 mg × kg-1. However Ca levels were found to be similar to those 
reported by Helland et al., (2006) for salmon parr of about the same size, who estimated that 
whole body Ca concentration for well mineralised salmon is between 3900 - 3600 mg × kg-
1 and 2500 mg × kg-1 for Ca deficient individuals. At Day 97 the average Ca concentration 
in body cross-sections of Atlantic salmon parr with an average weight of 165 g was found 
to be within 2100-2200 mg × kg-1 for SPC35, SPC50 and SPC65 salmon parr and 1800 mg 
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× kg-1 for the SPC80 group of salmon. These values are lower than those described by 
Helland et al. (2006) for Ca deficiency in Atlantic salmon parr and could be pointing at a 
state of subclinical Ca deficiency in these fish. Normally the Ca:P ratio should be close to 
1.0 in whole body, however similarly to the ratios reported by Helland et al. (2006) (~ 0.9 
whole body Ca:P ratio for well mineralised Atlantic salmon parr) the credible values 
calculated in the current study at Day 63 presented a linear reduction with the expected Ca:P 
ratios ranging from 0.91 to 0.78 in salmon fed increasing levels of SPC. This is an indication 
of reduced calcification of the bony structures and therefore reduced bone mass in SPC80 
salmon compared to the other groups, which could lead to an increased prevalence of 
vertebral deformities. Since Ca metabolism is closely related to that of P the above 
observation is more probably linked with the reduced availability of P from phytate which 
represents the main storage form of P in SPC. Moreover, the results of the analysis at Day 
97 could be an indication of subclinical Ca deficiencies in all dietary groups of salmon parr 
since both Ca concentrations were below 2500 mg × kg-1 while Ca: P ratios ranged between 
0.62-0.55, which is far below the levels reported before by Helland et al.(2005, 2006). 
Shearer et al. (1994) reported that manganese (Mn) levels could range from 3.0 to 1.0 
mg × kg−1 in the whole body of Atlantic salmon parr. Credible manganese concentrations in 
the present study were closer to the lower end of these values, either due to the larger size of 
the fish or the fact that body cross-sections instead of whole body samples (which contain 
the liver tissue; the main storage organ of Mn) were used for the determination of mineral 
levels. The linear reduction of this mineral with increasing SPC inclusion could be related 
to the combined effect of the increased dietary inclusion of phytate and other minerals such 
as iron (Fe), copper (Cu) and vanadium (V), which are found in higher quantities within SPC 
(Table 6 of Chapter 5) competing with Mn for the same binding sites for absorption 
(Andersen et al., 1996). Previously, Cheng et al. (2004) reported that supplementation with 
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500 FTU phytase × kg-1 of a soy-based diet, could improve Mn availability in rainbow trout, 
indicating that phytate could affect body concentration levels. 
Whole body magnesium (Mg) concentration in well mineralised Atlantic salmon 
shown by Baeverfjord et al. (1998) was 426 mg × kg−1 while Shearer et al.  (1994) reported 
similar whole body Mg levels for Atlantic salmon parr. On the other hand El-Mowafi and 
Maage (1998) found that whole body Mg concentrations in Atlantic salmon parr are around 
300 mg × kg−1, whereas Helland et al. (2006) documented values between 253 and 284 mg 
× kg−1. The expected values obtained in the current study at Day 63 and Day 97 of the feeding 
trial were intermediate to those reported by El-Mowafi and Maage (1998) and Helland et al. 
(2006). Helland et al., (2006), reported that diets with high phytate levels can have a negative 
impact on whole body concentration of Ca, Mg, and the Ca: P ratio.  
Expected Zn levels in the current study were lower than the whole body Zn values 
reported to be normal for Atlantic salmon parr (40-60  mg × kg-1) by Shearer et al. (1994). 
Closer to the Zn values reported in the current study at Day 63 were the whole body Zn 
values described by Helland et al. (2006), which were between 21-33 mg × kg-1. Helland et 
al. (2006) suggested that the reported Zn levels of 21-33 mg × kg-1 could be an indication of 
Zn deficient salmon. At Day 97 (34 dpv) Zn values were found to be lower than 15 mg × kg-
1 for all dietary groups, indicating even higher Zn deficiencies (Helland et al., 2006). 
However, similarly to the current study no external signs of Zn deficiency including lens 
cataracts, fins and skin erosion, and short body dwarfism described in rainbow trout (Ogino 
and Yang, 1978; Satoh et al., 1983) were displayed in the Atlantic salmon parr fed increasing 
levels of phytate at both time points (Helland et al., 2006). 
The reduction in expected pooled body cross-section ash, Ca: P ratio, Ca, P, Mg, Mn, 
and Zn levels detected at Day 97 (34 dpv) of the study compared to Day 63 (prior 
vaccination) seems to have a multifactorial cause and could potentially point at a state of 
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sub-clinical Ca, P, Mg, Mn and Zn deficiency for salmon parr by the end of the study. 
Salmon parr in this study were reared under continuous light for the prevention of 
smoltification and fish maturation (Bromage et al., 2001; Stefansson et al., 2007; Stefansson 
et al., 2008). Stefansson et al. (2007; 2008) stated that Atlantic salmon parr reared under 
constant light photoperiod can develop into “pseudo-smolts” exhibiting all the external 
changes in appearance which characterise smoltifying salmon but not the physiological 
changes required for seawater adaptation. However, there is a lack of information regarding 
the way ion and osmo-regulation is affected in Atlantic salmon pseudo-smolts. It is thus 
possible that the reduced elemental levels at Day 97, could have been influenced by 
disturbances in the ion and osmo-regulation of the sampled individuals. Another possible 
hypothesis for the diminished elemental amounts obtained at this timepoint could be the 
enhancement of salmon growth through the application of constant light (Kråkenes et al., 
1991; Fjelldal et al., 2005; Stefansson et al., 2008).  
In the current study salmon parr with an initial weight of 29 g had achieved an average 
weight of 174 g in a period of 97 days, while salmon parr of an average 36.5 g used by 
Helland et al. (2006) achieved  a weight of 100 g  in a period of 80 days. In the current trial 
a daily WG of almost 1.5 g × day-1 was achieved in comparison to the overall 0.8 g × day-1 
WG in the aforementioned study. Furthermore, it has also been reported that fast growing 
Atlantic salmon post-smolts after 6 months under continuous light (Fjelldal et al., 2006) 
demonstrated lower mineral content and mechanical strength in vertebral bones than slower 
growing salmon under natural light. Furthermore, it has been stated that during periods 
characterised by fast growth, the actual time required for bone matrix to be produced and 
mineralised could be reduced to a critical level (Hernandez et al., 2000), leading to under-
mineralised and soft bony tissues. This was one of the proposed reasons for the higher 
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incidence of vertebral deformities in fast growing under-yearling Atlantic salmon smolts 
compared to slower growing yearling smolts (Fjelldal et al., 2006).  
Vaccination on the contrary, is known to delay growth due to stress induction, the 
reduction of circulating hormones promoting fish growth and the increased energy 
expenditure for immune induction (Pickering, 1993; van Muiswinkel and Wiegertjes, 1997; 
Wendelaar Bonga, 1997). It has also been demonstrated that i.p. injected oil-based vaccines 
can affect bone mineralisation depending on the experimental conditions (Berg et al., 2005, 
2006, 2012). One hypothesis for the lower levels of ash and mineral seen at 34dpv is the 
combined effect of continuous light promoting fast growth in the salmon and the vaccination 
process promoting lower mineralisation of bone. Rungruangsak-Torrissen et al. (2009) 
reported that increased growth through increased lipid deposition by continuous light 
stimulation can be associated with reduced vertebral mineralisation and strength. Perhaps in 
order to retain higher mineralisation upon vaccination under constant light conditions, a diet 
with even higher available protein content should have been provided to the fish 
(Rungruangsak-Torrissen et al., 2009). This is crucial in terms of preventing deformities 
during the early growth period, as a high protein deposition is important for the normal 
growth and mineralisation of the skeleton (Rungruangsak-Torrissen et al., 2009). 
Despite the large reduction in bone ash and minerals, revealing a subclinical state of 
mineral deficiency, most likely promoted by the interaction of fish vaccination and the 
application of continuous light, an improvement in these parameters was observed in 
vaccinated salmon maintained on diets with increased SPC levels. Fjelldal et al. (2010) 
reported that high inclusion levels of plant derived products could have a positive effect on 
bone health in fast growing Atlantic salmon post smolts by delaying salmon growth. This 
could be reflected in ash levels and explain the observed improvement in body cross-section 
Chapter 3. Effects of increasing dietary levels of SPC and constant dietary supplementation of phosphorus 
on growth and elemental composition of juvenile Atlantic salmon 
 
 
113 | P a g e  
 
ash values of fish fed diets with more than 35% of dietary protein from SPC, which in general 
exhibited lower growth rates throughout the whole study period.  
3.5 CONCLUSIONS 
The present study, confirms the usefulness of SPC as a partial substitute for good quality 
FM in late stage salmon parr feeds, since the reduction in SPC80 salmon growth (mean 
weight and WG) was only 8% of that in SPC35 fed fish during the study, which was much 
less than the growth changes observed in salmon fed diets of different FM varieties 
(Anderson et al., 1997). Moreover, the reduction of P, Ca, Mg and Mn levels in body cross-
sections due to the increasing dietary SPC inclusion, determined for the initial 63 day period 
seems to improve in the long term and upon vaccination. Whether this is an outcome of the 
long term provision of Atlantic salmon parr with high SPC inclusion in their diets or the 
interaction of the increased dietary SPC inclusion and fish vaccination, is still unknown.  
Furthermore, it was shown that the exposure of Atlantic salmon to constant light as a 
means of delaying fish maturation and smoltification, promoting fast growth could 
compromise the elemental composition of the fish. Therefore, research on high FM 
replacement with plant products such as SPC, should also consider the conditions in which 
fish are exposed. Dietary levels of available P can influence the dietary uptake of many other 
important minerals including Ca and Zn which are integral for healthy bones. In the current 
trial it is clear that upon increased dietary SPC inclusion, the supplementation of P in salmon 
diets should be increased appropriately. This is pivotal for salmon normal growth and bone 
mineralisation. It is also possible that increasing dietary supplementation of Zn in salmon 
feeds with increasing SPC inclusion could improve growth performance, the uptake and 
body concentration of the specific mineral in Atlantic salmon parr. Furthermore, it was 
shown that the use of body cross-sections for elemental examination in Atlantic salmon, 
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gives similar patterns to the already reported whole body elemental concentrations. 
Therefore the use of body cross-sections could potentially be a very informative way for the 
evaluation of the mineral status of Atlantic salmon at various life stages. 
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4.1 INTRODUCTION 
The culture of carnivorous piscine species such as Atlantic salmon (Salmo salar L) requires 
the production of compounded aqua-feeds that have traditionally been made with a high 
inclusion of fishmeal (FM) as the main source of protein and IAAs. However, the rapid 
growth of intensive aquaculture necessitates the use of alternative protein sources since there 
is a limited supply of FM. Besides its limited availability, FM is also a relatively expensive 
feedstuff for aqua-feed production. For this reason fish nutrition research has focused on 
alternative protein sources and plant-based ingredients, which are currently readily available 
(Kaushik, 1990; Tacon, 1994; Carter and Hauler, 2000). Among plant proteins, SBM is 
considered to be one of the most nutritious plant protein sources (Dersjant-Li, 2002). 
However, high amounts of antinutritional factors (ANFs), resulting in reduced nutrient 
digestibility, poor performance and hind gut enteritis, have limited its inclusion in Atlantic 
salmon aqua-feeds (Dersjant-Li, 2002). 
On the other hand, in alcohol extracted SPC most of the ANFs are eliminated making 
this feedstuff an increasingly important protein alternative to FM (Peisker, 2001). Many 
studies have demonstrated the suitability of SPC as an alternative dietary protein source for 
Atlantic salmon post smolts (Refstie et al., 1998; Storebakken et al., 2000, 1998b) and the 
absence of soybean induced enteritis in salmonids receiving diets with even 100% 
substitution of FM with SPC (Escaffre et al., 2007; Krogdahl et al., 2000). However, while 
it has been shown that SPC is an excellent ingredient for practical feeds for many 
commercially important salmonid species and is widely used as a feed ingredient, further 
information is needed about the effects of SPC on Atlantic salmon health. To date only one 
published study by (Krogdahl et al., 2000) has investigated the effects of diets with 30% of 
dietary protein from SPC on the disease resistance and intestinal immunity of seawater 
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adapted Atlantic salmon. In this study increased lysozyme activity and total IgM levels were 
demonstrated in the intestinal mucosa of seawater adapted Atlantic salmon smolts 
maintained on feeds with 30% of dietary protein from soy products (SBM and SPC). 
Moreover, SPC-fed salmon demonstrated enhanced disease resistance when challenged with 
Aeromonas salmonicida compared to the groups fed a FM or a SBM diet. Nonetheless, a 
lack of information about the effects of increasing dietary levels of SPC on the general 
immune status of Atlantic salmon parr still exists. In addition, the majority of the reported 
studies observing the effects of diets with increasing dietary levels of vegetable proteins 
(VPs) on the immune responses of several farmed fish have focused on innate immune 
responses of fish that have not been stimulated immunologically. Thompson et al.(1996) 
proposed that measuring defence mechanisms prior to immune stimulation only represents 
resting levels. However, determining immune responses shortly or later after immune 
stimulation (via vaccination in the current study) may highlight dietary modifications that 
were not evident before. Vaccination is an integral prophylactic practice in large scale 
salmon culture, which usually takes place during the freshwater salmon parr stage, 
increasing salmon’s resistance against several lethal bacterial diseases such as furunculosis 
(Poppe and Koppang, 2014). 
The aim of the present trial was to monitor how increasing dietary SPC inclusion on 
the immunological responses of Atlantic salmon parr, prior to and post-vaccination (at 7 and 
34 dpv) with a commercial anti-A. salmonicida vaccine. 
4.2 MATERIALS AND METHODS 
4.2.1 Diets and fish husbandry 
The present study is the same to that presented in Chapter 3, giving however an insight on 
the immunological responses of Atlantic salmon pre-smolts fed on increasing amounts of 
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dietary levels SPC. Four diets were formulated so that SPC supplied 35, 50, 65 and 80 % of 
totaldietary protein (termed SPC35, SPC50, SPC65 and SPC80 respectively) with high 
quality FM providing the rest of the dietary protein in all cases. The diets were manufactured 
by EWOS Innovation, Dirdal, Norway and were formulated so that protein: fat ratios were 
constant, while lysine, methionine and threonine were supplemented to give the same AA: 
protein ratios among dietary treatments (Table 5 of the Chapter 3). The amount of 
supplemented dicalcium phosphate was constant between all four experimental diets at 30 g 
× kg-1 of feed, exceeding Atlantic salmon reported phosphorus requirements (Åsgard and 
Shearer, 1997; Lall, 2003) in order to mediate problems, which could be caused by increased 
amounts of phytate found in SPC (Storebakken et al., 1998b, 2000). The feeding trial, 
conducted at EWOS Innovation experimental facilities in Dirdal, Norway, was performed in 
sixteen circular tanks each containing 60 l of freshwater. Water temperature was maintained 
at 13 ± 1ºC, whilst photoperiod was constant (24 h of light). The diffused oxygen level of 
inlet water to the tanks was constantly 90-100 % saturation. A total of one thousand nine 
hundred and twenty unvaccinated Atlantic salmon parr (from a SalmoBreed strain selected 
for improved growth) of an average weight of 29 g (i.e. 120 fish/tank) were randomly 
allocated to the tanks. Fish were acclimatised to tanks for 28 days prior to the commencement 
of the trial, during which time they were provided a commercial EWOS freshwater diet for 
salmonids (EWOS micro). During the feeding study period quadruplicate tanks of fish were 
provided one of the 4 experimental diets. Fish were fed with automatic belt feeders, 
continuously every 435 seconds for 20 seconds. Feeding time and period within feed 
intervals were the same for the acclimation and trial period. The daily ration depended on 
the trial period and fish appetite. A daily ration of 3.5 % of tank biomass was recorded during 
the acclimation period, while this proportion was decreased to 2.75, 2.5 and 1.5% of tank 
biomass during the first, second and third month of the trial period, respectively. A high 
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daily feed ration was used to avoid differences in feed intake often associated with satiation 
feeding of plant substituted diets (Refstie et al., 1998). It should be mentioned that as the 
level of SPC was increased in the diets of Atlantic salmon parr, the food ration was 
decreased, however direct feed intake through waste feed collection was not determined due 
to the difficulty in dividing uneaten feed of such a small size from faecal material.  
Fish were weighed after being anaesthetized (metacaine, 30 mg × l-1). The growth trial 
was conducted for a total of 97 days, at which time all fish were removed and weighed. On 
Day 37 all fish in the tanks were bulk weighed. Fish were also weighed on Day 63 (prior 
vaccination) before being intraperitoneally (i.p.) vaccinated with 100μl of a commercial 
vaccine (AquaVac™ Furovac, Intervet UK Ltd., Milton Keynes) against A. salmonicida, and 
on Day 97 (34 days post vaccination (dpv)). Fish were sampled for the evaluation of their 
immune responses on Days 63, 70 and 97 (termed pre vaccination, 7 and 34 dpv). Feed 
formulations and chemical analyses as well as growth performance, and pooled body cross-
section proximate and elemental composition data from the same trial are reported in Chapter 
3. 
4.2.2 Sample collection 
Blood was withdrawn from the caudal vein of 6 ﬁsh per tank per dietary group on Days 63, 
70 and 94 after the start of the study (i.e. pre vaccination, 7 and 34 dpv) using 1 ml syringes 
rinsed with heparin (10 IU × ml-1; Sigma-Aldrich, Dorset, UK), and used to assess a variety 
of haematological and immunological parameters in dietary fish. Haematocrit values were 
determined for all sampled fish at each sampling point. Total and differential leucocyte 
counts were determined from only three fish per tank. These numbers were decided due to 
time and personnel limitations at the study site, since total leucocyte count observations and 
respiratory burst activity of HKMs had to be performed on the sampling day, in order not to 
Chapter 4. Effects of increasing dietary SPC and constant dietary supplementation of phosphorus on the 
immune function of juvenile Atlantic salmon 
 
 
120 | P a g e  
 
compromise the quality of the samples, undermining the validity of the observations. 
Measurement of the aforementioned blood parameters aimed the highest possible degree of 
information that could be extracted from the present study, using traditional immunological 
techniques. Three blood smears were prepared for each fish for the determination of 
differential leucocyte counts, which were air dried then stained with Rapid Romanowsky 
stain (Raymond A lamb, Eastbourne, UK) and examined at × 1000 magniﬁcation to 
determine the percentage of different leucocyte types and the numbers of these cells per ml 
of blood according to total leucocyte numbers. Two pooled blood samples per tank were 
then obtained (2 pools of 1.2 ml of blood from three individuals per tank, giving 8 pools of 
blood per treatment). The blood was centrifuged at 3000 × g for 20 min at 4ºC and pooled 
serum then aliquoted into seven eppendorf tubes (around 40-50 µl per tube) and stored at -
70 oC until used. 
Head kidney samples (approximately 5 mm) from three individuals (from the same 
tank), were aseptically removed and pooled into plastic 5-ml bjoux containers containing 5 
ml of ice-cold Leibovitz medium (L-15; Sigma-Aldrich) and 40 μl heparin (10 IU × ml -1). 
Two pools per tank were used for the determination of the superoxide anion (O-2) production 
by head kidney macrophages.  
4.2.3 Head kidney macrophage isolation and respiratory burst by head kidney 
macrophages 
For the isolation of head kidney macrophages (HKMs), the head kidney was teased through 
a 100-lm nylon mesh (BD Falcon; BD Biosciences, Franklin Lakes, NJ, USA) into 2.5 ml 
Leibovitz medium (L-15; Sigma-Aldrich) containing 40 µl of heparin (10 IU × ml-1). The 
mesh was rinsed with 2.5 ml of the medium and cells placed on ice. The superoxide anion 
(O-2) production by head kidney macrophage suspensions were measured by the conversion 
Chapter 4. Effects of increasing dietary SPC and constant dietary supplementation of phosphorus on the 
immune function of juvenile Atlantic salmon 
 
 
121 | P a g e  
 
of NBT (Sigma-Aldrich) to formazan, according to the method published by Secombes 
(1990) with some modifications described by Korkea-aho et al. (2011). A more detailed 
description about the methodologies applied is given in Section 2.4.1. 
4.2.4 Determination of plasma protein and lysozyme activity 
Protein content of plasma was determined by the Pierce BCA (bicinchoninic acid) Protein 
Assay kit (Thermo Scientific, IL, USA) based on the conversion of Cu2+ to Cu1+ under 
alkaline conditions (Biuret reaction) using bovine serum albumin (BSA) as a standard. 
Serum lysozyme activity was based on the lysis of lysozyme sensitive Micrococcus 
lysodeikticus as described by Korkea-aho et al. (2011). A more detailed description about 
the methodologies applied is given in Section 2.4.3 and 2.4.4. 
4.2.5 Measurement of natural haemolytic activity 
Plasma haemolytic activity used was based on a method described by (Langston et al., 2001) 
with modifications. Briefly defibrinated SRBCs (Oxoid, UK) were used as target cells at a 
final concentration of 2.5× 108 cells × ml-1 of blood. Serum was diluted in double serial 
dilutions in 0.1 % gelatine-complement fixation buffer (0.1% G-CFB) (1 complement 
fixation tablet (Oxoid, UK) and 0.1 g of gelatine (Sigma-Aldrich) in 100 ml of warm distilled 
water) and 25 μl added to each well of a non-absorbent U-well micro-plate (Sterilin) in 
duplicate. Ten microlitres 0.5 % SRBC suspension was added to each serum dilution. 
Controls on each plate comprised 0.1 % anhydrous Na2CO3 (v/v) (100 % lysis) replacing 
serum. G-CFB replacing serum (0 % lysis) and serum blanks (duplicate wells of serum 
dilutions with G-CFB replacing SRBC suspension). The micro-titre plates were incubated at 
22°C for 90 min with constant shaking and the reaction terminated by the addition of 140 μl 
G-CFB with 20 mM EDTA, followed by centrifugation to pellet the remaining SRBCs. After 
centrifugation 100 μl of the supernatant from each well was transferred to a new flat-
Chapter 4. Effects of increasing dietary SPC and constant dietary supplementation of phosphorus on the 
immune function of juvenile Atlantic salmon 
 
 
122 | P a g e  
 
bottomed 96-well non-absorbent micro-titre plate (Sterilin). The absorbance of the wells was 
read at 450 nm using a micro-plate reader (Synergy HT; BioTek Instruments, Winooski, VT, 
USA) and the percentage lysis of SRBCs calculated. More details about the estimation of 
plasma haemolytic activity are given in Section 2.4.5.10. Details regarding the preparation 
of SRBCs and the various buffers are presented in Sections2.4.5). 
4.2.6 Total plasma Immunoglobulin M (IgM) assay 
The level of IgM in sera of experimental fish was determined using indirect enzyme linked 
immunosorbent assay (ELISA) (Magnadottir and Gudmundsdottir, 1992), with 
modifications. A more detailed description of the methodology used is given in Section 
2.4.7. 
4.2.7 Determination of antibody titres against A. salmonicida 
An ELISA was used to measure the specific antibody response of Atlantic salmon to the A. 
salmonicida vaccine using a modification of the method outlined by Adams et al. (1995). A 
more detailed description of the method used is given in Section 2.4.8. 
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4.2.8 Anti-protease Activity 
The method used was designed to detect anti-protease activity in trout plasma, and was based 
on the method described by Ellis (1990), modified for use in microtitre plates. The method 
is described in detail in Section 2.4.6. 
4.2.9 Statistics 
A hierarchical (multilevel) statistical model was used since multiple observations from a 
single tank were available (several individuals and/or several pools) (Espe et al., 2012; 
Nanton et al., 2012; Hartviksen et al., 2014). At first, data were normalised as described in 
Section 2.9. The statistical analysis was carried out with the help of the R language (R Core 
Development Team, 2014) and its lme4 package (Bates et al., 2014). The statistical approach 
applied was model-based. This means that to find if any specific effect was statistically 
significant data were fitted in three different models with increasing complexity where tank 
was included as random effect, sampling time as a categorical variable and the percentage 
of protein from SPC as a continuous factor possibly having non-linear effects: 
1. a model with only sampling time (Tank considered as a random effect). 
2. a model with sampling time and % protein from SPC with their interaction (Tank 
considered as a random effect). 
3. a model as above but with an additional quadratic effect of % protein from SPC 
with interactions to reveal any non-linearity in the response (Tank considered as a 
random effect). 
The three models were nested and compared with a Likelihood ratio test (LRT) that 
evaluated if the improvement in the likelihood required a more complex model or whether 
the simpler model could be applied. Models demonstrating possibilities (P values) < 0.05 
were selected for the description of data in the majority of the cases. Adopted models are 
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demonstrated by plotting the expected mean response with 95% confidence intervals. The 
continuous effect of the increasing dietary SPC proportions on salmon immune responses 
are presented as curves with shaded confidence region. The expected mean and 95% 
confidence intervals were solved by a posterior simulation from the adopted statistical model 
(n=1500 random draws were used throughout this study) (Gelman and Hill, 2007).  
4.3 RESULTS 
The “raw data” for measured haematological and immune responses are shown in Table 7. 
Vaccination was found to affect all the health parameters measured post-vaccination. 
Haematocrit levels declined with increasing dietary proportions of SPC at all time-points 
(Modelled response is presented in Fig.16A). Significant differences were demonstrated 
between SPC80 compared to SPC35 salmon at prior vaccination/PBS injection (since the 
expected confidence intervals given with the shaded regions for each treatment are 
overlapping with the expected mean values of the four groups). Overall lower haematocrits 
were obtained at 7 dpv. The decrease in haematocrit values with increasing SPC inclusion is 
much more noticeable at 7 dpv compared to the other sampling dates. Seven days after 
vaccination, haematocrit decreased significantly in the SPC50, SPC65 and SPC80 groups of 
salmon compared to the SPC35 control. At 34dpv despite the slight improvement in 
haematocrit values exhibited for the former groups of salmon, salmon receiving diets with 
higher than 35% of protein from SPC demonstrated significantly lower haematocrits 
compared to the SPC35 group. Higher haematocrit levels were recorded for all groups at 34 
dpv in comparison to the previous two timepoints. 
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Table 7 Haematological and immunological responses of Atlantic salmon juveniles. 
PRE VACCINATION SPC35 SPC50 SPC65 SPC80 
Haematocrit (%) 53.0±4.5 51.9±4.7 51.8±4.7 51.3±4.4 
Leucocytes (× 107× ml-1) 6.7±2.3 7.5± 1.7 7.1± 0.9 6.4 ±2.0 
Lymphocytes (×107× ml-1) 4.2±1.6 4.3±1.1 4.1±0.6 3.6±1.4 
Thrombocytes (×107× ml-1) 2.2±0.9 3.0±1.0 2.6±0.7 2.7±1.2 
Granulocytes (×107× ml-1) 0.1±0.1 0.1±0.1 0.1±0.1 0.1±0.04 
Monocytes (×107× ml-1) 0.02±0.02 0.02±0.02 0.02±0.02 0.02±0.03 
Lysozyme act. (units × min-1× ml-1 of plasma) 369.8±80.4 480.2±90.9 442.1±78.2 389.7±118.5 
Haemolytic act. (units H50  × ml-1 of plasma) 444.3±87.9 497.4±130.4 528.4±105.2 416.4±64.8 
HKMs resp. burst (NBT) (OD for 105 nuclei) 0.2±0.2 0.2±0.1 0.2±0.1 0.3±0.1 
Stimulated HKMs resp. burst (OD for 105 nuclei) 0.4±0.3 0.4±0.2 0.4±0.3 0.5±0.2 
Total plasma protein (mg × ml-1 of plasma) 48.3±5.2 49.5±3.6 47.7±2.8 47.4±4.9 
Antiprotease activity (Units TI75 × ml-1)** 845.6±96.6 908±39.8 855.7±60.2 891.6±67.4 
Total plasma IgM (mg × ml-1 of plasma) 1.9±3.0 1.3±2.3 2.3±2.0 0.9±1.1 
7 DAYS POST VACCINATION     
Haematocrit (%) 52.2±5.1 49.4±4.3 51.6±6.7 47.8±4.3 
Leucocytes (× 107 × ml-1) 8.4±1.7 8.5±1.9 8.2±3.0 6.4±2.5 
Lymphocytes (×107× ml-1) 4.5±1.3 4.7±1.5 4.8±1.9 3.5±1.5 
Thrombocytes (×107× ml-1) 3.4±1.0 3.3±0.9 3.1±1.3 2.6±1.2 
Granulocytes (×107× ml-1) 0.4±0.3 0.4±0.3 0.4±0.3 0.3±0.2 
Monocytes (×107× ml-1) 0.02±0.03 0.04±0.04 0.03±0.04 0.02±0.02 
Lysozyme act. (units × min-1× ml-1 of plasma) 639.4±216.0 719.4±75.1 662.0±184.1 698.63±97.0 
Haemolytic act. (units H50 × ml-1 of plasma) 446.0±96.1 447.2±108.1 529.0±133.7 507.6±209.1 
HKMs resp. burst (NBT) (OD for 105 nuclei) 0.6±0.5 0.8±0.4 0.9±0.3 0.8±0.2 
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Stimulated HKMs resp. burst (OD for 105 nuclei) 0.9±0.8 1.0±0.6 1.1±0.4 1.1±0.3 
Total plasma protein (mg × ml-1 of plasma) 42.1±5.7 39.5±2.6 40.3±3.1 37.3±3.5 
Antiprotease activity (Units TI75 × ml-1)** 653.3±98.6 677.9±138.2 647.1±98.0 667.8±97.6 
Total plasma IgM (mg × ml-1 of plasma) 3.6±2.3 4.9±3.6 6.5±4.1 3.8±2.9 
34 DAYS POST VACCINATION     
Haematocrit (%) 55.3±4.1 54.5±2.8 54.4±3.3 53.0±4.9 
Leucocytes (× 107× ml-1) 8.7±1.5 8.6±1.5 9.4±2.9 9.3±2.9 
Lymphocytes (×107× ml-1) 4.1±0.9 3.9±1.2 4.8±1.7 5.5±2.7 
Thrombocytes (×107× ml-1) 4.2±1.1 4.5±1.2 4.8±2.2 3.8±1.2 
Granulocytes (×107× ml-1) 0.4±0.2 0.2±0.1 0.3±0.2 0.2±0.1 
Monocytes (×107× ml-1) 0.05±0.05 0.03±0.03 0.05±0.05 0.04±0.05 
Lysozyme act. (units × min-1× ml-1 of plasma) 438.4±68.4 373.3±96.3 450.4±62.7 390.0±78.9 
Haemolytic act. (units H50 × ml-1 of plasma) 1183.7±126.7 1344.6±242.2 1424.9±208.2 1072.4±126.9 
HKMs resp. burst (NBT) (OD for 105 nuclei) 0.2±0.1 0.3±0.2 0.2±0.1 0.3±0.2 
Stimulated HKMs resp. burst (OD for 105 nuclei) 0.3±0.1 0.3±0.2 0.2±0.1 0.3±0.2 
Total plasma protein (mg × ml-1 of plasma) 46.4±7.7 8.6±1.5 9.4±2.9 9.3±2.9 
Antiprotease activity (Units TI75 × ml-1)** 596.6±15.9 604.0±16.8 600.6±30.2 598.9±11.6 
Total plasma IgM (mg × ml-1 of plasma) 3.6±3.8 6.4±2.6 5.6±2.8 2.9±2.2 
Specific IgM (plasma titers) 0.02±0.01 0.02±0.01 0.02±0.01 0.02±0.01 
Values for immune responses are means ±SD of 8 pools of 2 fish per diet ±SD; haematocrit values are means ±SD of 24 fish; leukocyte and differential leucocyte counts are 
means ± SD of 12 fish per diet. Abbreviations: SPC 35 - diet with 35 % soy protein concentrate (SPC); SPC 50 - diet with 50 % SPC; SPC 65 - diet with 65 % SPC; SPC 80 - 
diet with 80% SPC.  
**Units TI75 × min-1 × ml-1 of plasma. 
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The same trend as in haematocrit was obtained for leucocyte numbers for the first two 
time-points (pre vac and 7 dpv) with decreasing numbers observed upon increased dietary 
SPC inclusion. Significant differences were revealed for the SPC65 and SPC80 groups 
compared to SPC35 salmon at both timepoints, while increased leucocyte counts were 
demonstrated for all dietary groups at 7dpv compared to pre vaccination levels. However, at 
34 dpv leucocyte concentrations followed the opposite pattern, demonstrating increasing 
numbers in salmon fed diets with increasing dietary SPC inclusion (Modelled response is 
presented in Fig. 16B). No significant differences in total leucocyte levels were recorded 
among the three dietary groups of salmon at this timepoint. Regarding the expected 
differential leucocyte numbers, lymphocytes and thrombocytes were the only types of 
leucocytes affected by increasing SPC inclusion. Lymphocytes followed similar trends to 
that of total leucocytes. Prior to vaccination and at 7 dpv, lymphocyte numbers exhibited a 
linear reduction in salmon fed diets with increasing levels of SP. Significantly lower 
lymphocyte numbers were detected in SPC50, SPC65 and SPC80 salmon compared to 
SPC35 salmon before the vaccination of the fish. However, at 7 dpv lymphocyte numbers 
exhibited a slight increase in salmon fed on diets with higher than 35% of total protein from 
SPC, whereas SPC35 salmon lymphocytes presented a slight reduction. At this point 
significantly lower lymphocyte counts were demonstrated in SPC65 and SPC80 salmon in 
contrast to the SPC35 group of fish. At 34 dpv a linear increase in lymphocytes was observed 
in salmon fed with higher dietary amounts of SPC (Modelled response is presented in Fig. 
17A). Nonetheless, no differences on lymphocyte levels were recorded among the three 
dietary groups at 34dpv. On the other hand, thrombocytes were affected curvilinearly in 
salmon fed increasing amounts of SPC with SPC50 and SPC65 salmon demonstrating the 
highest levels of thrombocytes and the SPC35 group having slightly higher thrombocyte 
numbers than SPC80 salmon, at all time- points (Modelled response is presented in Fig. 
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17B). However, no significant differences were revealed prior to and 7 days post 
vaccination. Overall, thrombocytes increased upon vaccination with levels peaking at 34 
dpv. At this point significantly higher amounts of thrombocytes were revealed for the SPC50 
and SPC65 groups compared to SPC35 salmon. Increasing dietary SPC inclusion in the diets 
of Atlantic salmon parr had no significant effect circulating granulocyte and monocyte 
levels. Neutrophilic granulocytes increased after vaccination with the highest levels obtained 
at 7 dpv, while at 34 dpv the levels of these leucocytes decreased. Contrary to the results 
above, monocytes demonstrated a gradual increase post-vaccination, showing the highest 
levels 34 dpv. 
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Figure 14 Modelled haematological responses (haematocrit and total leucocyte counts). Statistical models 
showing the linear (Models selected with P values < 0.05) effect of the percentage of dietary protein from SPC 
on: (A) haematocrit (%); (B) leucocytes (× 107 × ml-1). Red, green and blue lines connect the expected mean 
values for each measurement prior to vaccination –pre vacc (Day 63 post feeding), 7 days post vaccination (7 
dpv-Day 70 post feeding) and 34 dpv (Day 97 post feeding) respectively, while shaded regions of the same 
colours indicate the 95% confidence regions for the values of these measurements. Dashed horizontal lines of 
the aforementioned colours denote the mean values for salmon fed diets with 35% of dietary protein from SPC. 
Mean values which lie outside the 95% C.I. of the group receiving 35% of dietary protein from SPC are 
considered significant. Asterisks of the same colours denote significant differences between salmon fed 35% 
of protein from SPC and salmon fed diets with higher percentage of dietary protein from SPC at different 
timepoints. 
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Figure 15 Modelled haematological responses (lymphocytes and thrombocyte counts).Statistical models 
showing the linear and curvilinear (Models selected with P values < 0.05) effect of the percentage of dietary 
protein from SPC on: (A) lymphocytes (× 107 × ml-1); (B) thrombocytes (× 107 × ml-1). Red, green and blue 
lines connect the expected mean values for each measurement prior to vaccination –pre vacc (Day 63 post 
feeding), 7 days post vaccination (7 dpv-Day 70 post feeding) and 34 dpv (Day 97 post feeding) respectively, 
while shaded regions of the same colours indicate the 95% confidence regions for the values of these 
measurements. Dashed horizontal lines of the aforementioned colours denote the mean values for salmon fed 
diets with 35% of dietary protein from SPC. Mean values which lie outside the 95% C.I. of the group receiving 
35% of dietary protein from SPC are considered significant. Asterisks of the same colours denote significant 
differences between salmon fed 35% of protein from SPC and salmon fed diets with higher percentage of 
dietary protein from SPC at different timepoints. 
Chapter 4. Effects of increasing dietary SPC and constant dietary supplementation of phosphorus on the 
immune function of juvenile Atlantic salmon 
 
 
131 | P a g e  
 
Statistical models revealed no effect of increasing dietary SPC inclusion on the 
respiratory burst activity of both PMA-stimulated and non-stimulated HKMs (the model 
with the time effect was selected with a P <0.05). Head kidney macrophages in general 
demonstrated an increased respiratory burst a week after vaccination and a subsequent 
reduction to pre-vaccination levels at 34dpv.  
Increasing dietary SPC inclusion in the diets of Atlantic salmon parr had no significant 
effect on their plasma protein levels and plasma anti-protease activity (the model with the 
time effect was selected with a P <0.05). Plasma protein concentrations demonstrated a 
sharp reduction at 7 dpv compared to pre-vaccination levels. At 34 dpv plasma protein 
presented an increase compared to protein levels at 7 dpv. Nonetheless, protein levels at this 
timepoint were found to be lower than pre-vaccination values. Plasma anti-protease, activity 
on the other hand, presented a gradual decrease at the post-vaccination periodcompared to 
pre-vaccination levels, with the lowest activity obtained at 34dpv. Plasma specific antibody 
titres against A. salmonicida were only measured at 34 dpv, so there was no time effect to 
model. Thus, the plausible statistical models consisted of only the SPC inclusion effects. The 
likelihood comparison demonstrated no effect of dietary SPC inclusion, however. 
Increasing SPC levels in the diets had a curvilinear effect on plasma haemolytic and 
lysozyme activity and total plasma IgM levels (Modelled responses are presented in Fig.18, 
19A and 19B). At prior to vaccination, expected lysozyme activity, appeared to be higher in 
salmon receiving the SPC50 and SPC65 dietary treatments compared to the SPC35 and 
SPC80 salmon. Significant differences were also demonstrated between the former two 
groups and SPC35 salmon. At 7dpv a similar trend was observed, however, the levels of 
lysozyme activity were markedly higher than prior to vaccination. At this point significantly 
higher lysozyme activity was demonstrated for the SPC65 group of fish in contrast to SPC35 
salmon. The pattern of lysozyme activity with respect to the level of dietary SPC inclusion 
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was the same at 34 dpv, as seen with the previous time points, however the activity was 
lower than prior to vaccination. Moreover, significantly higher activity was demonstrated in 
SPC50 and SPC65 salmon compared to the SPC35 group (Modelled response is shown in 
Fig. 18). Expected plasma IgM levels prior to vaccination demonstrated no differences 
among the four dietary groups of salmon. At both post vaccination points (7dpv, 34dpv), 
total plasma IgM concentrations were found to be significantly higher for SPC50 and SPC65 
salmon compared to SPC35 salmon while similar levels were demonstrated for SPC35 and 
SPC80 salmon (Modelled response is illustrated in Fig.19A). Expected haemolytic activity 
demonstrated minor differences among the four experimental dietary groups of salmon prior 
to and at 7 dpv. However, at 34 dpv alternative complement activity presented a salient 
increase for fish from all the dietary treatments with fish fed on medium levels of SPC 
inclusions possessing the highest values. Significant differences were denoted for the 
SPC50, SPC65 and SPC80 groups in comparison to SPC35 salmon at 34dpv (Modelled 
response is shown in Fig.19B). 
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Figure 16 Modelled plasma haemolytic activity. Expected haemolytic activity (Units H50 × ml-1). The model 
for haemolytic activity was selected with a P value< 0.05. Red, green and blue lines connect the expected mean 
values for each measurement prior to vaccination –prevacc-(Day 63 post feeding), 7 days post vaccination (7 
dpv-Day 70 post feeding) and 34 dpv (Day 97 post feeding) respectively, while shaded regions of the same 
colours indicate the 95% confidence regions for the values of these measurements. Dashed horizontal lines of 
the aforementioned colours denote the mean values for salmon fed diets with 35% of dietary protein from SPC. 
Mean values which lie outside the 95% C.I. of the group receiving 35% of dietary protein from SPC are 
considered significant. Asterisks of the same colours denote significant differences between salmon fed 35% 
of protein from SPC and salmon fed diets with higher percentage of dietary protein from SPC at different 
timepoints. 
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Figure 17 Modelled immunological responses. Statistical models showing significant linear or curvilinear 
(Models selected with P values < 0.05) effect of the percentage of protein from SPC on: (A) lysozyme activity 
(Units × min-1 × ml-1); (B) total plasma IgM (mg × ml-1). Red, green and blue lines connect the expected mean 
values for each measurement prior to vaccination –prevacc-(Day 63 post feeding), 7 days post vaccination (7 
dpv-Day 70 post feeding) and 34 dpv (Day 97 post feeding) respectively, while shaded regions of the same 
colours indicate the 95% confidence regions for the values of these measurements. Dashed horizontal lines of 
the aforementioned colours denote the mean values for salmon fed diets with 35% of dietary protein from SPC. 
Mean values which lie outside the 95% C.I. of the group receiving 35% of dietary protein from SPC are 
considered significant. Asterisks of the same colours denote significant differences between salmon fed 35% 
of protein from SPC and salmon fed diets with higher percentage of dietary protein from SPC at different 
timepoints. 
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4.4 DISCUSSION 
The immunological responses examined in the current study are considered essential 
components of salmon defence against pathogens, while the measured haematological 
indices can give an indication of the nutritional, immune or stress status of the fish. Changes 
in various blood parameters such as haematocrit, total serum protein, total leucocyte and 
differential leucocyte counts can be used to assess fish condition and health (Blaxhall, 1972; 
Waagbø et al., 1988). Regarding the estimated immune parameters, anti-protease activity is 
related to the inactivation of extracellular proteases released by invading pathogenic 
organisms (Ellis, 1990), lysozyme and phagocytes oxygen radical production are important 
bactericidal and parasiticidal agents (Rumsey et al., 1994; Secombes, 1990), whereas 
complement factors, lectins (participating in natural haemolysis), total and specific IgM are 
involved in the neutralization and opsonisation of a wide range of pathogenic agents 
(Nikoskelainen et al., 2002; Kiron, 2012). 
For Atlantic salmon parr, haematocrit values, which represent the oxygen carrying 
capacity of blood, normally range from 35 to 60 % (Hardie et al., 1990; Thompson et al., 
1996) and haematocrit levels were found to be within this range in the present study. 
However, expected mean haematocrit values, declined with increasing levels of SPC 
inclusion. Blaxhall (1972) reported that reduction in haematocrit values could be an indicatio 
of reduced feed intake, for which data were not collected. Furthermore the reduction in 
erythrocyte size, reported by Hemre et al. (2005) in Atlantic salmon fed on diets with 
increased FM substitution by soybean products, could explain the aforementioned 
observation. Another possible explanation could be the dilution of blood due to 
osmoregulatory changes caused by a reduction in Ca and Mg body levels as it was 
demonstrated in the previous chapter and possibly their circulating amounts, which was also 
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shown previously by Klinger et al.(1996) in channel catfish (Ictalurus punctatus). Ion and 
osmoregulatory changes could have also been promoted by the exposure of salmon parr to 
constant light promoting a state of “pseudo-smolts” for which not much information is still 
available (Stefansson et al., 2007). The lowest haematocrit values for the four dietary salmon 
groups were obtained at 7dpv. This could be attributed to increased stress induction arising 
from vaccination which could have reduced fish appetite, nutrient uptake and thus 
erythropoiesis ( van Muiswinkel and Wiegertjes, 1997; Wendelaar Bonga, 1997; Melingen 
and Wergeland, 2000; Poppe and Koppang, 2014). This can also explain the observed 
reduction in plasma protein levels in all dietary salmon groups at 7 dpv. However, no 
differences were observed in plasma protein levels among different dietary groups.  
Increased  leucocyte levels due to immune stimulation are expected after vaccination 
(Nikoskelainen et al., 2007; Silva et al., 2009), which was the case in the present study. 
Similarly to haematocrit values, total leucocyte counts declined with increasing dietary SPC 
prior to and 7 dpv. Contrary to this, Rumsey et al. (1994) showed that naïve rainbow trout 
fed on diets containing soy proteins exhibited increased numbers of circulating leucocytes. 
The increase in leucocyte numbers at 34dpv in salmon fed diets with higher than 35% of 
dietary protein from SPC is an indication of immune and/or haemostatic stimulation due to 
vaccination (Nikoskelainen et al., 2007; Silva et al., 2009), since both lymphocyte and 
thrombocyte levels demonstrated an increase in the medium and high SPC inclusion groups. 
The former type of leucocytes presented a slight increase in salmon fed high levels of SPC 
compared to the SPC35 group, a week after vaccination. Nonetheless, the magnitude of this 
increase was even higher at 34 dpv, revealing a trend of linear increase in vaccinated salmon 
receiving increased dietary SPC at this point, however, in the absence of significant changes 
among the four treatment groups. Overall, the state of leucocyto- and lymphocytopenia prior 
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to vaccination in the high SPC inclusion groups could be an indication of increased stress 
(Maule and Schreck, 1990; Ainsworth et al., 1991) due to poor nutrition caused by the 
increased dietary levels of ANFs present in SPC (Fletcher, 2011). In this case measurement 
of cortisol activity from the various sampling points of the present trial could have been 
useful in order to assess that. Another possible reason for that is the fact that naive salmon 
fed on diets with moderate to high SPC inclusion levels exhibited a general suppression of 
various pathways including the ones involved in systemic immunity and possibly 
haematology, utilizing most of the dietary energy on growth (Tacchi et al., 2012). This trend 
however, was reversed upon immune stimulation through vaccination, with salmon fed on 
high SPC inclusion diets investing more energy for the stimulation of the immune responses. 
On the contrary to circulatory lymphocytres, thrombocytes were affected curvilinearly by 
the increased dietary SPC amounts, with SPC50 and SPC65 salmon possessing higher levels 
than the other two experimental groups. Overall, thrombocytes increased post-vaccination 
with the highest levels being measured at 34 dpv, when SPC50 and SPC65 salmon presented 
higher levels compared to the SPC35 group. Thrombocytes are mainly involved in 
haemostasis regulation, although they have been associated with cellular immunity 
(Meseguer et al., 2002). Thrombocyte levels were found to be well correlated with 
complement activity in the present study. Complement cascade and blood coagulation 
systems (which participate in wound healing in association with thrombocytes) are 
intimately related due to the presence of enzymes that are involved in both pathways (Amara 
et al., 2008). The exact relation between these two observations requires further investigation 
and could have been influenced by differences in ion absorption and regulation between the 
dietary groups of salmon, especially for Ca and Mg which are known cofactors for many of 
the enzymes in both cascades (Yano et al., 1988). Nonetheless, circulating neutrophilic 
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granulocytes, which represent the main innate immune cells determining salmon resistance 
against bacterial diseases ( Øverland et al., 2009; Kumar et al., 2010), increased at 7 dpv. 
Neutrophils demonstrated a subsequent reduction at 34 dpv, however their numbers were 
still higher than pre-vaccination levels, exhibiting an extended stimulation of salmon 
immunity due to vaccination.  Monocytes connect the innate immune system with the 
adaptive system by migrating to the sites of infection and differentiate into macrophages, 
where they partake in phagocytosis, antigen presentation and the production of cytokines 
that stimulate lymphocyte activity. These cells demonstrated numerical increases after 
vaccination, with the highest values obtained at 34 dpv, revealing their importance in both 
innate and acquired immune responses (Nikoskelainen et al., 2007). The increase in 
granulocyte and monocyte levels at post-vaccination in the current study were similar to 
earlier reports by Chin and Woo (2005) and  Nikoskelainen et al. (2007), who demonstrated 
significant increases in circulating granulocyte and monocyte numbers in salmonids 
vaccinated against parasites or several different bacterial pathogens. The extent of change 
observed in these leucocyte populations at post-vaccination was the same in all dietary 
groups, indicating that increasing SPC levels did not compromise the production of these 
immunologically important cells. 
Respiratory burst of both PMA-stimulated and naive HKMs did not appear to be 
affected by the percentage of SPC protein added to the diets. In accordance to that, neutrophil 
oxygen radical production has been shown to be unaffected in Atlantic salmon fed on 
dehulled lupin meal at 40% inclusion, compared to FM protein feeds Bransden et al. (2001a), 
and  Burrells et al.(1999) found that dehulled solvent extracted SBM at inclusion levels of 
10-50 % in rainbow trout diets, had no significant effect on macrophage oxidative radical 
formation, whereas inclusion levels of up to 80% caused a reduction in macrophage 
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respiratory burst activity. On the contrary, Sitjà-Sitja-Bobadilla et al. (2005)  reported higher 
respiratory burst levels by HK leucocytes in juvenile sea bream fed diets with 75 and 100 % 
substitution of FM by a mixture of different plant protein sources (i.e. corn gluten, wheat 
gluten, extruded peas, rapeseed meal and sweet white lupin) balanced with essential amino 
acids. Moreover, rainbow trout fed on diets with different soy proteins, demonstrated 
increased peripheral leucocytic respiratory burst activity (Rumsey et al., 1994).  
Plasma protein levels decreased upon vaccination. This could be attributed to the 
reduction in fish appetite after vaccination as a result of stress due to the handling and the 
injection procedure (Melingen and Wergeland, 2000). However, no differences were 
observed in plasma protein levels among different dietary groups. Similarly, no differences 
in anti-protease activity were exhibited between the groups. Anti-protease levels usually 
reduction in fish after vaccination, infection or intra-peritoneal injection (Secombes and 
Olivier, 1997), which agrees with the findings of the present study. Bransden et al. (2001) 
showed that Atlantic salmon could be fed on diets with 40% substitution of FM with dehulled 
lupin meal without any adverse effects on anti-protease activity. They also found, plasma 
lysozyme activity and total IgM levels to be unaffected, which is similar to Jalili et al.(2013), 
who reported no differences in serum lysozyme and total IgM in rainbow trout receiving 
diets with up to 100% substitution of FM with plant proteins. This is not in line with the 
current results, where higher lysozyme activity was recorded for SPC50 and SPC65 salmon 
at all time points while higher levels of total IgM were revealed at both timepoints post 
vaccination compared to SPC35 salmon. In accordance to the present results Rumsey et 
al.(1994) reported increased lysozyme activity in rainbow trout fed SBM diets. The increase 
in total IgM levels, obtained as a result of salmon vaccination at 7 and 34 dpv is expected 
(Melingen and Wergeland, 2000). Regardless, the increased levels of total IgM and 
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lysozyme activity observed for the SPC50 and SPC65 groups of salmon could point at better 
regulation of certain innate immune responses of salmon at post vaccination which could be 
a favourable trade upon an unexpected disease outbreak. Specific antibody titres against A. 
salmonicida were determined at 34 dpv and there appeared to be no effects of SPC inclusion 
levels on specific antibodies. Kiron et al.(1995; 1993) demonstrated that specific antibody 
production is not affected by the level of dietary protein in rainbow trout. Hence, it is possible 
that differences in protein intake or protein digestibility, affected by the presence of ANFs 
present in the diet, do not affect specific antibody production in vaccinated salmon  
Haemolytic activity in the plasma of experimental fish, as a consequence of 
complement activation (mainly through the alternative and partially the classical pathway as 
a result of the presence of natural antibodies) and/or other substances such as lectins and 
haemolysins (Alexander and Ingram, 1992) did not seem to be affected linearly by increasing 
dietary SPC inclusion. Prior to and 7 dpv, salmon from the different dietary groups exhibited 
no differences in plasma haemolytic activity (overall complement activity). However at 34 
dpv, there was a marked increase of haemolytic activity in fish from all the dietary 
treatments, with salmon fed diets with higher than 35% of protein from SPC demonstrating 
significantly higher activity than SPC35 salmon. Stimulation of alternative complement 
activity as a result of altering the dietary composition through the inclusion of plant proteins, 
has been previously reported by Jalili et al. (2013) and Sitjà-Bobadilla et al. (2005), who 
found similar or increased complement activity in rainbow trout and gilthead sea bream 
respectively, in fish fed 50% plant protein diets, while decreased activity was observed in 
fish fed on diets with higher levels of plant proteins. The present findings, clearly 
demonstrate an increase in the overall complement activity of salmon fed on the SPC50 and 
SPC65 dietary treatments.  
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4.5 CONCLUSIONS 
The current study demonstrated  that feeding juvenile Atlantic salmon on diets with up to 
65% of protein from SPC, appropriate dietary supplementation with lysine, methionine and 
threonine and  a constant supply of P at 30 g × kg-1, could enhance some of the non-specific 
immune responses prior to and post-immunisation. Therefore, it is possible that juvenile 
salmon diets with such specifications could be applied without undermining the health status 
of the fish. On the contrary,  SPC seems to contain certain amounts of immunogenic 
compounds which seem to exert their beneficial health effects only at the aforementioned 
level of dietary SPC supplementation (Krogdahl et al., 2000). Higher SPC inclusions in 
salmon diets are possibly resulting in additional dietary limitations, revealing the necessity 
for further nutritional supplementation of such diets. An alternative hypothesis could be that 
the immunological changes among the dietary groups of salmon could have been influenced 
by differences in the availability of P in the four dietary treatments. Despite the fact that 
inorganic phosphates in the dietary treatments were supplemented at levels higher than the 
known P requirements of Atlantic salmon according to NRC (1993), the availability of P in 
the diets can be reduced, especially in diets with very high SPC inclusion due to the increased  
presence of phytate found in SPC. Hence, it is possible that diets with intermediate levels of 
SPC (SPC50 and SPC65) were more optimally balanced  in terms of available dietary P, 
compared  to the other two treatments (SPC35 and SPC80), suggesting the requirement for 
lower supplementation of P (< 30 g × kg-1)  in the SPC35 diet and higher addition of P in the 
SPC80 treatment (> 30 g × kg-1). 
The involvement of P in the immune mechanisms of the fish is still not clear. However, 
P could affect fish immunity either directly through supplying the energy required for 
immunological stimulation (Kiron, 2012), or indirectly by influencing the digestion of other 
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dietary elements including Zn, Mg or Ca (Lall, 2003),  modulating several important immune 
responses including the complement activity (Yano et al., 1987, 1988; Lim et al., 2001). 
Whether the level of immune stimulation provided by these diets would provide higher 
resistance to infectious disease is still unclear. It is more likely that a combined dietary 
increment of SPC levels with a concomitant increased addition of P and possibly other 
elements (e.g. Zn) or compounds in which SPC is deficient of, could promote better growth 
and immunity in Atlantic salmon parr. Nevertheless, the impact of increasing dietary SPC 
inclusion on the immune status of Atlantic salmon parr requires further investigation and the 
best way to validate the results derived from this study is through the performance of disease 
challenges. 
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5.1 INTRODUCTION 
Farmed salmon are bred for rapid growth, and the main aim of the salmon aquaculture 
industry is to achieve an optimal growth rate in their stock through optimization of both diets 
and environmental conditions accordingly. However, intensive rearing conditions are linked 
with an increased occurrence of skeletal-related pathologies (Silverstone and Hammell, 
2002; Fjeldall et al., 2004, 2005, 2006). The growing need to replace FM in commercial fish 
feeds has also come into focus, together with the deformities related to feed ingredient 
replacements and unbalanced macro-nutrient supplementation leading to low nutrient 
availability (Baeverfjord et al., 1998; Storebakken et al., 1998b, 2000). Suboptimal supply 
of minerals (phosphorus and potentially zinc) and nutritional imbalances of fatty acids, 
vitamins and amino acids are considered the main challenges in regard to normal skeletal 
development (Lall and Lewis-McCrea, 2007). The challenges related to nutrient 
bioavailability are further amplified with the introduction of vegetable meals, some of which 
are rich in ANFs (e.g. phytic acid and polysaccharides) that may further impair the 
absorption of these nutrients (Storebakken et al., 1998b, 2000).  
SPC, made from SBM through aqueous ethanol extraction, contain a reduced 
carbohydrate fraction and typically have lower concentrations in ANFs related to intestinal 
enteritis (Dersjant-Li, 2002). Most of the nutritional characteristics that a good plant-based 
alternative protein source needs to replace high quality FM in salmon diets can be met using 
SPC (Dersjant-Li, 2002; Naylor et al., 2009). SPC contains high levels of digestible protein, 
with a favourable amino acid profile (with the exception of lysine and methionine), high 
nutrient digestibility, and is reasonably acceptable by the fish. Hart and Brown (2007) 
showed that up to 50% of FM can be replaced with SPC (with supplemented methionine) in 
Atlantic salmon fingerling diets without adversely affecting growth performance. However, 
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the presence of several ANFs and the lack of certain bioactive compounds found in FM still 
limit the use of SPC in diets for early stage Atlantic salmon parr that have an  undeveloped  
digestive system (Burr et al., 2012). High dietary levels of SPC have been linked with 
decreased feed intake and reduced growth in salmonids (Storebakken et al., 1998b; 
Mambrini et al., 1999), whereas phytate the main ANFs present in SPC were found to reduce 
intestinal enzyme activity, and protein and mineral bioavailability, with decreased levels of 
Ca, Mg and Ca:P ratio detected in the body of the fish, together with decreased skeletal Zn 
concentrations (Denstadli et al., 2006; Helland et al., 2006). Measurements of body and 
skeletal mineral composition are sensitive indicators of both mineralisation and health, 
which in turn, can reveal dietary deficiencies (Shearer et al., 1994; Helland et al., 2005, 
2006). Low bone mineralisation in on-growing and apparently healthy salmon can be an 
indicator of subclinical deficiency for a range of elements, which in the long term could 
increase the prevalence of bone deformities (Fjelldal et al., 2007, 2009a, 2009b, 2012) or 
even worst, cause increased  mortalities due to negative elemental balance (Baeverfjord et 
al., 1998). 
Intraperitoneal injection of oil adjuvanted vaccines is a common prophylactic practice 
in salmon aquaculture. Some studies have shown that vaccination can induce vertebral 
deformities in Atlantic salmon, visible by the time of harvest (Berg et al., 2005, 2006). 
Moreover, Berg et al. (2012) demonstrated a correlation in the increased occurrence of bone 
deformities with reduced bone mineralisation. Contrarily, other studies have demonstrated 
increased bone mineralisation in vaccinated salmon under certain post-vaccination 
temperature regimes, such as 10˚C for 6 weeks in freshwater followed by 16˚C for 6 weeks 
in saltwater or 16˚C for 6 weeks in freshwater followed by 16˚C for 6 weeks in saltwater 
(Grini et al., 2011), while Berg et al. (2005) reported similar findings with increased levels 
Chapter 5. Increased bone mineralisation in Atlantic salmon parr fed increasing dietary levels of SPC and 
phosphates 
 
 
146 | P a g e  
 
of bone mineralisation in salmon after vaccination. Additional studies have found no signs 
of vertebral deformities in Atlantic salmon post-vaccination, however (Gil Martens et al., 
2010; Grini et al., 2011). It is apparent that the effect of vaccination on bone depends on 
vaccination strategy (Berg et al., 2006; Grini et al., 2011), especially associated with the size 
of fish during vaccination (Berg et al., 2006; Grini et al., 2011), the type of vaccine applied 
(Aunsmo et al., 2008) and environmental parameters (Grini et al., 2011). It would seem that 
low mineralisation as a result of vaccination, may contribute to an increased frequency of 
spinal deformities in smoltifying Atlantic salmon, especially during the early period of 
seawater transfer (Fjelldal et al., 2006). Salmon with bone mineral deficiencies are prone to 
developing spinal deformities (Fjelldal et al., 2007, 2012), do not swim efficiently, are less 
capable of acquiring food and are more susceptible to physiological imbalances, as well as 
being down-graded at slaughter (Silverstone and Hammell, 2002). In the study performed  
in Chapter 3, a decrease in body cross-section ash, Ca: P ratio, Ca, Mg, Mn, P and Zn levels 
were found in late stage Atlantic salmon parr when the fish were fed for 63 days with diets 
containing increasing levels of SPC and balanced levels of lysine and methionine, but 
constant amounts of supplemental di-calcium phosphate. It was suggested that this might 
have been a result of reduced bio-availability of P in the diets containing increased amounts 
of SPC, due to the presence of certain ANFs, such as phytate, oligosaccharides and non-
starch polysaccharides, present in SPC (Francis et al., 2000). However, at 32 days post-
vaccination (dpv), using a commercial vaccine (i.e. 95 days from the onset of feeding), both 
ash and mineral levels except Zn, presented an overall improvement in bone mineralisation 
of salmon fed increasing levels of dietary SPC, revealing a positive effect of vaccination on 
bone mineralisation in these dietary groups. 
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Meanwhile, the aqua-feed industry still relies on the application of inorganic salts to 
improve mineral retention in fish diets containing increased amounts of plant products. For 
this reason, the present study was undertaken to identify the effects of increasing dietary 
levels of SPC, lysine, methionine and mono-calcium phosphate in the diets of salmon parr 
and the interaction these diets have with vaccination on salmon parr growth and bone mineral 
levels, which are indicative of bone mineralisation in dietary fish. Skeletal mineral analysis 
was used as a tool to assess if there are any additional mineral requirements for Atlantic 
salmon parr fed with these SPC diets. 
5.2 MATERIALS AND METHODS 
5.2.1 Diets and growth trial 
A dietary trial was conducted for 154 days (June 2013-December 2013) in the Aquatic 
Research Facility (ARF) at the Institute of Aquaculture, University of Stirling. A fresh water 
system consisting of twenty four 100-litre circular tanks supplied with flow-through water 
at a rate of 1.5 l × min-1 was used to hold the fish. The water temperature was maintained at 
an ambient temperature, whilst photoperiod was constant to prevent smoltification (12 hours 
of light: 12 hours of darkness). Dissolved oxygen, ammonia, nitrate, nitrite and pH were 
monitored and remained within limits recommended for Atlantic salmon. Before the start of 
the feeding trial, unvaccinated Atlantic salmon parr (S0) purchased from Scottish Seafarms 
Ltd (Hollywood, Dumfries) from AquaGen QTL (AquaGen Ltd, Kilmacolm, Scotland) 
eggs, selected for improved growth and resistance to Infectious Pancreatic Necrosis Virus 
(IPNV), previously maintained on a commercial BioMar (BioMar Ltd, Grangemouth, 
Scotland) diet (BioMar Inicio PLUS) were allowed to acclimate for one week in two stock 
tanks. During this period fish were maintained on a commercial EWOS (EWOS Ltd, 
Westfield, Near Bathgate, Scotland) diet (EWOS micro). One hundred and thirty fish were 
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then randomly allocated into each of the 12 tanks and allowed to acclimate for 7 days. At 
the beginning of the trial, the average weight of fish was 9.3g. The fish were starved for two 
days and then subsequently fed the trial diets they had been assigned. The experimental diets 
used contained different levels of SPC protein (35, 58 and 80% of protein from SPC). The 
diets were manufactured by EWOS Innovation, Dirdal, Norway and were formulated in a 
way to ensure that any observed differences among treatments would only be attributed to 
the protein source. Feed formulations are given in Table 8. Therefore protein/fat ratios were 
kept constant (~3.0) while methionine, lysine and phosphorus (P) supplementation increased 
concomitantly with increased dietary SPC inclusion to give similar amino acid/protein ratios 
and increase the availability of P in diets with higher levels of SPC. Four replicate tanks 
were used for each one of the 3 trial diets, and parr were acclimatised to the feeds for 3 days 
prior to the starting the trial. The feeding trial lasted for almost 6 months (154 days). On day 
92 of the feeding trial, 8 fish per tank were sampled to monitor their immune status and 
vertebral mineral composition. The remainder of the parr (77 fish per tank) was divided 
between the original set of 12 tanks and a further set of 12 replicate tanks. The fish in the 
original tanks were intraperitoneally (i.p.) injected with 0.1ml of a commercial A. 
salmonicida /Infectious Pancreatic Necrosis Virus (IPNV) vaccine (Pharmaq, Alphaject 
2.2), while the salmon within the replicate set of tanks were i.p. injected with 0.02 M 
phosphate buffer saline (PBS) (0.15M NaCl, pH = 7.2). Whole fish samples were taken prior 
to vaccination/PBS-injection (Day 92 of the feeding trial) and at 62 dpv/dpPBSinj (Day 154 
of the feeding trial) for vertebral composition analysis. Fish were bulk weighed on Day 92 
(prior to injection) and Day 154 of the feeding trial (62 dpv/PBS injection) to monitor their 
growth performance (Final weight, weight gain and specific growth rate). 
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Table 8 Formulation and chemical composition of experimental diets with varying soy protein 
concentrate levels. 
Feed composition (× kg-1) SPC35 SPC58 SPC80 SPC35 SPC58 SPC80 
 2mm 3mm 
Fishmeal a (g) 449.2 269.8 114.6 449.2 269.8 114.6 
SPC b (g) 288.3 453.8 598.6 288.3 453.8 598.6 
Tapioca c (g) 110.0 100.0 90.0 110.0 100.0 90.0 
MonoCalcium phosphate d (g) 20.0 30.0 40.0 20.0 30.0 40.0 
Vitamin and mineral premixese (g) 4.00 4.00 4.00 4.00 4.00 4.00 
Vitamin C 35% e (g) 1.00 1.00 1.00 1.00 1.00 1.00 
Methionine f (g) 2.10 4.00 5.50 2.10 4.00 5.50 
Lysine 78% f (g) 1.80 2.60 3.30 1.80 2.60 3.30 
L-Threonine f (g) 0.6 0.8 1.0 0.6 0.8 1.0 
Nobacithin Powder g (g) 10.00 10.00 10.00 10.00 10.00 10.00 
Fish Oil h(g) 113.0 124.0 132.0 113.0 124.0 132.0 
Chemical composition (× kg-1)       
Dry matter (g) 959.7 944.1 923.0 923.2 936.1 922.5 
In dry matter basis 
Energy (KJ) 222.4 218.9 216.3 223.8 218.8 217.1 
Crude protein (g) 531.2 515.2 494.1 532.4 511.8 489.8 
Crude fat (g) 182.4 170.6 162.0 177.7 165.4 1621 
Crude prt: Crude fat ratio 29.1 30.2 30.5 30.0 31.0 30.3 
Ash (g) 95.5 92.5 89.0 96.1 91.1 87.6 
Carbohydrate (g) 289.7 307.9 332.4 287.8 308.0 318.8 
Crude fibre (g) 0.1 0.2 0.3 0.1 0.2 0.3 
Phytate (g) 11.49 14.71 15.41 10.65 13.71 14.22 
P (g) 16.01 16.08 14.98 15.74 16.13 15.38 
Ca (g) 15.12 13.96 11.52 14.85 13.63 11.50 
Ca: P ratio 0.94 0.87 0.77 0.94 0.84 0.75 
Zn (mg) 295.32 295.3 266.54 280.63 285.88 267.58 
Mg (mg) 2.27 2.44 2.43 2.11 2.33 2.42 
Mn (mg) 83.98 89.58 84.4 82.38 87.78 85.51 
Abbreviations: SPC 35 - diet with 35% of dietary protein from soy protein concentrate (SPC); SPC 50 - diet 
with 50% of dietary protein from SPC; SPC 65 - diet with 65% of dietary protein from SPC; SPC 80 - diet with 
80% of dietary protein from SPC. 
 a Fishmeal (Egersund  Sildoljefabrikk, Norway) with an apparent protein digestibility coefficient (ADC 
protein) of 90.2 % ; b SPC (Imcopa, - Importação, Exportação e Indústria de Óleos Ltda., Araucária - Paraná, 
Brazil) with an apparent protein digestibility coefficient (ADC protein) of 90.8%; c Tapioca (Hoff Norske 
Potetindustrier, Gjøvik, Norway); d Monocalcium Phosphate (Normin AS, Hønefoss, Norway); e Vitamin 
premix and Mineral premix (EWOS AS, Bergen, Norway); f Amino acids (Evonik Degussa International AG, 
Hanau, Germany); g Nobacithin: De-oiled lecithin powder (Noba Vital Lipids, Netherlands); h Fish Oil 
(Egersund  Sildoljefabrikk, Norway).  
Chapter 5. Increased bone mineralisation in Atlantic salmon parr fed increasing dietary levels of SPC and 
phosphates 
 
 
150 | P a g e  
 
5.2.2 Calculations 
The following formulae were applied to the data: 
Weight gain: 
𝑊𝐺 (
𝑔
𝑑𝑎𝑦
) =
𝑊𝑒𝑖𝑔ℎ𝑡 𝑔𝑎𝑖𝑛(𝑔)
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑑𝑎𝑦𝑠
 
Specific Growth Rate: 
𝑆𝐺𝑅 = (
𝑙𝑛𝑊1 − 𝑙𝑛𝑊0
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑑𝑎𝑦𝑠
) × 100 
Thermal Growth Rate: 
𝑇𝐺𝐶 = (
√𝑊1
3
− √𝑊0
3
(𝑡 × 𝑇)
) × 100 
In the above formulae W0 and W1 is the initial and the final fish mean weights in grams. 
5.2.3 Diet composition analysis 
Dietary crude fat was determined following acid hydrolysis using a Soxtec System 1047 
hydrolysing unit (Tecator Application note 92/87) followed by exhaustive Soxhlet extraction 
using petroleum ether (40–60°C boiling point) on a Soxtec System HT6 (Tecator application 
note 67/83)as described by (Bell et al., 2001). Dry weight and ash contents of diets were 
determined after oven-drying the samples to constant weight (at 100ºC) and by ashing dried 
samples in an oven at 550°C (AOAC, 1990). Dietary energy content was determined by 
performing bomb calorimetry (AOAC, 1990). For the determination of phytate content in 
the diets a Megazyme Phytate/Total Phosphorus Assay kit (Megazyme, Ireland) was used. 
Dietary energy content was determined through bomb calorimetry (AOAC, 1990). More 
details regarding the aforementioned methodologies are given in Section 2.6.  
Dietary carbohydrate was determined following a modified Dubois phenol sulphuric 
method. Dietary fibre was determined after subjecting defatted dietary samples (3 washes 
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with petroleum ether) within pre-weighed organic capsules, to acid (with 1.25% sulphuric 
acid solution)and alkaline hydrolysis (with 1.25% sodium hydroxide solution) for 35 min 
each, using a Fibertec system 1020 hot Extractor. Following one last defatting step (3 washes 
with petroleum ether), the samples were ashed at 600°C in a muffle furnace (Gallenkamp 
Muffle Furnace) for 4 hours, cooled in a desiccator and reweighed (W2).  Extracted fibre 
was expressed as percentage of the original undefatted sample and calculated according to 
the formula: 
𝐹𝑖𝑏𝑟𝑒(%) =
(𝑊1 × 1.0011) − 𝐶𝑎𝑝𝑠𝑢𝑙𝑒 𝑤𝑒𝑖𝑔ℎ𝑡 − (𝑊2 − 0.0025)
𝑆𝑎𝑚𝑝𝑙𝑒 𝑤𝑒𝑖𝑔ℎ𝑡 (𝑔)
  × 100 
Where W1 is the initial weight of the unprocessed dietary sample and W2 is the weight after 
processing. More details regarding the determination of dietary carbohydrates and fibre 
levels are given in Sections 2.6.7 and 2.6.8. 
Dietary minerals and phosphorus were determined using inductively coupled plasma 
mass spectroscopy (ICP-MS) with collision cell technology (CCT) (Thermo XSeries 2). A 
more thorough description of the method is given in Sections 2.6.1, 2.6.4, 2.6.5. 
5.2.4 Bone examination and composition analysis 
A total of 288 fish were examined for external signs of deformities and analyzed for bone 
moisture and mineral composition. Eight individuals were collected from each tank at each 
time point. The samples were divided into 3 groups of 96 fish each, consisting of naïve fish 
(prior to vaccination/PBS injection), vaccinated salmon and PBS-injected salmon from Day 
154 (62 dpv/PBS injection). After undergoing an initial external gross examination, in which 
fish were examined for external signs of malformations, discoloration and other 
irregularities, fish were scored and then placed within trays and stored at -70 °C. Salmon 
were defrosted prior to the analysis. The thawed samples were placed on trays, weighed 
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individually, and transferred into an oven at 160°C for 30 min in order to soften the flesh. 
The soft tissues were carefully removed to display the spine and ribs as intact as possible. 
Then, bony structures were visually evaluated for anomalies and any lesions were examined 
using a dissection microscope according to Baeverfjord et al. (1998b). Subsequently, the 
bones of each individual were then defatted in isohexane for 20 h, placed on small trays and 
weighed. Dry matter and moisture were determined according to standard methods (AOAC, 
1990) by oven drying for 16 h to constant weight. After drying, spine samples were weighed 
again, homogenised and used for ash and mineral determination. In order to determine the 
amount of ash, 4 pools of 2 individuals were made. Bone pools were then ashed in a muffle 
furnace (Gallenkamp Muffle Furnace) at 550ºC according to (AOAC, 1990). Minerals and 
phosphorus in homogenised dried bone pools were determined using inductively coupled 
plasma mass spectroscopy (ICP-MS) with collision cell technology (CCT) (Thermo XSeries 
2). Twenty milligrams of bone homogenates were added in Teflon digestion tubes with 5 ml 
of 69% nitric acid. The same steps described in section 2.3 for determination of dietary 
minerals and P levels were followed. More details regarding the applied methodologies are 
given in Section 2.6.1, 2.6.4 and 2.6.5.  
5.2.5 Statistics 
Growth trajectories based on the mean weight estimates at Day 92/prior vaccination, Day 
and Day 154/ 62 days post vaccination were modelled as repeated measures (Crampton et 
al., 2010; Espe et al., 2012). Moreover a hierarchical (multilevel) statistical model was used 
for the mineral analysis of pooled body cross-sections from each tank, since multiple 
observations from a single tank were available (several pools) (Espe et al., 2012; Nanton et 
al., 2012; Hartviksen et al., 2014). Firstly, data were normalised as described in Section 2.9. 
The statistical analysis was carried out with the help of the R language (R Core Development 
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Team, 2014) and its lme4 package (Bates et al., 2014). The statistical approach applied was 
model-based. This means that to find if any specific effect was statistically significant, four 
nested models with increasing complexity were fitted to the data and compared with a 
likelihood ratio test (LRT). In the applied models tank was considered as a random effect, 
sampling time as a categorical variable and the percentage of protein from SPC as a 
continuous factor possibly having non-linear effects. The four nested models are presented 
below: 
1. a model with only sampling time (Tank considered as a random effect). 
2. a model with sampling time and % protein from SPC with their interaction (Tank 
considered as a random effect). 
3. a model as above but with an additional quadratic effect of % protein from SPC 
with interactions to reveal any non-linearity in the response (Tank considered as a 
random  effect). 
Models demonstrating probabilities (P values) < 0.05 were selected for the description of 
data. The simplest possible of the three latter models was adopted according to Occam's 
razor principle. The adopted model was demonstrated by plotting the expected mean 
response with 95% confidence intervals. The expected mean and 95 % confidence intervals 
were solved by a posterior simulation from the adopted statistical model (n=1500 random 
draws was used throughout this study) (Gelman and Hill, 2007). In the present study two 
differentially treated (vaccinated and PBS-injected) salmon populations were achieved by 
the end of trial, therefore data obtained from the vaccinated and PBS-injected groups of 
salmon were modelled separately, together with data obtained for pre-injected salmon as 
described above.  
5.3 RESULTS 
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5.3.1 Growth performance 
In general, negligible mortalities (< 1%) were observed in the 3 dietary groups of salmon 
prior and post vaccination/PBS-injection. Growth performance parameters (mean daily WG 
model plotted in Fig. 20, TGC model plotted in Fig. 22A, SGR model plotted in Fig. 22B) 
were generally adversely affected in a linear fashion by the inclusion of increased dietary 
SPC in vaccinated salmon. On the other hand, growth indices for the PBS injected group of 
fish were affected in a curvilinear fashion, with SPC58 salmon demonstrating similar 
performance to the SPC35 group and SPC80 salmon exhibiting a greater reduction in growth 
parameters compared to SPC35 salmon at 62 days post PBS injection compared to the 
previous timepoint, prior to the vaccination/PBS-injection of the fish (mean daily WG model 
presented in Fig. 23, TGC model plotted in Fig. 25A, SGR model plotted in Fig. 25B). An 
overall reduction of 6 and 12% in expected weight gain (WG) was observed for the initial 3-
month feeding period in SPC58 and SPC80 groups of salmon parr respectively, compared 
to the SPC35 group (Fig 20). Similar trends were confirmed for the naive dietary groups of 
fish from the statistical models selected for the best description of the data in both vaccinated 
and PBS-injected groups, revealing a more or less linear trend in WG reduction. Adaptation 
of the linear model of decrease in mean WG for this timepoint, revealed significant decreases 
for both SPC58 and SPC80 salmon in comparison to SPC35 fish prior vaccination/PBS 
injection (since the expected 95% confidence intervals of the former group did not overlap 
with the expected mean value of the latter in all combinations of modelled growth 
responses). These reductions corresponded to approximate decreases of 5 and 10% in 
expected mean weight for the medium and high SPC inclusion dietary groups of fish 
compared to SPC35 salmon, with SPC80 salmon demonstrating a significantly lower mean 
weight than the SPC35 group (Fig. 21). Significant differences were also demonstrated in 
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TGC and SGR values for both SPC80 and SPC58 salmon compared to the SPC35 group at 
this timepoint.  
At 62 days post vaccination, the reduction in daily WG for the SPC58 and SPC80 
groups of salmon was 8.5 and 17%, corresponding to decreases of  7 and 14% in the mean 
salmon weight values when compared to SPC35 salmon (Fig. 20 and 21).  Significantly 
higher WG was demonstrated for the SPC35 group compared to both SPC58 and SPC80 
salmon. Moreover, significant decreases in salmon mean weight were revealed for the 
SPC58 and SPC80 groups of salmon in contrast to SPC35 salmon. Nonetheless, no 
differences in TGC and SGR values were demonstrated among the vaccinated dietary groups 
(Fig. 22A and 22B).  At 62 dpPBSinj,  the reduction in daily WG for the SPC58 and SPC80 
groups of salmon was 6 and 25%, corresponding to decreases of 5 and 18% in the mean 
weight values when compared to SPC35 salmon (Fig. 23 and 24). Significant changes in 
WG, TGC and SGR were demonstrated for the SPC80 group in comparison to SPC35 
salmon while no differences were detected between SPC58 and SPC35 salmon for the 
aforementioned growth performance indices (Fig. 25A and 25B). However, both SPC58 and 
SPC80 salmon exhibited significantly lower mean weight in contrast to the SPC35 group.  
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Figure 20 Modelled daily weight gain (WG) response for the vaccinated dietary groups of salmon plotted 
against values obtained for naive salmon groups. Expected mean daily weight gain (g × day-1× fish-1) (with 
95% C.I.) in relation to dietary protein from SPC prior and post vaccination. Red and blue lines connect the 
expected mean values for each measurement prior to and 62 days post vaccination respectively, while shaded 
regions of the same colours indicate the 95% confidence regions for the values of these measurements. Red 
Dashed horizontal lines of the aforementioned colours denote the mean values for salmon fed diets with 35% 
of dietary protein from SPC for each timepoint. Mean values which lie outside the 95% C.I. of the group 
receiving 35% of dietary protein from SPC are considered significant. Asterisks of the aforementioned colours 
denote significant differences between salmon fed 35% of protein from SPC and salmon fed diets with higher 
percentage of dietary protein from SPC at different timepoints. 
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Figure 21 Modelled growth performance (mean weight) for the vaccinated dietary groups of salmon 
plotted against values obtained for naive salmon groups. Expected mean weight (g × fish-1) (with 95% C.I.) 
in relation to dietary protein from SPC prior and post vaccination. Red and blue lines connect the expected 
mean values for each measurement prior to and 62 days post vaccination respectively, while shaded regions of 
the same colours indicate the 95% confidence regions for the values of these measurements. Dashed horizontal 
lines of the aforementioned colours denote the mean values for salmon fed diets with 35% of dietary protein 
from SPC for each timepoint. Mean values which lie outside the 95% C.I. of the group receiving 35% of dietary 
protein from SPC are considered significant. Asterisks of the aforementioned colours denote significant 
differences between salmon fed 35% of protein from SPC and salmon fed diets with higher percentage of 
dietary protein from SPC at different timepoints. 
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Figure 22 Modelled growth performance indices for the vaccinated dietary groups of salmon plotted 
against values obtained for naive salmon groups. (A) Expected TGC and (B) SGR values (with 95% C.I.) 
in relation to dietary protein from SPC prior and post vaccination. Red and blue lines connect the expected 
mean values for each measurement prior to and 62 days post vaccination respectively, while shaded regions of 
the same colours indicate the 95% confidence regions for the values of these measurements. Dashed horizontal 
lines of the aforementioned colours denote the mean values for salmon fed diets with 35% of dietary protein 
from SPC for each timepoint. Mean values which lie outside the 95% C.I. of the group receiving 35% of dietary 
protein from SPC are considered significant. Asterisks of the aforementioned colours denote significant 
differences between salmon fed 35% of protein from SPC and salmon fed diets with higher percentage of 
dietary protein fromSPC at different timepoints. 
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Figure 23 Modelled daily weight gain (WG) response for the PBS-injected dietary groups of salmon 
plotted against values obtained for naive salmon groups. Expected mean daily WG (g × day-1) (with 95% 
C.I.) in relation to dietary protein from SPC prior and post vaccination. Red and blue lines connect the expected 
mean values for each measurement prior to and 62 days post vaccination respectively, while shaded regions of 
the same colours indicate the 95% confidence regions for the values of these measurements. Dashed horizontal 
lines of the aforementioned colours denote the mean values for salmon fed diets with 35% of dietary protein 
from SPC for each timepoint. Mean values which lie outside the 95% C.I. of the group receiving 35% of dietary 
protein from SPC are considered significant. Asterisks of the aforementioned colours denote significant 
differences between salmon fed 35% of protein from SPC and salmon fed diets with higher percentage of 
dietary protein from SPC at different timepoints. 
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Figure 24 Modelled growth performance (mean weight) for the PBS-injected dietary groups of salmon 
plotted against values obtained for naive salmon groups. Expected mean weight (g × fish-1) (with 95% C.I.) 
in relation to dietary protein from SPC prior and post PBS-injection. Red and blue lines connect the expected 
mean values for each measurement prior to and 62 days post PBS injection respectively, while shaded regions 
of the same colours indicate the 95% confidence regions for the values of these measurements. Dashed 
horizontal lines of the aforementioned colours denote the mean values for salmon fed diets with 35% of dietary 
protein from SPC for each timepoint. Mean values which lie outside the 95% C.I. of the group receiving 35% 
of dietary protein from SPC are considered significant. Asterisks of the aforementioned colours denote 
significant differences between salmon fed 35% of protein from SPC and salmon fed diets with higher 
percentage of dietary protein from SPC at different timepoints. 
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Figure 25 Modelled growth performance indices for the PBS-injected dietary groups of salmon plotted 
against values obtained for naive salmon groups. (A) Expected TGC and (B) SGR values (with 95% C.I.) 
in relation to dietary protein from SPC, prior and post vaccination. Red and blue lines connect the expected 
mean values for each measurement prior to and 62 days post vaccination respectively, while shaded regions of 
the same colours indicate the 95% confidence regions for the values of these measurements. Dashed horizontal 
lines of the aforementioned colours denote the mean values for salmon fed diets with 35% of dietary protein 
from SPC for each timepoint. Mean values which lie outside the 95% C.I. of the group receiving 35% of dietary 
protein from SPC are considered significant. Asterisks of the aforementioned colours denote significant 
differences between salmon fed 35% of protein from SPC and salmon fed diets with higher percentage of 
dietary protein from SPC at different timepoints.  
Chapter 5. Increased bone mineralisation in Atlantic salmon parr fed increasing dietary levels of SPC and 
phosphates 
 
 
162 | P a g e  
 
5.3.2 Bone gross pathology and composition 
5.3.2.1 Skeletal pathology 
None of the sampled fish from any of the groups at anyone of the two timepoints 
demonstrated external signs of malformations or discolorations.  At both timepoints salmon 
exhibited dark colouration and presence of parr marks along the flanks revealing the absence 
of smoltification. Dorsal fin erosion was apparent for about 15% in all dietary groups. No 
signs of cataracts were observed in anyone of the sampled fish. The observations were 
consistent at both prior and post vaccination/PBS-injection. Moreover, upon necropsy 
operculae and gill arches were noted to be fairly rigid, presenting normal resistance to 
manipulation and cutting. Operculae of salmon parr were bent > 90° and samples were 
evaluated on their resistance to tortion. The results were also consistent among the different 
dietary groups of salmon at both timepoints and states of vaccination. Scales in their majority 
presented the same degree of rigidity and thickness under the dissection microscope. Again 
observations were consistent among groups. Upon ovening of the samples for 30 minutes, 
structural distortions of the ribs and spinal arches were only minor and regarded only a 
percentage of less than 2% from all sampled fish. Individuals presenting shortened and 
wrinkly ribs (throughout the full length of the rib) were accounted as carriers of  rib 
deformities and recorded.  Furthermore vertebral samples with crooked spinal arches were 
also recorded as carriers of malformations. Approximately 15% of the samples presented 
some form of anomaly in the ribs, while another 10% of the samples demonstrated 
distortions in spinal arches. Similar numbers were observed for all groups prior and post 
vaccination/PBS-injection. Approximately 2% of the sampled fish presented vertebral 
fusions in the mid and caudal section with the latter fusions being more prominent. Once 
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again even numbers were revealed for all dietary groups at both points and states. No 
fractures of the bone structures were seen. 
5.3.2.2 Skeletal composition 
The modelled proximate skeletal composition responses are plotted in Fig. 26 (naive against 
PBS-injected salmon bone composition data) and Fig. 27 (naive against vaccinated salmon 
bone composition data). Significant differences in the modelled graphs are denoted when the 
95% confidence intervals for each one of the SPC58 and SPC80 groups, do not overlap with 
the expected mean value of salmon fed the diet with 35% of dietary protein from SPC. A 
linear decrease in expected bone ash levels of salmon receiving higher dietary SPC was 
detected prior to injection with PBS. Nonetheless, no significant differences were observed 
among the 3 dietary groups of fish. This trend was reversed at 62 days post-injection with 
PBS, in salmon parr fed increasing levels of dietary SPC exhibiting an increase in bone ash 
concentrations (Fig. 26A). Significant increases in credible skeletal ash were demonstrated 
for both PBS-injected SPC58 and SPC80 groups, compared to the SPC35 salmon at this 
point (since 95% confidence intervals from the modelled skeletal ash concentrations of the 
former groups did not overlap with the mean ash levels of the SPC35 batch). At 62 dpv, 
salmon fed increasing dietary SPC levels demonstrated a linear increase in expected skeletal 
ash concentrations (Fig. 27A). However, no significant changes were recorded among the 
vaccinated dietary groups. An increase in expected bone moisture levels was observed in 
salmon fed increasing levels of SPC prior to vaccination/PBS-injection, while a linear 
reduction was witnessed at 62 dpPBSinj (model plotted in Fig. 26B). Significant reductions 
were recorded for the PBS-injected SPC58 and SPC80 salmon in comparison to the 
corresponding SPC35 group. For vaccinated salmon, the model using a squared term of the 
percentage of protein from SPC resulted in an improvement of the data (model plotted in 
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Fig. 27B). Expected bone moisture levels in vaccinated salmon followed a curvilinear line 
at 62 dpv in fish fed increasing amounts of dietary SPC, with SPC35 and SPC80 salmon 
demonstrating similar moisture concentrations and SPC58 salmon exhibiting the lowest 
levels of credible bone moisture. No significant changes were observed among the dietary 
groups of fish. 
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Figure 186 Modelled skeletal bone proximate analysis measurements (PBS-injected salmon). Expected 
mean bone composition (with 95% C.I.) from bone pools of 2 individuals per tank (4 pools × tank-1) (y axis) 
of naïve and PBS-injected Atlantic salmon parr in relation to dietary protein from SPC (x axis): (A) Ash levels 
(g × kg-1 of defatted bone); (B) Moisture levels (g × kg-1 of defatted bone). Red line connects the expected 
mean values for each measurement at prior vaccination/PBS injection (Day 92 of the feeding trial) while red 
shaded region indicates the 95% confidence region. Similarly, blue lines and its corresponding shaded region 
represent the respective values at 62 days post PBS injection (Day 154 of the feeding trial). Dashed horizontal 
lines of the aforementioned colours denote the mean values for salmon fed diets with 35% of dietary protein 
from SPC for each timepoint. Mean values which lie outside the 95% C.I. of the group receiving 35% of dietary 
protein from SPC are considered significant. Asterisks of the aforementioned colours denote significant 
differences between salmon fed 35% of protein from SPC and salmon fed diets with higher percentage of 
dietary protein from SPC at different timepoints. 
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Figure 27 Modelled skeletal elemental levels (vaccinated salmon). Expected mean bone composition (with 
95% C.I.) from bone pools of 2 individuals per tank (4 pools × tank-1) (y axis) of naïve and PBS-injected 
Atlantic salmon parr in relation to dietary protein from SPC (x axis): (A) Ash levels (g × kg-1 of defatted bone); 
(B) Moisture levels (g × kg-1 of defatted bone).Red line connects the expected mean values for each 
measurement at prior vaccination/PBS injection (Day 92 of the feeding trial) while red shaded region indicates 
the 95% confidence region. Similarly, blue lines and its corresponding shaded region represent the respective 
values at 62 days post vaccination (Day 154 of the feeding trial). Dashed horizontal lines of the aforementioned 
colours denote the mean values for salmon fed diets with 35% of dietary protein from SPC for each timepoint. 
Mean values which lie outside the 95% C.I. of the group receiving 35% of dietary protein from SPC are 
considered significant. Asterisks of the aforementioned colours denote significant differences between salmon 
fed 35% of protein from SPC and salmon fed diets with higher percentage of dietary protein from SPC at 
different timepoints. 
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The selected modelled responses of bone elemental analysis are plotted in Fig. 28, 29 
and 30 (naive against PBS-injected salmon bone composition data) and Fig. 31, 32 and 33 
(naive against vaccinated salmon bone composition data). Overall, naive salmon (pre-
vaccinated/PBS-injected fish) showed a linear decrease in Ca, Mg, P and Zn levels, a linear 
increase in Mn and almost constant Ca:P ratios with increasing dietary SPC inclusion. At 
this timepoint, significant differences were detected in expected skeletal Ca, P, Mg and Zn 
concentrations between the SPC80 group and SPC35 salmon while a significant decrease in 
skeletal Mg and Zn was also apparent for the SPC58 salmon compared to the SPC35 group 
of fish. At 62 days post PBS-injection, expected Ca:P ratio and  Mg levels increased linearly 
as dietary SPC levels increased, with SPC35 salmon showing lower values than seen prior 
to injection. On the contrary, concentrations for the SPC58 and SPC80 groups were higher 
at post PBS-injection (model plotted in Fig. 29A and 29B). Moreover, significantly higher 
Mg concentrations and Ca:P ratios were demonstrated for the SPC58 and SPC80 group 
compared to SPC35 salmon. Expected bone Zn levels followed a similar trend, however, a 
25 and an approximate 13% decrease in credible bone Zn was observed in SPC35 and SPC58 
salmon respectively, with the SPC80 group being the only group exhibiting an increase at 
post PBS-injection (model plotted in Fig. 30B). No significant differences in skeletal Zn 
were obtained among the PBS-injected dietary groups at 62 days post injection. On the other 
hand, credible bone Ca, P and Mn levels increased curvilinearly with SPC58 and SPC80 
salmon values being higher than in naïve salmon (models plotted in Fig 28A, 28B and 30A 
respectively). On the contrary, expected concentrations for the aforementioned elements 
were found to be lower in PBS-injected SPC35 salmon in contrast to their naive counterparts. 
Credible bone Ca and P concentrations were similar in the SPC58 and SPC80 groups of 
PBS-injected salmon. SPC80 salmon was the group exhibiting the highest expected levels 
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in bone Mn.  Significantly higher levels of Ca, P and Mn were demonstrated in the PBS-
injected SPC58 and SPC80 groups of salmon in comparison to the SPC35 group at the end 
of the study.  
 
 
Figure 198 Modelled skeletal elemental levels (PBS-injected salmon).Expected mean bone composition 
(with 95% C.I.) from bone pools of 2 individuals per tank (4 pools × tank-1) (y axis) of naïve and PBS-injected 
Atlantic salmon parr in relation to dietary protein from SPC (x axis): (A) Phosphorus levels (mg × kg-1 of 
defatted bone); (B) Calcium levels (mg × kg-1 of defatted bone). Red line connects the expected mean values 
for each measurement at prior vaccination/PBS injection (Day 92 of the feeding trial) while red shaded region 
indicates the 95% confidence region. Similarly, blue lines and its corresponding shaded region represent the 
respective values at 62 days post PBS injection (Day 154 of the feeding trial). Dashed horizontal lines of the 
aforementioned colours denote the mean values for salmon fed diets with 35% of dietary protein from SPC for 
each timepoint. Mean values which lie outside the 95% C.I. of the group receiving 35% of dietary protein from 
SPC are considered significant. Asterisks of the aforementioned colours denote significant differences between 
salmon fed 35% of protein from SPC and salmon fed diets with higher percentage of dietary protein frm SPC 
at different timepoints. 
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Figure 209 Modelled skeletal elemental levels (PBS-injected salmon).Expected mean bone composition 
(with 95% C.I.from bone pools of 2 individuals per tank (4 pools × tank-1) (y axis) of naïve and PBS-injected 
Atlantic salmon parr in relation to dietary protein from SPC (x axis): (A) Ca: P ratio; (B) Magnesium levels 
(mg × kg-1 of defatted bone).  Red line connects the expected mean values for each measurement at prior 
vaccination/PBS injection (Day 92 of the feeding trial) while red shaded region indicates the 95% confidence 
region. Similarly, blue lines and its corresponding shaded region represent the respective values at 62 days post 
PBS injection (Day 154 of the feeding trial). Dashed horizontal lines of the aforementioned colours denote the 
mean values for salmon fed diets with 35% of dietary protein from SPC for each timepoint. Mean values which 
lie outside the 95% C.I. of the group receiving 35% of dietary protein from SPC are considered significant. 
Asterisks of the aforementioned colours denote significant differences between salmon fed 35% of protein 
from SPC and salmon fed diets with higher percentage of dietary protein from SPC at different timepoints. 
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Figure 30 Modelled skeletal elemental levels (PBS-injected salmon). Expected mean bone composition 
(with 95% C.I.) from bone pools of 2 individuals per tank (4 pools × tank-1) (y axis) of naïve and PBS-injected 
Atlantic salmon parr in relation to dietary protein from SPC (x axis): (A) Manganese levels (mg × kg-1 of 
defatted bone); (B) Zinc levels (mg × kg-1 of defatted bone). Red line connects the expected mean values for 
each measurement at prior vaccination/PBS/injection (Day 92 of the feeding trial) while red shaded region 
indicates the 95% confidence region. Similarly, blue lines and its corresponding shaded region represent the 
respective values at 62 days post PBS injection (Day 154 of the feeding trial). Dashed horizontal lines of the 
aforementioned colours denote the mean values for salmon fed diets with 35% of dietary protein from SPC for 
each timepoint. Mean values which lie outside the 95% C.I. of the group receiving 35% of dietary protein from 
SPC are considered significant. Asterisks of the aforementioned colours denote significant differences between 
salmon fed 35% of protein from SPC and salmon fed diets with higher percentage of dietary protein from SPC 
at different timepoints. 
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In vaccinated salmon, expected bone Ca, Ca:P ratios, Mg, Mn and Zn were affected in 
a linear fashion by increasing dietary SPC inclusion (models plotted in Fig. 31B, 32A, 32B, 
33A and 33B). Most of these elements presented a linear increase with increasing dietary 
SPC supplementation except Zn, which exhibited a slight decrease at 62 dpv.  Significantly 
higher expected bone Ca: P ratio and Mn levels were obtained for both vaccinated SPC58 
and SPC80 salmon in comparison to the SPC35 group. Moreover, significantly higher 
expected bone Ca and Mg were obtained for the SPC80 group in contrast to SPC35 salmon. 
Credible bone P concentrations presented a curvilinear mode of increase at 62 dpv, with 
SPC58 and SPC80 salmon demonstrating the highest levels (model plotted in Fig 31A). 
However, no significant differences in bone P concentrations were observed among the 
dietary groups of fish. 
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Figure 31 Modelled skeletal elemental levels (vaccinated salmon).Expected mean bone composition (with 
95% C.I.) from bone pools of 2 individuals per tank (4 pools × tank-1) (y axis) of naïve and PBS-injected 
Atlantic salmon parr in relation to dietary protein from SPC (x axis): (A) Phosphorus levels (mg × kg-1 of 
defatted bone); (B) Calcium levels (mg × kg-1 of defatted bone). Red line connects the expected mean values 
for each measurement at prior vaccination/PBS injection (Day 92 of the feeding trial) while red shaded region 
indicates the 95% confidence region. Similarly, blue lines and its corresponding shaded region represent the 
respective values at 62 days post vaccination (Day 154 of the feeding trial). Dashed horizontal lines of the 
aforementioned colours denote the mean values for salmon fed diets with 35% of dietary protein from SPC for 
each timepoint. Mean values which lie outside the 95% C.I. of the group receiving 35% of dietary protein from 
SPC are considered significant. Asterisks of the aforementioned colours denote significant differences between 
salmon fed 35% of protein from SPC and salmon fed diets with higher percentage of dietary protein from SPC 
at different timepoints. 
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Figure 32 Modelled skeletal elemental levels (vaccinated salmon).Expected mean bone composition (with 
95% C.I.) from bone pools of 2 individuals per tank (4 pools × tank-1) (y axis) of naïve and PBS-injected 
Atlantic salmon parr in relation to dietary protein from SPC (x axis): (A) Ca:P ratio; (B) Magnesium levels 
(mg × kg-1 of defatted bone). Red line connects the expected mean values for each measurement at prior 
vaccination/PBS injection (Day 92 of the feeding trial) while red shaded region indicates the 95% confidence 
region. Similarly, blue lines and its corresponding shaded region represent the respective values at 62 days post 
vaccination (Day 154 of the feeding trial). Dashed horizontal lines of the aforementioned colours denote the 
mean values for salmon fed diets with 35% of dietary protein from SPC for each timepoint. Mean values which 
lie outside the 95% C.I. of the group receiving 35% of dietary protein from SPC are considered significant. 
Asterisks of the aforementioned colours denote significant differences between salmon fed 35% of protein 
from SPC and salmon fed diets with higher percentage of dietary protein from SPC at different timepoints. 
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Figure 33 Modelled skeletal elemental levels (vaccinated salmon).Expected mean bone composition (with 
95% C.I.) from bone pools of 2 individuals per tank (4 pools × tank-1) (y axis) of naïve and PBS-injected 
Atlantic salmon parr in relation to dietary protein from SPC (x axis): (A) Manganese levels (mg × kg-1 of 
defatted bone); (B) Zinc levels (mg × kg-1 of defatted bone). Red line connects the expected mean values for 
each measurement at prior vaccination/PBS injection (Day 92 of the feeding trial) while red shaded region 
indicates the 95% confidence region. Similarly, blue lines and its corresponding shaded region represent the 
respective values at 62 days post vaccination (Day 154 of the feeding trial). Dashed horizontal lines of the 
aforementioned colours denote the mean values for salmon fed diets with 35% of dietary protein from SPC for 
each timepoint. Mean values which lie outside the 95% C.I. of the group receiving 35% of dietary protein from 
SPC are considered significant. Asterisks of the aforementioned colours denote significant differences between 
salmon fed 35% of protein from SPC and salmon fed diets with higher percentage of dietary protein from SPC 
at different timepoints. 
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5.4 DISCUSSION 
5.4.1 Growth performance 
In the present trial, salmon expected growth performance indices (mean weight, daily WG, 
TGC and SGR) were adversely affected, upon feeding with diets with 58 and 80% of dietary 
protein from SPC compared to salmon fed diets with only 35% of protein from SPC, for an 
initial period of 92 days. While significantly lower mean weights were also demonstrated 
for both SPC58 and SPC80 salmon compared to the SPC35 group at post vaccination/PBS-
injection, no differences in WG, TGC and SGR values were exhibited in both vaccinated 
and PBS-injected SPC58 in contrast to SPC35 fish. This suggests an improvement in the 
overall performance of salmon and the fact that larger size parr  (30-35 g), with a more 
developed digestive tract, can  make a more efficient use of the nutrients within the SPC58 
diet compared to smaller size parr (9g initial size of the fish) (Denstadli et al., 2006; Helland  
et al., 2006). Contrary to this, no improvement in anyone of the growth performance indices 
was observed in the SPC80 group in comparison to SPC35 salmon during the second period 
of the study in both vaccinated and PBS-injected fish. In particular, PBS-injected SPC80 
salmon presented significant reductions in daily WG, TGC and SGR compared to the 
corresponding SPC35 group which far exceeded the ones observed during the first study 
period. Vaccination  in general, is a stressful process, especially when administered by 
injection, resulting in reduced growth (Poppe and Koppang, 2014), which could explain the 
differences in growth performance between vaccinated and PBS-injected salmon. The reason 
is that vaccination increases the use of energy for stress and immune induction (Wendelaar 
Bonga, 1997) and reduces energy expenditure for growth. Furthermore, vaccination-induced 
stress inhibits growth by affecting the levels of certain hormones such as the growth and 
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thyroid hormones and the insulin-like growth factor (IGF-1), regulating positive growth 
(Brown et al., 1991; Pickering, 1993; Plisetskaya and Duan, 1994). 
Overall, 75 % reduction of high quality FM (since the lowest FM inclusion was one 
quarter of the highest) caused a reduction of 17% in daily WG in vaccinated SPC80 salmon 
and 25% in their PBS-injected SPC80 counterparts. This suggests that this replacement is 
beyond the optimal level for early stage Atlantic salmon parr. In Experiment I described in 
Chapter 3 an overall decrease of only 8% in the WG of bigger size juvenile Atlantic salmon 
(~30g) fed with the SPC80 was demonstrated by the end of a 97-day trial in fish that had 
been vaccinated on Day 63 of the study. Previously, it was stated that Atlantic salmon needs  
long adaptation periods before fully accepting diets containing very low levels of FM and/or 
FO substituted with alternative protein or oil sources (Torstensen et al., 2008). Moreover, 
Burr et al. (2012) demonstrated that the growth performance of Atlantic salmon parr fed 
diets in which protein was supplied from alternative protein blends improved with the age 
and size of the fish, with late stage parr fed on these diets, presenting improved growth 
compared to the FM-fed control group of salmon. In general, the reduction of growth in fish 
fed diets with higher levels of SPC could be attributed to the increased amounts of phytate 
reducing nutrient digestibility and availability (Storebakken et al., 1998b; Mambrini et al., 
1999; Storebakken et al., 2000; Denstadli et al., 2006), or the lower concentrations of several 
key nutritional components (macro-minerals, trace minerals, sterols and non-nitrogen 
compounds), which are abundant in FM (Espe and Lied, 1999; Liaset and Espe, 2008) 
promoting feed acceptability and thus growth in fish.  
5.4.2 Bone assessments 
Expected bone moisture levels increased in salmon parr fed increasing levels of SPC during 
the initial 92 day feeding period, prior to vaccination, in the absence significant changes 
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among the three dietary groups of fish. This trend was reversed at the post-vaccination 
period, with vaccinated fish demonstrating a curvilinear decrease at 62 dpv, with lower levels 
detected in SPC58 salmon, while the decrease observed in bone moisture concentration 
followed a linear trend. Since lipid and moisture levels are inversely related (Shearer, 1994), 
the decrease in moisture suggests that higher levels of lipid were stored in salmon bones at 
62 dpi, which seems to be related to the growth retardation induced by the induction of stress 
following vaccination. In general, higher expected bone moisture levels were obtained in 
PBS-injected salmon than in vaccinated salmon, with concentrations ranging from 270 g × 
kg-1 for SPC35 salmon to 180 g × kg-1 for SPC80 salmon. For vaccinated salmon, credible 
bone moisture values ranged from 175 g × kg-1 to 150 g × kg-1 with SPC35 and SPC80 
salmon having similar values and SPC58 salmon demonstrating the lowest bone moisture 
concentrations. Fast growing juvenile salmon generally tend to have higher body moisture 
levels at the expense of lipid (Shearer, 1994). Therefore, low moisture levels are related to 
growth retardation due to vaccination (Melingen and Wergeland, 2000), which seems to be 
the case in vaccinated fish. Moreover, decreased bone moisture could be linked to the higher 
levels of dietary SPC inclusion, which seems to have a detrimental effect on early salmon 
parr growth performance as discussed above.  
Credible bone ash concentrations of naïve Atlantic salmon parr at 92 days post feeding 
with the diets ranged from about 270 g × kg-1 for the SPC80 fed salmon to 300 g × kg-1 for 
the SPC35 group, while the SPC58 group of salmon presented intermediate ash values of 
about 280 g × kg-1. No significant differences were detected among the 3 dietary groups of 
fish. The expected bone ash content of PBS-injected salmon spanned from 280 to 330 g × 
kg-1 moving from the SPC35 to the SPC80 group, with both SPC58 and SPC80 salmon 
exhibiting significantly higher ash than the SPC35 group, while bone ash for vaccinated 
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salmon parr varied from 330 to 350 g × kg-1 progressing from the SPC35 to SPC80 salmon 
and no significant differences among the treatment groups. Recorded ash levels from 
different time points were similar to those reported by Gil Martens et al. (2006) (~320 g × 
kg-1) for smoltifying salmon parr ready for seawater transfer, pointing at well mineralised 
bones free from malformations.   
For the initial 3-month feeding period and prior to vaccination/PBS-injection 
significantly lower expected bone Ca,  P,  Mg and Zn concentrations were demonstrated for 
the SCP80 group compared to SPC35 salmon, while SPC58 salmon exhibited lower Mg and 
Zn values in contrast to the SPC35 group. Despite the observed  reductions in SPC58 and 
SPC80 salmon compared to the SPC35 group, most skeletal elements in all the dietary 
groups were found to be close to the normal range reported by Gil Martens et al. (2006). 
Expected bone Zn levels were the only exception, demonstrating 13 and 25% lower 
concentrations in the SPC58 and SPC80 groups compared to SPC35 salmon. In line with 
this, Storebakken et al. (1998b)  reported decreased levels of whole body ash, P, Ca, Mg and 
Zn in salmon post-smolts fed 75% of dietary protein from undephytinized SPC after 84 days 
of feeding, compared to a fish maintained on a full FM diet. Moreover, Helland et al. (2006) 
reported decreased bone Zn levels in salmon fed increased levels of dietary phytate, which 
is the main ANF in SPC. Most of the bone elemental values determined in the current study 
were approximately 3 times higher than the ones reported by Helland et al. (2005, 2006). 
This is attributed to the fact that bone elemental concentrations in the current trial were 
determined from defatted skeletal samples. Moreover, previously it was reported that 20-
30% of normal salmon bone is composed of lipids (Toppe et al., 2007), which could explain 
the differences between the two studies. Baeverfjord et al. (1998b) reported that reductions 
in bone ash and mineral content of Atlantic salmon parr fed on low levels of P for 84 days 
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contributed to abnormally soft vertebral structures, wrinkly ribs and scoliotic spines. In this 
study, no obvious external signs of mineral depletion were observed in salmon parr, while 
gross examination of dissected vertebral bone revealed negligible differences in terms of 
deformities (rib and arch distortions and various spinal changes) among different dietary 
groups of salmon parr at all time points. Furthermore, bony structures appeared to be fairly 
rigid and hard for all groups.  
In addition, constant skeletal Mn and Ca:P ratios were reported for salmon fed on 
increasing  levels of SPC and monocalcium  phosphate for the initial period of the current 
study. The observed increment in bone Mn levels could be explained by the higher 
concentrations of these elements in SPC compared to FM (Table 13), increasing their 
availability for Atlantic salmon. Credible Ca:P  ratios  in  naïve salmon parr were found to 
be 1.7 and were similar to the lower end of the values reported by Helland et al. (2006) and 
close to the ones determined by Gil Martens et al. (2006). However, contrary to Helland et 
al. (2006), who reported a reduction in bone Ca:P ratios, the results of the present trial 
revealed constant Ca:P ratios, which could be related to the increased supplementation of 
inorganic phosphorus in the high SPC inclusion diets (Åsgard and Shearer, 1997). In Chapter 
3 a linear decrease in expected  body cross-section ash, Ca:P  ratio, Ca,  Mg,  P and Zn, in 
late stage salmon parr fed on diets containing increasing levels of SPC and constant addition 
of di-calcium phosphate after 63 days of feeding, was demonstrated. This reduction was 
combined with significant differences between the SPC35 group and salmon fed diets with 
higher than 35% of dietary protein from SPC. Increased amounts of phytate as proven from  
the dietary analysis in Table 6 were previously reported to reduce mineral availability and 
digestibility in fish (reviewed by Francis et al. 2001). One hypothesis is that the possible 
reduction in mineral digestibility due to the higher levels of phytate in diets with high SPC 
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levels combined with the under-developed gastro-intestinal tract of the fish (Denstadli et al., 
2006; Burr et al., 2012) during the first period of the trial, might have led to temporary 
mineral deficiencies, in farmed Atlantic salmon parr, which were subsequently compensated 
in the second part of the study, over a longer period. 
At 62 dpv, higher skeletal ash and elemental levels were measured in vaccinated fish 
compared to PBS-injected salmon, revealing greater retention of minerals in the bones of 
vaccinated salmon.  Expected elemental concentrations were higher than the ones reported 
by Gil Martens et al. (2006) for well mineralised Atlantic salmon smolts. In addition, Ca:P 
ratios in the PBS-injected salmon were found to be similar to the values measured for naïve 
individuals, while values for vaccinated salmon were around 1.8 and closer to the higher end 
of the ratios reported by Helland et al. (2006),  further supporting higher retention of minerals 
in the bone tissues. Similar ratios were also reported by Gil Martens et al. (2006) for salmon 
smolts. These observations are supported by previous studies revealing an increment in bone 
mineral rate and strength in Atlantic salmon at the post-vaccination period  (Berg et al., 2005; 
Grini et al., 2011). One hypothesis for the higher levels of bone ash and elemental levels in 
vaccinated salmon compared to the non-vaccinated group is the fact that vaccination in 
general reduces fish growth for all the reasons proposed previously. Another striking fact 
was that lower levels of expected bone ash, Ca:P ratios and elemental concentrations were 
demonstrated in the PBS-injected SPC35 group, while higher values were observed in 
SPC58 and SPC80 salmon compared to their pre-PBS-injection values. Moreover, the initial 
trend of linear reduction in expected bone ash, Ca:P ratios, Ca, Mg, Mn and P in salmon fed 
increasing dietary SPC inclusion, prior to vaccination, was reversed at 62 dpv in both PBS-
injected and vaccinated groups of salmon. Fjelldal et al. (2010) suggested that high inclusion 
levels of vegetable ingredients in salmon diets could have a positive effect on bone health in 
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Atlantic salmon post-smolts by delaying salmon growth. This may also reflect the 
differences in bone ash and elemental concentrations seen here and explain the improved 
bone elemental concentrations observed in SPC58 and SPC80 salmon, which in general 
exhibited lower growth rates at 63 dpv compared to the faster growing SPC35 group. 
Moreover, it has been suggested that during periods of rapid growth the time required for 
bone matrix to be produced and mineralised to occur can be reduced to a critical level 
(Hernandez et al., 2000), resulting  in soft bones. This has been proposed as the cause for 
the higher incidence of vertebral deformities in fast growing under-yearling Atlantic salmon 
smolts compared to slower growing smolts (Fjelldal et al., 2006).  
Expected bone Zn concentrations demonstrated no significant differences among the 
three dietary groups in both vaccinated and PBS-injected salmon. Moreover, an 
improvement in Zn concentrations was revealed in the vaccinated group compared to pre-
vaccination levels with expected Zn levels being closer to the values reported by Gil Martens 
et al. (2006) for a normal healthy skeleton. On the other hand, credible bone Zn levels for 
the PBS-injected salmon groups were found to be lower than the ones reported by Gil 
Martens et al. (2006), especially for the fast growing SPC35 group of salmon; possibly 
indicating a state of subclinical Zn deficiency or a trend towards it. Overall, an effect of the 
growth rate on bone Zn levels during the second period of the feeding trial was demonstrated, 
with slow growing vaccinated fish showing higher skeletal Zn values. It is suggested that 
despite the high level of Zn present in the diets of the salmon (an average of (250 mg × kg-
1), and considering that Atlantic salmon requirement for Zn is 37-67 mg × kg-1 (Maage and 
Julshamn, 1993),  Zn availability from both protein sources used for the formulation of the 
diets (FM and SPC) seems to be low, especially for fast growing salmon parr of ~30g. It is 
thus possible that higher supplementation of these diets with inorganic Zn salts (ZnSO4 and 
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ZnNO3) could compensate for the reduced dietary Zn availability (Lall, 2003). Therefore, a 
combined increment in both P and Zn supplementation is suggested for diets containing 
increasing levels of dietary SPC, to balance the availabilities of these elements and their 
incorporation into bones. 
Estimated vertebral Mn levels for fast growing SPC35 salmon were found to be lower 
than the values reported by Gil Martens et al. (2006) at 62 dpv, while SPC58 and SPC80 
salmon revealed similar or higher levels. This could be an indication of decreased 
availability of Mn in the SPC35 diet and the requirement for increased Mn supplementation. 
Storebakken et al. (1998b) suggested that the uptake of Mn in Atlantic salmon could be 
entirely controlled by the gut, which could explain the increasing amounts of this element in 
salmon fed increasing amounts of SPC (containing higher Mn Table 8) at all sampling time 
points. In Chapter 3 an improvement in body cross-section expected ash, Ca: P ratio, Ca, 
Mg, Mn and P levels in salmon juveniles receiving increased dietary SPC for a total of 97 
days (and 34 dpv) was recorded, compared to the levels detected at Day 63, just prior to 
vaccination, despite an overall trend of linear reduction over the full course of the trial. 
However, the main difference was that dietary levels of supplemental phosphates were kept 
constant among dietary treatments (30 g × kg-1) in the aforementioned trial. Therefore, diets 
with increasing SPC levels contained  lower amounts of  bioavailable P (Storebakken et al., 
1998b, 2000). In addition, the dietary source of P was di-calcium instead of mono-calcium 
phosphate, which was used as an alternative P source in the present study. Since phosphates 
with an adverse Ca:P ratio are preferred for salmonid nutrition due to their higher 
digestibility and increased availability of P (Davies and Serwata, 2004), the use of mono-
calcium  phosphate as a source of inorganic P in salmon feeds could have influenced a better 
P and mineral concentration in the long term. Another discrepancy between the previous and  
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the current study was that salmon in the previous trial were maintained under continuous 
light, which acts as a growth promoter (Kråkenes et al., 1991), thus reducing mineral levels 
in salmon (Fjelldal et al., 2004, 2005; Wargelius et al., 2009). Lastly, the developmental 
stage of Atlantic salmon parr could have been an additional factor for the observed 
differences in elemental levels prior and post-vaccination seen between the two trials (Poppe 
and Koppang, 2014). 
5.5 CONCLUSIONS 
Replacement of 80% of high quality FM protein with SPC in the diets of early stage Atlantic 
salmon parr is not recommended and the penalty in growth is quite severe with 17 and 23% 
loss in WG in vaccinated and PBS injected-salmon, respectively. Diets for early stage 
Atlantic salmon parr with 58% of protein from SPC can provide similar growth to parr fed 
on a commercial diet containing 35% of protein from SPC without compromising skeletal 
mineralisation. Furthermore, it was shown that the decrease in bone mineral levels observed 
during the initial 3 month period in early stage salmon parr fed with high SPC inclusion diets 
when combined with increased mono-calcium phosphate could be reversed over time, with 
vaccinated fish exhibiting even higher levels of vertebral mineralisation than unvaccinated 
fish. Therefore, the interaction of dietary SPC and fish vaccination does not negatively affect 
bone mineral concentrations. In addition, it was shown that long term provision of high SPC 
inclusion diets could eliminate the initial reductions in bone minerals observed in the initial 
3 month feeding period. Thus, increasing dietary SPC levels balanced with increased 
phosphate and amino acid inclusion do not seem to adversely affect bone mineralisation when 
fish are held under 12h light:12h dark conditions.  
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6.1 INTRODUCTION 
Farmed Atlantic salmon are typically raised in intensive aquaculture production systems and 
fed nutritionally complete formulated diets. Historically, fish meal (FM) has been the source 
of protein and essential amino acids for salmon feeds (Rumsey, 1993). In 2009, 
aquaculture’s use of global FM production was estimated to be 68%, with salmonid aqua-
feeds consuming 13.7% (FAO, 2012). Unless alternative sources are used, the reliance on 
FM for aquafeed diets may reduce the potential for salmon culture growth, since the 
worldwide demand for FM is rapidly exceeding supply, and new sources of protein are 
needed for the sustainable production of Atlantic salmon. Given that plant feedstuffs are 
readily available, these have received most attention as an alternative to FM (Kaushik, 1990; 
Tacon, 1994; Olli et al., 1994; Carter and Hauler, 2000).  
Among plant protein ingredients, SPC manufactured through aqueous alcohol 
extraction is a very promising protein source for Atlantic salmon. Alcohol extracted SPC has 
a protein content, which is very similar to that of FM (NRC, 1993), while its EAA content 
compares favourably with FM, with the exception of methionine and potentially lysine 
(Masumoto et al., 1996). Furthermore, lectins, saponins soy antigens and trypsin inhibitors 
concentrations, which are ANFs, are found at lower the concentrations than those found in 
conventional SBM  (Peisker, 2001; Russett, 2002; Hart et al., 2007). Several studies have 
demonstrated the suitability of SPC as an alternative to FM in Atlantic salmon post smolt 
diets (Refstie et al., 1998; Storebakken et al., 1998b, 2000). Moreover, a few studies reported 
the absence of soybean-induced intestinal inflammation in salmonids receiving diets with 
even 100% substitution of FM with SPC (Krogdahl et al., 2000; Escaffre et al., 2007). 
However, the tolerance of salmon for plant feedstuffs depends on salmon size and stage. 
Burr et al. (2012) demonstrated that early stage Atlantic salmon parr are much more sensitive 
to dietary vegetal protein inclusion than late stage Atlantic salmon parr. While studies on the 
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use of soybean meals in salmonid diets and their subsequent effects on immune function 
have been widely undertaken, only one reported study by Krogdahl et al. (2000) has 
investigated the effects of dietary SPC on the immunity of Atlantic salmon. Krogdahl et al. 
(2000) demonstrated an enhancement of lysozyme activity and total IgM levels in the 
intestinal mucosa of Atlantic salmon smolts, maintained on feeds with 30% of dietary protein 
from soy products (SBM and SPC), and in turn, enhanced the resistance of SPC fed salmon 
to infection by A. salmonicida the causative agent of furunculosis. Furunculosis is a highly 
infectious disease, causing serious fish losses, such as those observed during the epidemic 
of 1991-1992, which led to the loss of approximately 25% of the total Scottish salmon 
production (Austin, 1997). Successful vaccination has enabled the disease to be brought 
under control and currently the majority of farmed Scottish and Norwegian Atlantic salmon 
are vaccinated against fununculosis. Thus, vaccination with a commercial A. salmonicida 
vaccine and subsequent infection challenge of the experimental Atlantic salmon parr in this 
study was used to describe the effects of increasing dietary SPC levels on vaccination and 
resistance of Atlantic salmon parr against furunculosis. Since the site(s) of pathogen uptake 
into fish, is a subject of conjecture and seems likely to include gills, mouth, anus and/or 
surface injury (Klontz, 1968; McCarthy, 1980; Hodgkinson et al., 1987) an i.p. injection of 
A. salmonicida was used for the infection of Atlantic salmon parr in this study. 
Generally, soy products and several other vegetable derived products used as FM 
replacements have been shown to stimulate several innate immune responses in fishes and 
these have been interpreted as inflammatory/hypersensitivity or immunostimulatory effects 
(Rumsey et al., 1994; krogdahl et al., 2000; Sitjà-Bobadilla et al., 2005). The aim of the 
current study was to monitor how increased dietary SPC, methionine, lysine and phosphate 
inclusion (to give similar amino acid/protein ratios and increase the availability of P in diets 
with higher levels of SPC) affects the immunological responses of naïve and vaccinated 
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(against A. salmonicida) Atlantic salmon parr and their protection against furunculosis after 
i.p. infection with A. salmonicida. 
6.2 MATERIALS AND METHODS 
6.2.1 Diets and fish husbandry 
The dietary trial was carried out at the Aquatic Research Facility (ARF), Institute of 
Aquaculture, University of Stirling and lasted 177 days. The feeding trial started in June, 
2013 and ended in December 2013. The fresh water system consisted of twelve 100 l circular 
tanks supplied with flow-through water at a rate of 1.5 l × min-1. Water temperature was 
maintained at 12 ± 1ºC (ambient temperature of 12 ±  ºC for the first 3 months of  the study 
and application of  heating later on Day 115 of the feeding trial to maintain the temperature 
constant throughout the study), whilst photoperiod was constant to prevent smoltification 
(12 hours of light: 12 hours of darkness). Dissolved oxygen, ammonia, nitrate, nitrite and 
pH were monitored and remained within limits recommended for Atlantic salmon. Prior to 
the trial unvaccinated S1 Atlantic salmon parr (AquaGen QTL eggs - AquaGen Ltd, 
Kilmacolm, Scotland - selected for improved growth and resistance to IPNV) purchased 
from Scottish Seafarms Ltd (Dumfries, Scotland, UK) previously maintained on a 
commercial BioMar (BioMar Fishes Ltd, Grangemouth, Scotland) diet (BioMar Inicio 
PLUS) were allowed to acclimate for a week within two stock tanks, during which time they 
were maintained on a commercial EWOS (EWOS Ltd, Westfield, Near Bathgate, Scotland) 
diet (EWOS micro). The fish were then randomly allocated into the twelve trial tanks, each 
tank containing 130 individuals in which they were allowed to acclimatise for 7 days. The 
fish had an average weight of 9.3 g at the start of the trial. The fish were then starved for two 
days and were subsequently fed a mixture of the commercial feed and the trial diets they 
were assigned to. The experimental diets contained different levels of protein from SPC (35, 
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58 and 80% of protein from SPC) replacing FM and were manufactured by EWOS 
Innovation, Dirdal, Norway.  Protein/fat ratios were kept constant (~3.0), while methionine, 
lysine and phosphorus (P) supplementation increased concomitantly with increased dietary 
SPC inclusion. Each dietary treatment included four replicate tanks. Dietary formulations 
are presented in Table 8 of Chapter 5. Parr were acclimatised to the trial feeds for 3 days 
prior to the start of the trial. After the initiation of the trial the fish were maintained on the 
trial feeds for about 6 months (177 days). Eight fish per tank were sampled on Day 92 of the 
feeding trial prior to vaccination with a commercial anti A. salmonicida and infectious 
pancreatic necrosis virus vaccine (Alpha-Ject 2-2, Pharmaq) to monitor their immune status 
(2 serum and 2 head kidney pools from 4 fish per tank were sampled for the performance of 
several different immunoassays) and vertebral mineral composition (8 fish per tank for 
vertebral mineral analysis). After the first sampling approximately 80 fish per tank were 
divided between the original set of tanks and another set of 12 replicate tanks with the ones 
kept in the original set of tanks being vaccinated with the above vaccine and the salmon parr 
transferred to the replicate set of tanks being injected with 0.02 M phosphate buffer saline 
(PBS) (0.15M NaCl, pH 7.2). The remaining salmon parr (~40 fish distributed in a third set 
of 3 tanks -1 tank per diet-) were to establish the lethal dose of bacteria giving 70% 
mortalities when fish were experimentally infected with A. salmonicida. In order, to trigger 
specific antibody production in vaccinated fish at post vaccination water temperature in the 
tanks was increased at 10ºC with the use of heaters. Pools of serum samples (2 serum and 2 
head kidney pools from 4 fish per tank) were taken at 2 days post vaccination (2 dpv) (serum 
samples from only vaccinated individuals/head kidney samples from both vaccinated and 
PBS-injected salmon) (Day 94 of the feeding trial) and at 62 dpv (Day 154 of the feeding 
trial-sampling of vaccinated and PBS-injected salmon).  
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6.2.2 Disease resistance 
On Day 154 of the feeding trial (62 dpv), twenty five salmon from each tank of vaccinated 
and PBS-injected fish were removed and stocked in another two sets of 12 replicate tanks in 
the ARF. The tanks used were also circular fiberglass tanks supplied with flow-through fresh 
water as described above. The fish were housed under a controlled photoperiod (12 h of 
light: 12 h of darkness) at a controlled temperature of 13-15ºC. Seventy five hours before A. 
salmonicida was administered; a fresh culture of the passaged bacterium was prepared on a 
blood agar plate. Twenty seven hours before the commencement of the challenge, seven 
bacterial colonies were cultured in tryptone soy broth (15ºC for 18 h). Subsequently the 
bacteria were washed twice with sterile PBS with intermediate centrifugation (3500 × g, 10 
min). The OD of the bacterial suspension was then adjusted to 1.0 at 610 nm (6 × 108 cfu × 
ml-1), and serially diluted to 0.25 × 10-7 (corresponding to ~ 2 × 102 cfu × ml-1), which was 
the dilution found to give approximately 70% mortalities in salmon parr in a pre challenge 
trial. Cell densities were confirmed by distributing eight 25 μl drops of each one of the 
obtained serial bacterial suspensions (1.0 × 10-7, 0.5 × 10-7, 0.25 × 10-7, 1.0 × 10-6) onto 
tryptone soy agar plates (TSA) (Sigma-Aldrich) and colonies counted after 48 h. One-
hundred microlitres of the 0.25 × 10-7 bacterial suspension (corresponding to and 2 × 101 cfu 
× fish-1) was i.p. injected into each Atlantic salmon after anaesthetizing them (benzocaine, 
30 mg × l-1). Specific mortalities were confirmed by culturing kidney swabs onto TSA and 
checking colonial morphology. The challenge was terminated after 30 days, at which time 
mortalities had ceased. 
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6.2.3 Head kidney macrophage isolation, respiratory burst and phagocytic activity by 
head kidney macrophages 
For the isolation of head kidney macrophages (HKMs), the head kidney was teased through 
a 100 µm nylon mesh (BD Falcon; BD Biosciences, Franklin Lakes, NJ, USA) into 2.5 ml 
L-15 containing 40 µl of heparin (10 IU × ml-1). The mesh was rinsed with 2.5 ml of the 
medium and the cell suspension placed on ice. Levels of O-2 production by head kidney 
macrophage suspensions were measured by the conversion of nitroblue tetrazolium (NBT; 
Sigma-Aldrich) to formazan, following the method described by Secombes (1990), with 
some modifications described by Korkea-aho et al. (2011). The head kidney cell suspension 
was also used to determine phagocytosis activity by head kidney macrophages as described 
by Korkea-aho et al. (2011). A more thorough description of the methodologies is given in 
Section 2.4.1. 
6.2.4 Determination of serum glucose, protein and lysozyme activity 
Serum glucose was determined using a CONTOUR blood glucose monitoring system (Bayer 
HealthCare LLC) according to manufacturer’s instructions. Briefly a CONTOUR strip was 
inserted accordingly into the Contour blood glucose monitor and then 5μl of serum were 
pipetted onto the blood receiving end of the CONTOUR strip and held for 5 sec until the test 
result was displayed on the screen of the monitor. Protein content of serum was determined 
using a Pierce BCA (bicinchoninic acid) protein determination kit (Thermo Scientific, IL, 
USA) using bovine serum albumin (BSA) as a standard. Serum lysozyme activity was 
estimated according to the protocol described by Korkea-aho et al. (2011), based on the lysis 
of lysozyme sensitive Micrococcus lysodeikticus. A thorough description of the latter two 
methodologies is given in Sections 2.4.4 and 2.4.3 respectively. 
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6.2.5 Determination of serum total IgM 
The level of IgM in sera of experimental fish was determined using an indirect enzyme 
linked immunosorbent assay (ELISA) (Magnadottir and Gudmundsdottir, 1992), with 
modifications. A more detailed description of the applied method is illustrated in Section 
2.4.7. 
6.2.6 Determination of specific antibody against Aeromonas salmonicida 
An ELISA was used to measure the specific antibody response of Atlantic salmon to the A. 
salmonicida vaccine using a modification of the method outlined by Adams et al. (1995). 
Briefly, 96-well Immulon™ 4HBX plates (ThermoScientific, Maine, USA) were coated 
with 50 µl of 0.05 % w/v poly-L-lysine (Sigma-Aldrich) in 0.05 M sodium 
carbonate/bicarbonate buffer, pH 9.6 and incubated for 60 min at 21°C. Plates were then 
washed twice with a LSWB. A.salmonicida (Hooke) in 0.1M PBS was added to the wells at 
100 μl × well-1 and plates incubated overnight at 4°C. Fifty microliters per well of 0.05 % 
v/v glutaraldehyde in PBS was added to the bacteria and the plate incubated at 21°C for 30 
min before washing three times with LSWB. Non-specific binding sites were blocked by 
incubating plates with 3% w/v skimmed milk powder in water at 21°C for 120 min. After 
washing the plates three times with LSWB, 100 µl of serially diluted fish serum diluted in 1 
% casein (from 1: 50, 1: 200 and 1: 1000) was transferred to the ELISA plate, which was 
then incubated overnight at 4°C. Both positive (serum pools from challenged salmon 
survivors which have been vaccinated prior to challenge) and negative controls (serum 
blanks/ pooled serum from naïve salmon) were also added to each plate. Plates were washed 
five times with HSWB with a 5 min soak on the last wash. Anti-rainbow trout/Atlantic 
salmon IgMmonoclonal antibody (F11-monoclonal anti trout/salmon IgM - Aquatic 
Diagnostics Ltd, Stirling, Scotland) was then added and plates were incubated at 21°C for 
Chapter 6. The effects of increasing dietary levels of SPC and phosphates on the disease resistance 
(furunculosis) of Atlantic salmon 
 
 
192 | P a g e  
 
60 min. The steps followed until the development of the plates were the same with those 
described above. The percentage of specific antibody production was estimated by the 
comparison of positive (pooled serum from vaccinated and challenged salmon, 100 % 
antibody production) and negative controls (pooled naïve salmon serum, 0% antibody 
production) and was expressed as percentage of specific antibody production. 
6.2.7 Measurement of alternative, classical and overall complement activity 
Salmon antiserum against sheep RBC was produced by immunising fish i.p. with 109 sheep 
red blood cells (SRBC) in PBS (0.15 M phosphate-buffered saline, pH 7.2). Four weeks after 
priming a booster injection (109) was given, and two weeks later, fish were bled. Control 
fish were injected with PBS. Endogenous complement activity of anti-SRBC salmon serum 
was inactivated by heating at 50°C for 30 min and the anti-SRBC serum was diluted with 
0.1% Gelatin-Complement Fixation Buffer (G-CFB) (1 tablet of Oxoid complement fixation 
tablets in 100 ml of warm water and 0.1 g of gelatin from Sigma-Aldrich) with 20mM EDTA. 
Diluted anti-SRBCs were then stored at – 20°C. Sheep blood (Oxoid) was stored at 4°C in 
Alsever’s solution (1: 1) for 1 week before use. The SRBCs were used to determine lysis by 
the alternative complement pathway (ACP), while SRBCs, sensitized (60 minutes, 37°C) 
with pooled and diluted (1: 400) salmon anti-SRBC serum, was used for determination of 
total (TC) and classical complement pathway (CCP) activity. Buffer for the AC was 0.01 M 
EGTA-Mg-G-CFB and for determination of the total and classical haemolytic activity G-
CFB. Tests were done in round-bottomed 96-well microtiter plates (Sterilin).Briefly 
complement activity determination was based on methods described by (Yano et al., 1987, 
1988) with modifications. Briefly serum was diluted four times in double serial dilutions 
accordingly (starting from 1:4 for the estimation of AC activity and 1: 16 for the estimation 
of TC and CC activity) and 25 μl of each dilution was added to each well of a non-absorbent 
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U-well micro-plate (Sterilin) in duplicate. Ten microliters of 0.5 % SRBC suspension was 
added to each serum dilution. Controls on each plate comprised 0.1 % anhydrous Na2CO3 
(v/v) (100 % lysis) replacing serum. G-CFB replacing serum (0 % lysis) and serum blanks 
(duplicate wells of serum dilutions with G-CFB replacing SRBC suspension). The plates 
destined for the estimation of TC and CCP activity also included, a CC control sensitization 
of SRBC with non-immune pooled carp serum and a standard complement sample (serum 
pool) for correction of plate differences were included. Microtitre plates were incubated at 
22°C for 90 min with constant shaking and the reaction terminated by the addition of 140 μl 
G-CFB with 20mM EDTA, followed by centrifugation at 1500 × g to spin down the 
remaining SRBCs. After centrifugation 100 μl of the supernatant from each well was 
transferred to a new flat-bottomed 96-well non-absorbent micro-titre plate (Sterilin). The 
absorbance of the wells was read at 450 nm using a micro-plate reader (Synergy HT; BioTek 
Instruments, Winooski, VT, USA) and the percentage lysis of SRBCs calculated. The 
absorbance values of samples were corrected by subtracting the absorbance of the sample 
blank control (0 % haemolysis). Details regarding the estimation of serum haemolytic 
activity by the different complement pathways are given in Section 2.4.5.11, whereas 
descriptions about the preparation of SRBCs, buffers, collection of salmon anti-SRBC 
serum, dilution of serum required for optimal sensitization and preparation of sensitized 
SRBCs are given in Section 2.4.5. 
6.2.8 Diet composition analysis 
Dietary crude fat was determined following acid hydrolysis using a Soxtec System 1047 
hydrolysing unit (Tecator Application note 92/87) followed by exhaustive Soxhlet extraction 
using petroleum ether (40–60°C boiling point) on a Soxtec System HT6 (Tecator application 
note 67/83) as described by (Bell et al., 2001). Dry weight and ash contents of diets were 
determined after oven-drying the samples to constant weight (at 100 ºC) and by ashing dried 
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samples in an oven at 550°C (AOAC, 1990). Dietary energy content was determined through 
bomb calorimetry (AOAC, 1990). For the determination of phytate content in the diets a 
Megazyme Phytate/Total Phosphorus Assay kit (Megazyme, Ireland) was used. Dietary 
energy content was determined through bomb calorimetry (AOAC, 1990). More details 
regarding the aforementioned methodologies are given in Section 2.6.  
Dietary carbohydrate was determined following a modified Dubois phenol sulphuric 
method. Dietary fibre was determined after subjecting defatted dietary samples (3 washes 
with petroleum ether) within pre-weighed organic capsules, to acid (with 1.25% sulphuric 
acid solution)and alkaline hydrolysis (with 1.25% sodium hydroxide solution) for 35 min 
each, using a Fibertec system 1020 hot Extractor. Following one last defatting step (3 washes 
with petroleum ether), the samples were ashed at 600°C in a muffle furnace (Gallenkamp 
Muffle Furnace) for 4 hours, cooled in a desiccator and reweighed (W2).  Extracted fibre 
was expressed as percentage of the original undefatted sample and calculated according to 
the formula: 
𝐹𝑖𝑏𝑟𝑒(%) =
(𝑊1 × 1.0011) − 𝐶𝑎𝑝𝑠𝑢𝑙𝑒 𝑤𝑒𝑖𝑔ℎ𝑡 − (𝑊2 − 0.0025)
𝑆𝑎𝑚𝑝𝑙𝑒 𝑤𝑒𝑖𝑔ℎ𝑡 (𝑔)
  × 100 
Where W1 is the initial weight of the unprocessed dietary sample and W2 is the weight after 
processing. More details regarding the determination of dietary carbohydrates and fibre 
levels are given in Sections 2.6.7 and 2.6.8. 
Dietary minerals and phosphorus were determined using inductively coupled plasma 
mass spectroscopy (ICP-MS) with collision cell technology (CCT) (Thermo X Series 2). A 
more thorough description of the method is given in Section 2.6.5. 
6.2.9 Statistics 
Growth trajectories based on the mean weight estimates at Day 36/prior vaccination, Day 
63/prior vaccination and Day 97/ 34 days post vaccination were modelled as repeated 
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measures (Crampton et al., 2010; Espe et al., 2012). Moreover a hierarchical (multilevel) 
statistical model was used for the mineral analysis of pooled body cross-sections from each 
tank, since multiple observations from a single tank were available (several pools) (Espe et 
al., 2012; Nanton et al., 2012; Hartviksen et al., 2014). Firstly, data were normalised as 
described in Section 2.9. The statistical analysis was carried out with the help of the R 
language (R Core Development Team, 2014) and its lme4 package (Bates et al., 2014). The 
statistical approach applied was model-based. This means that to find if any specific effect 
was statistically significant data were fitted in three different models with increasing 
complexity where tank was included as a random effect, sampling time as a categorical 
variable and the percentage of protein from SPC as a continuous factor possibly having non-
linear effects: 
1. a model with only sampling time (Tank considered as a random effect). 
2. a model with sampling time and % protein from SPC with their interaction (Tank 
considered as a random effect). 
3. a model as above but with an additional quadratic effect of % protein from SPC with 
interactions to reveal any non-linearity in the response (Tank considered as a random 
effect). 
The three models were nested and compared with a likelihood ratio test (LRT) that evaluated 
if the improvement in the likelihood required a more complex model or whether the simpler 
model could be applied. Models demonstrating possibilities (P values) < 0.05 were selected 
for the description of data. The simplest possible model was adopted according to Occam's 
razor principle. The adopted model was demonstrated by plotting the expected mean 
response with 95% confidence intervals. For a categorical effect these were represented as 
points with error bars and for a continuous effect as a curve with shaded confidence region. 
The expected mean and 95% confidence intervals were solved by a posterior simulation from 
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the adopted statistical model (n=1500 random draws were used throughout this study) 
(Gelman and Hill, 2007).  In the present study two differentially treated (vaccinated and 
PBS-injected) salmon populations were achieved by the end of trial, therefore data obtained 
from the vaccinated and PBS-injected groups of salmon were modelled separately, together 
with data obtained for pre-injected salmon as described above.  
Further statistical modelling was applied using R language and its corresponding 
packages (reshape, xtable and coxme) for the analysis of the disease challenge trial results. 
The three SPC levels were modelled with the help of polynomial models. Nested models 
with increasing complexity up to a second-degree polynomial of the SPC inclusion were 
fitted and compared by a LRT, based on a multilevel Cox proportional hazard model. 
6.3 RESULTS 
6.3.1 Immune Responses 
Credible levels of serum proteins were only affected by time and not by dietary levels of 
SPC in both vaccinated and PBS-injected groups of salmon, when modelled together with 
pre-injected naïve salmon (the model with only the sampling time was selected with a 
P<0.05). A sharp decrease in serum protein levels was exhibited in vaccinated salmon at 2 
dpv while at 62 dpv serum protein increased compared to the levels at 2 dpv. Nevertheless, 
serum protein concentrations were found to be lower than initial pre-vaccination levels. On 
contrast, serum protein levels in PBS-injected fish doubled at 62 days post PBS injection (62 
dpPBSinj) when compared to naïve salmon.  
Expected concentrations of serum total IgM did not exhibit any differences among 
salmon dietary groups (the models with only the sampling time were selected with P 
values<0.05 in both cases). While no differences were observed in total IgM levels between 
naïve and PBS-injected salmon serum, in vaccinated salmon total IgM levels demonstrated 
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a decrease at 2 dpv compared to their initial pre-vaccination values, whereas at 62 dpv total 
IgM increased 4-fold compared to the concentration in the serum of naïve salmon. Specific 
IgM was measured at 62 dpv and no differences were detected among the three dietary 
groups of salmon.  
Lysozyme activity was another immune response exhibiting no changes among the 
dietary groups of salmon. Both naïve and PBS-injected salmon at 62 dpPBSinj exhibited no 
changes in expected lysozyme activity levels, however an increment was obtained at 2dpv 
compared to naïve parr values, followed by a further increase at 62dpv (the model with only 
the sampling time was selected with a P<0.05). Credible serum glucose concentrations did 
not show any differences among experimental dietary groups. Moreover, no changes were 
detected in naïve and PBS-injected salmon serum glucose. However at 2 dpv, glucose levels 
were found to be higher than pre-vaccinated salmon, while at 62 dpv glucose levels in 
vaccinated groups were lower than in naïve salmon (the model with only the sampling time 
was selected with a P<0.05).  
While the amount of SRBC haemolysis due to total complement activity did not show 
any differences between the dietary groups, the contribution made by the different 
complement pathways differed in fish receiving increasing levels of SPC. Statistical analysis 
has shown that serum expected ACP activity decreased linearly upon increased dietary SPC 
protein uptake at 62 dpPBSinj compared to naïve salmon, in which AC activity increased 
linearly (model plotted in Fig. 34A). No significant differences were observed prior 
vaccination/PBS-injection whereas both SPC58 and SPC80 salmon demonstrated significant 
reductions  in AC activity at post PBS-injection. Similarly, levels of serum AC activity 
presented a linear reduction at both time points post-vaccination when salmon were fed diets 
with increasing SPC levels (model plotted in Fig. 35A). Significantly lower expected AC 
activity was observed for both SPC58 and SPC80 salmon at both timepoints post vaccination 
Chapter 6. The effects of increasing dietary levels of SPC and phosphates on the disease resistance 
(furunculosis) of Atlantic salmon 
 
 
198 | P a g e  
 
compared to SPC35 salmon (Mean values lie outside the 95% C.I. of the SPC35 group). 
Furthermore, salmon parr fed increasing dietary levels of SPC presented a linear increase for 
expected classical complement activity (CCP) at both timepoints post vaccination, 
demonstrating an inverse trend in comparison to pre-vaccinated/PBS-injected salmon 
(model plotted in Fig. 35B). Significantly higher CC activity was observed at the last 
timepoint (62dpv) for both SPC58 and SPC80 salmon in contrast to SPC35 salmon. No 
differences on expected CC activity prior to or post-PBS injection, were demonstrated. 
Furthermore, credible levels of TC activity were unchanged among the different dietary 
groups of vaccinated and PBS-injected salmon, while no differences were noted between 
naïve and vaccinated salmon. However, an increase of almost 18 % in TC activity was 
obtained for all dietary groups at 62 days after their injection with PBS. 
No changes were detected in expected PMA-stimulated and non-stimulated HKM 
respiratory burst and HKM phagocytic activity among dietary groups of vaccinated or PBS-
injected salmon parr. For the vaccinated salmon parr, the trend obtained was similar for all 
the HKM responses measured between the dietary groups, with non- and PMA-stimulated 
respiratory burst activity, phagocytic index levels and the percentage of phagocytosis 
increasing sharply at 2 dpv compared to pretreated values and decreasing at 62 dpv below 
naïve salmon levels (the models with only the sampling time were selected with P values 
<0.05 in all cases). For PBS-injected salmon, respiratory burst and phagocytic index levels 
were similar to the ones obtained for vaccinated salmon at 2 and 62 dpv exhibiting an almost 
equal increase at 2 dpPBSinj, followed by a subsequent reduction at levels lower than the 
ones determined for naïve salmon except for PMA-stimulated HKM, which presented a 
higher activity at 62 days post injection compared to naïve salmon (the models with only the 
sampling time were selected with P values <0.05 for all the aforementioned cases). Lastly 
expected phagocytosis percentage was affected in a curvilinear fashion in PBS-injected 
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salmon.  Salmon at prior and 62 dpPBSinj presented similar trends with the SPC58 group 
demonstrating higher levels than the other two groups. Nonetheless, significant differences 
were detected only at 62 dpPBSinj, when both SPC58 and SPC80 salmon exhibited a higher 
percentage for HKM phagocytosis. A trend of an almost linear increment of HKM 
phagocytosis was detected at 2dpPBSinj (model plotted in Fig. 34B), however, no significant 
changes were detected among the dietary groups of fish.  
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Figure 34 Modelled Immune responses (PBS-injected salmon). Expected mean immune responses (with 
95% C.I.) from serum pools (4 fish × tank-1) of naïve and vaccinated Atlantic salmon parr in relation to dietary 
protein from SPC: (A) alternative complement activity (haemolytic units H50× ml-1); (B) Percentage (%) of 
head kidney macrophages performing phagocytosis.Red line connects the expected mean values for each 
measurement at prior vaccination (prevacc) (Day 92) while red shaded region indicates the 95% confidence 
region. Similarly, green and blue lines and their corresponding shaded regions represent the respective values 
for each one of the measurements above at 2 and 62 days post vaccination (2 and 62d post vacc) (Days 92 and 
154 of the feeding trial respectively). Dashed horizontal lines of the aforementioned colours denote the mean 
values for salmon fed diets with 35% of dietary protein from SPC for each timepoint. Mean values which lie 
outside the 95% C.I. of the group receiving 35% of dietary protein from SPC are considered significant. 
Asterisks of the aforementioned colours denote significant differences between salmon fed 35% of protein 
from SPC and salmon fed diets with higher percentage of dietary protein from SPC at different timepoints. 
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Figure 35 Modelled Immune responses (vaccinated salmon).Expected mean immune responses (with 95% 
C.I.) from serum and head kidney macrophage pools (4 fish × tank-1) of naïve and PBS-injected Atlantic salmon 
parr in relation to dietary protein from SPC: (A) alternative complement activity (haemolytic units H50 × ml-1); 
(B) classical complement activity (haemolytic units H50 × ml-1).Red line connects the expected mean values 
for each measurement at prior PBS-injection (Day 92) while the red shaded region indicates the 95% 
confidence region. Similarly, green and blue lines and their corresponding shaded regions represent the 
respective values for each one of the measurements above at 2 and 62 days post PBS-injection (Days 92 and 
154 of the feeding trial respectively). Dashed horizontal lines of the aforementioned colours denote the mean 
values for salmon fed diets with 35% of dietary protein from SPC for each timepoint. Mean values which lie 
outside the 95% C.I. of the group receiving 35% of dietary protein from SPC are considered significant. 
Asterisks of the aforementioned colours denote significant differences between salmon fed 35% of protein 
from SPC and salmon fed diets with higher percentage of dietary protein from SPC at different timepoints. 
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6.3.2 Disease resistance trial 
No mortalities were observed for any of the dietary groups vaccinated against A. salmonicida 
after challenging them with the bacterium. Therefore, no further statistics for the 
establishment of survival differences among different dietary groups were performed. The 
raw data of PBS-injected salmon cumulative survival during the experimental infection are 
presented in Fig. 36. However, mortalities were obtained from all dietary groups in PBS-
injected and subsequently challenged dietary groups of Atlantic salmon parr. Mortalities 
from these fish first started to occur at 6 days post challenge, but only for the SPC35 salmon 
group. On Day 7 post-challenge the first mortalities from SPC58 salmon were observed, 
while on Day 8, mortalities from the SPC80 group of salmon also started to occur. 
Mortalities ceased on Day 19 post-challenge. At this time, the survivors for the SPC35 group 
from all tanks were 38 fish corresponding to 56% survival. Fourty five surviving salmon 
were recorded for the SPC58 group which was equivalent to 66% survival while 48 survivors 
revealing a 71% survival were reported for the SPC80 group of salmon. Statistical analysis 
revealed no significant differences among different dietary groups (P value < 0.05).  
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Figure 36 Observed survival in the quadruplicate tanks of the experimental dietary groups of intra-
peritoneally challenged against A. salmonicida Atlantic salmon parr. Stripped text above each panel gives 
the percentage of protein from SPC. Broken lines with different colouration give the percentage of daily 
survival in each one of the quadruplicate tanks in each treatment for 23 days. 
 
6.4 DISCUSSION 
In the present study, determination of serum protein levels was used to evaluate the general 
condition of experimental salmon (Waagbø et al., 1988), whereas serum glucose was 
measured for the evaluation of the general stress status of fish from different dietary groups 
(Iwama, 1998). Furthermore the immune parameters measured in the present study are 
salient components of salmon defence mechanisms against diseases. Lysozyme and 
macrophage phagocytosis followed by oxygen radical production, are important bactericidal 
and parasiticidal agents (Secombes, 1990; Rumsey et al., 1994), while complement, and total 
and specific IgM are linked with the neutralisation and opsonisation of various pathogens 
(Nikoskelainen et al., 2002; Kiron, 2012).  Furthermore, Thompson et al. (1996) suggested 
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that measuring defence mechanisms prior to challenge only represents resting levels. 
However, measuring immune function after immune stimulation (either through challenge 
or vaccination) may highlight dietary modifications that were not evident before. This is 
further highlighted by mammalian research, which has demonstrated that nutrients are 
preferentially directed towards the immune system, rather than growth, during times of 
infection (Beisel, 1977). This includes the distribution of amino acids towards the liver for 
the synthesis of acute phase proteins (Wannemacher, 1977) and suggests suboptimal nutrient 
intake prior to infection may result in a diminished immune response. It therefore seems a 
logical step to evaluate the immune function of the fish after its dietary protein source has 
been altered. Therefore, salmon parr receiving the experimental diets in the present trial were 
initially vaccinated and subsequently challenged with A. salmonicida.  
While most of these immunological parameters (serum lysozyme, protein, total IgM, 
head kidney macrophage phagocytic activity and oxygen radical production) have been 
previously shown to be modulated by dietary change in various teleosts (summarized by 
Kiron, 2012), no modification relative to the control SPC35 diet occurred prior or post-
vaccination in the present study. Similar to the current trial, Bransden et al. (2001) reported 
no differences in lysozyme activity, plasma concentrations of total IgM, total protein or 
glucose levels of non-immunized salmon parr fed on diets where dehulled lupin meal 
replaced 40% of FM. Furthermore, in line with the present study, Jalili et al. (2013) 
demonstrated no differences in serum lysozyme levels of non-immunized rainbow trout 
(Oncorhynchus mykiss) fed on diets fully based on mixed plant proteins. Rumsey et al. 
(1994) reported increased lysozyme activity in rainbow trout fed SBM diets. Contrary to 
this, Farhangi and Carter (2001) revealed decreased serum protein levels in rainbow trout 
receiving 30, 40 and 50 % of dehulled lupin meal, compared to trout fed 10% dehulled lupin 
meal, whereas no changes were detected in serum glucose levels. Vaccination is a stressful 
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process, which could explain the sharp increase in serum glucose at 2 dpv (van Muiswinkel 
and Wiegertjes, 1997; Siwicki et al., 2002). Furthermore, the stress-related reduction in fish 
appetite due to vaccination could explain the concomitant reduction in serum protein and 
total IgM levels observed at 2 dpv in vaccinated salmon (Melingen and Wergeland, 2000). 
The observed initial reduction in serum total IgM could also be related to the formation of 
antibody-antigen complexes, reducing the number of free circulating natural antibodies at 2 
dpv (Bricknell et al., 1999; Villumsen et al., 2012).   
The reduction in serum glucose levels below those of pre-vaccinated or PBS-injected 
salmon at 62 days post injection demonstrates the reduced responsiveness to acute stressors 
(e.g. sampling processes such as netting and exposure to anaesthetic) of salmon subjected to 
higher stress for a prolonged time period (e.g. vaccinated salmon vs PBS-injected salmon 
due to immune stimulation) (Espelid et al., 1996; Kvamme et al., 2013). However, the 4-
fold increase in total IgM for all dietary groups at 62 dpv is an indication of the efficacy of 
vaccination (Melingen and Wergeland, 2000), and the absence of polyetiological stress 
during the study, which could have compromised this response (Siwicki et al., 2002). In the 
study performed in Chapter 4 increased total plasma IgM and  lysozyme activity in SPC50 
and SPC65 salmon at all time-points was demonstrated, whereas SPC80 fish presented lower 
levels by comparison with the aforementioned groups; and similar levels to the SPC35 
group. However, the overall pattern of serum lysozyme activity post-vaccination showed 
that lysozyme increased sharply at 7 dpv, while a reduction below pre-vaccination levels 
were observed at 34 dpv, whereas total IgM increased rapidly by 7 dpv to a level which was 
more or less maintained until 34 dpv. The trends in the levels of measured immune responses 
post-vaccination were not similar between this and the previous study. However, the 
differences obtained could be attributed to experimental disparities, such as the use of 
different commercial adjuvanted vaccines (i.e. liquid paraffin vs montanide) (Anderson, 
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1992), the timing of sampling (2 and 62 dpv vs 7 and 34 dpv), the photoperiod applied (12 
h dark: 12 h light vs constant light) (Uribe et al., 2011),  the developmental stage of salmon 
parr used (early vs late stage salmon) (summarised by Gannam and Schrock, 1999) and the 
dietary P balance (increasing vs constant dietary P addition) (Kiron, 2012). No effects of the 
SPC inclusion levels on specific antibody production were detected, which is in line with 
the data from the study presented in Chapter 4, on increasing dietary SPC levels on late 
salmon parr by our group. Kiron et al. (1993, 1995) demonstrated that the adaptive response 
(in terms of humoral antibody levels) in rainbow trout fed on different dietary protein levels 
does not seem to depend on protein quantity in the diet. This could explain why in the present 
trial, differences in protein intake attributed to the presence of ANFs disrupting normal 
feeding activity or reduction of protein digestibility, did not affect the production of specific 
antibodies. Moreover, many studies on the effects of dietary or injectable immuno-stimulants 
have found no effect on specific antibody production in fish (summarised by (Anderson, 
1992; Gannam and Schrock, 1999), which could be an indication that increasing dietary 
levels of plant proteins with potential immunostimulatory effects, do not promote specific 
antibody production. 
Complement signals the presence of potential pathogens to the host, and engages in 
destroying and eliminating them through phagocytosis, cytolysis of the pathogens, initiation 
of the inflammatory response, promoting humoral immunity and the coordination of 
adaptive immunity development (Boshra et al., 2006). Complement is triggered by one or a 
combination of three pathways, the alternative, lectin and classical (Boshra et al., 2006). The 
alternative complement (AC) pathway is a major humoral component of the innate immune 
response. The classical complement (CC) pathway is an integral part of the specific humoral 
immunity of the fish, initiated by a complex between an antigen and an antibody, which 
activates the enzymatic cascade associated with this pathway. Finally, the lectin pathway is 
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triggered by the formation of complexes between lectins including mannose binding lectin 
and ficolins, with sugar moieties located on the surface of invading microorganisms (Fujita, 
2002; Turner, 2003). The results of the present study indicated that AC activity in early 
salmon parr could be adversely affected by long term feeding with increased dietary levels 
of SPC solely or in combination with vaccination, used to assess immuno-stimulation. 
Furthermore, it was shown that upon vaccination CC activity increased in salmon parr 
receiving increased dietary levels of SPC, whereas for SPC35 salmon CC activity was found 
to be reduced.  Nevertheless, no differences were detected in TC activity among dietary 
treatments indicating that overall complement activity (the sum AC, CC and lectin activity) 
remained constant by maintaining a balance between the different pathways of this integral 
immunological component, linking both innate and specific immunity. The present study is 
the first one giving an insight on both complement pathways upon increased dietary plant 
protein inclusion. In similar studies, increased or unaffected AC activity were reported in 
gilthead sea bream (Sparus aurata) and rainbow trout respectively, in fish fed up to 50% of 
protein from plant ingredients, while decreased activity was observed in fish fed on diets 
with higher levels of plant proteins (Sitjà-Bobadilla et al., 2005; Jalili et al., 2013).  
While most of the immune related responses measured for HKMs did not show any 
differences among the different dietary groups, a quadratic effect of dietary SPC on the 
percentage of HKM phagocytosis was detected in salmon injected with PBS at 62 dPBSinj, 
when plotted against pre-injection values. This curvilinear effect was much more obvious at 
62dpPBSinj, when the percentage of HKMs performing phagocytosis presented higher 
values in both SPC58 and SPC80 salmon compared to the SPC35 group. This could be an 
indication of immunostimulation by increasing SPC levels in non-vaccinated salmon. 
Similarly, Rumsey et al. (1994) demonstrated  increased  phagocytosis and respiratory burst 
activity by circulating leucocytes in rainbow trout fed on SBM. However, those findings 
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were attributed to inflammatory and hypersensitivity processes, since SBM ANFs are linked 
with intestinal inflammation (Krogdahl et al., 2000). Previously, Burrells et al.(1999)  
reported  that  HKM respiratory burst in rainbow trout fed on diets containing 10-50 % of 
SBM remained unaffected, whereas inclusion levels of up to 80 % caused a reduction of this 
immune response. Sitjà-Bobadilla et al.(2005), on the other hand, reported higher respiratory 
burst levels by HK leucocytes in juvenile sea bream fed on balanced diets in which 75 and 
100% of FM was substituted with a mixture of different plant protein sources.  
Challenge with A.salmonicida in the present trial resulted in lower mortality levels (44 
%), than expected (~70%) according to the pre-challenge. Reduced virulence for this strain 
of A.salmonicida has been previously observed after long-term storage (6-7 months) of these 
bacteria in beads at -70ºC or in glycerol at -20ºC (Herath,T., personal communication; 
Chalmers, L., personal communication). Nevertheless, the data presented suggest that the 
increasing dietary SPC levels were not detrimental to disease resistance. Similar to the 
present findings, Bransden et al.(2001) reported no differences in the resistance of salmon 
parr fed diets with 0 or 40% of FM substitution with dehulled lupin meal when 
experimentally infected with Vibrio anguillarum, whereas Jalili et al. (2013) found no 
differences in the mortality of rainbow trout fed diets with 0, 40, 70 and 100% replacement 
of FM when challenged against Yersinia ruckerii. Furthermore, Krogdahl et al. (2000) 
reported increased survival in SPC-fed salmon compared to FM-fed fish challenged through 
cohabitation with A. salmonicida. The proposed reason for the observed reduction in 
mortalities in SPC fed salmon was the observed increase in IgM levels in the intestinal 
mucosa of these fish compared to the FM-fed salmon. 
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6.5 CONCLUSIONS 
Overall careful replacement of high quality FM protein with SPC did not promote any 
differences in the immune parameters or disease resistance of naïve and/or vaccinated 
salmon against A. salmonicida, suggesting that nutritionally balanced diets do not 
compromise salmon immunity. The current study shows that replacement of 80% of dietary 
protein with SPC combined with an increased addition of lysine, methionine and P could be 
used in feeds for early stage juvenile salmon without compromising their immunity or 
disease resistance against A. salmonicida. Further challenge experiments against other 
bacterial, viral and parasitic diseases are required to further evaluate the effects of high SPC 
inclusion diets on the disease resistance of Atlantic salmon parr.
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7.1 INTRODUCTION 
The production of aqua-feeds, especially for carnivorous fish such as Atlantic salmon, is 
currently dependent on the use of FMs and FOs. In the last two decades the increasing 
demand, for FM and FO, allied to their volatile price and stable demand, has emphasized the 
need to find alternative protein and lipid sources for salmon aqua-feeds. Numerous protein 
and lipid sources have the potential to be used as substitutes for FM and FO, respectively, in 
aquafeeds, including animal by-products (ABPs), vegetable proteins (VPs) and oils (VOs) 
and products from lower trophic levels such as algal meals and oils. However, due to their 
high availability, competitive prices compared to FM and FO and their high nutritional 
properties, VPs and VOs have been the main focus of aquaculture nutrition, as sustainable 
alternatives to marine derived feedstuffs.  On the contrary, the use of other protein sources, 
such as animal by-products (ABPs) from terrestrial slaughterhouses, although of great 
potential has not been explored to a similar extend in Atlantic salmon feeds, despite the fact 
that they have been used in many salmon producing countries including Australia, Canada 
and Chile. The main reason for that were the legal restrictions established by the European 
Union (EU), regarding the use of the greater majority of animal derived products, aiming the 
eradication of transmissible spongiform encephalopathies (TSE) (EU, 2001, 2003). 
However, these rules have now changed for aqua-feeds (van Dyck, 2012).  
Using vegetable-based proteins in aqua-feeds requires that the applied feedstuffs 
possess certain nutritional characteristics, such as the low levels of non-starch 
polysaccharides (fibre), oligosaccharides and ANFs (Naylor et al., 2009). Vegetable proteins 
should also contain a relatively high protein content, favourable amino acid profile, high 
nutrient digestibility, and reasonable acceptability by the fish. Some of these protein sources 
such as SPC, wheat and corn gluten possess most of the aforementioned desirable 
characteristics (Naylor et al., 2009). On the contrary, ABPs are free from ANFs and therefore 
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their application in salmon feeds could be more desirable compared to their plant protein 
counterparts. To date several studies using various salmonid species (Higgs et (Higgs et al., 
1979; Steffens, 1994; Twibell et al., 2012; Hatlen et al., 2013, 2014) have evaluated the 
potential of some of these ABPs with promising results. Moreover, recent studies have 
proven that close to 100% FM replacement with good quality plant and animal- proteins is 
possible in diets for Atlantic salmon with no negative effect on growth and feed intake when 
the amino acid profile of the diet is well balanced (Espe et al., 2006; Torstensen et al., 2008). 
While a few studies have investigated the effects of moderate FM substitution with plant 
feedstuffs on Atlantic salmon immune responses (Krogdahl et al., 2000; Bransden et al., 
2001) the current knowledge about the effects of the complete dietary FM substitution on 
Atlantic salmon immune responses is non-existent. Moderate levels of dietary SPC in salmon 
diets have been shown to promote gut immune responses such as lysozyme and total IgM 
levels and resistance to A. salmonicida (Krogdahl et al., 2000). However, Bransden et 
al.(2001) demonstrated that moderate FM replacement with dehulled lupin meal (DLM) or 
a blend of DLM with hydrolysed poultry feather meal (HPFM) is possible in Atlantic salmon 
diets without compromising salmon growth, immune responses and disease resistance. On 
the other hand, no changes in disease resistance against Yersinia ruckerii despite the reduced 
serum total IgM and alternative complement activity, have been reported in rainbow trout 
(Jalili et al., 2013). 
Similarly to FM, several feeding trials have revealed that  FO can be completely 
substituted by selected single or mixed VOs in Atlantic salmon diets, leaving the FM lipid 
as the only source of long chain polyunsaturated fatty acids (LC PUFAs) (Bell et al., 2001, 
2002; Torstensen et al., 2005, 2008). In fact, Atlantic salmon fed on VO diets demonstrated 
significantly improved growth and protein utilisation (Torstensen et al., 2005). In salmonids, 
the dietary inclusion of VO affects membrane composition while alterations on the ratios of 
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n-6/n-3 C20 PUFAs, could have pronounced effects on haematological indices and immune 
responses of the fish (Waagbø et al., 1993; Thompson et al., 1996; Kiron et al., 2004; Balfry 
et al., 2006; Petropoulos et al., 2009). In the present trial, diets with complete replacement 
of FO were supplemented with algal oil as a source of n-3 PUFAs while the n-3/n-6 C20 
PUFA ratio was relatively constant among FO and FO-free diets (dietary n-3/n-6 C20 PUFA 
ratio ~ 1). Carter et al.(2003) reported no changes on the growth performance and the 
immune responses of Atlantic salmon fed on diets containing a mixture of canola oil and FO 
or canola oil and algal (traustochytrids) oil. Today, aquaculture nutrition requires knowledge 
on the effects of the concomitant complete replacement of FM and FO on both growth 
performance and immune responses, and similar studies have not yet been reported. 
Currently FM inclusion levels in commercial salmon feed formulations range from 
15% to 55%, while dietary FO concentrations span from 3% to 40%. These variations largely 
depend on the country feeds are manufactured, and could partly reflect discrepancies in the 
employed production systems, local regulations or legal restrictions as well as differences 
among the cultured salmon breeds (DeSilva et al., 2012). The aim of the present study was 
to compare the performance of Atlantic salmon post-smolts fed on commercially applied 
marine protein and oil feed formulations, either according to the European standards of 
2011-12 or non-EU standards for salmon producing countries, to salmon fed on fully VP or 
VO diets or two feeds with complete substitution of both FM and FO with vegetal products 
(VP and VO) or a combination of VP and ABPs and VO.  The evaluation of salmon 
performance was done by determining the growth, feed consumption and efficiency, carcass 
proximate composition and lastly the immune function of the tested Atlantic salmon groups. 
For the present trial, the FM used was tested along with many other FM sources and was 
found to be consistently the highest performing source. Protein and lipid sources utilised in 
the present trial were selected on the basis that they are of high quality. To ensure that any 
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of the observed dietary differences would only be attributed to the selected protein and oil 
sources, protein/oil ratios were constant in the six diets whereas macro- and micro-nutrients 
were supplemented to give similar patterns and ratios among the commercial and the 
experimental dietary treatments.  
7.2 MATERIALS AND METHODS 
7.2.1 Diets and growth trial 
Six different feeds with different levels of FM and FO substitution (Table 9) were tested for 
their effects on growth performance and health status of Atlantic salmon post-smolts.  
Table 9 Feed formulations of the six diets. 
FEED FORMULATION 
Ingredient composition (g×kg-1) 
DIETS 
MBE MBABP MFABP VP VO VP/VO 
LT Fishmeala 300.0 200.0 - - 300.0 - 
Plant Protein Concentratesb 255.3 207.6 386.8 528.1 255.3 528.1 
Starch Binder 87.9 85.4 88.6 92.8 87.9 92.8 
Animal By-Productsc - 155.0 160.0 - - - 
Amino Acidsd 9.1 7.4 15.2 1.7 9.1 1.7 
Vitamin/Mineral & Pigment Mixese 35.9 35.9 41.9 41.9 35.9 41.9 
Fish Oilf 148.0 157.6 - 177.0 - - 
Plant Lipidsg 163.8 150.9 220.3 138.4 239.0 228.2 
Algal Lipidsh - - 87.2 - 72.8 87.2 
       
*Diet abbreviations: LT Fishmeal, fishmeal of superior quality due to the fact that is treated at lower drying 
temperatures allowing fish meal to keep a great essential amino acid profile and low biogenic amines; MBE, 
European commercial marine based diet (2011-12); VP, vegetable protein diet; VO, vegetable oil diet; VO/VP, 
vegetable protein/vegetable oil diet; MBABP, Non-EU commercial marine based diet with inclusion of animal-
by-product (2011-12); MFABP, marine protein- (fishery-) free with inclusion of animal-by-product proteins 
diet; a LT Fishmeal (low temperature fishmeal from Egersund Sildeoljefabrikk AS, Egersund, Norway); b 
Vegetable proteins: includes protein concentrates from soy (Imcopa, - Importação, Exportação e Indústria de 
Óleos Ltda., Araucária - Paraná, Brazil) and pea (AgriMarin, Stavanger, Norway) and wheat gluten (Henan 
Tianguan, Nanyang City, China); c Animal by-products: includes Poultry by-product meal (Poultry by-product 
meal, GePro Geflügel-Protein Vertriebs- GmbH & Co, Diepholz, Germany) and porcine blood meal (Daka 
Proteins, Løsning, Denmark); d Amino acids from Evonik Degussa International AG, Hanau, Germany; e 
proprietary of EWOS Innovation; Plant lipids: includes mainly rapeseed oil (Cargill PLC, Lincoln, UK); f Fish 
Oil: Capelin oil (Egersund Sildeoljefabrikk AS, Egersund), Norway; h Algal lipids: includes oil from 
heterotrophically grown algal species (Origin Unknown). 
 
Two commercially applied feed formulations by EWOS were used as controls. Both of the 
control diets contained FM and FO. However, partial inclusion of vegetable protein 
concentrates (VPCs) and vegetable oils (VOs) according to the EU standards of 2011-12 
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were used in the first control diet namely European marine based (MBE) diet, while partial 
addition of a mixture of VPCs, proteins from land animal by-products (ABPs) and VOs 
according to non-EU standards were utilised in the second control denoted as marine based 
with inclusion animal by-products diet (MBABP). In the VP diet the FM was completely 
substituted by VPCs, while complete replacement of FO by VOs and algal lipids (the latter 
used as a source of long chain n-3 PUFAs) was applied in VO diet. Despite the full 
substitution of FO with VOs, the elimination of FO from such diets containing FM as the 
main protein source is impossible, since notable amounts of FO are present within the FM 
fraction. Complete substitution of marine proteins and lipids was tested using two different 
diets, a fully vegetarian one with complete replacement of FM and FO with VPCs and a 
combination of VOs and algal oils denoted as VP/VO diet and a second one combining also 
the inclusion of land animal by-product proteins (poultry and porcine blood meal) namely 
MFABP diet. Diets with partial or total substitution of FM with alternative protein sources 
were supplemented with synthetic amino acids and premixes with a starch binder in order to 
balance nutrients. Diets were pelleted through extrusion (EWOS Innovation, Dirdal, 
Norway). All diets were formulated to meet and exceed the nutrient requirements of Atlantic 
salmon according to the (NRC, 1993). 
Growth trials were conducted at EWOS Innovation facilities at Dirdal, Norway. Before 
the acclimation period, unvaccinated Atlantic salmon post-smolts (S0 smolts) of a mean 
body weight of about 250g, from a commercial SalmoBreed AS (Bergen, Norway) strain 
selected for improved growth performance, were sampled for the evaluation of their 
immunity status. Atlantic salmon post-smolts were randomly allocated in two sets of 12 
seawater supplied tanks, located in the same block, until a total of 55 fish were in each tank. 
Fish were acclimatised to the experimental tanks for 84 days prior to starting the experiment, 
during which time they were fed a commercial diet (EWOS OPAL 500) and later allocated 
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their experimental diet. Fish were weighed before the acclimation period (16th of December 
2010), at the start of the trial (day 0) (10th of March 2011), at days 104-105(22nd and 23rd of 
June 2011) and at the end of the study (days 175-176) (2nd and 3rd of September 2011). Fish 
were reared in cylindrical fibreglass tanks with a water volume of 3.0 m3. Each tank was 
supplied by running seawater pumped from the nearby fjord at 50m depth (salinity range of 
29 ± 1.3 g × l-1 and temperature ranging from 6.3 ºC in March (lowest temperature recorded) 
to 9.1 ºC in August (25th) (highest temperature recorded) (Average water temperature 7.7 ± 
1.4 ºC) at a flow rate of 0.8 l × kg × biomass-1× min-1.  
A continuous lighting regime was used during the acclimation and feeding trial period. 
During the study period quadruplicate tanks of fish were fed one of the 6 experimental diets. 
Salmon were fed with pellets of 5mm during the full period of the trial. Two different batches 
of the feeds were used during the full duration of the study. The first batch was given to the 
fish during the first period of the study from the 10th of March until the 21st of June whereas 
the second lot was used for the second part of the trial from the 24th of June until the 31st of 
August. Fish were fed four times daily (feed intervals 01:00, 07:00, 19:00, and 22:00) using 
an automatic feeding system (Exact; Storvik Aqua, SV, Sundalsøra, Norway). The daily 
amount of feed was equally distributed within these four feed intervals. Feeding period for 
each feed interval was about 30-60 min depending on the total feed amount per day. Feed 
doses were delivered every 60 sec to the tanks for each feeding period whilst the total amount 
of feed delivered at each feeding time of the feeding period was 3-7 g. Feeding time and 
period within feed intervals were the same for acclimation and trial period. The level of daily 
feed ratio was about 0.5-1.5 of total biomass. To ensure that all fish (or at least as many fish 
as possible) received adequate feed each day, daily feed ration was adjusted accordingly so 
that the amount of uneaten feed laid between 15-30% of the total feed amount offered. An 
average of 25% "overfeeding" was obtained for the full trial period. Uneaten feed was 
Chapter 7. Effects of marine protein-, marine oil- and marine-free diets on growth and innate immune 
responses of Atlantic salmon 
 
 
217 | P a g e  
 
collected using waste feed collectors. Therefore, estimates of the actual feed consumption 
and thereby FCRs were available. The growth trial was conducted for a total of 196 days, at 
which time all fish were removed from the tanks and weighed 2 times (days 125-126 and 
days 194-197) after being anaesthetised (MS222,  2g × l-1). On days 125-126 twenty fish 
from each tank were euthanised with an overdose of  MS222 (7 g × l-1) to keep biomass 
densities below 90 kg × m-3 in the tanks resulting in a final number of 35 fish × tank-1 (starting   
mean biomass density of 52 kg × m-3 (55 post-smolts); intermediate mean biomass density 
of 67 kg × m-3 after the removal of 20 salmon (35 salmon); final mean biomass density of 87 
kg × m-3 (35 salmon)). 
7.2.2 Sample collection 
For immunological analyses, blood was withdrawn from the caudal vein of 6 ﬁsh from each 
tank on days 194 and 195 from start of the experiment, using 1 ml syringes rinsed with 
heparin (10 IU × ml-1); Sigma-Aldrich, Dorset, UK) while pools of Norwegian quality cut 
(NQC) fillet samples from 4 fish per tank were obtained for carcass proximate composition 
analyses. A heparinised capillary tube per sampled fish was filled with blood from the 
syringe for haematocrit observations. Haematocrit determination was performed for 6 fish 
per tank. Haematocrit values were measured after centrifugation at 6000 revolution per 
minute (rpm) for 25 min. The remaining blood from three first blood samples was used to 
determine the total leucocyte and differential leucocyte numbers from 3 fish per tank. A 10-
3 dilution of blood in L-15 was used to determine total leucocyte counts. The cells were 
counted in four squares of a haemocytometer per sample and expressed as:  
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓𝑐𝑒𝑙𝑙𝑠 × 𝑚𝑙−1 = 𝑁 × 𝐷𝑖𝑙𝑢𝑡𝑖𝑜𝑛𝐹𝑎𝑐𝑡𝑜𝑟 × 104 
where N is the average number of counted blood cells.  
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For the determination of differential leucocyte counts 3 blood smears were obtained 
(for the determination of the percentages of the different leucocyte types in each blood 
sample initially and their transformation into numbers of cells × ml-1 of blood according to 
total leucocyte numbers). The cells on the blood smears were left to air dry and were stained 
with Rapid Romanowsky’s stain (Raymond A lamb, Eastbourne, UK) in the Institute of 
Aquaculture, University of Stirling. The slides were later examined at × 400 magniﬁcation 
for the determination of differential leucocyte proportions. After sampling the blood from 
individual fish for haematocrit, blood smears and red blood cell counts (using blood samples 
diluted 1: 1000), blood samples from 3 individuals from the same tank were pooled together 
in one eppendorf tube (3 × 400 µl of blood × sampled fish-1× tube-1). The blood was left to 
clot overnight at 4oC and the next day the pooled plasma was aliquoted into 7 eppendorf 
tubes (about 40-50 µl) and stored at -80oC. Head kidney samples (approximately 5 mm) from 
three individuals (derived from the same tank), were aseptically removed according to 
Secombes (1990), pooled in plastic bjoux vials containing 5ml ice-cold L-15 medium 
containing 40 μl heparin (10 IU × ml -1) and used for respiratory burst assays. Two pools per 
tank were used to determine the level of superoxide anion (O-2) produced by head kidney 
macrophages. 
7.2.3 Calculations 
Feed intake is the calculated amount of food ingested by fish per treatment expressed in g  
Feed Conversion Ratio (FCR): 
𝐹𝐶𝑅 =
 𝐹𝑒𝑒𝑑 𝐼𝑛𝑡𝑎𝑘𝑒 (𝐹𝐼) (𝑔)
𝑊𝑒𝑡 𝑤𝑒𝑖𝑔ℎ𝑡 𝑔𝑎𝑖𝑛 (𝑔)
 
Specific Growth Rate: 
𝑆𝐺𝑅 = (
𝑙𝑛𝑊1 − 𝑙𝑛𝑊0
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑑𝑎𝑦𝑠
) × 100 
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Thermal Growth Rate: 
𝑇𝐺𝐶 = (
√𝑊1
3
− √𝑊0
3
(𝑡 × 𝑇)
) × 100 
Weight gain (WG): 
𝑊𝐺 (
𝑔
𝑑𝑎𝑦
) =
𝑊𝑒𝑡 𝑤𝑒𝑖𝑔ℎ𝑡 𝑔𝑎𝑖𝑛(𝑔)
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑑𝑎𝑦𝑠
 
Condition Factor (K): 
𝐾 =
𝐹𝑖𝑠ℎ 𝑤𝑒𝑖𝑔ℎ𝑡 (𝑔)
𝐹𝑖𝑠ℎ 𝑙𝑒𝑛𝑔𝑡ℎ (𝑐𝑚)3
 
 
In the above formulae W is the weight of the sampled fish in grams; W0 and W1 are the 
initial and the final fish mean weights in grams. 
7.2.4 Isolation of head kidney macrophages and respiratory burst of head kidney 
macrophages 
For the isolation of head kidney macrophages, the head kidney was teased through a 100μm 
nylon mesh (BD Falcon; BD Biosciences, Franklin Lakes, NJ, USA) into 2.5 ml Leibovitz 
medium (L-15; Sigma-Aldrich) containing 40 µl of heparin (10 IU × ml-1). The mesh was 
rinsed with 2.5 ml of the medium and placed on ice. The O-2 production by head kidney 
macrophages was measured by the conversion of NBT (Sigma-Aldrich) to formazan, 
following the method of Secombes (1990) with some modifications described by Korkea-
aho et al. (2011). A more detailed description of the methology is presented in Section 2.4.1. 
7.2.5 Determination of plasma protein and lysozyme activity 
Protein content of plasma was determined using the Pierce BCA (bicinchoninic acid) Protein 
Assay kit (Thermo Scientific, IL, USA) based on the conversion of Cu2+ to Cu1+ under 
alkaline conditions (Biuret reaction) using BSA as standard. Serum lysozyme activity was 
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based on the lysis of lysozyme sensitive Micrococcus lysodeikticusas described by Korkea-
aho et al. (2011). More details about the methods used are given in Section 2.4.3. 
7.2.6 Measurement of natural haemolytic activity 
The assay used was based on a method described by Langston et al. (2001) with 
modifications. A more detailed description of the methodology is given in Section 2.4.5.10 
(details about the preparation of SRBCs and the various buffers are presented in Section 
2.4.5). 
7.2.7 Total plasma Immunoglobulin M (IgM) 
The level of IgM in sera of experimental fish was determined using indirect enzyme linked 
immunosorbent assay (ELISA) (Magnadottir and Gudmundsdottir, 1992), with 
modifications. The methodology is thoroughly described in Section 2.4.7.  
7.2.8 Plasma anti-protease activity 
The method used was designed to detect anti-protease activity in trout plasma, and was based 
on the method described by Ellis et al. (1990), modified for use in microtitre plates. The 
method is described in more detail in Section 2.4.6. 
7.2.9 Carcass and dietary composition analysis 
The assessment of dietary lipid and FA composition was conducted by The Nutrition 
Analytical Services (NAS) of the Institute of Aquaculture, University of Stirling and were 
run in duplicates. Dietary crude fat was determined using two different methodologies. 
Firstly dietary lipid content was determined following acid hydrolysis using a Soxtec System 
1047 hydrolysing unit (Tecator Application note 92/87) followed by exhaustive Soxhlet 
extraction using petroleum ether (40–60°C boiling point) on a Soxtec System HT6 (Tecator 
application note 67/83)as described by Bell et al.(2001). In addition, dietary lipid fraction 
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was determined according to the Folch method (Folch et al., 1957) with non-lipid impurities 
removed by washing with 0.88% (w/v) KCl. The lipid weight was determined 
gravimetrically after evaporation of solvent under nitrogen and desiccation under vacuum 
for at least 16 h. Dietary Fatty acid methyl esters (FAME) were prepared from total lipid by 
acid catalyzed transesterification as described by Christie (2003) and FAMEs extracted and 
purified as described by Tocher and Harvie (1988). FAMEs were separated and quantified 
by Gas Liquid Chromatography (GLC) (Carlo Erba Vega 8160, Milan, Italy) using a 30 m 
× 0.32 mm capillary column (CP Wax 52CB, Chrompak, London, UK). Hydrogen was used 
as carrier gas and temperature programming was from 50 to 150°C at 40°C × min-1 and then 
to 230°C at 2.0°C × min-1. Individual methyl esters were identified by comparison with 
known standards and by reference to published data (Ackman, 1980). Peak data was 
processed using Chromcard for Windows (version 1.19) computer package (Thermoquest 
Italia S.P.A., Milan, Italy). Dry weight and ash contents of diets just like NQC fillet samples 
were determined after oven-drying the samples to constant weight and by ashing dried 
samples in an oven at 550ºC (AOAC, 1990). Dietary nitrogen was determined by Eurofins 
Scientific (Norway) after total combustion using a Nitrogen-Analyser (Perkin Elmer, 2410 
Ser. II, Norwalk, CT, USA), crude protein content calculated assuming that proteins contain 
16% N. Amino acid composition of the feed raw materials was analysed by near infrared 
reflectance (Fontaine et al., 2001) and was also performed by Eurofins Scientific (Norway). 
Amino acid composition of compound feed was analysed according to (Llames and 
Fontaine, 1994). 
Pools of homogenised NQC fillet carcass samples (1 pool of 4 individuals per tank) 
for chemical  analysis  were  frozen  and  then  thawed  before  blending (whole). Dry matter, 
moisture, ash and crude protein levels were determined according to standard methods 
(AOAC, 1990) by oven drying to constant weight. Crude protein from dry carcass samples 
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was estimated by Kjeldahl’s method using the TecatorKjeltec System. Lastly, crude fat from 
dried NQC carcass was determined using petroleum ether (40–60 °C boiling point) on a 
Soxtec System HT6 (Tecator application note 67/83) (Christie, 2003). More thorough 
description of the techniques can be found in Section 2.6. 
7.2.10 Statistics 
The statistical analysis was carried out with the help of the R language (R Core Development 
Team, 2014) and its lme4 package (Bates et al., 2014). Similar statistical analyses are 
presented by Espe et al. (2012) and Hartviksen et al. (2014). To investigate the effect of the 
diets on the haematological and immunological responses, the data were fitted in two 
different models without (only the tank effect was added) and with the feed variable (tank 
effect nested within the dietary effect), which were then nested and compared with a 
likelihood ratio test (LRT).  
Feed intake (FI) and feed conversion ratio (FCR) over the full trial period and during 
first and second study period were modelled as an ordinary linear model since there is no 
multilevel structure (only one observation per tank). TGC and SGR were also modelled as 
ordinary linear models since there no multilevel structure was used (only one observation 
per tank was used for the analysis). Gutted weights are available from a subsample of fish at 
the end of the trial. Daily WG for the same period was modelled with the help of splines to 
allow the identification of non-linear responses of the diets in time. Since there were three 
weight points available, the degree of freedom for the spline was constrained to 2. Two 
models were then fitted without and with the dietary effect, and compared with LRT. 
The modelling of the condition factor was conducted by fitting a length-weight 
relationship and adding the treatment as a covariate to the model. Since round weights were 
available at the end of the trial, these were used as a predictor, in order for the model to 
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adjust for an average-sized sampled fish and for a direct comparison to be possible. Lastly, 
two nested models were fitted, without and with the dietary effect, and compared with a LRT 
as above. 
Composition percentages were modelled with an ordinary linear model (only one 
observation per tank) using an arcsin transformation to the responses which were expressed 
as a percentage of wet weight and adding the mean weight of the sample as a covariate. 
Sample mean weights were mean-centred before the analysis so that the results are easy to 
interpret as for the average-sized sampled fish. 
Models demonstrating possibilities (P values) of 0.1 were selected for the description 
of data. For the modelled immune responses affected by the dietary treatments, the results 
are summarised as graphs with the mean response and 95% confidence interval. Confidence  
intervals were solved by a posterior simulation from  the statistical model with 1500 random  
draws (Gelman and Hill, 2007). Differences among dietary treatments were revealed when 
the 95% confidence intervals for a certain response of a dietary group did not overlap with 
the mean values of the same response from another group. 
7.3 RESULTS 
7.3.1 Diets 
The dietary amino acid profiles of the six experimental diets differed as a consequence of 
plant protein substituting for fishmeal (Tables 10 and 11) reflecting the amino acid 
composition of the different protein ingredients used.  
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Table 10 Chemical composition of the first lot of the six diets expressed in wet weight (w.w.) 
basis. 
Chemical 
composition (w.w.) 
DIETS  
MBE MBABP MFABP VP VO VP/VO 
Moisture (g × kg-1) 72.3 60.7 81.3 69.4 76.5 85.9 
Protein N*6.25 (g × kg-1) 394.0 384.0 385.0 380.0 393.0 384.0 
Lipid (g × kg-1) 371.3 359.2 345.9 361.3 374.9 332.7 
Crude fibre (g × kg-1) 9.1 9.7 10.7 10.6 8.1 10.6 
Ash (g × kg-1) 47.6 59.7 30.2 19.9 41.2 15.5 
P (g × kg-1) 12.00 15.0 10.00 7.7 12.0 9.1 
Ca (g × kg-1) 14.00 20.00 11.00 8.1 14.00 9.4 
Mg (g × kg-1) 1.6 1.5 0.8 0.9 1.5 1.0 
Zn (mg × kg-1) 265.00 288.00 255.00 233.00 259.00 284.00 
AMINO ACID COMPOSITION       
Methionine (g × kg-1)* 9.40 8.60 8.20 8.70 9.50 9.20 
Cysteine (g × kg-1) 4.30 4.60 4.50 5.00 4.50 5.40 
Lysine (g × kg-1)* 30.60 29.40 28.10 30.30 30.90 30.50 
Threonine (g × kg-1)* 15.70 15.70 14.00 14.80 16.00 15.50 
Isoleucine (g × kg-1)* 18.40 16.90 15.20 18.10 17.60 17.60 
Histidine (g × kg-1)* 8.90 9.40 7.90 8.50 8.90 8.60 
Valine (g × kg-1)* 20.20 19.20 16.40 18.80 19.50 18.20 
46.60 
22.90 
Leucine (g × kg-1)* 29.50 32.20 42.20 44.90 29.50 
Arginine (g × kg-1)* 24.80 23.60 22.30 22.30 25.00 
Phenylalanine(g × kg-1)* 16.60 17.20 18.90 20.50 17.20 21.40 
15.80 
20.40 
Tyrosine (g × kg-1) 13.10 13.00 14.30 15.80 13.60 
Alanine (g × kg-1) 20.40 23.00 23.30 19.90 20.50 
Glycine (g × kg-1) 20.00 21.80 21.30 13.50 29.70 13.60 
0.1 
0.1 
27.00 
Hydroxyproline(g × kg-1) 1.90 2.80 5.30 0.1 1.20 
Ornithine (g × kg-1) 0.1 0.1 0.2 0.1 0.1 
Proline (g × kg-1) 20.50 20.90 24.00 25.30 20.30 
Serine (g × kg-1) 17.10 18.00 18.50 18.00 18.50 20.40 
3.80 Tryptophane (g × kg-1)* 4.30 4.50 3.30 4.10 4.40 
IAA: DAA ratio 1.7 1.6 1.5 1.9 1.6 1.8 
       
* Diet abbreviations: MBE, European commercial marine based diet (2011-12); VP, vegetable protein diet; 
VO, vegetable oil diet; VO/VP, vegetable protein/vegetable oil diet; MBABP, Non-EU commercial marine 
based diet with inclusion of animal-by-product (2011-12); MFABP, fish free animal-by-product diet. 
Significant differences (P values < 0.05) between dietary groups are denoted by different letters. (a Vegetable 
proteins: includes protein concentrates from soy, pea, corn and wheat; b Animal by-products: includes Poultry 
by-product meal and porcine blood meal; c Plant lipids: includes rapeseed oil and other lipid sources). 
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Table 11 Chemical composition of the second lot of the six diets expressed in wet weight 
(w.w.) basis. 
Chemical 
composition (w.w.) 
DIETS  
MBE MBABP MFABP VP VO VP/VO 
Moisture (g × kg-1) 72.3 60.7 81.3 69.4 76.5 85.9 
Protein N*6.25 (g × kg-1) 394.0 384.0 385.0 380.0 393.0 384.0 
Lipid (g × kg-1) 371.3 359.2 345.9 361.3 374.9 332.7 
Crude fibre (g × kg-1) 9.1 9.7 10.7 10.6 8.1 10.6 
Ash (g × kg-1) 47.6 59.7 30.2 19.9 41.2 15.5 
P (g × kg-1) 12.00 15.0 10.00 7.7 12.0 9.1 
Ca (g × kg-1) 14.00 20.00 11.00 8.1 14.00 9.4 
Mg (g × kg-1) 1.6 1.5 0.8 0.9 1.5 1.0 
Zn (mg × kg-1) 265.00 288.00 255.00 233.00 259.00 284.00 
AMINO ACID COMPOSITION       
Methionine (g × kg-1)* 9.40 8.60 8.20 8.70 9.50 9.20 
Cysteine (g × kg-1) 4.30 4.60 4.50 5.00 4.50 5.40 
Lysine (g × kg-1)* 30.60 29.40 28.10 30.30 30.90 30.50 
Threonine (g × kg-1)* 15.70 15.70 14.00 14.80 16.00 15.50 
Isoleucine (g × kg-1)* 18.40 16.90 15.20 18.10 17.60 17.60 
Histidine (g × kg-1)* 8.90 9.40 7.90 8.50 8.90 8.60 
Valine (g × kg-1)* 20.20 19.20 16.40 18.80 19.50 18.20 
46.60 
22.90 
Leucine (g × kg-1)* 29.50 32.20 42.20 44.90 29.50 
Arginine (g × kg-1)* 24.80 23.60 22.30 22.30 25.00 
Phenylalanine(g × kg-1)* 16.60 17.20 18.90 20.50 17.20 21.40 
15.80 
20.40 
Tyrosine (g × kg-1) 13.10 13.00 14.30 15.80 13.60 
Alanine (g × kg-1) 20.40 23.00 23.30 19.90 20.50 
Glycine (g × kg-1) 20.00 21.80 21.30 13.50 29.70 13.60 
0.1 
0.1 
27.00 
Hydroxyproline(g × kg-1) 1.90 2.80 5.30 0.1 1.20 
Ornithine (g × kg-1) 0.1 0.1 0.2 0.1 0.1 
Proline (g × kg-1) 20.50 20.90 24.00 25.30 20.30 
Serine (g × kg-1) 17.10 18.00 18.50 18.00 18.50 20.40 
3.80 Tryptophane (g × kg-1)* 4.30 4.50 3.30 4.10 4.40 
IAA: DAA ratio 1.7 1.6 1.5 1.9 1.6 1.8 
       
* Diet abbreviations: MBE, European commercial marine based diet (2011-12); VP, vegetable protein diet; 
VO, vegetable oil diet; VO/VP, vegetable protein/vegetable oil diet; MBABP, Non-EU commercial marine 
based diet with inclusion of animal-by-product (2011-12); MFABP, fish free animal-by-product diet. 
Significant differences (P values < 0.05) between dietary groups are denoted by different letters. (a Vegetable 
proteins: includes protein concentrates from soy, pea, corn and wheat; b Animal by-products: includes Poultry 
by-product meal and porcine blood meal; c Plant lipids: includes rapeseed oil and other lipid sources). 
 
The ratio of IAAs to DAAs fluctuated in the experimental diets ranging from 1.6 to 1.9. 
Supplementation of the fully VP-based treatments (VP and VP/VO) with lysine, methionine 
and threonine in which VP are known to be devoid of, improved the dietary levels of these 
amino acids. However, it seems that an overestimation of the aforementioned amino acid 
concentrations in the ABP proteins applied resulted in lower supplementation of the MBABP 
and the MFABP diet with these amino acids. As a result decreased methionine was recorded 
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for these diets. Furthermore, reduced lysine and threonine levels were demonstrated in the 
MFABP diet in comparison to the control diet. Furthermore, reduced levels of isoleucine, 
histidine were recorded for the MFABP diet compared to the MB one. Reduced dietary levels 
of valine and arginine (~10% decrease) were observed in the diets containing the highest 
levels of VPs (VP, VP/VO, MFABP treatments) compared to the MB control with valine 
exhibiting a 19% reduction in MFABP diet. Higher levels of cysteine, leucine, phenylalanine 
and tyrosine were demonstrated for diets containing the highest levels of VPs compared to 
the control. 
The dietary FA concentrations of the two lots of the experimental diets used in the 
present study are presented in Tables 12 and 13. Lower amounts of total saturated fatty acids 
and higher levels of total PUFAs were observed for the VO-based diets. However, LC-
PUFAs and monounsaturated FAs were found to be constant among all dietary treatments. 
Complete substitution of FO with the VO blend (which included algal oils) resulted in 
increased proportions of 18:3n−3, 18:2n−6 and 18:1n−9, with concomitant decreased 
proportions of 20:5n-3 (EPA) and long chain monoenoic FAs (LC-MUFAs) including 20:1, 
22:1 and 24:1. The level of 22:6n-3 was found to be higher for the VO-based diets due to 
the inclusion of algal oils, characterised by increased levels of this FA (Carter et al. 2003; 
Miller et al. 2007). Furthermore, the ratio of n-3 to n-6 PUFAs demonstrated a gradual 
decrease in the diets in the following order: MB =MBABP>VP>VO> VP/VO=MBABP. 
For the second batch of feeds, amino acids presented similar levels to the initial dietary 
batch. However, FO based diets demonstrated a decrease in the proportions of n-3 PUFAs 
with 22:6n-3 exhibiting the most striking reduction. In addition, higher amounts of 16:1, 
18:1, 20:1 and 22:1 monoenoic FAs were observed, resulting in a general increase in total 
monounsaturated FAs. Furthermore, the total amount of unsaturated FAs presented a 
reduction with VO-based diets exhibiting higher levels than their FO-based counterparts. No 
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striking variations were observed in the total concentrations of n-6 PUFAs among the two 
batches of trial feeds. 
Table 12 Fatty acid composition of the first lot of the six diets expressed in wet weight (w.w.) 
basis. 
Fatty acid  
composition (g×kg-1)(w.w.) 
DIETS 
MBE MBABP MFABP VP VO VP/VO 
14:0 30.00 32.00 16.00 33.00 17.00 14.00 
15:0 3.00 3.00 1.00 4.00 2.00 1.00 
91.0 16:0  127.0 141.0 103.0 139.0 94.0 
18:0  29.0 33.0 28.0 36.0 25.0 27.0 
20:0 4.00 4.00 5.00 4.00 5.00 5.00 
3.00 22:0 2.00 2.00 3.00 2.00 3.00 
Sum saturated 165.00 183.00 140.00 185.00 129.00 127.00 
16:1n-7 30.00 33.00 5.00 31.00 7.00 2.00 
16:1n-9 3.00 3.00 2.00 3.00 2.00 1.00 
18:1n-7  26.00 25.00 23.00 24.00 24.00 22.00 
18:1n-9 359.00 349.0 448.00 355.00 458.00 453.00 
20:1n-7 1.00 1.00 <1.00 1.00 1.00 <1.00 
20:1n-9  34.00 29.00 11.00 27.00 17.00 10.00 
20:1n-11 5.00 4.00 <1.00 4.00 1.00 <1.00 
22:1n-9 6.00 5.00 4.00 5.00 5.00 4.00 
22:1n-11 52.00 49.0 3.00 44.00 13.00 1.00 
2.00 24:1n-9 6.00 6.00 2.00 6.00 4.00 
Sum MUFAs 522.00 504.00 499.00 500.00 532.00 496.00 
18:2n-6 109.0 108.0 157.0 119.0 146.0 164.0 
18:3n-6 1.00 1.00 1.00 <1.00 <1.00 1.00 
20:2n-6 2.00 2.00 1.00 2.00 1.00 1.00 
20:3n-6 <1.00 <1.00 1.00 <1.00 1.00 1.00 
20:4n-6 3.00 3.00 3.00 3.00 2.00 2.00 
Sum n-6 PUFAs 115.5 114.5 163.00 125.00 150.5 169.00 
18:3n-3 47.00 43.00 56.00 44.00 59.00 60.00 
18:4n-3 13.00 12.00 1.00 12.00 2.00 1.00 
20:3n-3 <1.00 <1.00 <1.00 <1.00 <1.00 <1.00 
20:4n-3 3.00 3.00 2.00 3.00 2.00 2.00 
20:5n-3 38.00 39.00 4.00 36.00 8.00 3.00 
22:5n-3 4.00 4.00 1.00 3.00 1.00 1.00 
89.0 
156.5 
0.9 
22:6n-3 56.0 60.0 84.0 53.0 75.0 
Sum n-3 PUFAs 161.5 161.5 148.5 151.5 147.5 
n-3/n-6 1.4 1.4 0.9 1.2 1.0 
       
* Diet abbreviations: MBE, European commercial marine based diet (2011-12); VP, vegetable protein diet; 
VO, vegetable oil diet; VO/VP, vegetable protein/vegetable oil diet; MBABP, Non-EU commercial marine 
based diet with inclusion of animal-by-product (2011-12); MFABP, fish free animal-by-product diet. 
Significant differences (P values < 0.05) between dietary groups are denoted by different letters. (a Vegetable 
proteins: includes protein concentrates from soy, pea, corn and wheat; b Animal by-products: includes Poultry 
by-product meal and porcine blood meal; c Plant lipids: includes rapeseed oil and other lipid sources). 
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Table 13 Fatty acid composition of the second lot of the six diets expressed in wet weight 
(w.w.) basis. 
Fatty acid  
composition (g×kg-1) (w.w.) 
DIETS 
MBE MBABP MFABP VP VO VP/VO 
14:0 33.00 31.00 18.00 31.00 19.00 17.00 
15:0 2.00 2.00 1.00 2.00 1.00 1.00 
86.00 16:0  94.00 93.00 97.00 97.00 85.00 
18:0  22.00 24.00 25.00 24.00 23.00 21.00 
20:0 3.00 4.00 4.00 4.00 4.00 4.00 
3.00 22:0 <1.00 2.00 3.00 2.00 3.00 
Sum saturated 121.5 125.00 130.00 129.00 116.00 115.00 
16:1n-7 44.00 41.00 6.00 41.00 9.00 3.00 
16:1n-9 2.00 1.00 1.00 2.00 1.00 1.00 
18:1n-7  32.00 32.00 22.00 32.00 24.00 21.00 
18:1n-9 325.00 331.00 421.00 303.00 419.00 420.00 
20:1n-7 3.00 3.00 <1.00 4.00 1.00 <1.00 
20:1n-9  111.00 108.00 11.00 113.00 23.00 10.00 
20:1n-11 <1.00 <1.00 <1.00 <1.00 <1.00 <1.00 
22:1n-9 11.00 11.00 2.00 12.00 3.00 2.00 
22:1n-11 84.00 79.00 3.00 81.00 15.00 1.00 
2.00 24:1n-9 6.00 7.00 2.00 6.00 3.00 
Sum MUFAs 618.5 613.5 469.00 594.5 498.5 461.00 
18:2n-6 108.00 112.00 173.00 133.00 146.00 181.00 
18:3n-6 <1.00 1.00 <1.00 1.00 <1.00 <1.00 
20:2n-6 2.00 2.00 1.00 2.00 1.00 1.00 
20:3n-6 <1.00 1.00 1.00 1.00 1.00 1.00 
20:4n-6 2.00 2.00 2.00 2.00 2.00 2.00 
Sum n-6 PUFAs 113.00 118.00 177.5 139.00 150.5 185.5 
18:3n-3 43.00 42.00 59.00 39.00 60.00 63.00 
18:4n-3 11.00 10.00 1.00 10.00 3.00 1.00 
20:3n-3 <1.00 <1.00 <1.00 <1.00 <1.00 2.00 
20:4n-3 2.00 2.00 2.00 2.00 2.00 2.00 
20:5n-3 28.00 26.00 2.00 28.00 10.00 2.00 
22:5n-3 2.00 2.00 1.00 4.00 2.00 1.00 
109.00 
180.00 
1.0 
22:6n-3 27.00 25.00 102.00 21.00 103.00 
Sum n-3 PUFAs 113.5 107.5 167.5 104.5 180.5 
n-3/n-6 1.0 0.9 0.9 0.8 1.2 
       
* Diet abbreviations: MBE, European commercial marine based diet (2011-12); VP, vegetable protein diet; 
VO, vegetable oil diet; VO/VP, vegetable protein/vegetable oil diet; MBABP, Non-EU commercial marine 
based diet with inclusion of animal-by-product (2011-12); MFABP, fish free animal-by-product diet. 
Significant differences (P values < 0.05) between dietary groups are denoted by different letters. (a Vegetable 
proteins: includes protein concentrates from soy, pea, corn and wheat; b Animal by-products: includes Poultry 
by-product meal and porcine blood meal; c Plant lipids: includes rapeseed oil and other lipid sources). 
 
7.3.2 Growth and chemical composition of NQC carcass samples 
The raw performance data for the six dietary groups of Atlantic salmon post-smolts are 
presented in Table 14.The results of this study demonstrated negligible mortality (<1%) in 
all dietary groups during the experimental period. Salmon fed the control MBE diet had 
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higher FI levels than the rest of the experimental groups (Fig. 37A) (since the expected mean 
FI values of the MBE group did not overlap with the 95% C.I. of the other dietary groups). 
Furthermore, VP-fed salmon exhibited higher FI than the MBABP, MFABP and VP/VO 
groups, while the latter group demonstrated lower FI than the VO-fed group. For the same 
period the MBE control group exhibited higher weight gain (WG) than the majority of the 
dietary groups except for the VO-fed salmon (Fig. 37B). The majority of the other dietary 
groups exhibited no differences in WG. The only exception was the VP/VO salmon which 
exhibited lower WG in contrast to the VO-fed fish. Higher FCR values were obtained for 
the MBE and VP-fed salmon compared to all the other dietary groups, during the first period 
of the feeding trial (Fig. 37C). No differences were detected between the two former groups. 
Specific growth rates demonstrated significant differences among all the experimental 
dietary groups of salmon for the first part of the study, with MBE salmon exhibiting the 
highest levels followed in order of highest to lowest by the 
VO>MBABP>VP>VP/VO>MFABP groups of fish. At the same time, thermal growth rates 
presented significant differences in almost all dietary groups of salmon. MB salmon 
demonstrated the highest TGC followed by VO>VP>MBABP>VP/VO=MFABP salmon 
(Fig. 38A and 38B). Both FI and WG demonstrated no differences among the six dietary 
groups of salmon for the second period of the study. Nevertheless, a significant increment 
in FI was observed for the MBABP, MFABP and VP/VO groups, while a rather substantial 
but not significant increase was also witnessed for the VO group during this period compared 
to the initial phase of the study. Furthermore, a significant reduction in WG was observed 
for the MBE at the second period in comparison to the initial one while no significant 
differences were witnessed for all other groups. Significantly higher TGC and SGR were 
demonstrated for the VP/VO group of fish in comparison to the other dietary groups at this 
timepoint. VP salmon was the group with the second best growth performance indices 
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followed in by the VO, MBABP and MFABP groups which exhibited similar growth ratios 
and coefficients and lastly the MBE group which demonstrated the lowest values for this 
period (Fig. 38A and 38B).  
Overall, salmon post-smolts maintained on the MBE diet had a higher FI at the end of 
the trial compared to most of the other dietary groups, except VP-fed salmon (Fig. 37A). In 
addition, higher FI was observed for VP salmon in comparison to the MBABP salmon and 
the marine-free (MFABP and VP/VO) groups of salmon. Furthermore, higher WG was 
observed for the MBE salmon compared to the MBABP, MFABP and VP/VO fed salmon 
(Fig. 37B). FCR values for the full duration of the trial were found to be higher for the MBE 
and VP salmon in contrast to all other dietary groups while no differences were observed 
between the former groups (Fig. 37C). 
The final K values were found to be higher for the VP group, while salmon fed the VO 
diet exhibited lower K values compared to the rest of the groups. Moreover MBABP, salmon 
presented higher K values than the MBE group and salmon maintained on the marine free 
diets (MFABP and VP/VO). Furthermore, higher K was obtained for VP/VO salmon in 
comparison to the MBE salmon, while no difference was noticed between the latter group 
and MFABP salmon (Fig. 39). 
The raw proximate analysis data of the NQC carcass samples are presented in Table 
14. Statistical analysis of NQC carcass samples proximate analysis data, revealed no 
differences in moisture fat, protein and ash levels among the 6 dietary groups of salmon.
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Table 14 Performance data and NQC proximate composition of Atlantic salmon post-smolts. 
Growth and survival 
DIETS 
MBE MBABP MFABP VP VO VP/VO 
Initial weight (g) 992.30±119.80 901.78±58.14 924.80±32.25 940.70±127.20 983.90±66.80 892.93±29.86 
Intermediate weight (g) 2041.30±224.60 1858.40±111.90 1856.70±113.10 1927.10±301.20 2014.70±142.40 1795.70±39.34 
Final weight (g) 2608.70±268.60 2417.50±171.10 2415.60±197.10 2528.90±417.00 2626.90±286.80 2381.70±11.20 
*Final Condition Factor (K) 1.52±0.11 1.54±0.12 1.51±0.11 1.61±0.12 1.46±0.10 1.52±0.10 
**Feed Intake 1st Period (g) 48668±5461 34930±3244 33551±5475 41960±9074 39515±4007 33084±2803 
Feed Intake 2nd Period (g) 20019±3384 19111±2996 18616±3260 20425±3518 20707±4049 20040±1910 
Feed Intake full Period (g) 68687±6772 54042±1461B 52168±1418 62386±12277 60222±7390 53124±3386 
Mortalities (%) 0.25±0.5 0 0 0 0.25±0.5 0 
NQC composition       
Moisture (%) 65.07±0.23 65.19±1.17 65.67±1.10 64.27±0.57 65.75±1.08 65.65±0.29 
Protein (%) 18.46±0.23 18.87±0.27 18.69±0.51 18.82±0.81 18.89±0.70 18.99±0.28 
Crude Lipid (%) 13.56±0.21 12.57±0.58 12.64±0.82 13.47±1.03 12.07±0.32 12.92±0.48 
Ash (%) 1.37±0.04 1.34±0.05 1.27±0.06 1.38±0.08 1.33±0.09 1.38±0.11 
Data for performance factors are referred as means ± SD of 4 replicate tanks.  Data for the proximate composition of Norwegian quality cut (NQC) carcass samples are referred 
as means ± SD of 4 pooled samples per diet (1 pool per tank).  
Diet abbreviations: MBE, European commercial marine based diet (2011-12); VP, vegetable protein diet; VO, vegetable oil diet; VO/VP, vegetable protein/vegetable oil diet; 
MBABP, Non-EU commercial marine based diet with inclusion of animal-by-product (2011-12); MFABP, marine protein- (fishery-) free with inclusion of animal-by-product 
proteins diet. 
*Condition factor (K) = 100 × fish weight (g) × ﴾length (cm)﴿ -3 
**Feed intake = Amount of food ingested by fish per treatment (g); 
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Figure 37 Expected performance indices at different study points. (A) Feed Intake (FI); (B) Daily weight 
gain (WG); (C) Feed Conversion Ratio (FCR) of the Atlantic salmon groups over the periods 1 and 2 and the 
full duration of the trial and (D) condition factor (K) of the salmon groups for the full period of the trial. These 
parameters were affected by the diets and the results are summarised as graphs with the mean response and 
95% confidence interval. Confidence intervals were solved by a posterior simulation from the statistical model 
with 1500 random draws. Significant differences among dietary groups are revealed when the confidence 
intervals bars for a certain response of a dietary group do not overlap with the mean values of the same response 
from another group. The effect of feeds on the above growth performance indices was confirmed by fitting a 
model without the dietary effect (only tank effect) and with it (tank effect nested within it) and comparing the 
models with a likelihood ratio tests (LRT). FI and FCR are modelled as ordinary linear models since there is 
no multilevel structure (only one observation per tank) whereas WG modelled with the help of splines to allow 
non-linear response in time. FI and WG are expressed as g × fish-1× day-1 to adjust for the different duration of 
the periods. Diet abbreviations: MBE, European commercial marine based diet (2011-12); VP, vegetable 
protein diet; VO, vegetable oil diet; VO/VP, vegetable protein/vegetable oil diet; MBABP, Non-EU 
commercial marine based diet with inclusion of animal-by-product (2011-12); MFABP, fish free animal-by-
product diet. Significant differences (P values < 0.05) between dietary groups are denoted by different letters. 
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Figure 38 Expected growth performance indices at different study periods. (A) TGC and (B) SGR, of the 
Atlantic salmon groups over the periods 1 and 2 of the feeding trial. These parameters were affected by the 
diets and the results are summarised as graphs with the mean response and 95% confidence interval. 
Confidence intervals were solved by a posterior simulation from the statistical model with 1500 random draws. 
Significant differences among dietary groups are revealed when the confidence intervals bars for a certain 
response of a dietary group do not overlap with the mean values of the same response from another group. The 
effect of feeds on the above growth performance indices was confirmed by fitting a model without the dietary 
effect (only tank effect) and with it (tank effect nested within it) and comparing the models with a likelihood 
ratio tests (LRT). TGC and SGR are modelled as ordinary linear models since there is no multilevel structure 
(only one observation per tank). Diet abbreviations: MBE, European commercial marine based diet (2011-12); 
VP, vegetable protein diet; VO, vegetable oil diet; VO/VP, vegetable protein/vegetable oil diet; MBABP, Non-
EU commercial marine based diet with inclusion of animal-by-product (2011-12); MFABP, fish free animal-
by-product diet. Significant differences (P values < 0.05) between dietary groups are denoted by different 
letters. 
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Figure 39 Expected condition factor for the different groups of salmon at the end of the study. Condition 
factor (K) of the salmon groups for the full period of the trial.  K values were affected by the diets and the 
results are summarised as graphs with the mean response and 95% confidence interval. Confidence intervals 
were solved by a posterior simulation from the statistical model with 1500 random draws. Significant 
differences among dietary groups are revealed when the confidence intervals bars for a certain response of a 
dietary group do not overlap with the mean values of the same response from another group. The effect of 
feeds on the above growth performance indices was confirmed by fitting a model without the dietary effect 
(only tank effect) and with it (tank effect nested within it) and comparing the models with a likelihood ratio 
tests (LRT). The modelling of the K values was conducted by fitting the values and adding the treatment as a 
covariate to the model. Mean-centred round weights were used as the predictor. Since round weights were 
available at the end of the trial, these were used as a predictor, in order for the model to adjust for an average-
sized sampled fish and for a direct comparison to be possible. Diet abbreviations: MBE, European commercial 
marine based diet (2011-12); VP, vegetable protein diet; VO, vegetable oil diet; VO/VP, vegetable 
protein/vegetable oil diet; MBABP, Non-EU commercial marine based diet with inclusion of animal-by-
product (2011-12); MFABP, fish free animal-by-product diet. Significant differences (P values < 0.05) 
between dietary groups are denoted by different letters. 
 
 
7.3.3 Haematology and innate immune responses 
The raw haematological and immunological data collected from the current study are 
presented in Table 15. No significant differences were revealed for the majority of the 
estimated haematological parameters. However, lower haematocrit values were obtained for 
the MBE group compared to the MBABP, MFABP and VP/VO groups, while the latter two 
groups of salmon presented higher values in comparison to the VO-fed group (Fig. 40A). 
No differences in total and differential leucocyte numbers were detected among the six 
dietary groups of Atlantic salmon post-smolts. 
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No differences were observed among the six dietary salmon groups, regarding plasma 
haemolytic activity, plasma protein and total IgM levels, stimulated and non-stimulated head 
kidney macrophage respiratory burst activity. Nonetheless higher lysozyme activity was 
demonstrated for the MBE group of salmon compared to all other dietary groups of salmon 
(Fig. 40B). No further differences regarding lysozyme activity were witnessed amongst the 
other dietary groups. Furthermore, higher levels of anti-protease activity were exhibited for 
the MFABP salmon compared to the salmon fed the marine based (MBE and MBABP) and 
VO diets while higher anti-protease activity was observed for the VP and VP/VO dietary 
groups in contrast to the MBABP group (Fig. 40C).
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Table 15 Haematological and immunological responses of Atlantic salmon post-smolts. 
 
Haematological & Immune 
parameters 
MBE MBABP MFABP VP       VO    VP/VO 
Haematocrit (%) 47.9±5.3 51.4±5.7 52.7±6.5 50.9±3.7 48.6±3.7 53.5±6.3 
Leucocytes (× 107×ml-1) 10.3±4.0 10.2±2.9 10.2±2.8 11.7±3.7 10.4±3.9 8.3±1.9 
Lymphocytes (× 107×ml-1) 5.2±2.1 5.6±1.4 4.8±1.4 5.8±1.6 4.9±1.4 4.3±1.3 
Thrombocytes (× 107×ml-1) 4.4±1.7 4.2±1.7 4.80±1.60 5.3±1.9 4.9±2.8 3.6±1.4 
Granulocytes (× 107×ml-1) 0.6±0.4 0.4±0.15 0.50±0.30 0.6±0.3 0.51±0.46 0.5±0.2 
Monocytes (× 107×ml-1) 0.05±0.08 0.03±0.04 0.04±0.05 0.05±0.06 0.06±0.06 0.03±0.03 
Lysozyme activity (units × min-1× ml-1) 1259.8±252.1 913.7±319.5 794.7±372.2 791.9±289.6 912.4±185.1 830.1±317.0 
Plasma haemolytic activity (units SH50×ml-1) 928±298.2 954.6±139.1 1043.1±378.3 928.5±260.1 986.8±444.2 906.8±271.4 
HKMs respiratory burst (NBT) (O.D.610 for 10
5 nuclei) 0.40±0.15 0.5±0.3 0.4±0.2 0.4±0.2 0.4±0.2 0.4±0.2 
Stimulated HKMs respiratory burst (O.D.610 for 10
5 nuclei) 0.55±0.22 0.7±0.3 0.5±0.2 0.5±0.3 0.5±0.2 0.5±0.3 
Total plasma protein (mg×ml-1) 66.4±6.3 66.1±8.3 65.3±6.7 66.5±6.3 67.9±4.3 67.9±5.9 
Plasma antiprotease act. (Units TI75 × min-1× ml-1) 713.6±15.9 665.4±66.0 757.9±32.1 740.2±12.0 701.0±57.3 727.5±28.2 
Total plasma IgM (mg×ml-1) 6.4±2.8 5.8±2.6 3.7±2.8 5.1±3.1 7.9±2.6 3.9±2.8 
       
Data for immune responses are means ± SD from 8 pools of 2 fish per diet; for haematocrit values are means ± SD from 24 individual fish per diet; and for leucocyte and 
differential leucocyte counts values are means ± SD from 12 individual fish per diet. Within a row, means with different superscript letters differ significantly.  
Diet abbreviations: MBE, European commercial marine based diet (2011-12); VP, vegetable protein diet; VO, vegetable oil diet; VO/VP, vegetable protein/vegetable oil diet; 
MBABP, Non-EU commercial marine based diet with inclusion of animal-by-product (2011-12); MFABP, marine protein- (fishery-) free with inclusion of animal-by-product 
proteins diet. 
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Figure 40 Expected levels of the affected haematological and immunological responses.(A) Haematocrit 
(%); (B) Lysozyme (Units × min-1 × ml-1); Plasma anti-protease activity (Units TI75 × ml-1); (%); of the dietary 
groups of Atlantic salmon post-smolts for the full period of the trial. These parameters were affected by the 
diets and the results are summarised as graphs with the mean response and 95% confidence interval. 
Confidence intervals were solved by a posterior simulation from the statistical model with 1500 random draws. 
Significant differences among dietary groups are revealed when the confidence intervals bars for a certain 
response of a dietary group do not overlap with the mean values of the same response from another group. The 
dietary effect on the health responses was confirmed by fitting a model without the dietary effect (only tank 
effect) and with it (tank effect nested within it) and comparing the models with a likelihood ratio tests 
(LRT).The modelling for all above parameters Diet abbreviations: MB, marine based diet; VP, vegetable 
protein diet; VO, vegetable oil diet; VP/VO, vegetable protein/vegetable oil diet; MBABP, marine based 
animal-by-product diet;  MFABP, marine free animal-by-product diet. 
 
7.4 DISCUSSION 
7.4.1 Growth and carcass chemical composition 
Total replacement of FM or FO and/or both marine ingredients in the experimental feeds 
was done in order not to compromise salmon known nutrient requirements (NRC, 1993). 
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The corn gluten, wheat gluten, soy and pea protein concentrate were selected based on 
previous studies reporting adequate growth in fish (de Francesco et al., 2004; Kaushik et al., 
2004; Espe et al., 2006; Øverland et al., 2009). Nonetheless, the results of feed composition 
analysis from the two lots of feeds used in the present study reveal inconsistencies in the 
quality of the raw materials demonstrating the requirement for nutritional assessment of 
feedstuffs prior to the production of the feeds.  This could allow for adjustments in dietary 
formulations and consistencies in the quality of aquafeed supplies by feed manufacturers. 
Firstly it should be mentioned that the growth performance in terms of WG and FI for 
the first and full period of the study were largely influenced by the initial size differences of 
the fish assigned to the different diets. Redistribution salmon populations in the tanks prior 
to the initiation of the feeding trial, could have given even more sound and clear results 
regarding the overall performance of the experimental groups of salmon. However, 
comparable to the present study, were also the differences in salmon starting weights before 
the commencement of a similar commercial feeding study conducted by EWOS and reported 
by Crampton et al. (2011), utilising a commercial EWOS marine based and a low FM diet 
in Atlantic salmon post-smolts reared in sea cages. All the above, highlight the difficulties 
when conducting large scale scientific studies involving salmon of large size like the present 
one. However, this should not detract from the significance of this investigation as important 
conclusions could still be drawn from it. 
MBE salmon demonstrated a significantly higher FI than the rest of the experimental 
dietary groups, during the initial period of the feeding trial. This finding however, could have 
been influenced by the bigger size of the fish assigned to the MBE diet by the end of the 
acclimation period and before the initiation of the feeding trial. Contrary to this the MBABP 
group of fish presented lower levels of FI than the group of salmon receiving the VP diet 
which also demonstrated greater size at the start of the trial, while no differences were 
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observed between the former group and salmon receiving both of the marine-free diets 
(MFABP and VP/VO). Previous studies, have reported that total (de Francesco et al., 2004; 
Espe et al., 2006) or partial replacement of FM (Gomes et al., 1995; Kaushik et al., 2004) in 
salmonid diets can negatively affect the FI in fish. Moreover, Liland et al. (2012), proposed 
that dietary FA composition might be a regulating component of Atlantic salmon appetite 
and that VOs characterised by increased levels of 18:2n-6 and decreased n-3/n-6 ratio which 
is the case in the VO-based diets of the present study could decrease FI in Atlantic salmon. 
This could only explain the numerically lower FI in VO-fed fish in comparison to the VP 
group and the absence of differences between MBABP salmon in contrast to the former 
group, despite the size difference at the start of the study. In addition to that, previous trials 
investigating self-selecting feeding demonstrated that rainbow trout prefer diets containing 
FO over those with VO, suggesting that some fish do actively select feeds based on marine 
lipids (Geurden et al., 2005, 2007). In accordance to this, the present trial demonstrated that 
the elimination of FO from salmon diets seems to affect salmon FI to a higher degree, than 
FM withdrawal. Moreover, low amounts of FO are always present in FM which could 
explain the absence of differences among the VO, MBABP and VP-fed salmon groups. In 
contrast to our findings, Carter et al. (2003) and Miller et al. (2007) reported unaffected FI 
in Atlantic salmon fed diets containing just algal oil, a combination of algal and palm oil or 
just palm oil compared to salmon fed a full FO based diet. However, these studies also 
demonstrated unaffected growth performance in salmon fed a FM based diet containing algal 
oils, which is in agreement with our results.  
In addition to the higher FI values higher growth performance indices (WG, SGR and 
TGC values) were observed for MBE salmon during the first period. No significant changes 
in daily WG were observed between VO and MBE salmon  which is in line with previous 
FO replacement studies (Bell et al., 2001, 2002; Torstensen et al., 2005). VO salmon was 
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the second best performing dietary group exhibiting higher SGR and TGC values than the 
rest of the groups. On the contrary, MFABP and VP/VO salmon presented the lowest growth 
while MBABP and VP-fed salmon demonstrated intermediate growth to the VO and latter 
groups. The initial size discrepancies promoting contrasting FIs and thus further size 
differences among the latter groups of salmon seem to be the main reason for the last 
observation. Despite the higher levels of FI and WG for the MBE control group, FCR values 
in MBE salmon for the first period of the study were found to similar to that of VP salmon 
and significantly higher from that of the other dietary groups, revealing a more efficient 
dietary nutrient utilisation in all other groups.  
Increased feed consumption and thus growth (defined as “compensatory growth”) after 
periods of restricted FI have been demonstrated in Atlantic salmon (Johansen et al., 2001; 
Torstensen et al., 2008). This growth can be greater or equal compared to normal growing 
fish, although incomplete or impartial gain has also been known to occur (Jobling and 
Johansen, 1999; Johansen et al., 2001). During the second study period, a significant increase 
in FI was observed for the MBABP-, MFABP-, VP/VO- and VO-fed salmon, while 
numerically higher levels were also noticed for the VP group of fish in comparison to their 
initial values, revealing an initiation of the compensatory growth process. Further signs of 
compensatory growth, for all the aforementioned groups, were the increased SGR and TGC 
values which were found to be higher than the ones obtained for MBE group. The above 
findings demonstrate that Atlantic salmon requires long adaptation period before accepting 
any diet with high levels of alternative protein and lipid sources as previously reported by 
Torstensen et al. (2008). Furthermore, a significant reduction in WG for MBE salmon was 
witnessed, in comparison to the first period. The latter observation coincided with the 
provision of the second lot of the diets which was in general characterised by the poor 
nutritional profile of the applied FO source. Among the changes observed  in the two lots of 
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the aforementioned diets, mentioned in Section 7.3.1, the most striking change was the 
reduced n-3/n-6 ratio in the second batch of FO-based feeds (MBE, MBABP and VP) as a 
result of the low levels of n-3 PUFAs, with the 22:6n-3 (DHA) demonstrating the greatest 
reduction in this FA group, while reduced levels of 20:5n-3 (EPA), were also presented for 
these diets. The aforementioned group of FAs is required for the maintenance of membrane 
integrity and as precursors for the synthesis of eicosanoids which are important signalling 
molecules made from the C20
 
EFAs controlling many bodily functions including 
inflammation and immune regulation (De Pablo et al., 2000; Tocher, 2003). No further 
changes on the physical characteristics of the pellets (floatability, sinking rate, colour or 
durability) were recorded. Furthermore, MBE presented significantly higher FCR than most 
of the experimental groups, excluding VO-fed salmon while no differences were detected 
among the rest of the salmon, indicating higher efficiency for these diets. 
Overall, higher FI for the full period of the feeding trial was revealed in MBE and VP 
salmon compared to the other groups. This could highlight the important role of the FO 
fraction on the acceptability of aquafeeds in Atlantic salmon (Liland et al. 2012), as lower 
FI was obtained for the VO group regardless the greater initial size of these fish compared 
to VP salmon. Significant WG differences however, were only revealed among the MBE 
and salmon from the MBABP and the two marine free dietary groups. These were most 
likely caused by size discrepancies among these groups at the start as previously mentioned. 
On the contrary, significantly higher FCR values were obtained in MBE and VP salmon in 
contrast to the other groups, during the full trial period. Therefore, among the two control 
groups, MBE salmon exhibited lower feed efficiency while MBABP salmon with 
intermediate growth performance values demonstrated better efficiency in the utilisation of 
dietary nutrients. Excluding VP salmon, the low FCR values demonstrated for the majority 
of the experimental groups during the full study period, indicate that judicious selection of 
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alternatives to FM and FO and careful formulation of salmon feeds in order to satisfy their 
nutrient requirements could promote adequate growth even when both marine-derived 
proteins and lipids are fully excluded. Espe et al. (2006) reported equal FCR values in 
Atlantic salmon fed a FM-based compared to FM-free diets, which in the case of the present 
study was true only for the MBABP compared to the VP and the two marine-free dietary 
groups. However, in the latter study marine based by-products were included in the 
experimental diets in order to improve their acceptance by the fish. Contrary to our findings, 
were also the increased FCR values reported in Atlantic salmon post-smolts fed on diets 
where marine and plant derived ingredients from commercial salmon diets were partially 
substituted by terrestrial ABPs (Hatlen et al., 2013, 2014). Similar to our results, unaffected 
FCRs were also reported in Atlantic salmon fed low marine ingredient diets compared to a 
fully marine dietary group (Torstensen et al., 2008). Moreover, most FO replacement studies 
for Atlantic salmon diets demonstrated unaffected FCRs for VO- in comparison to FO-fed 
salmon which are partially in agreement with the present findings (Bell et al., 2002; 
Torstensen et al., 2005; Karalazos et al., 2007).   
Condition factor (K) values at the end of the trial ranged between 1.25 and 1.75 for the 
majority of the fish, describing salmon with fairly good to excellent quality (Barnham and 
Baxter, 1998). The VP group possessed the highest K values, while the VO-fed salmon 
exhibited the lowest values compared to the rest of the groups. Since K factor describes the 
relationship between the full weight and salmon length, the high values obtained for VP-fed 
salmon is an indication of “stocky” salmon whereas the low K values observed for the VO-
fed fish show that these salmon were leaner than all the other dietary groups. In general, 
Atlantic salmon post-smolts of 2.5 kg (mean final salmon weight for all groups) are 
characterised by increased carcass growth, hepatic and visceral fat deposition (Shearer, 
1994). Therefore, the increased K values exhibited for VP salmon could actually be an 
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indirect indication of higher hepatic and visceral fat accumulation. The low K values of VO-
fed salmon, on the contrary, could point at lower adiposity, however, a more thorough 
investigation is required. Nonetheless, data regarding the hepato-somatic and viscero-
somatic indices were not obtained, therefore the above comment consists a speculation and 
reveals one more flaw of the experimental design. Despite the fact that the opposite trend 
was illustrated for the VO-fed group, the assumption of lower adiposity in these fish requires 
a more thorough investigation. Ruyter et al. (2006) and  Jordal et al. (2007) demonstrated 
that diets with high levels of soybean oil or complete substitution of FO with VO blends 
could induce visceral and/or hepatic adiposity. Furthermore, Torstensen et al. (2011) 
reported increased visceral adiposity in salmon fed diets with high levels of FM and FO 
substitution with VP and VO respectively. Since fat levels in the liver, intestine and pancreas 
were not estimated in the current study no further comments could be made on this matter. 
In contrast to our findings, Espe et al. (2006) demonstrated that K values were not 
significantly altered by feeding Atlantic salmon with diets in which FM had been completely 
replaced with VPs. Furthermore, Torstensen et al. (2008) reported lower K values in Atlantic 
salmon maintained on diets with high levels of VPs and moderate or high supplementation 
with VOs compared to fish fed a marine-based diet or a diet containing a moderate inclusion 
of VPs and high inclusion of VOs. 
The results of NQC carcass proximate analysis revealed no differences in moisture, 
crude protein, lipid and ash levels among the six dietary groups, suggesting similar levels of 
nutrient accumulation in the carcass for all the salmon groups. Similarly, previous studies 
have demonstrated that complete substitution of FO with VO in feeds for salmonids does 
not have an effect on their carcass composition  (Karalazos et al., 2007; Turchini and Francis, 
2009). Contrary to our findings, a body of literature has demonstrated concomitant 
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reductions in carcass lipid and increases in carcass protein in salmonids fed diets in which 
FO was replaced with VOs (Jokumsen and Alsted, 1990; Bell et al., 2001, 2002).  
7.4.2 Haematological parameters and immune responses 
To our knowledge reports on the effects of a concomitant dietary substitution of FM and FO 
with alternative ingredients on Atlantic salmon haematology have not yet been investigated. 
In the present study it is apparent that the elimination of the FM fraction from the diets 
resulted in increased haematocrit values, while the elimination of both fractions promoted 
even higher haematocrits. Most of the existent reports of FM and FO substitution with 
alternative feed ingredients are contradictory to the present findings. Twibell et al. (2012) 
reported lower haematocrit levels in coho salmon and rainbow trout (Oncorhynchus mykiss) 
fed on VP and ABP in combination with VO diets compared to salmon fed MB diets. 
Furthermore, complete replacement of dietary FM with ABPs did not significantly affect 
haematocrit levels in previous feeding trials with coho salmon (Higgs et al., 1979) or  
rainbow  trout (Steffens, 1994) compared with fish fed a FM control diet. On the other hand 
Hemre et al. (1995; 2005) reported decreased haematocrit levels in Atlantic salmon fed on 
diets with increased substitution of FM with soybean products or increased dietary inclusion 
of crude fibre which is the case at high levels of FM replacement with most plant derived 
feed proteins. In addition, Thompson et al. (1996) reported unaffected haematocrit in 
Atlantic salmon fed on diets with complete substitution of FO with sunflower oil (SO). The 
observed changes in haematocrit seem to have a multifactorial cause, which could be quite 
complex to put into context. The most promising finding however, was that haematocrit 
values for all dietary salmon groups were found to be within normal ranges varying from 
43-60%, indicating healthy fish (Hardie et al., 1990; Waagbø et al., 1994; Thompson et al., 
1996) without compromised blood oxygen carrying capacity, since there was lack of 
anaemia which could be related to iron or other mineral deficiencies. Total and differential 
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leucocyte numbers did not demonstrate any significant changes among the six dietary groups 
of salmon which is an indication that all of the diets are modulating similar levels and 
patterns of leucocyte production. In line, Thompson et al. (1996) reported that Atlantic 
salmon fed on diets with complete replacement of FO with sunflower oil (SO) did not exhibit 
differences in total and differential circulating leucocyte levels. On the contrary Rumsey et 
al. (1994), showed that rainbow trout fed on soy proteins presented increased numbers of 
circulating leucocytes.  
The only two innate immune responses demonstrating differences among diets were 
the plasma lysozyme and anti-protease activity. No differences were observed among the six 
dietary groups of salmon regarding plasma haemolytic activity, plasma protein and total IgM 
levels, stimulated and non-stimulated HKM burst activity.On the contrary, (Jalili et al., 2013) 
demonstrated no notable negative effects on lysozyme levels in rainbow trout fed on diets 
with full replacement of FM with VPs. In contrast to the present results, were the reduced 
levels of total serum IgM reported by Jalili et al. (2013) in rainbow trout fed on diets with 
total substitution of FM with VPs. Moreover, Jalili et al. (2013) and Sitjà-Bobadilla et al. 
(2005) reported decreased alternative complement activity in rainbow trout and gilthead sea 
bream fed diets with 100% substitution of FM with VPs. 
In line with the present study, no differences in HKM respiratory burst activity were 
observed in feeding trials where Atlantic salmon and rainbow trout were fed on FM-based 
diets supplemented only with soybean oil or linseed oil (Kiron et al., 2004; Seierstad et al., 
2009). Furthermore, Carter et al. (2003) demonstrated no changes in serum total 
immunoglobulin and protein levels, serum anti-protease activity and circulating leucocytes 
respiratory burst activity for Atlantic salmon fed diets with complete replacement of FO with 
canola oil (CO) or 2 blends of CO and FO or CO and algal oil which are in line with the 
present findings. Similar results were also obtained by (Thompson et al., 1996) who 
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demonstrated no differences in serum complement, anti-protease and HKM respiratory burst 
activities of Atlantic salmon fed full soybean oil diets compared to FO fed salmon. However, 
in both aforementioned studies unaffected plasma lysozyme was also reported which is in 
contrast to the present study. The present findings demonstrated higher lysozyme activity 
from for MBE salmon which could be a favourable trade against bacterial or viral diseases 
(Saurabh and Sahoo, 2008). However, it should be stressed that several disease resistance 
selection trials have observed a negative correlation between survival rate and lysozyme 
activity in Atlantic salmon challenged against furunculosis, bacterial kidney disease (BKD) 
and vibriosis (Røed et al., 1993; Fevolden et al., 1994; Lund et al., 1995), demonstrating that 
disease resistance in salmon might be more dependent on other immune responses or the 
efficiency in detoxifying from the by-products of immune activation. Moreover, Fevolden 
et al. (1994) suggested that for salmonids, lysozyme activity following a disease challenge 
is not a reflection of a superior immune mobilisation of the fish, but an indication of stress 
induction which could increase the susceptibility of these fish under challenging conditions. 
In the present study, the second period of the trial coincided with a great growth reduction 
(which could also be related to increased stress) (Pickering, 1993; Plisetskaya and Duan, 
1994) in MBE salmon could indicate increased stress for this dietary group. 
In the present study, it was also shown that diets containing only plant proteins (VP 
and VP/VO) or high levels of plant proteins (MFABP) promoted plasma anti-protease 
activity, which could be a favourable feature for combating several bacterial infections 
(Ellis, 1990). Several plant extracts used as additives in aqua-feeds in previous studies 
demonstrated an increase in serum anti-protease activity (Rao and Chakrabarti, 2004; 
Kaleeswaran et al., 2011)  It is possible that high levels of plant derived ingredients and more 
specifically plant protein concentrates even after processing manipulations targeting the 
improvement of their nutritional quality, (through protein concentration primarily and the 
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removal of ANFs secondarily) might contain certain levels of bioactive compounds exerting 
an immunostimulatory activity to the fish. However, the identification of such compounds 
in plant derived products and the positive effect of marine-free diets on antiprotease activity 
requires further investigation. 
7.5 CONCLUSIONS 
The findings of the current study suggest that marine protein-, marine oil- and marine-free 
diets can be utilised satisfactorily by Atlantic salmon post-smolts in comparison to 
commercial feed formulations, stimulating both adequate growth and innate immune 
responses. However, longer adaptation periods might be required for the fish to fully accept 
these diets. Therefore complete substitution of FM or FO or both marine derived ingredients 
is possible without undermining the general condition of the fish, however future application 
of such feeds will depend on the prices of the applied raw materials, which currently do not 
consist a cost-efficient solution compared to the already applied feedstuffs found in 
commercial feed formulations. Nevertheless, future studies on similar levels of FM and FO 
replacement in salmon feeds should evaluate these feed formulations under the stressful 
commercial conditions or assess the resistance of salmon fed on these diets, against 
industrially important diseases. 
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8.1 GENERAL DISCUSSION AND CONCLUSIONS 
Farming of fish and especially the culture of carnivorous fish species, including salmonids 
relies on high protein feeds. Atlantic salmon (Salmo salar) in general requires 55-60% of 
dietary protein in juvenile stages, thereafter the protein requirement declines (NRC, 1993). 
Historically the protein source in salmon diets has been FM, produced from wild fisheries, 
while the lipid source has been FO from the same source. For the last 30 years worldwide 
production of farmed Atlantic salmon  has increased  steadily whereas the production from 
wild caught fish has been stable for the same period  (Tacon and Metian, 2008; FAO, 2013). 
Therefore, if a continued increase of farmed fish is to occur, both alternative protein and 
lipid sources need to be evaluated as feedstuffs for commercial aquafeeds. FM and FO 
replacement should be done in the basis of supporting good growth without compromising 
the health and welfare of farmed fish. Currently, dietary FM inclusion percentage in Atlantic 
salmon feeds ranges from 15% to 55% while FO level spans from 3% to 40% and these 
variations depend on the country diets are manufactured, partially reflecting differences in 
the production systems employed and differences among the farmed salmon breeds applied 
commercially in these countries (DeSilva et al., 2012).  
SPC based diets supplemented with lysine, methionine and threonine (the main IAA 
found below requirement levels for salmon in SPC) are very promising since they can 
support good growth in both juvenile and adult Atlantic salmon stages, in the absence of 
enteritis while also promoting several local immune responses in the GIT, thus increasing 
the resistance of salmon to Aeromonas salmonicida (causative agent of furunculosis). 
Despite the benefits of using SPC, the high levels of phytate (the main source of P in 
soybean) found in this product could limit the uptake of P from the diets since this substance 
cannot be digested by salmon digestive enzymes (due to the lack of phytase), influencing 
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also the absorbance of several other elements. Furthermore, phytate was found to form non-
digestible complexes with several positively charged dietary ions, rendering them 
unavailable for absorption in the gut of monogastric animals such as fish, resulting in 
elemental deficiencies. These, could potentially result in bone deformities or clinical 
conditions which could increase the susceptibility of farmed Atlantic salmon to 
environmental stressors. Moreover, modern salmon farming is also characterised by the use 
of several procedures aiming  the increase of its productivity, including  vaccination of the 
fish in order to improve their survival and  resistance against commercially important 
diseases such as furunculosis (Austin, 1997; Poppe and Koppang, 2014) and the use of 
continuous light to prevent salmon smoltification and  maturation (Taranger et al., 1991; 
Sigholt et al., 1995; Duncan and Bromage, 1998; Duncan et al., 1998; Taranger et al., 1998; 
Bromage et al., 2001; Handeland et al., 2001), directing salmon energy on growth. In the 
second case, improved growth performance of Atlantic salmon has been reported. However, 
the application of different production techniques (such as the use of elevated water 
temperatures) targeting the improvement of salmon growth performance and vaccination  
have been  linked with the increased prevalence of bone deformities in Atlantic salmon post-
smolts (Ytteborg et al., 2009; Grini et al., 2011). Often, the presence of bone deformities in 
Atlantic salmon post-smolts, coincides with elemental deficiencies in earlier juvenile stages 
(Grini et al., 2011).  
For all the aforementioned reasons, the primary objective of the present thesis was to 
assess the effects of increasing dietary SPC, lysine, methionine and threonine levels and the 
constant (1st experimental study, Chapter 3 and 4) or increasing (2nd experimental study, 
Chapter 5 and 6) supplementation of P (above recommended Atlantic salmon requirements 
according to NRC, 1993) in juvenile Atlantic salmon diets, on growth and the overall health 
status and welfare of vaccinated individuals exposed to different light regimes in the two 
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experimental studies. In the present thesis, juvenile Atlantic salmon from different 
developmental stages fed on increasing levels of dietary protein from SPC for extended 
periods (62 days in the first study and 92 days in the second study), were assessed for a wide 
range of immunological responses prior to and after vaccination, using traditional 
immunological techniques (immunity before and after vaccination was assessed in both the 
first and second experimental studies). In the second study a second group of non-vaccinated 
Atlantic salmon was used as a control for the vaccinated dietary groups of salmon, while 
both vaccinated and PBS-injected fish were then challenged against A.salmonicida at the 
end of the study and 62 days post vaccination/ PBS injection for the evaluation of their 
overall resistance against furunculosis. Nevertheless, in both experimental studies growth 
performance and elemental concentrations in body cross-sections (in the 1st experiment) and 
whole vertebral tissues (in the 2nd experiment) were used for the assessment of normal 
growth performance and elemental deficiencies which could potentially result in 
pathological conditions (bone deformities and other pathologies increasing their 
susceptibility to environmental stressors). An additional aim of the present thesis was to 
assess the effects of FM-, FO- and marine-free diets on growth, carcass proximate 
composition and the immunological responses of Atlantic salmon post-smolts on-grown 
under a continuous light regime during the full period of the study. 
From the two experimental trials using diets with increasing SPC levels, we were able 
to detect increasing amounts of phytate in diets with higher SPC inclusions. As mentioned 
phytate could be a major limiting factor in such diets and as such, it should be monitored in 
a regular basis as it could promote several issues in the production of farmed fish. Therefore, 
the increasing levels of dietary phytate could have reduced the nutrient digestibility and thus 
the growth performance of Atlantic salmon fed on increasing dietary SPC levels (Kumar et 
al., 2012). In addition, it was shown that salmon pre-smolts receiving higher dietary SPC 
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levels exhibited better growth performance compared to early stage parr.  In line with this, 
Burr et al. (2012) demonstrated that the growth performance of Atlantic salmon parr fed 
diets in which protein was supplied from alternative protein blends improved with the age 
of the fish, with late stage parr showing improved growth. Moreover,  Denstadli et al. (2006) 
reported that  large Atlantic salmon parr can adapt more easily to diets with increased phytate 
levels due to a more developed gastrointestinal tract, making a more efficient use of the 
dietary nutrients. Due to experimental limitations the calculation of actual FI and thus FCR 
was not possible in both of these trials. Therefore we were not able to prove if the actual 
reason for the observed growth reduction was a decrease in FI or the increasing amounts of 
phytate. However, it should be stressed that several studies have reported  reduced FI and 
thus compromised growth in a wide variety of fish species receiving increased dietary SPC 
with or without AA supplementation (Kissil et al., 2000; Arãgao et al., 2003; Deng et al., 
2006). Mambrini et al. (1999) on the other hand reported reduced FI in rainbow trout, only 
when fish fed diets with 75 and 100% of dietary protein from SPC with or without 
supplementation of the diets with methionine, resulting in inadequate growth of the fish. 
From the existing literature, the best approach for the evaluation of the mineral status 
in fish is generally the use of full body samples (Shearer, 1994). The first trial of the present 
thesis, was primarily designed to focus on the effects of the diets on the immunity of the fish. 
Therefore, various samples were obtained for immunological evaluation (head kidney and 
plasma for the performance of immunoassays) while gill, intestine, liver and spleen samples 
were also collected for immune gene expression. In an attempt to make a more efficient use 
of the sampled fish and to reduce the pressure at sample collection, body cross-sections were 
preferred over whole body samples for the assessment of proximate and elemental 
composition in salmon. Due to the novelty of this technique and the fact that whole body 
samples were not taken at anyone of the chosen timepoints, data taken for body cross-
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sections were compared with literature data on full body samples, which does not consist an 
orthodox and direct comparison of datasets. Albeit, important conclusions could be drawn 
from the study, on the potential use of body cross-sections for elemental assessments which 
could apply even for bigger size salmon, the processing of which consists a challenge in 
order to perform mineral analyses. Furthermore, we were still able to elucidate changes in 
several key elements upon feeding juvenile salmon with increasing amounts of dietary 
protein from SPC. These were related with reduced amounts of ash and several elements 
such as P, Ca, Zn, Mg, Mn as well as reduced Ca: P ratios in Atlantic salmon juveniles 
maintained on diets with increased dietary levels of SPC and constant supplementation of P 
at 30 g × kg-1of feed, under continuous light. Phosphorus and calcium concentrations 
presented significant reductions throughout the full study period (prior and post vaccination) 
in most of the dietary groups receiving higher than 35% of dietary protein from SPC 
compared to SPC35 salmon (SPC65 and SPC80 for both timepoints and SPC50 only for the 
first timepoint). Zinc demonstrated significant reductions only in the SPC65 and SPC80 
groups of fish compared to SPC35 salmon at both timepoints, whereas Mg and Mn 
demonstrated reductions only during the first part of the study, prior to the vaccination of 
the fish. At this point SPC65 and SPC80 salmon exhibited significant Mn reductions 
compared to the SPC35 group, while all groups fed on diets with higher than 35% of dietary 
protein from SPC, presented significantly lower Mg levels in contrast to SPC35 salmon. In 
general, improved body cross-section elemental amounts were revealed in salmon fed 
increasing dietary SPC levels at 32dpv compared to the SPC35 group. It is suggested that 
this could be an effect of the long term provision of salmon with high SPC diets or an 
interaction of this with fish vaccination (Storebakken et al., 1998b; Storebakken et al., 2000; 
Grini et al., 2011). Both of these processes have been shown to delay salmon growth having 
a beneficial effect in bone mineral deposition. Overall, lower elemental amounts were 
Chapter 8. General Discussion, Conclusions and Future Perspectives 
 
 
254 | P a g e  
 
detected for all dietary groups at the end of the study. The most prominent reason for that 
seems to be the exposure of salmon to constant lighting which could have promoted salmon 
growth, reducing the time for the developing bone matrix to mineralise adequately. More 
experiments are required to further strengthen the abeove hypothesis. Notably Ca, P and Zn 
levels at the end of the study were much lower from already reported whole body levels of 
these elements in juvenile salmon and could possibly be an indication of subclinical 
elemental deficiencies which could potentially trigger salmon welfare issues including bone 
deformities and increased susceptibility to diseases. It was also suggested that increased 
dietary inclusion of SPC in salmon diets should be combined with increased supplementation 
of P (since most of the P in SPC is in the form of phytate and is largely unavailable) and this 
seems to lie between 30 and 40 g × kg-1 for salmon diets with higher than 50%   and up to 
80% of dietary protein from SPC containing about 15-16 g × kg-1 phytate. The adequate 
provision of P in salmon diets could promote the dietary uptake of minerals such as Ca and 
Zn which are integral for healthy bones and thus robust fish (Lall and McCrea, 2007).  
Measured haematological parameters of naive salmon juveniles were adversely 
affected by increased dietary SPC levels, in the first study. Significant reductions in 
haematocrit, leucocyte and lymphocyte counts were demonstrated in SPC65 and SPC80 
salmon compared to the SPC35 group. While haematocrit values demonstrated significant 
reductions in salmon receiving higher than 35% of dietary protein from SPC throughout the 
full study period, both leucocyte and  lymphocyte levels presented a substantial increase in 
these fish at 34 dpv, eliminating the differences observed at the two first timepoints, between 
the dietary groups and possibly revealing an increased capacity for cellular immune 
modulation. Moreover, increased thrombocyte levels were observed for the SPC50 and 
SPC65 groups of salmon. These were significantly higher at 34 dpv compared to the SPC35 
group and were well correlated with the changes observed in complement activity at this 
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timepoint. Complement and blood coagulation systems are closely linked via the use of the 
same enzymes (Amara et al., 2008). It is believed that the two pathways could have been 
influenced by changes and differences in ion absorption, osmo- and ion regulation between 
the four dietary groups, especially for Ca and Mg which are cofactors for many enzymes 
involved in both pathways.  In addition, to the increased complement activity, groups with 
intermediate levels of SPC inclusion demonstrated increased lysozyme activity and 
circulating amounts of total IgM in their plasma which shows that these diets can stimulate 
a range of  integral innate immunological responses, potentially influencing beneficially the 
health status of  juvenile salmon. The reason for that seems to be the presence of specific 
immunogenic compounds in SPC, which at these levels of FM substitution do exert an 
immunostimulatory effect in treated salmon (Krogdahl et al., 2000). On the contrary, higher 
supplementation of FM with SPC seems to result in nutritional limitations which have to be 
addressed before implementing higher levels of SPC. Moreover, differences in the 
availability of P in the four dietary groups of salmon could have been an alternative cause 
for the observed changes in the aforementioned humoral immune responses. It is suggested 
that diets with intermediate levels of SPC had a more optimum  level of available dietary P 
in comparison to the low and high SPC inclusion groups Therefore,  lower (< 30 g × kg-1)  
and  higher (> 30 g × kg-1) P supplementation  is proposed for the SPC35 and SPC80 
treatment respectively. 
Having the first experiment as a driver, in the second trial  increasing dietary SPC 
levels were combined with increasing P supplementation from 20 g × kg-1 to 40 g × kg-1 
moving from SPC35 to SPC80 (20 g × kg-1 for  SPC35, 30 g × kg-1 for SPC58 and 40 g × 
kg-1 for SPC80 diet). In the second trial, early stage salmon parr were used and fish were 
exposed to a more conventional lighting regime of 12h L: 12h D. Salmon after an initial 
feeding period of three months, were vaccinated against furunculosis or PBS-injected with 
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the feeding trial extending for an additional period of 2 months. A linear decrease in bone 
minerals was revealed for the initial 3-month feeding period, moving from SPC35 to SPC80 
salmon. Significant differences in P, Ca, Mg and Zn were demonstrated between SPC80 and 
SPC35 salmon for this period while significantly lower bone concentrations of Mg and Zn 
were demonstrated for the SPC58 group in comparison to SPC35 salmon. However, the 
observed skeletal elemental reduction was reversed by the end of the feeding trial in both 
vaccinated and PBS-injected groups of salmon with the SPC80 group exhibiting higher 
levels for the majority of the analysed bone elements in contrast to SPC35 salmon. In 
addition, it was shown that vertebral mineralisation in vaccinated salmon was higher than in 
unvaccinated fish. Combining the observations from both vaccination studies it could be said 
that the interaction of dietary SPC and fish vaccination does not negatively affect bone 
mineralisation. However, commonly applied culture techniques having direct (feeding 
regimes, thermoperiod) or indirect (photoperiod) effects on salmon growth (Jørgensen and 
Jobling, 1992; Stefansson et al., 2008; Grini et al., 2011), should be taken into account when 
monitoring the concentrations of elements in salmon bones. In this case a lighting regime of 
12h L:12h D, resulted in improved bone elemental concentrations compared to the 
continuous lighting regime of the first study, which was shown to demote body cross-section 
elemental levels. 
In the second study, it was shown that replacement of 80% of dietary protein with SPC 
combined with an increased addition of lysine, methionine, threonine and P did not 
compromise the overall immune capacity of salmon and their resistance against A. 
salmonicida.  Nonetheless, differential regulation of the different complement pathways was 
exhibited among the three dietary groups of salmon. More specifically, the second 
experimental study demonstrated that the AC activity in early salmon parr was adversely 
affected by the long term feeding of the fish with medium or high SPC inclusion feeds solely 
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or in combination with vaccination which was applied to assess their capacity for 
immunostimulation.  Furthermore, it was shown that upon vaccination CC activity increased 
in salmon parr receiving increased dietary levels of SPC, whereas for SPC35 salmon CC 
activity was found to be reduced, while no differences were detected in TC activity among 
the dietary treatments. The latter indicates that the overall complement activity (the sum AC, 
CC and lectin activity) remained constant, and this was achieved by maintaining a balance 
between the different pathways of complement system, which seems to operate on the 
crossroads of both innate and specific immunity. The combined findings from both studies 
investigating the effects of increasing SPC levels on immunity, show that complement and 
its components is a target system for the immunological evaluation of salmon or other fish 
receiving diets with increased inclusion of SPC and other soy protein aqua-feed products, 
since it was found to be modulated in both studies (Jalili et al., 2013). 
The last objective of the present thesis was to assess the effects of FM-, FO- and 
fishery- free diets on the growth performance and innate immune responses of salmon post-
smolts. In the corresponding study, MBE (EWOS commercial dietary formulation for EU 
countries) salmon demonstrated the highest FI and WG in contrast to the other dietary groups 
for the first and the full period of the study. These results were however, largely influenced 
by differences in the size of the fish assigned to the diets and the greater size of salmon 
assigned to the MBE diet, revealing an important fault in the experimental plan.  A more 
even distribution of the fish in the tanks by the end of the acclimation period in order to 
eliminate size differences between the tanks at the start of the study, would have been a 
major refinement for the experimental design, allowing for better assessment of the feed 
efficiency and the growth performance of the different groups. This fact also highlights the 
difficulties encountered when conducting large scale scientific studies like the present one. 
The reduction in FI and growth in salmon fed FM- and FO-free diets is in line with many 
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other previous studies showing that complete substitution of FM or FO can negatively affect 
the acceptability of such feeds by the fish, their FI and eventually their growth (Espe et al., 
2006; Kousoulaki et al., 2012; Liland et al., 2012). Overall, the treatment demonstrating the 
best performance during the first period of the study was the VO diet, since lower FCR was 
exhibited for VO salmon compared to the MBE and VP groups, in conjunction with higher 
growth rates (SGR, TGC) compared to the other four experimental groups excluding MBE 
fish. In agreement with these results, unaffected FCRs were previously reported in rainbow 
trout fed diets with complete replacement of FM compared to fish fed a FM based diet, while 
no changes in FCR were also recorded for Atlantic salmon post-smolts fed diets with low 
marine ingredients compared to a fully marine based dietary group. Diets with complete 
substitution of both fishery-based feedstuffs together with the MBABP (EWOS commercial 
diet for non EU countries) feed exhibited similar FCR to the VO group and significantly 
lower values than MB and VP salmon, also pointing at better efficiency in dietary nutrient 
utilisation in contrast to the latter groups. Lower FCRs were also demonstrated, during the 
second period of the study, for the majority of the experimental dietary groups of salmon in 
contrast to the MBE group, revealing better nutrient utilisation. At this timepoint, lower 
FCRs were combined with improved FI and growth performance indices (TGC and SGR). 
Both TGC and SGR values for all diets with low levels of marine derived ingredients, 
including the MBABP group were found to be higher than in MB salmon, with VP and 
VP/VO salmon presenting the highest SGR and TGC values. The results are in agreement 
with previous studies demonstrating increased FI and compensatory growth after periods of 
restricted FI due to dietary modifications, in Atlantic salmon post-smolts (Torstensen et al., 
2008). It is thus shown in one more trial that Atlantic salmon requires longer adaptation 
periods to diets with low levels of marine feedstuffs or complete absence of them.  
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Moreover, at the end of the study VP salmon demonstrated the highest condition factor 
while VO salmon, the lowest. The latter seems to be an indication of higher fat accumulation 
in the viscero-hepatic tissues of VP salmon, however, neither data of the hepato- or 
viscerosomatic indices were taken, nor analyses on the lipid composition of the 
aforementioned tissues was performed revealing an additional flaw in the experimental 
design. Torstensen et al. (2008) reported lower K values for Atlantic salmon post smolts fed 
diets with high levels of VPs and moderate to high levels of VOs in comparison to salmon 
fed a full marine based diet and a diet with intermediate levels of VPs for a year. Further 
analysis of the whole body lipid storage pattern, revealed increased levels of whole body and 
visceral fat deposition in salmon fed high VP and VO diets (Torstensen et al., 2011). 
Proximate analyses on salmon carcasses demonstrated no differences in moisture, lipid, 
protein or ash concentrations. As mentioned before similar analysis on the viscero-hepatic 
tissues or the whole bodies could have been much more informative regarding the 
assessment of salmon adiposity in the different dietary groups of fish. In fact several studies, 
reported increased visceral and hepatic adiposity in Atlantic salmon fed on diets with plant 
derived products (Ruyter et al., 2006; Jordal et al., 2007; Torstensen et al., 2011) 
Overall, in the present study it is demonstrated that complete replacement of FM or 
FO and simultaneous substitution of both FM and FO are possible in salmon diets, without 
undermining the growth performance of the fish, in comparison to currently applied 
commercial feed formulations. The promotion of adequate growth rates in Atlantic salmon 
with the provision of marine-free diets is an important novel finding, revealing that salmon 
diets can be potentially, completely free from FM and FO, two of the integral feedstuffs, 
supporting the growth of the industry for the past 40 years. Nonetheless, still the commercial 
application of such diets is far from being possible since many of the feed ingredients applied 
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in the marine free diets are characterised by high production costs which make their current 
use unaffordable. 
In the last study, the majority of measured haematological and immune responses did 
not exhibit significant differences among the dietary groups of salmon, revealing adequate 
stimulation of salmon innate immune responses. Haematocrit was the only one of the 
measured haematological responses exhibiting changes among the dietary groups of salmon.  
Briefly, it was shown that diets with complete replacement of FM with both VPs or VPs and 
ABPs,  resulted in higher haematocrit values, while total substitution of both FM and FO  
influenced even  higher haematocrit levels which contradicts previous studies reporting 
unaffected or reduced haematocrits in salmonids receiving diets with high levels of ABPs or 
VPs or a combination of ABPs and VOs (Higgs et al., 1979; Steffens et al., 1994; Hemre et 
al., 1995; Hemre et al., 2005; Twibell et al., 2012). The observed differences between the 
dietary groups seem to have a multifactorial cause and could be quite complex to explain. 
Most importantly, haematocrit values were found within normal reported ranges for the 
specie (Waagbø et al., 1988; Hardie et al, 1990; Waagbø et al., 1994; Thompson et al., 1996) 
indicating normal levels of blood oxygen carrying capacity and the general condition of the 
different salmon groups since there was lack of anaemia which could be related to iron or 
other mineral deficiencies. Of the immune responses demonstrating changes was lysozyme 
activity, which was found to be higher for the MB group by the end of the study in 
comparison to all other salmon which exhibited similar levels of this immune parameter. 
The use of lysozyme activity as an indicator of improved immune response and thus survival 
however, has been argued in several studies which have demonstrated that increased 
lysozyme activity upon challenge with several bacterial diseases including furunculosis, 
vibriosis and BKD, was inversely correlated with survival (review by Saurabh and Sahoo, 
2008). For this reason it was proposed that lysozyme activity is not a good indicator for 
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improved immunomodulation, but a reflection of stress induction (Fevolden et al., 2004). In 
this case, the assessment of plasma cortisol, glucose and lactate levels could have been ideal 
for the assessment of the stress status of salmon from different groups, especially since a 
significant reduction in the overall performance of MBE fish was witnessed during the 
second part of the study, which could point at increased stress levels during this period. It is 
suggested that changes in the nutritional profile of the second lot of feeds and suboptimal 
nutrient requirements could have acted as stress promoters in MBE salmon. Moreover, it 
was shown that diets with total substitution of FM by VPs (VP and VP/VO diets) or high 
levels of VPs (MFABP), promoted plasma antiprotease activity which could be a favourable 
trait especially against bacterial diseases (Ellis , 1990, 1991). Similar results regarding the 
enhancement of antiprotease activity in fish fed diets with complete replacement of FM with 
VPs have never been reported before in the literature, simply because most FM and FO 
replacement studies are mainly focused on the growth rather the immunological performance 
of fish. Nonetheless, various plant extracts are known to contain bioactive compounds, 
which can enhance anti-protease activity in fish (Rao and Chakrabarti, 2004; Kaleeswaran 
et al., 2011). 
8.2 FUTURE PERSPECTIVES 
In general it is accepted that performing experimental disease challenges is the best way for 
the evaluation of the overall health status of an animal. Therefore, experimental infection 
against various industrially important diseases, with mortality or morbidity, as the end point 
would have been ideal for the assessment of FM-, FO-, fishery-free diets or feeds with 
increasing levels of SPC. Unfortunately, the lack of disease challenge facilities at EWOS, 
where two out of the three experimental trials took place, did not allow this to be undertaken. 
Instead, vaccination as a mode of immunostimulation was used in both studies using diets 
with increasing SPC inclusion to test the immunological status of the dietary fish. However, 
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it is likely that the vaccination of the fish is not enough to illustrate the differences among 
dietary treatments, since fish are not under the same levels of stress as when they are infected 
and which could alter the magnitude of the observed responses. Another useful method for 
the immunological evaluation of the above diets would be the performance of stress 
challenges (applying one or more stressors which are commonly experienced by the fish 
under open sea culture conditions) with post-exposure stress mapping. One of the main 
objectives of this thesis was to assess the resistance of Atlantic salmon fed increasing levels 
of dietary SPC, against A. salmonicida. Despite the results showing no effects of increasing 
dietary SPC inclusion on salmon immune responses or resistance against furunculosis, the 
study is not representative to how salmon would respond when infected against different 
diseases involving other bacteria, parasites or viruses. Nonetheless, the study could be 
roughly appointed as a bacterial model. 
Regarding the effects of increasing dietary SPC on salmon bone health the current 
thesis has generated some additional information regarding the skeletal mineralisation of 
salmon parr fed on diets with constant or increasing supplementation of inorganic 
phosphates before and after vaccination, under different photoperiodic regimes. This thesis 
clearly presents the necessity for supplementing diets with high levels of SPC with elements 
such as P and Zn. Elemental supplementation of high SPC inclusion diets for Atlantic salmon 
parr reared in inland facilities were emissions can be controlled (through the application of 
recirculation systems or the use of special filters) is possible and could potentially be 
beneficial for both salmon’s health and normal vertebral development (Fjelldal et al., 2010). 
The use of high SPC inclusion diets supplemented on high levels of P for Atlantic salmon 
growers reared in sea cages or pens could increase the levels of P emissions in the open sea, 
giving rise to environmental concerns. Therefore, environmentally friendlier solutions are 
required rather than increasing the levels of inorganic P in high SPC inclusion diets for the 
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on-growing of Atlantic salmon smolts and post-smolts, including the use of microbial 
enzymes such as phytases and/or carbohydrases or fermentation. However, further 
processing of the SPC could dramatically increase the cost of the SPC-based aquafeeds, 
while the use of such enzymes cannot currently guarantee the elimination of polysaccharides 
and phytates, as these enzymes have a requirement for certain temperatures and pH to 
demonstrate activity on their substrates (as discussed previously in Section 1.4.4). 
Fermentation of primary soy products, such as soy flour or SBM (Teng et al., 2012), could 
potentially be a more cost efficient solution to these problems, while experiments using 
fermented products in piglet, broiler and fish diets demonstrated similar or improved growth 
and enhanced immune responses in animals fed these diets when compared with groups fed 
commercial diets (Shimeno et al., 1993; Wang et al., 2011; Zhou et al., 2011; Azarm and 
Lee, 2014).  
Nevertheless, further testing of high SPC inclusion in diets for Atlantic salmon is 
recommended, over the course of their production cycle. For these experiments, mineral 
analyses from sampled fish at different points of the production cycle should be combined 
with full radiographs to reveal any effects of increasing dietary SPC inclusion on the 
prevalence of deformities and how these are related with bone mineralisation.  Nonetheless, 
the present study shows that the use of certain commonly apllied salmon production 
strategies including photoperiodic regimes and vaccination can influence the mineralisation 
status of salmon parr, with the latter having a positive effect on body mineralisation at least 
when planned and/or applied properly. 
While the extent to which dietary SPC, VP and VO inclusion can be used without 
affecting the growth of Atlantic salmon at various life stages is well investigated and largely 
known; the use of fishery-free diets on salmon growth is unexplored and the current thesis 
includes one of the first studies regarding this. However, the extent to which all of the above 
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diets affect Atlantic salmon health and the welfare is largely unknown and should be further 
investigated. The successful application of low marine or marine free diets for salmon in the 
future seems to be possible. Meanwhile, the main salmon feed producers rely on the dietary 
nutritional recommendations provided by the National Research Council (NRC, 1993). 
Nevertheless, many studies have repeatedly addressed the necessity to update salmon’s 
nutritional requirements according to their growth rate and life stage (Espe et al. 2006, 2007; 
Torstensen et al. 2008), since most of these recommendations are based on the performance 
of juvenile freshwater salmon parr. Low marine ingredient diets can result in poor uptake of 
essential nutrients (including essential amino and fatty acids and minerals) when diets are 
high in alternative protein and lipid sources and mainly plant derived proteins (which have 
lower levels of certain indispensable amino acids, minerals and lacking of EPA and DHA 
compared to FM). Further research is required to fill the knowledge gaps regarding Atlantic 
salmon’s amino acid and mineral requirements, especially for smolt and post-smolt stages. 
Once this is achieved, the necessary information relating to dietary formulation should be 
comprehensive enough to satisfy all the nutritional requirements for Atlantic salmon, and 
their manufacture by feed companies should be methodised to ensure a standardised quality 
for these diets. Ultimately, the future utilisation of low marine ingredient diets in salmon 
feeds will depend on the price of the available raw materials. 
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